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SUMMARY 
 
Impaired cerebral autoregulation following traumatic brain injury (TBI) in adults has been linked to worse global 
outcome.  Continuously updating indices of cerebrovascular reactivity provide a convenient and continuous metric 
regarding an individual patients’ autoregulatory status. To date, the vast majority of the literature has focused on 
pressure reactivity index (PRx), which has emerged as the “gold standard” for continuous monitoring of 
cerebrovascular reactivity in adult TBI, but many questions concerning its clinical utility remain unanswered. The 
focus of this thesis was to address some of these previously unanswered questions, using data from experimental 
models and from multi-modality monitoring (MMM) in adult TBI patients. 
Specific questions addressed in this thesis include: [A] Do other ICP-derived indices to assess cerebrovascular 
reactivity exist? [B] Do ICP-derived indices actually measure autoregulation? [C] What are the inter-index 
relationships between various MMM techniques? [D] Can one estimate/predict the “gold standard” invasive PRx 
using non-invasive means? [E] What are the critical thresholds associated with outcome for ICP derived indices? [F] 
Are any specific ICP derived index/indices superior for outcome prediction? and [G] What role do intra-cranial (IC) 
and extra-cranial (EC) injury burden play in driving autoregulatory function in TBI?   
These studies evaluated a newly described index derived from pulse amplitude of ICP and cerebral perfusion 
pressure (CPP), RAC, which provides information regarding both cerebrovascular reactivity and compensatory 
reserve.  Using experimental models of arterial hypotension and IC hypertension, it was demonstrated that the 
three ICP derived indices (including RAC) of cerebrovascular reactivity measure the lower limit of autoregulation 
(LLA), providing some of the first evidence to validate these indices as measures of autoregulation.  It still remains 
unclear as to whether these indices can measure the upper limit of autoregulation (ULA). 
Indices derived from MMM display reproducible inter-index relationships between various populations of adult TBI 
patients.  Transcranial Doppler (TCD) based systolic flow index is most closely associated with ICP indices, while 
cortical autoregulation (measured using laser Doppler) is more closely linked to mean flow index. Given these 
relationships and the potential for non-invasive measurement of systolic flow index, attempts at modelling the 
“gold standard” PRx were made. From this, it is possible to both estimate and predict PRx using non-invasive 
systolic flow index, employing complex time-series techniques. 
Outcome analysis showed that RAC provides superior outcome prediction, with more stable critical thresholds, 
compared to all other ICP derived indices. Furthermore, IC injury markers (subarachnoid hemorrhage thickness, 
diffuse axonal injury, and presence of subdural hematoma) were associated with impaired cerebral autoregulation 
as measured by ICP derived indices, implicating diffuse cerebral injury as a driver of impaired reactivity.  The data 
also suggest that EC injury burden may play a role in impairment of cerebrovascular reactivity.  
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CHAPTER 1: INTRODUCTION 
 
Cerebral autoregulation (CA) is defined as the innate ability of the cerebrovascular system to maintain 
relatively constant cerebral blood flow (CBF) despite changes in systemic mean arterial pressure (MAP) 
or cerebral perfusion pressure (CPP).1  Our current understanding of normal CA capacity stems from the 
work of Fog2 and Lassen,1 who identified that autoregulation was preserved in normal humans between 
approximately 50 mm Hg (referred to as the lower limit of autoregulation - LLA) and 150 mm Hg 
(referred to as the upper limit of autoregulation - ULA) of MAP.  Systemic MAP, or CPP, below the LLA 
may lead to impaired CBF, hypoperfusion, metabolic failure, cytotoxic edema and potentially ischemia or 
infarction, while CPP or MAP above the ULA could result in hyperaemia, vasogenic oedema and 
haemorrhage.1,3,4 
It is well understood that various neuropathologic states impact CA capacity, potentially leading to 
deleterious outcomes.3,5–7  Traumatic brain injury (TBI) is one pathologic state in which CA capacity has 
been thoroughly studied and linked to morbidity and mortality in the adult population.3,4,8,9  Various 
methods have been designed to measure CA in adult TBI, including both intermittent and continuous 
techniques,4,10 and patients displaying “impaired” autoregulatory capacity have been shown to be at 
higher risk of secondary neurological insult and increased morbidity/mortality.   
The most commonly employed methods of CA monitoring in TBI within the neuro-intensive care unit 
(NICU) involve continuously updating indices of autoregulation, which have received support through 
international consensus statements and recently published multi-modal monitoring guidelines in TBI.11,12 
These indices are derived on the premise that the correlation between slow-wave fluctuations in 
surrogate measures of pulsatile cerebral arterial blood volume (CBV), such as intracranial pressure (ICP), 
and slow-wave fluctuations in a driving pressure for CBF, such as MAP or CPP, providing insight into the 
autoregulatory function in any given patient.3,13  Based on this concept, various indices of CA have been 
developed based on signals derived from multi-modal monitoring (MMM) devices.4,10  
However, despite many options for continuous monitoring of autoregulatory capacity in adult TBI, and 
literature supporting an association with patient global outcome, there are some important questions 
which remain unanswered:   
1. Are there any relationships between commonly measured physiologic variables which may 
better approximate autoregulation/cerebrovascular reactivity in TBI patients? 
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2. Do these indices actually measure cerebral autoregulation? 
3. What are the inter-index relationships between these continuous CA indices derived from 
various multi-modal monitoring metrics? Are all indices the same or related to one another? 
4. Can one estimate indices of cerebrovascular reactivity using non-invasive surrogates, which 
correlate with more classical measures derived from invasive measures? 
5. How well do ICP derived indices predict outcome in adult TBI?  Is one superior? Are there 
critical thresholds? 
6. Does injury burden drive impaired cerebrovascular reactivity in adult TBI? 
Having answers to these questions is of great importance to:  the validity in clinical monitoring of CA in 
TBI, detection of failed CA and prediction of CA impairment.  Answers to these questions would also 
provide a validated and robust platform for future investigation of biologic drivers of impaired reactivity, 
understanding the long-term tissue consequences to impaired CA post-TBI, and potentially leading to 
therapeutic targets for the avoidance/treatment of CA dysfunction.  Thus, the goal of this dissertation is 
to shed light on these above defined questions. 
 
1.1 Aims and Hypothesis 
 
1.1.1 Defining a New Continuous Index 
 
Current continuous monitoring of cerebrovascular reactivity/autoregulation in adult TBI focus mainly on 
the use of the pressure reactivity index (PRx).4,11,12  This index is the defined as the moving Pearson 
correlation coefficient between slow-wave fluctuations in ICP and MAP.  PRx has emerged as the “gold 
standard” for continuous monitoring of vascular reactivity, with strong links to 6-month outcome and 
defined critical thresholds in adult TBI.3,9  Furthermore, this index has been validated as a measure of the 
LLA in an experimental model of arterial hypotension.14  Despite this, there exists a potential for other 
continuous indices to be derived from ICP and MAP monitoring.15 The first step within this thesis was to 
explore a new index of cerebrovascular reactivity in adult TBI, RAC: the correlation between pulse 
amplitude of ICP (AMP) and CPP. RAC stands for:  R = Pearson correlation coefficient, A = pulse 
amplitude of ICP, C = cerebral perfusion pressure.   
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Hypothesis I: The moving correlation coefficient between slow-wave fluctuations in AMP and CPP, 
defined as RAC, will provide information regarding cerebrovascular reactivity, and may be used in 
place of existing ICP based reactivity indices in adult TBI patients. 
 
1.1.2 Experimental Validation of ICP Derived Indices 
 
Within the current literature on continuous indices of cerebrovascular reactivity measurement, very few 
indices have been validated experimentally to measure autoregulation.14  The baseline assumption 
surrounding all MMM based continuous indices of vascular reactivity is based on the concept that the 
relationship between slow-wave fluctuations in a driving pressure (ie. MAP or CPP) and a surrogate 
measure of pulsatile CBV or CBF, is a measure of autoregulation.13  Unfortunately, only three indices to 
date have been validated experimentally to measure the LLA. These include PRx and two near infrared 
spectroscopy (NIRS) derived indices.14  Furthermore, validation against the ULA has not been clearly 
demonstrated within the literature.  Finally, the current validation studies focused on a model of arterial 
hypotension for assessing the LLA, with no literature to support that the assessed indices (ie. PRx) 
measure the LLA during intra-cranial (IC) hypertension.  This is an important aspect in TBI, given many 
patients suffer from ICP control issues during their acute phase of care.  Such preliminary validation with 
respect to the LLA would require:  A. demonstration of cerebrovascular reactivity indices to trend 
towards progressively more positive values at CPP levels below the LLA, and B. statistically significant 
logistic regression analysis for each cerebrovascular reactivity index in the prediction of having CPP 
values above or below the cohort defined LLA; similar to the previous existing experimental work.14  
Simiarly, preliminary validation work into the ULA would require:  A. demonstration of cerebrovascular 
reactivity indices to trend towards progressively more positive values at CPP levels above the ULA, and 
B. logistic regression analysis confirming statistically significant ability of cerebrovascular reactivity 
indices to predict CPP being above or below the ULA. Therefore, the second step of this thesis was to 
explore the LLA and ULA in data that were available in various pre-clinical experimental models, in order 
to provide validation for all ICP derived indices of cerebrovascular reactivity:  PRx, PAx (correlation 
between AMP and MAP), and RAC. 
 
Hypothesis II: PRx, PAx and RAC will measure the LLA in an experimental piglet model of arterial 
hypotension, displaying trends towards progressively more positive values below the LLA and logistic 
regression techniques demonstrating the ability to accurately predict CPP values about this threshold. 
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Hypothesis III: PRx, PAx and RAC will measure the LLA in an experimental rabbit model of sustained 
intracranial hypertension, displaying trends towards progressively more positive values below the LLA 
and logistic regression techniques demonstrating the ability to accurately predict CPP values about 
this threshold. 
 
Hypothesis IV: PRx, PAx and RAC will measure the ULA in an experimental piglet model of arterial 
hypertension, displaying trends towards progressively more positive values above the ULA and logistic 
regression techniques demonstrating the ability to accurately predict CPP values about this threshold. 
 
 
1.1.3 Multi-Model Index Relationships 
 
Various continuous indices of cerebrovascular reactivity exist in adult TBI.4  These measures are based 
on various invasive and non-invasive MMM devices commonly employed within the intensive care unit 
(ICU) in the treatment of TBI patients. Such monitoring includes: ICP,3,15 brain tissue oxygen (PbtO2),16–18 
transcranial Doppler (TCD)8 and NIRS.19,20 Numerous small studies exist providing some basic statistical 
links between individual indices.  However, one question remains:  Are all of these indices the same?  To 
date, there has not been an in-depth exploration of the inter-index relationships between multiple 
MMM devices simultaneously.  This approach could potentially shed light on which indices closely co-
vary and which may be used as a surrogate measure for the other.  The third step of this thesis involves 
exploring the inter-index relationships of MMM derived continuous indices of cerebrovascular reactivity 
across multiple adult TBI populations. 
 
Hypothesis V: Continuous indices derived from MMM are not all the same, and display specific 
covariance structure between monitoring devices used, which is reproducible across populations. 
 
1.1.4 Non-Invasive Modelling of Pressure Reactivity 
 
The literature supports a strong association between PRx and 6-month outcome in adult TBI.  Further, as 
aluded to above, PRx has emerged as the “gold standard” for continuous monitoring of cerebrovascular 
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reactivity in adult TBI.  The main limitation to PRx is that is requires invasive ICP monitoring.  Given this 
limitation, some important questions arise:  Is it possible to model PRx using non-invasive surrogates?  
Can PRx be accurately estimated non-invasively?  Can we forecast (ie. predict) PRx via non-invasive 
means?  The fourth part of this thesis attempts to answer these questions.  
 
Hypothesis VI: PRx can be accurately estimated via non-invasive TCD alternatives, systolic flow index 
(Sx_a) and mean flow index (Mx_a). 
 
Hypothesis VII: PRx can be predicted via the non-invasive TCD based alternative Sx_a. 
 
1.1.5 Critical Thresholds Associated with Outcome 
 
Thresholds associated with 6-month outcome in adult TBI have been defined for PRx9 and the TCD based 
Mx (correlation between mean flow velocity (FVm) and CPP).8  These thresholds have been defined for 
two dichotomized 6-month outcomes: A. mortality and B. favourable/unfavourable functional status (as 
per Glasgow Outcome Score (GOS)). Aside from these two indices, critical thresholds for other indices 
are unknown.  
 
Importantly, PRx isn’t the only ICP derived index, with PAx and RAC potentially providing similar (or 
superior) outcome prediction capacity.15,21 Furthermore, the previous study which defined PRx 
thresholds in adult TBI was based on grand mean PRx values from a large heterogeneous patient 
population, including those with decompressive craniectomy (DC) and those without.9  It is known that 
craniectomy in TBI impacts both ICP and PRx,22 leading to uncertainty in the assessment of 
cerebrovascular reactivity using PRx during the post-craniectomy phase of care. Thus, the current 
defined thresholds for PRx9 are difficult to apply to all TBI patients, with thresholds for non-DC patients 
(ie. the majority of critically ill TBI patients) currently unknown.  Determining which ICP index is superior 
for outcome prediction, and what the critical thresholds for these indices are in non-DC patients, would 
prove valuable for continued application of this monitoring within the ICU. The fifth part of the thesis 
addresses this. 
 
Hypothesis VIII: Outcome prediction with ICP indices are not equal, with RAC providing superior 
predictive capabilities for 6-month patient outcomes. 
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Hypothesis IX: Critical thresholds for 6-month outcome in adult TBI for ICP derived reactivity indices 
are not all the same, with some indices displaying more “stable” thresholds over time. 
 
Aside from invasive ICP derived indices for monitoring cerebrovascular reactivity, TCD provides a 
convenient and potentially completely non-invasive means of measuring CA. To date, Mx (correlation 
between TCD mean flow velocity (FVm) and CPP) and Mx_a (correlation between FVm and MAP) are the 
only TCD indices with defined critical thresholds in adult TBI.8 Given strong associations between ICP 
derived indices and those from TCD, particularly with Sx/Sx_a, determining the critical thresholds for 
other TCD indices may prove valuable for future work in the non-invasive assessment of cerebrovascular 
reactivity. This is also addressed within the fifth part of this thesis. 
 
Hypothesis X: Both Sx and Sx_a have well defined critical thresholds associated with 6-month outcome 
in adult TBI. 
 
 
1.1.6 Injury Burden as a Driver of Impaired Reactivity 
 
Finally, despite being able to monitor cerebrovascular reactivity in adult TBI with confidence, which 
would be provided through the previously mentioned aims/hypothesis of this thesis, understanding 
what drives impaired reactivity is also crucial.  Specifically, does injury pattern/burden play a role in 
developing impaired cerebrovascular reactivity?  What role does IC injury burden play?  What about 
extra-cranial (EC) injury burden?  Currently, these questions remain unanswered in the literature.  The 
sixth part of this thesis addresses and answers these questions.   
 
Hypothesis XI: Specific patterns of IC injury are associated with impaired cerebrovascular reactivity in 
TBI. 
 
Hypothesis XII: EC injury burden will be associated with cerebral vascular reactivity in polytrauma 
patients. 
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1.2 Overview of Thesis 
 
Chapter 2 provides an extensive review of the pertinent literature surrounding continuous monitoring of 
cerebrovascular reactivity in adult TBI.  This review includes both narrative and systematically conducted 
components.  The chapter will overview the concept of cerebral autoregulation and theorized 
mechanisms of control.  Subsequent sub-sections will highlight systematic reviews of the literature 
conducted as part of the review of literature for this thesis,4,10 including overviewing monitoring 
techniques for autoregulation and any existing literature documenting the association between 
autoregulation monitoring and injury burden. 
 
Chapter 3 provides an overview of general methodology for the studies conducted within the 
subsequent chapters.  This chapter covers the experimental models used, including experimental 
procedures. It also reviews the adult TBI patient populations studied and general treatment received 
while within the ICU.  General signal acquisition, processing, ethical considerations and statistics are also 
covered. 
 
Chapters 4 through 9 report the results from the studies performed in this thesis. Chapter 4 presents 
results from the description of a “new” physiologic index of cerebrovascular reactivity, RAC, in an adult 
TBI population (addressing hypothesis I).  Chapter 5 presents the results of experimental validation of 
ICP derived indices for measuring the LLA and ULA (addressing hypotheses II, III and IV).  Chapter 6 
presents the results of the assessment of inter-index relationships between MMM derived continuous 
measures of cerebrovascular reactivity, across various adult TBI populations (addressing hypothesis V).  
Chapter 7 presents the results of non-invasive modelling of PRx using TCD based surrogates (addressing 
hypotheses VI and VII).  Chapter 8 presents the results of the studies exploring of outcome prediction of 
ICP and TCD derived indices of cerebrovascular reactivity, with the assessment of critical thresholds 
(addressing hypotheses VIII, IX, and X). Finally, Chapter 9 presents the results of the analysis of injury 
burden and its association with impaired cerebrovascular reactivity in adult TBI (addressing hypotheses 
XI and XII).  
 
Chapter 10 summarizes the results of this thesis, providing an overall conclusion.  Chapter 11 overviews 
potential future directions of research regarding continuous cerebrovascular reactivity monitoring in 
adult TBI. 
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CHAPTER 2: REVIEW OF LITERATURE 
 
2.1 Cerebral Autoregulation 
 
2.1.1 Concept 
 
Cerebral autoregulation (CA) is defined as the cerebral vessel’s innate ability to regulate and maintain 
constant CBF across a wide range of MAP or CPP.1  First defined by Lassen, and outlined in his seminal 
work in 1959, CA in humans is characterized by the relationship between MAP and CBF seen in Figure 2.1.  
Lassen’s original description of this phenomenon consisted of a small heterogenous group of patients, in 
which measures of cerebral blood flow were conducted during manipulations in MAP and partial pressure 
of carbon dioxide (pCO2).1 Similar relationships between MAP and CBF were observed in Lassen’s 
observations, regardless of the physiologic manipulation undertaken.   
 
Figure 2.1:  Classical Representation of Cerebral Autoregulatory Curve in Humans  
 
CBF = cerebral blood flow, gm = gram, MAP = mean arterial pressure, min = minute, mL = milliliter, mmHg = millimetres of Mercury. 
Vertical dashed black lines represent the lower limit of autoregulation (ie. ~50 mm Hg) and the upper limit of autoregulation (ie. 
~150 mm Hg) seen within healthy subjects.  Vessel diameter changes can be seen along the top of the graph, indicating that at 
lower MAP values the vessel dilates allowing maintained CBF, while at high MAP the vessel constricts.  Beyond the lower and upper 
limits, CBF becomes pressure passive as the cerebral vessels are unable to regulate constant flow. Since its first appearance, the 
general understanding of autoregulation has been modified. First, x-axis has been scaled in cerebral perfusion pressure (CPP), 
acknowledging that not only variations in MAP may modify CBF outside limits of autoregulation, but variations of ICP may also 
contribute. Second, not only an inner diameter of flow regulating arteries changes, but outer diameter changes as well, with inner 
diameter (ie. luminal) changes leading to modulation of arterial cerebral blood volume. 
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This description, which has been validated in animal models and human studies, describes a range of 
“normal” cerebral autoregulation across MAP ranges of 50 to 150 mm Hg (ie. the “lower” and “upper” 
limits of autoregulation), allowing for a relatively constant CBF, near or around ~55 mL/100gm/min.1,3  
MAP outside of this range, exceeds the ability of cerebral vessels to regulate CBF, leading to deleterious 
consequences.  Below the LLA, MAP is low, and CBF cannot be maintained, leading to hypoperfusion, 
ischemia, and potentially infarction.  Above the ULA, the cerebral vessels are unable to regulate flow, 
leading to a hyperperfusion state.23  This quickly overwhelms the capillary bed, via elevated capillary filling 
pressures, leading to cerebral edema, impaired nutrient transport, and potentially intra-cerebral 
hemorrhage. 
The mechanism involved in cerebral autoregulation is believed to be related to variations in the cerebral 
vessel caliber in response to the driving pressure seen.23  While the caliber of vessels involved in this 
cerebral autoregulatory process is debated, pre-capillary arterioles, measuring up to a few hundred 
microns in diameter, remain the most likely candidates.24–26  The response of the cerebral vessels to 
changes in MAP are believed to occur in the frequency range of 0.005 to 0.05 Hertz (Hz), implicating “slow-
wave” responses of these vessels to alterations in MAP.13,27   
 
2.1.2 Theorized Regulatory Mechanisms 
 
The exact mechanisms involved cerebral autoregulation and the innate ability of cerebral vessels to 
regulate CBF through changes in tone and caliber are not clear.  Current theories include: myogenic, 
metabolic, neurotransmitter and endothelial based concepts.23,28 The myogenic theory focuses on the 
direct mechanical reflex of vascular smooth muscle in response to variations in cerebral perfusion 
pressure mediated via vascular stretch experienced by the cerebral vessels.  As perfusion pressure 
increases, there is an increase in stretch experienced by the tunica media, leading to a reflex 
vasoconstriction, ensuring constant CBF.  Conversely, low cerebral perfusion pressure leads to relaxation 
of the cerebral vessels consequent to decreased stretch of the tunica media.  This theory, however, fails 
to explain biochemically driven cerebrovascular responses seen in vitro. The metabolic theory states 
that byproducts of cerebral metabolism can impact or dictate cerebral vessel caliber. For example, in 
states of hypoperfusion, cerebral metabolism quickly shifts to anaerobic metabolism, generating lactate, 
amongst other metabolic products.  It is believed these products may impact vessel caliber, in an 
attempt to restore adequate CBF.  The downside to this theory is that it fails to explain the relatively 
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rapid temporal response of cerebral vessels, as it takes time to produce metabolic byproducts in 
significant concentrations such that the cerebral vasoreactivity would be impacted. The 
neurotransmitter theory implies that all cerebrovascular reactivity is driven via direct neural input to the 
smooth muscle.  This theory would account for the rapidity of cerebral vascular response, but does not 
fully explain other biochemical or endothelial responses.  Finally, the endothelial response implies that 
changes in perfusion pressure drive direct endothelial responses which regulate vessel caliber.  Such 
endothelial based mediators include nitric oxide (NO) produced by by nitric oxide synthase (NOS), 
eicosanoid release, and endothelin production.    
 
Aside from these mechanisms which apply in health, aspects of the injury response may modulate 
cerebrovascular reactivity in disease.  For example, the inflammatory response appears to play a role in 
outcome within TBI29 and SAH.30,31 The potential exists that the inflammatory response to both the 
primary and secondary injury may drive autoregulatory dysfunction.  Autonomic response via 
catecholamine action on cerebral vasculature, may directly modulate vascular tone and regulate 
autoregulatory capacity post-TBI.32 Other evidence suggests a role for abnormal cerebral 
electrophysiologic responses to injury. Spreading cortical depression (SCD) has recently emerged as 
potential player in cerebrovascular reactivity in animal models.33–36 The presence, or increased 
frequency, of such electrophysiologic patterns may also drive autoregulatory dysfunction post injury.37 
Furthermore, recent literature in humans supports an association CBF dysfunction and vascular 
reactivity dysfunction in adult TBI.38,39 Such SCD episodes have been demonstrated to occur frequently in 
moderate and severe TBI patients.38,39 In corollary, dynamic temporal links between SCD and impaired 
CBF has been demonstrated in small cohorts of adult TBI patients.38 Similarly, data suggests the 
temporal link between SCD and both excitotoxicity and metabolic crisis, as defined by elevated cerebral 
microdialysis glutamate and lactate:pyruvate ratio.40  Finally, disruption of solute/nutrient transport 
across the blood brain barrier (BBB) may play a role in the potentiation of autoregulatory dysfunction.   
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2.2  Review of Literature on Cerebrovascular Reactivity in Adult TBI 
 
In order to gain a comprehensive understanding of the available literature on:   intermittent/semi-
intermittent autoregulation measurement techniques,10 continuous methods of autoregulation 
measures in adult TBI,4 and association between injury burden and vascular reactivity, various 
systematic reviews (SR’s) were conducted.  
 
All SR’s were conducted independently for the review of literature component of this thesis, with the 
involvement of a second literature filterer only for the purpose of abiding by standard SR guidelines as 
outlined by the Cochrane Handbook of Systematic Reviews.41  For the SR’s presented in the sections to 
follow, Dr. Eric P. Thelin (Karolinska Institute) was the second reviewer. The summation of results, 
analysis and presentation were all conducted independently by the author of this thesis. 
 
The systematic reviews were conducted to outline the literature body in the following areas:   
 
A. Intermittent/semi-intermitent techniques for cerebrovascular reactivity measurement in adult TBI, 
evaluating the link between these measures and both:  other cerebral physiology measures and patient 
global outcome. The following intermittent/semi-intermitent techniques were evaluated:  computed 
tomographic perfusion (CTP)/Xenon-CT (Xe-CT), positron emission tomography (PET), magnetic 
resonance imaging (MRI), arterio-venous difference in oxygen (AVDO2) technique, thigh cuff deflation 
technique (TCDT), transient hyperemic response test (THRT), orthostatic hypotension test (OHT), mean 
flow index (Mx) and transfer function autoregulation index (TF-ARI). 
 
 B. Continuous techniques for cerebrovascular reactivity measurement in adult TBI, evaluating the link 
between these measures and both:  other cerebral physiologic measures and global patient outcome.  
The following continuous techniques were evaluated:  PRx, laser Doppler flowmetry (LDF), NIRS 
techniques, PbtO2, and thermal diffusion (TD) techniques. 
 
C. Evaluation of any link between systemic or intra-cranial injury burden and impaired cerebrovascular 
reactivity in adult TBI patients.  
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Each systematic review was conducted in a robust format, adhering to standard methodological 
processes for SR’s.  All methodological principles employed for the SR, including: search strategies, 
inclusion/exclusion criteria, article filtering processes, data curation and summary techniques can be 
found in the individual published manuscripts. The results of these SR’s conducted for this thesis, 
detailed in the subsections to follow, can be found in the various separate publications.4,10,29,31,42 
 
 
2.2.1  Methods of Measurement and Associations with Outcome  
 
 2.2.1.1 Intermittent/Semi-Intermittent Methods 
 
A systematic, scoping review of commonly described intermittent/semi-intermittent autoregulation 
measurement techniques in adult TBI was performed.  Techniques were defined as intermittent if they 
produced a single point measure of autoregulatory capacity.  Further, some TCD based techniques were 
defined as semi-intermittent, given the labor-intensive nature of TCD and limited duration of recordings 
obtainable in clinical practice, mostly due to unstable fixation of ultrasound probes. A detailed account 
of the results can be seen in the publication Zeiler et al.10 
Nine separate systematic searches were conducted for each intermittent technique: CTP/Xe-CT, PET, 
MRI, AVDO2 technique, TCDT, THRT, OHT, Mx and TF-ARI.  MEDLINE, BIOSIS, EMBASE, Global Health, 
Scopus, Cochrane Library (inception to December 2016) and reference lists of relevant articles were 
searched.     
The total number of articles utilizing each of the 9 searched techniques for intermittent/semi-
intermittent autoregulation techniques in adult TBI were:  CTP/Xe-CT (10),43–52 PET (6),53–58 MRI (0), 
AVDO2 (10),55,59–67 autoregulation index (ARI) based TCDT (9),47,68–75 THRT (6),62,76–80 OHT (3),79,81,82 Mx 
(17)3,8,54,83–96 and TF-ARI (6).94,97–101 Studies focusing on Mx were limited to those with 50 or more 
patients, assessing the association to patient outcome.  The premise behind all of the intermittent 
techniques is manipulation of systemic blood pressure/blood volume via either chemical (such as 
vasopressors) or mechanical (such as thigh cuffs or carotid compression) means. Exceptionally, Mx97 and 
TF-ARI94 are based on spontaneous fluctuations of CPP or MAP.  The method for assessing the cerebral 
circulation during these manipulations varies, with both imaging-based techniques and TCD utilized.   
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Despite the limited literature for intermittent/semi-intermittent techniques in adult TBI (apart from Mx), 
it is important to acknowledge the availability of such tests. They have provided fundamental insight into 
human autoregulatory capacity, leading to the development of continuous and more commonly applied 
techniques in the ICU.  Numerous methods of intermittent/semi-intermittent pressure autoregulation 
assessment in adult TBI exist, including: CTP/Xe-CT, PET, AVDO2 technique, TCDT based ARI, THRT, OHT, 
Mx and TF-ARI.  MRI based techniques in adult TBI are yet to be described, with the main focus of MRI 
techniques on metabolic based vascular reactivity and not pressure-based autoregulation.  A complete 
and detailed assessment of each intermittent/semi-intermittent measurement technique in adult TBI 
can be found in the Zeiler et al article.10 
Semi-intermittent measures deserve further mention, as they include TCD-derived continuously 
updating indices (such as Mx), and have been utilized in the studies conducted within this thesis.  Mx is 
derived from a moving Pearson correlation coefficient between two continuously measured signals, 
mean cerebral blood flow velocity (FVm) and CPP.97  In this context, cerebral blood flow velocity (CBFV) 
is obtained through TCD insonation of the middle cerebral artery (MCA). Given the need for continuous 
TCD monitoring to calculate this updating index, the duration of recording is typically limited to 60 
minutes or less.  Thus, this technique is referred to as a “semi-intermittent” autoregulatory 
measurement technique. 
The concept of this autoregulatory measure is that the slow wave responses in FVm to slow waves in 
CPP are believed to be governed by autoregulatory capacity. TCD ultrasound is used to capture the MCA 
velocity.  As with all the other TCD based measures the signal can be acquired either unilaterally or 
bilaterally, thus providing insight into the symmetry of cerebral autoregulation. In addition, continuous 
recording of MAP (via either invasive arterial line or continuous non-invasive techniques) and ICP are 
required for determination of CPP (based on:  CPP = MAP – ICP).  The signals are recorded and stored, 
with the option of both off-line and real-time calculation of Mx.  Both FVm and CPP are processed via a 
10-second moving average filter and sampling frequency decimated to 0.1 Hz (in other words replacing 
original FVm and CPP by times series composed of their non-overlapping 10s averages).  The correlation 
coefficient is then calculated based on 30 consecutive 10-second mean values (ie. 5 minutes), with the 
coefficient updated every 10 or 60 seconds.  This produces an Mx time series with the similar sampling 
rate as mean FVm/CPP. Variations in the correlation window length have been described, though the 
above-mentioned parameters are the most commonly cited, particularly in more recently. Similar to 
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pressure reactivity index (PRx – derived from invasive ICP and MAP), Mx in routine autoregulation 
monitoring should be averaged for a minimum period of 30 minutes to reduce its inherent variance. 
Some variations in the technique have been described.  The use of MAP instead of CPP has been 
explored (termed Mx_a) as this renders the technique potentially non-invasive.84  However, by using 
MAP and not CPP, the impact of ICP on FVm is not considered during the calculation of the correlation 
coefficient.  Literature comparing standard Mx to Mx_a has demonstrated that Mx is superior in terms 
of outcome prediction in TBI, hence Mx_a is limited to these cases when ICP is not directly monitored.84  
Similarly, instead of using FVm in the correlation, there has been investigation into utilizing either only 
systolic or diastolic flow velocities (FVs or FVd), creating two alternate indices (Sx and Dx, respectively; 
and their “non-invasive” versions Sx_a and Dx_a).84 Again, as with Mx_a, Sx/Sx_a and Dx/Dx_a have not 
been found to be grossly superior to Mx. Thus, Mx is most commonly quoted.10   
The metric generated by calculating these TCD indices ranges from -1 to +1, as it is a correlation 
coefficient.  A value that is highly positive indicates potentially “impaired” autoregulation, as it signifies a 
passive, linear relationship between CPP and FVm/FVs/FVd.  Similarly, a zero or negative index value 
indicates that fluctuations in CPP are heavily attenuated and phase shifted in recorded FV (FVm, FVs, or 
FVd), thus suggesting “intact” autoregulation.  The exact index value at which autoregulation is 
“impaired” and pathologic is not clear.  Sorrentino et al evaluated thresholds of Mx as they related to 
mortality and GOS at 6 months post-TBI.8  A double peaked threshold was found for Mx with threshold 
of +0.3 and +0.05 discriminating between both life versus death, and good versus poor outcome.  Both 
thresholds are utilized within the literature to denote “impaired” autoregulation. 
The search of the adult TBI literature yielded 17 studies, with 50 or more subjects, describing the 
association between Mx and patient outcome. 3,8,54,83–96  The patients suffered from moderate to severe 
TBI, with an average of 212 patients per study.  Of note, all of these papers originated from 
Addenbrooke’s hospital in Cambridge, as part of either retrospective reviews of a prospectively 
maintained database on TCD in TBI, or as prospective cohort studies. Thus, the actual number of unique 
patients overall across all of the studies is much lower, since there is overlap in patient inclusion across 
the multiple studies.  Despite this, across these 17 papers, Mx is noted to be strongly associated with 
patient outcome.  Furthermore, given the ability to obtain MCA velocities bilateral, asymmetry in 
autoregulatory capacity has been documented, with the greater right-left difference in Mx being 
associated with worse outcome.  The incidence of “impaired” autoregulation, as defined by Mx, was not 
clear in most of the included studies, as the search for TCD based Mx studies focused on those 
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documenting an association to patient functional outcome.  In addition, “impaired” autoregulation 
detection using Mx is difficult, given the lack of an exact threshold for this physiologic event, and only 
thresholds for morbidity and mortality that have been well defined.   
 
 2.2.1.2 Continuous Methods 
 
A systematic scoping review of the literature on commonly described continuous autoregulation 
measurement techniques in adult TBI was conducted.  The goal was to provide an overview of 
methodology for each technique.  This review is detailed in Zeiler et al.4 
Five separate systematic reviews were conducted for each of the continuous techniques: PRx, LDF, NIRS 
techniques, PbtO2, and TD techniques.  Articles from MEDLINE, BIOSIS, EMBASE, Global Health, Scopus, 
Cochrane Library (inception to December 2016) and reference lists of relevant articles were searched.  
The literature base identified from the individual searches was limited, except for PRx.   
The total number of articles utilizing each of the 5 searched techniques for continuous autoregulation in 
adult TBI were:  PRx (28),3,9,15,27,58,83,85,91,102–121 LDF (4),122–125 NIRS (9),20,126–133 PbtO2 (10),116,127,128,130,134–139 
and TD (8).38,64,128,135,140–143  Studies focusing on PRx were limited to those assessing the association to 
patient outcome. All continuous techniques described in adult TBI are based on moving correlation 
coefficients.  The premise behind the calculation of these moving correlation coefficients focuses on the 
impact of slow fluctuations in either MAP or CPP on some indirect measure of CBF or CBV, such as: ICP, 
LDF, NIRS signals, PbtO2 or TD CBF.  The conceptual basis for such measures is that the correlation 
between a hemodynamic driving factor (such as MAP or CPP), and a surrogate for CBF or CBV, sheds 
insight on the state of cerebral autoregulation.  Both PRx and NIRS indices were validated experimentally 
against the ‘gold standard’ static autoregulatory curve at least around the lower threshold of 
autoregulation.14 PRx has the largest literature base supporting the association with patient outcome.   
Various methods of continuous autoregulation assessment are described within the adult TBI literature.  
Many studies exist on these various indices, and suggest an association between their values and patient 
morbidity/mortality. Given these multi-modal monitoring (MMM) derived techniques are the main focus 
of this thesis, further details on each continuous technique can be found below: 
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1. Pressure Reactivity Index (PRx) 
The use of continuously updating PRx monitoring was first described in the mid to late 1990’s, and this 
technique is currently one of the most common methods for continuous assessment of autoregulation  
employed within the ICU.3  Furthermore, this index is one of the only continuous cerebrovascular 
reactivity indices that has been experimentally validated to measure the LLA.14 The concept behind this 
index of autoregulatory capacity is that the continuous relationship between slow-wave (ie. 0.005 to 
0.05 Hz) vasogenic fluctuations in ICP and MAP are an indirect measure of the cerebrovascular response. 
The correlation between slow-wave changes in a surrogate measure of fluctuating CBV (ie. ICP) and MAP 
provides information regarding signal phase-shift and autoregulatory status.  In order to obtain this 
value, a moving correlation coefficient is calculated between slow-waves ICP and MAP.  First, 
continuous, full waveform quality, signals of MAP (typically from a radial artery line) and ICP (typically 
from any invasive ICP monitoring device) are recorded.  Processing these signals to determine PRx may 
be conducted off-line or in real-time.  Next, a 10 second moving average is calculated for both ICP and 
MAP and decimated to 0.1Hz, using 10 second non-overlapping data windows averages (to remove the 
influence of cardiac cycle and respiration).  The Pearson correlation coefficient is then calculated using 
30 consecutive average ICP and MAP values, spanning 5 minutes of data.  This calculation is then 
repeated every 60 seconds (thus introducing 80% overlap, 4 min), producing a minute-by-minute update 
to the PRx value.  The concept behind PRx is that changes in ICP within the 5-minute window in this 
calculation represent a surrogate for changes in intracerebral blood volume which in turn represent 
most likely arteriolar vasodilation or constriction. Thus, PRx can be considered a measure of vascular 
reactivity.  A single value of PRx is difficult to interpret.  Averaging over a minimal period of 30 minutes is 
suggested, unless transient responses of PRx to deep and sudden events are being explored (such as a 
change in ICP during plateau waves, response to change in PaCO2, etc).  Other calculation window 
lengths have been described. 
PRx values produced from the above described calculation range from -1 to +1, given that they are 
correlation coefficients.  A positive value indicates a strong positive correlation between MAP and ICP 
such that any increase in MAP leads to an increase in ICP (ie. no phase shift between the ICP and MAP 
waveforms), and thus represents “impaired” autoregulation.  Conversely, a negative PRx indicates a 
negative correlation between MAP and ICP, indicating “intact” autoregulation.  The model which 
assumes MAP slow variations are an input to which responses in ICP can be observed, is not always 
relevant. For example, when ICP is already high, MAP responds in-phase to changes in ICP as a Cushing’s 
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response, which makes PRx continuously close to +1. While the physiological significance of these 
extreme PRx values are self-evident, the threshold value of PRx that represents a transition from 
functioning autoregulation to “impaired” autoregulation is, as yet, not clear.  Various thresholds of PRx 
have been identified within the literature.9 The most commonly quoted are those by Sorrentino et al.9  
Within this study, various thresholds of PRx (mean value over the entire monitoring period) were 
assessed by their association with mortality and good vs. poor functional outcome as assessed by the 
Glasgow Outcome Scale (GOS) at 6 months post-TBI.  Two thresholds were identified:  1. PRx of 0 or 
lower was associated with better 6-month GOS, 2. PRx >0.25 was associated with mortality. 9 Thus, to 
date, the threshold of 0.25 for PRx is the value many clinicians use to identify those patients with 
“impaired” autoregulation.  When PRx is negative, autoregulation is good.  The “intermediate” range of 
0 to 0.25 for PRx, based on the two thresholds identified by Sorrentino, may provide warning of 
imperfect autoregulation or impending autoregulatory dysfunction, or may signify the rare state that 
power of slow waves of ICP and AMP is too low, to contain any useful information about cerebral 
pressure reactivity.  
 The use of PRx has led to the development of patient tailored therapy for CPP targets.  By plotting PRx 
versus CPP, one can identify the CPP with the lowest PRx values (ie. “best” autoregulatory state).  A 
recent systematic review of CPP optimum, as derived from PRx, displayed trends to improved outcomes 
when CPP was within the “optimum range”.144  This has sparked some interest in a trial of CPP optimum 
guided therapy, versus conventional CPP targets in TBI, which is now being conducted in three European 
centres.  
The search strategy identified 28 papers which described the association of PRx to patient outcome in 
adult TBI. 3,9,15,27,58,83,85,91,102–121  Eighteen of these studies had 50 or more patients, with an average of 243 
patients per study.  The remaining 10 studies had less than 50 patients per study. The patients studied 
had moderate – severe TBI, with almost all patients within the included studies being of adult age.  A 
small number of pediatric patients (age <18 years) were embedded within the large data sets, making it 
impossible to extract the pediatric information.  Thus, the number of pediatric patients is quite small. 
The majority of the studies report strong associations between PRx and outcomes at various time points, 
regardless of study size.  PRx is also noted to correlate with the individual TCD based intermittently 
monitored indices of autoregulation.  Furthermore, correlation with individual NIRS based indices has 
also been confirmed.  
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2. LDF Based Techniques 
The use of LDF monitoring in TBI has ceased in the clinical setting, with only a few studies documenting 
its use. 122–125 This technique was included in order to be thorough and describe a technique based on 
the assessment of cortical small arteriolar/microvasculature.  
The LDF probe is placed in the subdural space, overlying the cortical surface of the brain. A low power 
solid-state laser diode emits infrared light onto the cortical surface.  The reflected photons are Doppler 
shifted in frequency, with the shift being a function of the velocity of moving blood in the area.  The 
reflected infrared signal is detected by the probe, with CBF reported in arbitrary units and recorded as a 
continuous signal.  To derive an index of autoregulatory capacity, the similar technique of calculation of 
moving a Pearson correlation coefficient (as with PRx) can be used. 10 second mean values for CBF and 
CPP (updated every 10 seconds), with the correlation coefficient based on 30 consecutive values from a 
moving window are computed.  This autoregulatory index based on LDF is called Lx. The premise here is 
that the impact of slow changes in CPP on LDF derived CBF are an indirect measure of autoregulatory 
capacity.  
Given the small literature base on LDF in TBI, the exact values of Lx which denote “intact” versus 
“impaired” autoregulatory capacity are unclear. Values above a Lx of 0 likely indicated some degree of 
impairment of autoregulatory capacity, while those less than 0 likely indicated intact autoregulation.   
The search of the adult TBI literature produced only 4 studies on the use of LDF for autoregulatory 
assessment. 122–125  The populations studied were moderate to severe TBI patients.  Conclusions 
regarding the technique are limited given small patient numbers. However, persistently positive Lx 
values were associated with poor GOS at 6 months.    
 
3. NIRS Techniques 
The use of NIRS has generated numerous new indices of cerebral autoregulatory capacity.  NIRS involves 
placing optodes on the patient’s scalp (typically with a bifrontal distribution, since optodes requires 
placement on a hairless area).  The NIRS device, depending on the manufacturer, uses two or more 
wavelengths of infrared light via typically a single emitter, with 2-4 detector photodiodes placed in line 
with the emitter at the distance of min 2.5 cm.20  Based on the diffusion characteristics of infrared light, 
various measures can be mathematically derived from the signal using the modified Beer Lambert law.  
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Typically indices measured include uncalibrated changes in oxyhemoglobin (HbO or Co2Hb), 
deoxyhemoglobin (HHb or CHb) and total hemoglobin concentration (HbT = HbO + Hb), hemoglobin 
difference (Hbdiff  = HbO – HHb).  Different indices (total hemoglobin – THI or HVI and and total 
oxygenation index - TOI, sometimes branded CO or rSO2, nomencleature depending on manufacturer) 
are derived from the spatially resolved spectroscopy, a technique designed to overcome the problem of 
calibration due to unknown scattering coefficient, absorption path length and partition coefficient, and 
at the same time attempt to minimize the influence of scalp blood flow on NIRS based measures.  Hb 
and HbO are believed to represent venous and predominantly arterial compartments respectively.  
Indices derived from both the oxygenated and deoxygenated NIRS measures are believed to represent 
blood transit from arterial to venous systems.  In addition to the NIRS monitoring, continuous MAP or 
CPP are required for continuous autoregulatory assessment. The change in NIRS based measures with 
respect to CPP is believed to represent autoregulatory function. 
Autoregulatory assessment with NIRS applied in TBI patients is all based on moving Pearson correlation 
coefficients between the various NIRS measures (HbO, HHb, HbT, TOI, THI and Hbdiff) and CPP or MAP.   
The method of calculation is the same as that for PRx or Mx.  The indices introduced in the literature 
include, TOx (or COx), based on TOI (or rSO2) and THx (also known as HVx), based on THI, or HbT 
respectively. Thresholds for autoregulatory “impairment” have not been determined, given a small 
number of studies available in adult TBI, evaluating a small number of patients.  Similar to PRx, positive 
index values may represent “impaired’ autoregulation, while negative values may denote “intact” status. 
The literature search identified 9 manuscripts describing NIRS bases autoregulatory indices in adult TBI. 
20,126–133 A total of 187 TBI patients were described across the 9 studies, with an average of 21 patients 
per study.  Within these studies various NIRS based autoregulatory indices were compared to existing 
indices (such as PRx and Mx) and patient outcomes. THx and TOx were found to be correlated to PRx and 
Mx.  
 
4. Brain Tissue Oxygen Monitoring (PbtO2) based ORx  
Brain tissue oxygen monitoring (PbtO2) can be utilized to derive a continuous index of autoregulation 
(ORx). The PbtO2 probe is typically a Clark electrode situated within the brain parenchyma, where 
diffusible oxygen is measured by the catheter tip continuously. This generates a value for the partial 
pressure of brain tissue oxygen (PbtO2). With continuous MAP and ICP recording, one can calculate a 
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moving Pearson correlation coefficient between CPP and PbtO2.  The thought is that the slow wave 
correlation between CPP and PbtO2 provides an indirect measure of autoregulatory function.  However, 
caution is needed in interpreting results, given that PbtO2 levels can fluctuate in response to many local 
and systemic factors.  The Pearson correlation coefficient is calculated in a similar manner to PRx, but 
over much longer windows (over 30 or 60 minutes in duration).  However, ORx has also been described 
using 5-minute moving windows as well. 
As with the less common indices (ie. Lx and NIRS), threshold-based studies do not exist for ORx. Thus, 
the exact point where autoregulation becomes “impaired” is unclear currently.  However, positive ORx 
values are believed to represent an impairment of the autoregulatory capacity, while negative ORx 
values are believed to represent an “intact” state. Although this point is controversial. Some authors 
think that positive ORx signifies that PbtO2 can be improved by rising CPP, and zero ORx informs that the 
range of PbtO2 regulation has been exhausted. 
The search of the adult TBI literature produced 10 studies on ORx. 14,125,126,128,132–137 A total of 159 
patients were described across these studies, with an average of 17 patients per study.  The main 
purpose of the individual studies was quite variable, with some reporting correlations with other indices 
(such as NIRS or PRx), while other were reporting CPP optimal based targets derived from ORx.  ORx 
displayed some correlation to NIRS based HHbx and PRx.  Furthermore, some agreement between CPP 
optimum derived from ORx and that from PRx has been noted.  To date, this index is not routinely 
utilized for autoregulatory assessment, given the PbtO2 signals propensity to be influence by various 
factors unrelated to the central nervous system.   
 
5. Thermal Diffusion (TD) Technique 
The use of thermal diffusion (TD) probes affords the ability to estimate regional cerebral blood flow and 
perfusion.  This device consists of a dual thermistor probe which is inserted directly into the brain 
parenchyma.  The distal thermistor generates heat at ~2 degrees Celsius above tissue temperature, 
while the proximal thermosensor (5 mm proximal) records the brain temperature outside of the distal 
thermistor’s heat field.134 Thus, the relative changes in brain temperature related to blood transit 
regionally can be measured and correlated with CBF.  The device regularly re-calibrates, interrupting 
continuity of the data stream, and the values it generates can be influenced by systemic factors, such as 
pyrexia,141 with a reduction in the reliability of CBF measurement using the device.  
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Regardless of limitations of the device, autoregulation measurement has been conducted with the TD 
catheter. Two methods have been described.  The first is intermittent and will be mentioned only in 
passing.  It involves the measurement of CBF via the catheter during active manipulation of the MAP 
using vasopressor agents.  Only, 2 studies to date have described this approach in adult TBI, and are 
included here for completeness on TD based autoregulation.64,142   
The second technique of autoregulation measurement is continuously updating, assuming an 
uninterrupted TD based CBF signal.  This technique is again based on a moving Pearson correlation 
coefficient between CBF and CPP, called CBFx.  The method of calculation is similar to PRx, Mx and Lx.  
The premise behind its association with autoregulation is similar to the concept for LDF based Lx 
measurement.  As with the other less utilized indices, there are no guidelines as to thresholds for CBFx 
during particular states of autoregulatory capacity.  Thus, positive CBFx values are believed to denote 
impairment of autoregulation, while negative CBFx values are believe to represent intact states. 
The search of the adult TBI literature yielded 8 papers on TD based autoregulatory assessment. 
38,64,128,135,140–143  As mentioned, 2 studies were intermittent, and only mentioned here for completeness. 
64,142   These were not included within the intermittent part of this manuscript series, as they it is not a 
“commonly” described technique of intermittent autoregulation assessment.  The remaining 6 studies, 
focused on CBFx calculation in adult TBI. Various physiologic outcomes were described in relation to 
CBFx.  Optimal CPP was derived from CBFx in one study.128 Very small patient numbers were found in 
these studies, so the conclusions drawn are limited.  
 
2.2.2  Potential Drivers of Impairment 
 
 2.2.2.1 Injury Burden 
 
To date, the available literature linking IC and EC injury burden to the development of impaired 
cerebrovascular reactivity in adult TBI is scarce.  Only one study by Hiler et al attempted to evaluate this 
association.107  This study focused on a heterogeneous group of 126 adult TBI patients, both with and 
without DC.  They evaluated whether the Marshall computed tomography (CT) grade on admission was 
associated with impaired cerebrovascular reactivity during the ICU stay, as defined by a grand mean PRx 
value greater than zero.  The results failed to demonstrate a strong link between IC injury burden and 
vascular reactivity post-TBI.  A few limitations existed, mainly:  including both DC and non-DC patients, 
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taking a grand mean over the entire recording period, and using a basic CT grading system (ie. Marshall 
CT grade).  Furthermore, no attempts to date have been made to assess the link between EC injury 
burden and host response, as they both relate to cerebrovascular reactivity post-TBI. 
 
2.2.3 Concepts Lacking Literature Support 
 
Considering the aims and hypotheses of this thesis, outlined in Chapter 1, it is important to highlight the 
areas where literature is lacking on cerebrovascular reactivity in TBI, all of which were identified by the 
results of the above outlined systematic review of literature.  First, currently the majority of literature on 
cerebrovascular reactivity monitoring in TBI focuses on PRx, as previously mentioned.  It is unclear as to 
whether a different correlation index would provide similar information, superior outcome prediction 
and more temporally stable critical thresholds.  Second, only PRx, TOx and HVx have been validated to 
measure the LLA in an experimental study of arterial hypotension.14  It is currently unclear as to whether 
PRx measures the LLA during IC hypertension.  Furthermore, it is unclear as to whether other ICP derived 
continuous indices measure the LLA during both arterial hypotension and IC hypertension.  Finally, for all 
continuous indices, it is unclear whether they can measure the ULA.  Third, the majority of studies 
evaluating indices derived from different MMM devices only investigated individual associations, failing 
to assess multi-variate co-variance structures.  Thus, the true inter-index associations are currently 
poorly understood.  Fourth, given difficulties with complex time-series analysis, there are currently a lack 
of robust attempts at modelling PRx using non-invasive surrogates.  Finally, as highlighted in 2.3.2.1, the 
literature on IC injury burden and cerebrovascular reactivity is limited.  The only available preliminary 
study failed to document an association using basic neuroimaging measures.107  EC injury burden and its 
links to cerebrovascular reactivity post-TBI has yet to be explored.   
Thus, based on the above-mentioned lack of literature, there exists the need to explore the hypotheses 
listed in Chapter 1.  The chapters to follow will outline the methodology and results of various studies 
conducted to address these hypotheses. 
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CHAPTER 3: GENERAL METHODS 
 
The experiments and results that comprise this thesis were, in some instances, conceptually complex, and 
the data required integrated analyses and a complex data-analysis approach.  Consequently, some of the 
initial concepts, methods and experiments are provided in several contexts.  This aim to provide relevant 
information close to sites where data and interpretation are being described has inevitably led to some 
repetition, but this has been retained to improve readability without having to move between chapters 
or sections of chapters. 
The methods outlined below provide a general overview of the analyzed populations described within the 
various studies conducted as a part of this thesis, both experimental models and human adult TBI. In 
addition, information regarding physiologic signal acquisition and processing is provided.  The statistics 
section provides a brief overview of methodology, however is not a detailed account of the techniques 
applied in individual studies.  Given the complexity of the statistical techniques employed as a part of this 
thesis, each subsequent chapter will contain the detailed explanation of the applied statistical 
methodologies.   
 
3.1 Experimental Model Management 
 
*Note:  Raw data from experimental studies was collected previously and retrospectively analyzed for the 
purpose of this thesis.  The data from New Zealand rabbits for evaluation of the LLA during IC hypertension 
was collected in the 1990’s at the University of Cambridge, with the raw data made available for this thesis 
by Prof Marek Czosnyka.  Similarly, raw data from an animal model (piglet model), collected in the late 
2000’s, were provided graciously by Dr. Jennifer Lee (John’s Hopkins) and Dr. Ken Brady (Baylor) for 
analysis of the LLA and ULA, using paradigms of arterial hypotension and arterial hypertension 
respectively.  None of the previous results reported using these experimental models have been included 
within this thesis.14,145–148  All analysis and results from these models reported in this thesis were 
conducted independently, addressing different questions from those posed in other publications from the 
above-mentioned investigators.  Table 3.1 summarizes the experimental models that were retrospectively 
analyzed for this thesis. 
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Table 3.1 - Experimental Models 
Population Source (lead 
investigator 
and institution) 
Number of Subjects Years Raw 
Physiologic Data 
Collected 
Chapters 
Piglets Jennifer Lee 
(Hopkins) and 
Ken Brady 
(Baylor) 
22 
 
*Model of pure 
arterial hypotension 
using IVC balloon 
inflation. 
 
2006 - 2011 5.1 
Piglets Jennifer Lee 
(Hopkins) and 
Ken Brady 
(Baylor) 
6 
 
*Model of pure 
arterial 
hypertension using 
aortic balloon 
inflation and 
vasopressors. 
 
2006 - 2011 5.3 
New Zealand White 
Rabbits 
Marek 
Czosnyka 
(Cambridge) 
12 
 
*Model of sustained 
IC hypertension 
using CSF infusion. 
1995 - 1996 5.2 
CSF = cerebrospinal fluid, IC = intra-cranial, IVC = inferior vena cava. 
 
 
3.1.1 New Zealand Rabbits 
 
Data from New Zealand (NZ) white rabbits were utilized for the study validating the ICP derived indices 
against the LLA during IC hypertension, Chapter 5.2. The animals described within this study have in part 
been described in previous studies related the physiologic response to intra-cranial hypertension.145,146  
Archived data from a subset of 12 animals from these previous studies was utilized for the analysis in this 
thesis.  The initial experiments were conducted between 1995 and 1996, in accordance with the standards 
of the UK Animals Scientific Procedures act of 1986, under a UK home office license and with permission 
form the institutional animal care and use committee at the University of Cambridge.   
Twenty-eight white New Zealand (NZ) rabbits (7 female, 21 male; weight 2.7 – 3.7 kg) were subjected to 
cerebrospinal fluid (CSF) infusions. No adverse events were recorded within this animal cohort. As with 
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previous publications on this animal cohort, experiments are reported in compliance with the ARRIVE 
guidelines for the reporting of animal experiments.149 
Animals were placed under general anesthetic via alphalaxone/alphadalone induction, with 1-3% 
halothane in 3:1 nitrous oxide/oxygen maintenance. Each animal subsequently had ligation of the 
common carotid arteries, leaving the brain entirely basilar artery dependent and allowing for TCD 
assessment of global blood flow. Once 2 weeks had passed, the animals were placed under general 
anesthestic again, with cannulation of the jugular vein and placement of a tracheostomy. Arterial blood 
pressure (ABP) was measured through in the dorsal aorta after catheter insertion in the femoral artery 
(GaelTec, Dunvegan, UK). Cerebral blood flow velocity was measured using an 8MHz Doppler ultrasound 
probe (PCDop 842, SciMed, Bristol, UK) positioned over the basilar artery (accessed through a 7 mm burr-
hole at the bregma). ICP was monitored using an intraparenchymal microsensor (Codman and Shurtleff, 
Raynham, MA, USA) inserted through a right frontal burr-hole, and an LDF probe was placed subdurally 
through a further right frontal burr-hole (Moor Instruments, Axbridge, Devon, UK).  
A lumbar laminectomy was performed to allow the positioning of a permanent catheter (sealed with 
cyanoacrylate after introduction) into the lumbar subarachnoid space. This facilitated the controlled 
infusion of artificial cerebrospinal fluid during the experimental protocol. Rectal temperature was 
monitored and the animals were placed on a padded warming blanket. The rabbits were given an 
intravenous infusion of pancuronium (pavulon, 0.5 mg/kg/h) and ventilation was controlled according to 
arterial pCO2 via periodic arterial blood gas analyses. The animals were supported in the Sphinx position 
using a purpose-built head frame with three-point skull fixation. All experiments were performed in an 
animal laboratory at the same time of day. 
The protocol for CSF infusion is identical to that previously reported. After completion of the lumbar 
laminectomy, the animals were allowed to rest for 20 minutes, with 5 minutes of baseline data 
recorded. Subsequently, the animals were subjected to raised ICP secondary to CSF infusion with 
Hartmanns solution into the lumbar cistern. Infusion rates were initially 0.1 mL/min, allowing ICP 
increase to reach a plateau of around 40 mm Hg after approximately 10 min. Thereafter the infusion 
rate was increased to rates between 0.2 and 2 mL/min to produce severe intracranial hypertension. ICP 
was increased until the point where diastolic flow velocity approached zero, which corresponded to an 
ICP of between 60 and 100 mm Hg (mean 75 mm Hg) at the termination of the experiment. Rabbits 
were euthanized with thiopental at the conclusion of the test.  No pCO2 manipulations occurred during 
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this experiment. Further details can be found in the previous studies reporting these experiments. ICP, 
ABP, LDF-CBF and TCD CBFV (from basilar artery) were recorded during this experiment. 
 
3.1.2 Piglets 
 
To explore the LLA during arterial hypotension and the ULA during arterial hypertension, a piglet model 
was utilized. The raw physiologic signal data were retrospectively analyzed for the purpose of this thesis. 
The neonatal piglet data described within this thesis were retrospectively amalgamated from 3 separate 
experiments.14,147,148 Inclusion criteria for the current study were normothermic, sham control piglets 
that had complete and time synchronized data for arterial blood pressure, laser Doppler flowmetry, and 
ICP from previously published studies. Twenty-two piglets met the inclusion criteria for the arterial 
hypotension LLA study:   
A. control animals from a study on LLA (n=8; age 5 to 10 days; weight 2.2 – 3.9 kg).   
B. sham controls for a model of cardiac arrest (n=7; age 3 to 5 days; weight 1 – 2.5 kg), and  
C. sham normothermic controls for a model of cardiac arrest with hypothermic therapy (n=7; age 3 to 5 
days; weight 1 – 2.5 kg).   
For the arterial hypertension ULA study, only 6 sham animals were included (n=6; age 5 to 10 days). All 
animals were male in both the LLA and ULA studies. All procedures were approved by the Animal Care 
and Use Committee at Johns Hopkins University and complied with the United States Public Health 
Service Policy on Human Care and Use of Laboratory Animals and the Guide for the Care and Use of 
Laboratory Animals.  Furthermore, animal care was in accord with National Institutes of Health 
Guidelines and ensured the animals’ comfort.   
Of note, a few limitations regarding these piglet models deserve mentioning. These piglet models and 
experiments were designed for investigation into cerebrovascular physiology with potential translation 
to neonatal care.  They were not intended to be translatable to adult cerebrovascular physiology.  As 
such, the prematurity of the cerebral vasculature in these models may have impacted the LLA and ULA 
values determined, and the behaviour of the derived cerebrovascular reactivity indices across the LLA 
and ULA with subsequent manipulation in CPP in the respective experiments.  Further to this, the skulls 
of these piglets were unfused given the neonatal age of the models employed.  As such, in the absence 
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of a fixed cranial vault, the measurement of ICP and derived vascular reactivity indices may have been 
impacted by this.  
 
LLA – Arterial Hypotension 
The male piglets were intubated and mechanically ventilated to maintain normocapnea. General 
anesthesia was provided with isoflurane in a 50%/50% nitrous oxide/oxygen mixture, fentanyl infusion 
and as needed boluses, and pancuronium or vecuronium infusions. Fentanyl and neuromuscular 
blockade were given through a femoral venous catheter. The isoflurane dose was held constant for the 
duration of the experiment. Arterial blood pressure was continuously monitored by an indwelling 
femoral artery catheter. A 5F esophageal balloon catheter (Cooper Surgical, Trundall Conn) was placed 
into the contralateral femoral vein and advanced into the inferior vena cava for later induction of 
hypotension. A ventricular ICP monitor and a cortical LDF probe (Moor Instruments, Devon, UK; model 
DRT4; 60Hz) to measure CBF were placed through small cranial burr holes. ICP and LDF were monitored 
in the same cerebral hemisphere.  ICP, ABP and cortical LDF-CBF were recorded during the experiment.  
The balloon catheter was slowly inflated in the inferior vena cava using a saline syringe pump. 
Hypotension was induced from baseline to near-zero blood pressure over 2 to 3 hours. This slow 
induction of hypotension permitted capture of slow wave intracranial pressure fluctuations for analysis 
of cerebrovascular reactivity. 
 
ULA – Arterial Hypertension 
The male piglets underwent a similar anesthetic as those for the LLA arterial hypotension study.  The 
only major variation is that the esophageal balloon catheter was placed in the femoral artery, and 
advanced towards the distal aorta.  This catheter was used to slowly increase systemic blood pressure to 
death of the animal. In addition, phenylephrine infusions were administered in attempt to push the MAP 
to maximal values. ICP, ABP and cortical LDF-CBF were recorded during the experiment.  
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3.2 Adult TBI Management 
 
Throughout the analysis presented in this thesis (Chapter 4, Chapters 6 through 9), various different 
populations of adult TBI patients were studied.  Table 3.2 provides a summary of those different 
populations.  
Table 3.2 - Adult TBI Populations 
Population Number of Subjects Years Raw 
Physiologic Data 
Collected 
Chapters 
Adult TBI with all MMM 37 
 
*TBI with ICP, PbtO2, 
NIRS and TCD 
monitoring. 
 
2008 - 2009 6.1 
Adult TBI with LDF 40 
 
*TBI with LDF, ICP and 
TCD monitoring. 
 
1994 - 1998 6.2 
Adult TBI with TCD 347 
 
*TBI with ICP and TCD 
monitoring. 
 
1992 - 2011 6.3, 7.1, 8.2 
Adult TBI with Long TCD 20 
 
*Prospectively collected 
with new robotic TCD for 
extended duration 
monitoring. ICP and NIRS 
signals also collected. 
 
2017 – 2018 7.2, 7.3 
Adult TBI without DC 358 
 
*TBI without DC and 
available admission 
neuroimaging. 
 
2005 – 2016 4, 8.1, 9  
DC = decompressive craniectomy, ICP = intra-cranial pressure, LDF = laser Doppler flowmetry, MMM = multi-modal monitoring, 
NIRS = near infrared spectroscopy, PbtO2 = brain tissue oxygen monitoring, TBI = traumatic brain injury, TCD = transcranial 
Doppler. 
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The management received by these patients within the NCCU at Addenbrooke’s Hospital (Cambridge 
University Hospitals NHS Foundation Trust (CUH)) was similar across all patient populations.  Patients 
were predominantly moderate or severe TBI patients, with moderate defined as a GCS of 9 to 12, and 
severe defined as a GCS or 8 or less.  These patients were admitted to the NCCU for purposes of critical 
care during the acute phase of their illness.  All patients had invasive ICP monitoring conducted as per 
Brain Trauma Foundation (BTF) guidelines.150  Some mild TBI patients, defined as GCS 13 to 15, 
subsequently deteriorated clinically after admission to hospital, warranting transfer to the NCCU for 
invasive monitoring and therapy.  Other monitoring modalities, such as PbtO2, NIRS and TCD are 
conducted as part of standard monitoring practices within the NCCU at Addenbrooke’s Hospital. All 
patients had ABP monitored during their NCCU stay.  ABP was zeroed at the level of the right atrium for 
all patients in the NCCU prior to 2015.151 Both ICP and ABP were zero referenced at the level of the 
tragus for all patients from 2015 onwards.151  
One important limitation of the information available in the retrospective database of TBI patients is 
related to this concept of arterial line zeroing.  Given data was not available on each and every patient as 
to where the arterial line was zero referenced, for the purpose of the analysis using this data set (ie. for 
Chapters 4, 6, 7, 8, and 9) it was assumed that most would have had the arterial line zeroed at the level 
of the tragus.151  This zero reference for the arterial line does not impact the sign or magnitude of 
derived cerebrovascular reactivity indices, given these indices are correlation coefficients, dependent on 
the co-variation in the correlated signals, not the magnitude of the raw physiological readings. As such, 
regardless of the level of arterial line zero reference, the calculated cerebrovascular reactivity indices are 
unimpacted.21,151,152  
General ICP and CPP directed therapy was provided to the patients as per the BTF guidelines,150 with an 
ICP goal of less than 20 mm Hg and CPP goal of 60 to 70 mm Hg.  ICP was controlled with various 
positioning techniques, mild hyperventilation (to ~33 mm Hg), bolus osmotic therapies (using mannitol 
or hypertonic saline), continuous sedation (typically with propofol and/or fentanyl) and CSF venting 
(when ventricular drain present for ICP monitoring).  Therapeutic hypothermia (to a lowest of 33 
degrees Celsius), neuromuscular blockade, barbiturate coma and decompressive craniectomy were used 
for refractory cases.  CPP was maintained using intra-venous vasopressor agents to maintain goal values.  
Seizures, electrolyte imbalances and blood glucose were treated as standard management in the NCCU. 
All physiologic signals were recorded and anonymized. Data on age, injury severity, and clinical status at 
hospital discharge were recorded at the time of monitoring in this database, and no attempt was made 
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to re-access clinical records for additional information. Since all data was extracted from the hospital 
records and fully anonymized, no data on patient identifiers were available, and formal patient or proxy 
consent was not required.  Section 3.6 overviews the ethical considerations for access and use of such 
human clinical data. 
 
 
3.3 Monitoring 
 
3.3.1 Invasive Cerebral Monitoring 
 
3.3.1.1 Intra-cranial Pressure (ICP) 
 
ICP was acquired via an intra-parenchymal strain gauge probe (Codman ICP MicroSensor; Codman & 
Shurtleff Inc., Raynham, MA).  This was conducted in both the experimental models and human adult TBI 
populations.   
 
3.3.1.2 Brain Tissue Oxygen (PbtO2) 
 
PbtO2 monitoring occurred via invasive parenchymal monitoring (Licox probe; Integra, Licox Brain 
Oxygen Monitoring System, Plainboro, NJ), typically placed in the right frontal lobe via a triple lumen 
bolt (Technicam Ltd).   
 
3.3.1.3 Cortical Laser Doppler Flowmetry (LDF) 
 
This invasive monitoring modality for adult TBI patients was only in place for a short period within the 
NCCU in the mid 1990’s. LDF based CBF was obtained via placement of a MBF3D dual channel laser LDF 
(Moor Instrument Ltd, Devon UK) in the subdural space, ipsilateral to the ICP monitor.  The LDF probe 
employed a low energy laser (0.5 to 1.5 mW) with light generated in the near infrared spectrum (780 to 
820 nm).  LDF signals were recorded at a frequency of 14.6 kHz.  All probes were pre-calibrated prior to 
insertion.  Details on the insertion technique and calibration method can be found in the 1994 study by 
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Kirkpatrick et al.122 A similar probe, from the same manufacturer, was utilized within the experimental 
studies described within this thesis. 
 
 
3.3.2 Non-Invasive Cerebral Monitoring 
 
3.3.2.1 Transcranial Doppler (TCD) 
 
Various different TCD devices were employed over the decades for measuring CBFV from the MCA.  TCD 
assessment was conducted via Doppler Box (DWL Compumedics, Singen, Germany) or Neuroguard 
(Medasonic, Fremont, CA, USA), for the patient populations described in Chapters 6, 7.1 and 8.2.  Finally, 
a new robotic TCD unit was employed for the purpose of this thesis, the Delica EMS 9D (Delica EMS 9D 
System, Shenzen Delica Medical Equipment Co. Ltd., China; http://www.delicasz/com).  This newer 
robotic system will be described in detail in Chapters 7.2 and 7.3. 
 
3.3.2.2 Near Infrared Spectroscopy (NIRS) 
 
NIRS signals were recorded bilaterally over the frontal lobes utilizing the NIRO-200 or NIRO-200NX 
monitoring (Hamamatsu Photonics, Hamamatsu City, Shizuoka, Japan, www.hamamatsu.com).  The 
following NIRS signals were recorded: oxygenated hemoglobin (HbO), deoxygenated hemoglobin (HHb), 
total oxygenation index (TOI), total hemoglobin index (THI) and total hemoglobin concentration (Hb). 
 
3.3.3 Systemic Monitoring 
 
3.3.3.1 Arterial Blood Pressure (ABP) 
 
ABP was obtained through either radial or femoral arterial lines connected to pressure transducers 
(Baxter Healthcare Corp. CardioVascular Group, Irvine, CA). 
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3.4 Signal Capture and Processing 
 
3.4.1 Signal Capture 
 
All physiologic signals from the various MMM devices (ie. ICP, ABP, PbtO2, NIRS, TCD and LDF) in both 
the experimental and human adult TBI studies were recorded in high frequency waveform (50 Hz or 
higher) using ICM+ software (Cambridge Enterprise Ltd, Cambridge, UK, 
http://icmplus.neurosurg.cam.ac.uk).  Digital signals were directly recorded by ICM+.  While analogue 
signals were digitized via analogue to digital converters (ADC) (DT300 for experimental studies, DT9801 
or DT9803 for human studies; Data Translation, Marlboro, MA). All signals were linked in time-series 
automatically by ICM+. 
 
 
3.4.2 Signal Processing 
 
Post-acquisition processing of the above signals was conducted using ICM+.  Signal artifact was cleared 
through a combination of manual and automated techniques. Pulse amplitude of ICP (AMP) was 
determined by calculating the fundamental Fourier amplitude of the ICP pulse waveforms over a 10 
second window, updated every 10 seconds.  For TCD CBFV, further processing was conducted to 
produce FVm, FVs and FVd. Systolic flow velocity (FVs) was determined by calculating the maximum flow 
velocity (FV) over a 1.5 second window, updated every second.  Diastolic flow velocity (FVd) was 
calculated using the minimum FV over a 1.5 second window, updated every second. Mean flow velocity 
(FVm) was calculated using average FV over a 10 second window, updated every 10 seconds (ie. without 
data overlap).  
A ten second moving average filter (updated every 10 seconds to avoid data overlap) was applied to all 
recorded signals:  ICP, ABP (which produced MAP), AMP, CPP, PbtO2, TCD CBFV, NIRS signals, and LDF-
CBF. This decimated the signal frequency to ~0.1Hz, focusing on slow-waves of the various MMM 
variables:  ICP, CPP, ABP, AMP, FVm, FVs, FVd, TOI, THI, PbtO2, and LDF-CBF. Details regarding derived 
variables (ie. CPP and continuous indices of cerebrovascular reactivity) will be covered in the section to 
follow.   
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All variables, including derived entities, were output into comma separated variable (CSV) files for future 
statistical analysis.  The update frequency for the time-series data that was output into the CSV files was 
minute-by-minute averages for all variables.  The only exceptions to this were the data from Chapters 
5.2 and 6.2, where the data was output in 10-second-by-10-second averages, due to short duration of 
these recordings. 
 
3.4.3 Derived Physiologic Measures 
 
3.4.3.1 Cerebral Perfusion Pressure (CPP) 
 
CPP was derived via the difference between MAP and ICP signals:  
 CPP = MAP – ICP      (3.1) 
Where CPP, MAP and ICP are measured in mm Hg. 
3.4.3.2 Continuous Indices of Cerebrovascular Reactivity 
 
All continuous indices of cerebrovascular reactivity were calculated via a similar moving Pearson 
correlation coefficient method, correlating slow wave fluctuations in a surrogate marker for pulsatile 
CBV (ie. ICP, AMP, TOI, THI, PbtO2) or CBF (ie. FVm, FVs, FVd, LDF-CBF) with that of a driving pressure (ie. 
MAP or CPP).  The following example is for PRx, with identical calculation methods utilized for the other 
indices.  PRx is calculated as the moving correlation coefficient between slow wave fluctuations of ICP 
and MAP.  This is calculated using 30 consecutive 10 second windows of ICP and MAP (ie. five minutes of 
data), with the PRx index updated every minute (ie. having 80% data overlap between each PRx 
measure), unless otherwise specified in the individual Chapters.  Table 3.3 displays all of the calculated 
continuous indices of cerebrovascular reactivity. These indices were calculated identically in both the 
experimental and human adult studies. 
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Table 3.3 – Continuous Indices of Cerebrovascular Reactivity Calculated 
Index Signals Correlated Signal 
Averaging (sec) 
Pearson 
Correlation 
Coefficient 
Calculation 
Window (min) 
Index Calculation 
Update Frequency 
(sec)* 
PRx ICP and MAP 10 5 60 
PAx AMP and MAP 10 5 60 
RAC AMP and CPP 10 5 60 
Mx FVm and CPP 10 5 60 
Mx_a FVm and MAP 10 5 60 
Sx FVs and CPP 10 5 60 
Sx_a FVs and MAP 10 5 60 
Dx FVd and CPP 10 5 60 
Dx_a FVd and MAP 10 5 60 
TOx TOI and CPP 10 5 60 
TOx_a TOI and MAP 10 5 60 
THx THI and CPP 10 5 60 
THx_a THI and MAP 10 5 60 
ORx-5 PbtO2 and CPP 30 5 60 
ORx-30 PbtO2 and CPP 30 30 60 
ORx-60 PbtO2 and CPP 30 60 60 
Lx LDF-CBF and CPP 10 5 60 
Lx_a LDF-CBF and MAP 10 5 60 
CPP = cerebral perfusion pressure, FVd = diastolic flow velocity, FVm = mean flow velocity, FVs = systolic flow velocity, ICP = 
intracranial pressure, LDF-CBF = laser Doppler flowmetry cerebral blood flow, MAP = mean arterial pressure, min = minute, 
PbtO2 = brain tissue oxygenation, sec = second, THI = total hemoglobin index, TOI = total oxygenated hemoglobin index. *Note: 
update frequency of the indices varied within the studies presented in this thesis, as a consequence of recording duration.  Each 
subsequent chapter will mention the update frequency within the respective Methods sections.  
 
3.5 Neuroimaging 
 
3.5.1 Computed Tomography (CT) 
 
Chapter 9 deals with the study of IC injury burden as it relates to cerebrovascular reactivity in adult TBI.  
For this, all admission CT scans of the brain were manually collected from the electronic imaging 
repository at Addenbrooke’s Hospital for adult TBI patients with archived ICM+ raw physiologic data.  
Each of these scans were downloaded and stored anonymously in DICOM format for future injury 
pattern or burden analysis.  Only patients from March 2005 to December 2016 had their imaging 
collected, given digital imaging was not available prior to March 2005.   
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Each CT scan had a detailed assessment of IC injury, as measured by standard CT scoring systems 
(Marshall,153 Rotterdam,154 Helsinki155 and Stockholm156). The CT scoring systems consist of the following: 
 
1. Marshall CT Score153 
a. A categorical/ordinal scoring system (range: 1 to 6) 
i. I = no visible injury on CT 
ii. II = diffuse injury; <5 milimeters (mm) midline shift (MLS); basal cisterns visible; 
no lesion >25 mililiters (mL) 
iii. III = diffuse injury; <5 mm MLS; basal cisterns compressed or absent; no lesion 
>25 mL 
iv. IV = MLS >5 mm; basal cisterns compressed or absent; no lesion >25 mL 
v. V = any MLS; any basal cistern status; mass lesion >25 mL that is surgically 
evacuated 
vi. VI = any mass lesions >25 mL that is NOT surgically evacuated 
 
2. Rotterdam CT Score154 
a. A summative scoring system consisting of the following point-based sytem (range:1 to 6) 
i. Basal Cisterns 
1. 0 = normal 
2. 1 = compressed 
3. 2 = absent 
ii. MLS 
1. 0 = no shift or <=5 mm 
2. 1 = Shift >5 mm 
iii. Epidural Mass Lesion 
1. 0 = present 
2. 1 = absent 
iv. Intraventricular Blood or Traumatic Subarachnoid Hemorrahge (tSAH) 
1. 0 = absent 
2. 1 = present 
v. Then total sum + 1 for final score 
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3. Helsinki CT Score155 
a. A summative scoring system consisting of the following point-based system (range: -3 to 
14) 
i. Mass Lesion Type 
1. 2 = Subdural Hematoma (SDH) 
2. 2 = Intracerebral Hemorrhage 
3. -3 = Epidural Hematoma (EDH) 
ii. Mass Lesion Size 
1. 2 = > 25 mL  
iii. Intraventricular Hemorrhage (IVH) 
1. 3 = Yes 
iv. Suprasellar Cisterns 
1. 0 = normal 
2. 1 = compressed 
3. 5 = obliterated 
 
4. Stockholm CT Score156 
a. A formula-based calculated scoring system based on the following formula: 
i. Score = (MLS/10) + (tSAH-IVH subscore/2) – 1(if EDH present) + 1 (if DAI present) 
+ 1 (if dual-sided SDH present) + 1 
ii. Where: 
1. MLS is in mm 
2. tSAH-IVH subscore is a summed score: 
a. subscore = convexity tSAH score + basal cistern tSAH score + 
(IVH score*2) 
b. Where: 
i. Convexity tSAH 
1. 0 = none 
2. 1 = vivisble in gyri 
3. 2 = extensive bilateral (ie. >90% filled convexity) 
ii. Basal cistern tSAH 
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1. 0 = none 
2. 1 = visible blood 
3. 2 = filled cisterns 
iii. IVH 
1. 0 = none 
2. 1 = visible blood 
 
The Stockholm score was also assessed as an ordinal score using the following system:  0 to 1 = 1; 1.1 to 
2 = 2; 2.1 to 3 = 3; 3.1 to 4 = 4; 4.1 to 5 = 5; 5.1 to 6 = 6, which displayed a strong correlation with the 
continuous Stockholm CT score (r=0.947). 
Next, a comprehensive CT lesion/characteristic database was constructed for each admission CT scan. 
This IC injury database consisted of: 
 
1. Continuous variables:  MLS – in mm, largest lesion volume – in mL, number of contusions, 
number of diffuse axonal injury (DAI) lesions, total contusion volume – in mL.  
MLS was measured on the admission CT using the distance of the septum pellucidum from 
bony midline (derived from the line connecting the crista gallae to the inion), at the level of 
the foramen of Monro. Volumes were calculated using the AxBxC/2 method for contusions 
and extra-axial hemotomas from the admission CT scans, where: A = maximal antero-
posterior length in centimeters (cm), B = maximal thickness in cm, and C = # of 1 cm CT slices 
(where slices with ≥75% Area of Hemorrhage: Counts as 1 slice; slices with 25-75% Area of 
Hemorrhage: Counts as 0.5 slices; slices with <25% Area of Hemorrhage: Counts as 0 
slices).157  Volumes for each contusion were calculated individually. 
 
2. Ordinal characteristics:  A. basal cistern compression (none, compressed, complete), B. 
lateral ventricle compression (none, compressed, complete), C. convexity gyral compression 
(none, compressed, complete), D. 4th ventricle compression (none, compression, complete), 
E. convexity tSAH extent (none, visible in gyri, >90% of bilateral hemispheric coverage), F. 
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convexity tSAH maximal thickness (none, 1-5 mm, >5 mm), G. cisternal tSAH extent (none, 
visible, completely filled). 
 
3. Binary characteristics:   
 
A. basal cistern compression (none, any 
compression amount) 
B. extreme basal cistern compression 
(none, complete effacement) 
 C. lateral ventricle compression (none, 
any compression) 
D. extreme lateral ventricle 
compression (none, complete 
effacement) 
E. 4th ventricle compression (none, any 
compression) 
F. extreme 4th ventricle compression 
(none, complete effacement) 
G. convexity gyri compression (none, 
any compression) 
H. extreme convexity gyri compression 
(none, complete effacement) 
I. tonsillar decent (no, yes), J. any lesion 
>25 mL (no, yes) 
K. evacuated mass lesion (no, yes) 
L. non-evacuated mass >25 mL (no, yes) 
M. convexity subdural hematoma (SDH) 
(no, yes) 
N. tentorial SDH (no, yes) 
O. falcine SDH (no, yes) 
P. bilateral convexity SDH (no, yes) 
Q. convexity EDH (no, yes) 
R. bilateral convexity EDH (no, yes) 
S. contusion present (no, yes) 
T. bilateral contusions (no, yes) 
U. IVH (no, yes) 
V. convexity tSAH (no, yes) 
W. convexity tSAH >90% of 
hemispheres (no, yes) 
Y. convexity tSAH >5mm thick (no, yes) 
 Z. cisternal tSAH (no, yes) 
AA. cisternal tSAH completely filled (no, 
yes) 
AB. DAI – subcortical (SC) (no, yes) 
AC. DAI – corpus callosum (CC) (no, yes) 
AD. DAI – basal ganglia (BG) (no, yes) 
AE. DAI – brainstem (BS) (no, yes) 
AF. Post-fossa SDH (no, yes) 
AG. Post-fossa (EDH) (no, yes) 
AH. Post-fossa contusion (no, yes) 
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3.6 Human Ethical Considerations 
 
For Chapters 4, 6, 7, 8 and 9, all studies on human data were conducted as a retrospective analysis of a 
prospectively maintained database cohort, in which high frequency clinical neuromonitoring data had 
been archived. Monitoring of brain modalities was conducted as a part of standard NCCU patient care 
using an anonymized database of physiological monitoring variables in neurocritical care. Data on age, 
injury severity, and clinical status at hospital discharge were recorded at the time of monitoring on this 
database, and no attempt was made to re-access clinical records for additional information. Since all 
data was extracted from the hospital records and fully anonymized, no data on patient identifiers were 
available, and need for formal patient or proxy consent was waived. Within this institution, patient data 
may be collected with waiver of formal consent, as long as it remains fully anonymized, with no method 
of tracing this back to an individual patient. Patient physiologic, demographic and outcome data was 
collected by the clinicians involved with patient care, and subsequently recorded in an anonymous 
format. This anonymous data is then provided for future research purposes. Such data curation remains 
within compliance for research integrity as outlined in the UK Department of Health - Governance 
Arrangements for Research Ethics Committees (GAfREC), September 2011 guidelines, section 6.0.158 
 
3.7 Statistical Analysis 
 
The statistical analysis utilized for the studies in this thesis varied significantly from study to study, and 
were complex.  Thus, a detailed account of each statistical method used is beyond the scope of this 
general section.  Detailed account of the statistical methods utilized in each study can be found in the 
respective chapter methodology sections for each individual study. All statistics were performed with 
either XLSTAT (Addinsoft, New York, United States; https://www.xlstat.com/en/) add-on package to 
Microsoft Excel (Microsoft Office 15, Version 16.0.7369.1323) or R statistical software (R Core Team 
(2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria. URL https://www.R-project.org/).159  For all statistical tests described, alpha was set at 
0.05 for significance. In general, no correction for multiple comparisons was undertaken, unless explicitly 
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stated in the specific chapter and section of this thesis.  Given the majority of the work presented is 
exploratory in nature, avoiding correction for multiple comparisons was acceptable. 
In general, continuous variables were described using means and standard deviations, with ordinal data 
described via median and inter-quartile range (IQR). Normality was confirmed in continuous variables 
using Shapiro-Wilks test.  Various x-y plots were produced within the studies, employing simple linear 
models and error bar plots. 
Comparison between parametric variables employed t-tests and analysis of variance (ANOVA), while 
non-parametric data was compared via Mann-Whitney-U test, Kruskal-Wallis test, Friedman test and 
Jonckheere-Terpstra test.  Correlation between variables was assessed via Pearson and Spearman 
ranked correlation coefficient, depending on the individual study. 
Multi-variate assessment of inter-index co-variance occurred via principal component analysis (PCA),159–
161 agglomerative hierarchal clustering (AHC)159,162 and k-means cluster analysis (KMCA).159,160 AHC results 
were quantified using Cophenetic correlation coefficients,162 while KMCA clustering was validated via the 
“elbow method”.159 
Linear modelling employed in the estimation and forecasting of PRx using non-invasive surrogates 
(Chapter 7.1, 7.2) utilized complex time-series techniques in R.159,163–166  Autoregressive integrative 
moving average (ARIMA) time-series models were used to model PRx over time, and subsequently 
embedded in linear mixed effects (LME) models in order to build models that accurately estimated PRx 
using non-invasive TCD surrogate.  Models were compared via autocorrelation function (ACF) plots, 
partial autocorrelation function (PACF) plots, Akaike Information Criterion (AIC), Bayesian Information 
Criterion (BIC), log likelihood (LL) and ANOVA. Further details can be found in Chapter 7.  
Logistic regression models, both univariate and multi-variable, were built under the principal of 
parsimony for the assessment of relationships to binary outcomes.  Models were compared via area 
under the receiver operating curve (AUC), chi-square testing, and Delong’s test. 
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CHAPTER 4: DEFINING A “NEW” CONTINUOUS INDEX OF 
CEREBROVASCULAR REACTIVITY IN ADULT TBI - RAC 
 
*The results of this study are also detailed in the publication:  Zeiler et al., J Neurotrauma. 2017; Dec 6. 
doi: 10.1089/neu.2017.5241. [Epub ahead of print].21 
 
4.1 Introduction 
 
Continuous indices of autoregulatory capacity have been implemented within ICU’s as a means of 
monitoring the pressure reactivity of the cerebrovascular system.  The TBI patient population has 
provided the substrate for most publications on the use of these indices,11,12 with data supporting an 
association between “poor” autoregulatory status, as assessed by these indices, with outcome.8,9  Such 
use of autoregulatory monitoring has been supported by recent authoritative statements on multi-
modal monitoring in TBI.12 
These continuous indices are typically derived as moving Pearson correlation coefficients between slow 
wave fluctuations in: surrogates of pulsatile CBV (e.g. ICP or AMP) and the driving pressure for CBF (ie. 
MAP or CPP).3 Two ICP derived indices of autoregulation have been described:  PRx (correlation between 
ICP and MAP)3 and PAx (correlation between AMP and MAP).15   
The majority of literature has focused on PRx and its association with outcome, and PRx values above 
+0.25 have been associated with mortality at 6 months.9   PRx has also been validated experimentally: 
CPP reduction below the LLA, defined using the gold standard of reductions in cerebral blood flow, is 
associated with an increase in PRx from negative to positive values.14  PRx has been utilized clinically to 
determine the individual optimal CPP in TBI, and is likely to be the basis for planned studies that assess 
the benefit of CPP targets that are associated with best autoregulation – optimum CPP (CPPopt).144 In 
contrast to this substantial literature on PRx, PAx is a relatively newly described autoregulatory index.  
However, preliminary data indicating potential superiority of PAx over PRx in outcome prediction in 
those with normal or low ICP.15  
Despite this substantial literature supporting the use of these ICP derived autoregulation indices, there 
still exists room for the exploration of new indices of physiologic measure.  In this chapter, a new 
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continuous index of cerebral physiology in a population of adult TBI patients without DC is defined.21  
This index is derived as the moving Pearson correlation between AMP and CPP, which is abbreviated as 
RAC (R for correlation coefficient, A for AMP and C for CPP). Given the potential added predictive 
capacity of the AMP-based index PAx over PRx in adult TBI,15 the fact that all current ICP-derived indices 
were based on MAP as the driver for CBF,3,15 and that the majority of non-ICP derived cerebrovascular 
reactivity indices (ie. TCD, NIRS, TD and PbtO2 based indices) are based on the correlation with CPP as 
the driver for pulsatile changes in CBV or CBF, it was only natural to explore the correlation between 
AMP and CPP as a potential metric of cerebrovascular reactivity. RAC is  potentially related to the 
general shape of the relationship between AMP and CPP observed clinically and also experimentally.145  
Given the correlation between CPP and AMP, it is possible that RAC combines information regarding 
cerebral compensatory reserve, similar to RAP (correlation coefficient between AMP and ICP), and 
cerebrovascular responsiveness, similar to PRx or PAx. 
 
4.2 Methods 
 
Patient Population 
 Extreme Physiology Examples 
Time trends of ICP, CPP, AMP, RAP, PRx, PAx and RAC in 2 individual patient examples of “extreme” 
physiology in adult TBI are described.  One patient displayed an episode of sustained intra-cranial 
hypertension (ICP >50 mm Hg for at least 1 hour), without return to baseline - Figure 4.1.  The second 
patient displays systemic arterial hypotension in the presence of relatively normal ICP’s - Figure 4.2.  
Both of these patients were chosen as examples in order to provide a large range of ICP and CPP 
variation during the recordings, allowing to display the AMP and RAC response in time over these 
ranges. 
 
 Non-DC Adult TBI Cohort 
In order to display the relationships between AMP/RAP/PRx/PAx and RAC with ICP and CPP in a wider 
population of patients, all non-DC adult TBI patients (n=358) were utilized. None of the patients, at any 
point during their hospital stay, underwent DC, even for refractory ICP. Those with mass lesions 
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identified upon admission, had subsequent evacuation immediately upon admission. For those with 
mass lesion evacuation, all follow-up CT scans were assessed to confirm that the bone flap was replaced 
post-operatively and that all follow-up scans confirmed that the bone flap was not removed at any point 
during their hospital stay. Any patient undergoing mass lesion evacuation without replacement of the 
bone flap were excluded. All patients were admitted to the NCCU at Addenbrooke’s Hospital, 
Cambridge, during the period of March 2005 to December 2016.  In addition, only patients with at least 
6 hours of recorded signals were included in this study. All patients suffered mild to severe TBI (defined 
as GCS of 8 or less).  Those small number of patients with mild TBI (defined as GCS 13 or higher on 
admission) had subsequent clinical deterioration requiring admission to the NCCU and invasive 
monitoring.  Treatment received during the recording periods included standard ICP-directed therapy, 
with an ICP goal of less than 20 mm Hg and CPP goal of greater than 60 mm Hg.   
Only patients without DC were selected in order to prevent the introduction of confounding ICP 
measurements post removal of the bone flap.22  It is known, that post-DC, PRx values are impacted.  This 
stems from the fact that PRx is dependent on CBV-driven changes in ICP, and these are are severely 
attenuated in the highly compliant intracranial cavity post-DC.  Thus, in order to prevent any impact 
from DC in assessing the relationship between all of the physiologic variables (ie. ICP, AMP, CPP) and the 
ICP derived indices (ie. RAC, PRx, PAx, RAP) these patients were excluded. 
 
Signal Acquisition and Processing 
Both ICP and ABP were recorded in all patients described within the manuscript.  ABP was obtained 
through either radial or femoral arterial lines connected to pressure transducers (Baxter Healthcare 
Corp. CardioVascular Group, Irvine, CA), zeroed at the right atrium, or tragus, depending on when the 
patient was admitted to hospital.  ICP was acquired via an intra-parenchymal strain gauge probe 
(Codman ICP MicroSensor; Codman & Shurtleff Inc., Raynham, MA).  Mathematically, such variance in 
ABP zero level does not impact the derived correlation values, sign or magnitude, between slow-wave 
changes in ICP, ABP, AMP or CPP. 
All signal acquisition and processing occurred as described with in Chapter 3.3 and 3.4.  Minute-by-
minute data for ICP, MAP, AMP, PRx, PAx and RAC were derived using ICM+, and utilized in further 
statistical analysis. RAP, the correlation coefficient between AMP and ICP (a measure of cerebral 
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compensatory reserve)167–169 was also derived for comparison with the indices of cerebrovascular 
reactivity (PRx, PAx, and RAC). 
 
Statistics 
Statistics were performed utilizing XLSTAT (Addinsoft, New York, United States; 
https://www.xlstat.com/en/) add-on package to Microsoft Excel (Microsoft Office 15, Version 
16.0.7369.1323) and R statistical software (R Core Team (2016). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/).   
As the purpose of this study was to define a new physiologic index and provide a time series description 
of RAC, PRx, PAx, RAP and AMP in a large, non-DC, cohort of adult TBI, very limited inferential statistical 
results are presented.  A variety of plots were produced: 
 
1. Plots of ICP, MAP, CPP, AMP, RAP, PRx, PAx and RAC over time for the 2 patient examples of 
extreme physiology.   
 
2. Plots of the number of minute-by-minute observations per 5 mm Hg bins of ICP and CPP for the 
entire non-DC cohort. 
 
3. Plots of AMP vs. ICP, AMP vs. CPP, RAP vs. ICP, RAP vs. CPP, PRx vs. ICP, PRx vs. CPP, PAx vs. ICP, 
PAx vs. CPP, RAC vs. ICP, and RAC vs. CPP for the entire non-DC cohort.  Plots utilizing 5 mm Hg bins of 
ICP or CPP against the mean AMP, RAP, PRx, PAx or RAC for observations within those bins were 
produced. 
 
4. CPPopt plots of PRx vs. CPP, PAx vs. CPP, and RAC vs. CPP (using 5 mm Hg CPP bins and mean 
PRx, PAx or RAC for observations in those bins) for the entire non-DC population. 
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Plots were created using R statistical software.  Plots described in #3 and #4 above, display mean values 
for AMP, RAP, PRx, PAx and RAC per 5 mm Hg bin of ICP or CPP, with standard error bars.  Values for CPP 
below 35 mm Hg were collated into 1 bin, given the small number of observations in a small number of 
patients.  Thus, the mean values and standard error bars for values in this CPP range must be interpreted 
with caution. Similarly, for ICP values above 90 mm Hg, all of these observations were collated into one 
bin, called “>90 mm Hg”, given the small number of patients and observations within this ICP range.  
Thus, the mean values and standard error bars in this ICP range must be interpreted with caution 
Finally, the inter-index Pearson correlation coefficients between RAC and PRx, PAx and RAP, using grand 
mean data for the patient population (ie. one mean value per patient) were assessed.  Linear regression 
analysis between RAC vs PRx, RAC vs. PAx and RAC vs. RAP was also performed. 
 
 
4.2 Results 
 
AMP and RAC During “Extremes” of ICP and CPP 
Figure 4.1 displays one patient with sustained intra-cranial hypertension.  Of note, there is substantial 
sustained increase in ICP, with subsequent decrease in CPP.  Furthermore, it is noted that AMP gradually 
increases with ICP increase until at break point at ~60 mm Hg of ICP.  This has been described previously 
as a probable effect caused by a collapse of cerebral arterial bed.91,145,170  RAP remains elevated, near 
+1.0 as AMP progressively increases to its break-point, after which is decreases to negative numbers. 
The RAP response indicates severely impaired cerebral compensatory reserve with values decreasing to 
negative range in the last 2 hours of recording. Finally, RAC gradually becomes more positive (ie. 
increasing positive correlation between AMP and CPP) as ICP continues to increase, and as CPP 
decreases.  This increase in RAC was initially gradual, but then appeared to sharply increase around the 
ICP range for the break point of AMP, with CPP falling below ~50 mm Hg.  This increase in RAC may 
reflect progressive decrease in cerebral compensatory reserve in line with steady increase in both PRx 
and PAx, indicating autoregulatory dysfunction.  
Figure 4.2 displays a patient with progressive arterial hypotension, in the setting of low ICP (<20 mm Hg).  
As MAP decreases, both ICP and CPP decrease.  Of note, AMP increases with MAP less than 80 mm Hg.  
RAP starts close to zero, indicating relatively good cerebrospinal compensatory reserve, followed by a 
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subsequent decrease with progressive decrease in MAP.  PRx, PAx and RAC progressively become more 
positive with decreases in MAP, potentially indicating impaired autoregulation with profound systemic 
hypotension.  
 
Figure 4.1:  Sustained Intra-Cranial Hypertension Patient Example – ICP, MAP, CPP, AMP, RAP, PRx and RAC Over Time 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, mm Hg = 
millimeters of Mercury, abp = MAP = mean arterial pressure, PAx = pulse amplitude index (correlation between AMP and MAP), 
PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation coefficient between AMP and CPP, RAP = 
correlation coefficient between AMP and ICP.  Panel A: ICP over time, Panel B: MAP over time, Panel C: CPP over time, Panel D: 
AMP over time, Panel E: RAP over time, Panel F: PRx over time, Panel G:  PAx over time, Panel H: RAC over time. 
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Figure 4.2:  Arterial Hypotension Patient Example – ICP, MAP, CPP, AMP, RAP, PRx and RAC Over Time 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, mm Hg = 
millimeters of Mercury, abp = MAP = mean arterial pressure, PAx = pulse amplitude index (correlation between AMP and MAP), 
PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation coefficient between AMP and CPP, RAP = 
correlation coefficient between AMP and ICP.  Panel A: ICP over time, Panel B: MAP over time, Panel C: CPP over time, Panel D: 
AMP over time, Panel E: RAP over time, Panel F: PRx over time, Panel G: PAx over time, Panel H: RAC over time. 
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AMP, RAP, PRx, PAx and RAC versus ICP and CPP in the Non-DC Cohort 
 
Non-DC Cohort Patient Demographics 
In total, there were 358 patients included for analysis.  All patients suffered moderate to severe TBI, or 
mild TBI with secondary deterioration requiring sedation and mechanical ventilation for intracranial 
hypertension.  In addition, all patients had at least 6 hours of high frequency signals recorded.  The mean 
age was 40.6 +/-17.2 years (range: 16 to 89), with a median (range) Glasgow Coma Scale score of 7 (3 to 
13).  There were 272 males (76.0%), and the mean length of signal recording was 189.1 +/-151.1 hours 
(range: 8.5 to 1033.0 hours; median = 152.7 hours).  The mean ICP, MAP, CPP, AMP, RAP, PRx, PAx and 
RAC were:  14.057 +/-7.6 mm Hg, 91.3 +/- 7.9 mm Hg, 77.5 +/- 8.5 mm Hg, 2.3 +/- 1.4 mm Hg, 0.638 +/- 
0.208, 0.046 +/-0.173, -0.057 +/- 0.195, and -0.350 +/- 0.254; respectively. 
 
Number of Data Points 
In total, there were 2,780,930 minute-by-minute observations for each physiologic variable and index 
(RAP, PRx, PAx and RAC) across the 358 non-DC TBI patients included for analysis.  Overall, 99.9% of the 
data points fell between ICP values of 0 and 65 mm Hg, and CPP values of 40 to 140 mm Hg. 
 
 Relationship Between AMP vs. ICP and AMP vs. CPP 
Using 5 mm Hg bins for ICP and CPP, the mean AMP, RAP, PRx, PAx and RAC values for those bins were 
calculated and a range of plots were produced.  Figure 4.3 displays the following relationships:  CPP vs. 
ICP, (Figure 4.3A), AMP vs. ICP (Figure 4.3B), RAP vs. ICP (Figure 4.3C), PRx vs. ICP (Figure 4.3D), PAx vs. 
ICP (Figure 4.3E) and RAC vs. ICP (Figure 4.3F).  Figure 4.4 displays:  ICP vs. CPP (Figure 4.4A), AMP vs. 
CPP (Figure 4.4B), RAP vs. CPP (Figure 4.4C), PRx vs. CPP (Figure 4.4D), PAx vs. CPP (Figure 4.4E) and RAC 
vs. CPP (Figure 4.4F).  Of note is the increase in AMP, as ICP increases, to a peak at an ICP of ~50-60 
(Figure 4.3B), followed by sharp decline in AMP with increasing ICP value.   
Similarly, as CPP decrease towards 50 mm Hg, AMP gradually increases and peaks at a CPP of ~40 mm 
Hg.  This is followed by a sharp decrease in AMP with progressive decrease in CPP below 40 mm Hg 
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(Figure 4.4B).  These two relations have both been previously described,145 with the current data 
supporting the previous literature.  
 
 Relationship Between RAP vs. ICP and RAP vs. CPP 
At low ICP, RAP starts at small positive values, indicating little correlation between AMP and ICP, thought 
to signify “good” cerebral compensatory reserve.  RAP subsequently trends towards +1.0 as ICP 
increases towards the “break-point” in AMP (ie. ICP of 50 to 60 mm Hg – Can be seen in Figure 4.3B).  
This signifies a direct positive correlation between ICP and AMP, thus low cerebral compensatory 
reserve.  Once ICP increases beyond 50-60 mm Hg (ie. the averaged AMP “break-point”), RAP rapidly 
declines towards zero.  This is believed to reflect exhaustion of cerebrovascular reserve and vascular 
transmural pressure approaching the critical closing pressure of the cerebral vessels. All of this can be 
seen in Figure 4.3C.   
Similarly, as CPP declines towards the LLA, we see a steep increase in RAP towards more positive values, 
implying poor cerebral compensatory reserve (Figure 4.4C).  As CPP increases, RAP decreases towards 
zero, with relative stability in RAP (ie. become more positive) with CPP values above the ULA (Figure 
4.4B).  However, it must be acknowledged that the number of data points above a CPP of 130-140 mm 
Hg is much less, as seen by the error bar plots in this range. 
 
 Relationship Between PRx vs. ICP and PRx vs. CPP 
PRx versus ICP plots display a consistent trend, with low PRx values during episodes of low ICP, and 
progressively more positive PRx values (ie. more impaired autoregulation) as ICP increases above 20 mm 
Hg (Figure 4.3D). The PRx versus CPP plots displays the classic parabolic distribution, with low PRx values 
(ie. intact autoregulation) within the CPP range of ~50 mm Hg to 130 mm Hg.  Outside of these two 
limits of CPP, PRx subsequently trends toward positive values (indicating potentially impaired 
autoregulation) (Figure 4.4D). 
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Relationship Between PAx vs. ICP and PAx vs. CPP 
Similar to PRx, PAx versus ICP plots display a consistent trend, with low PAx values during episodes of 
low ICP, and progressively more positive PAx values (ie. more impaired autoregulation) as ICP increases 
above 20 mm Hg (Figure 4.3E). The PAx versus CPP plots displays the classic parabolic distribution, with 
low PAx values (ie. intact autoregulation) within the CPP range of ~50 mm Hg to 130 mm Hg.  Outside of 
these two limits of CPP, PAx subsequently trends toward positive values (indicating potentially impaired 
autoregulation) (Figure 4.4E). 
 
 Relationship Between RAC vs. ICP and RAC vs. CPP 
Finally, interesting relationships were observed between RAC and both ICP and CPP.  As ICP increases, 
RAC becomes progressively more positive (Figure 4.3F).  This is similar to what was seen in the PRx vs. 
CPP plot (Figure 4.3D) and the PAx vs. CPP plot (Figure 4.3E). Thus, RAC may carry similar information 
regarding the cerebrovascular system as PRx and/or PAx.  However, given the nature of the RAC 
coefficient, this may also represent physiologic processes related closely to alterations in cerebral 
compensatory reserve:  
A. At low ICP (less than 20 mm Hg), RAC displays negative values, indicating a negative correlation 
between CPP and AMP (Figure 4.3F).  This potentially represents states of good cerebral compensatory 
reserve (as seen with RAP values closer to zero; Figure 4.3C) and preserved autoregulation (as seen with 
PRx and PAx at low values; Figure 4.3D and 4.3E), in which changes in MAP do not lead to direct changes 
in ICP, nor AMP.  Thus, the phase of slow wave fluctuations in both AMP and MAP (or CPP – since CPP is 
predominantly composed of MAP contribution at low ICP) are close to completely opposite in nature, 
hence the negative correlation coefficient generated by RAC.  Furthermore, it may also be reflected in 
the decrease in AMP (Figure 4.3B) and increasing CPP (Figure 4.3A), as ICP decreases. 
 
B. As ICP increases, above 20 mm Hg towards 60 mm Hg, we see a gradual increase in RAC towards 
zero (Figure 4.3F). During this ICP increase, cerebral compensatory reserve worsens, as seen with RAP 
approaching +1.0 (Figure 4.3B) and the increase in AMP (Figure 4.3B). However, this occurs during a 
progressive decrease in CPP, secondary to an increase in ICP (Figure 4.3A).  This CPP decrease leads to a 
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decreased amplitude of slow wave fluctuations in CPP, and thus little to no correlation between slow 
wave phase of CPP and AMP (generating RAC values close to zero). 
 
C. Finally, at further extreme levels of ICP (ie. above ~60 mm Hg), we see a gradual increase in RAC 
towards positive values (Figure 4.3F).  At this point, cerebral compensatory reserve is believed to be at 
its worst.  This is reflected in the “break-point” in the ICP versus AMP relationship (Figure 4.3A), and the 
progressive decrease in RAP towards zero (Figure 4.3C).  CPP continues to trend low (Figure 4.3A), 
however given severely impaired compensatory reserve and pressure reactivity (highly positive PRx and 
PAx), any slow wave fluctuations in MAP are potentially amplified in ICP (and thus AMP, but this time 
with negative relationship, Fig 4.4B) leading to slow waves of CPP and AMP becoming progressively 
more “in phase” and thus producing the positive RAC value observed in this ICP range.  Furthermore, 
AMP continues to decrease after this “break-point”, while CPP drops secondary to extreme ICP values, 
also reflected in the positive index value for RAC. (Figure 4.3D, 4.3E and 4.3F). 
 
The RAC vs. CPP plots also mimicked the PRx vs. CPP and PAx vs. CPP plots, displaying a parabolic 
relationship, with a minimum in the curve at a CPP of approximately 65 to 70 mm Hg for all three 
relationships.  This minimum corresponded to the “most negative” value for each index: PRx, PAx and 
RAC.  Thus, again, RAC may carry similar information regarding the cerebrovascular system as PRx 
and/or PAx.  However, again, given the nature of the RAC index, it may carry some additional 
information about cerebral compensatory reserve during changes in CPP:  
A. As CPP approaches the LLA (ie. ~50 mm Hg), RAC begins to gradually increase, with sharp 
increases towards more positive values as CPP continues to decrease below 50 mm Hg (Figure 4.4F).  
This corresponds to a steep increase in RAP towards +1.0, indicating progressing deterioration in 
cerebral compensatory reserve (Figure 4.4C) as it is associated with increases in ICP (Figure 4.4A). Thus, 
given impaired compensatory reserve, any slow wave fluctuations in MAP (and thus CPP) may be directly 
transmitted to ICP (and thus AMP), implying they become progressively more “in phase”, producing the 
positive RAC coefficient.  
Of more interest, is what happens as CPP progressively decreases below ~50 to 60 mm Hg.  RAC 
continues toward more positive values, similar to PRx.  However, RAP reaches its peak and subsequently 
decreases towards zero, reflective of the “break-point” in AMP and what is believed to be severely 
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impaired cerebral compensatory reserve. This may represent the point where cerebrovascular 
transmural pressure approaches critical closing pressure of the vessels, though this hasn’t been proven.  
Thus, RAC values below this point in CPP may strictly carry cerebrovascular physiologic information, and 
not both: cerebrovascular and compensatory reserve information, as seen during CPP ranges above this 
critical point.  However, it must be acknowledged that the majority the observations (ie. millions of data 
points) were in CPP ranges of 50 to 100 mm Hg, so interpretation of the relationships with CPP below 50 
mm Hg must be interpreted with caution. 
 
B. RAC reaches a minimum around CPP values of 65 to 70 mm Hg, similar to PRx.  Outside of this 
CPP range, both RAC and CPP increase towards positive values.  During this CPP range, there is a 
negative correlation between CPP and AMP.  Thus, the phase of slow wave fluctuations in AMP and MAP 
(or CPP – since CPP is predominantly composed of MAP contribution at the low ICP values seen in this 
range for CPP; Figure 4.4A) may be closer to completely opposite in nature, hence the negative 
correlation coefficient generated by RAC.   
 
C. Similarly, as CPP increases towards the ULA (ie. ~150 mm Hg), RAC gradually becomes more 
positive as well (Figure 4.4F), as seen with PRx (Figure 4.4D).  This is in states with low ICP (Figure 4.4A).  
Cerebral compensatory reserve improves with CPP values up to ~130 to 140 mm Hg, as indicated by the 
decrease in RAP towards zero (Figure 4.4C) and AMP progressively decreasing (Figure 4.4B).  With CPP 
values above ~140 mm Hg, RAP appears to remain low (Figure 4.4C), though we have a relatively low 
number of data points in this range (as previously mentioned), so this much be interpreted with caution 
given the error bar range.  RAC continues to increase towards zero as CPP increases up to and beyond 
the ULA (Figure 4.4F), despite decreasing AMP during this process (Figure 4.4B).  Thus, in this state of 
“good compensatory reserve”, and deceasing AMP with increasing CPP, the trend towards more positive 
RAC values may represent a purely cerebrovascular phenomenon, similar to PRx and PAx in this CPP 
range.  This could represent autoregulatory dysfunction at and beyond the ULA, as seen with both the 
PRx vs. CPP and PAx vs. CPP plots (Figure 4.4D and 4.4E), though this requires much further validation 
and again should be interpreted with caution given the limited data points beyond CPP values of ~130 to 
140 mm Hg. 
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Figure 4.3: Non-DC Cohort – CPP vs. ICP, AMP vs. ICP, RAP vs. ICP, PRx vs. ICP, PAx vs. ICP and RAC vs. ICP Plots 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, mm Hg = 
millimeters of Mercury, PAx = pulse amplitude index (correlation between AMP and MAP), PRx = pressure reactivity index, RAC = 
correlation coefficient between AMP and CPP, RAP = correlation coefficient between AMP and ICP. Panel A:  CPP vs. ICP plot, 
Panel B: AMP vs. ICP plot, Panel C: RAP vs. ICP plot, Panel D: PRx vs. ICP plot, Panel E: PAx vs. ICP plot, Panel F: RAC vs. ICP plot. 
 
 
 
74 
 
Figure 4.4: Non-DC Cohort – ICP vs. CPP, AMP vs. CPP, RAP vs. CPP, PRx vs. CPP, PAx vs. CPP, and RAC vs CPP Plots 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, mm Hg = 
millimeters of Mercury, PAx = pulse amplitude index (correlation between AMP and MAP), PRx = pressure reactivity index, RAC = 
correlation coefficient between AMP and CPP, RAP = correlation coefficient between AMP and ICP. Panel A:  CPP vs. ICP plot, 
Panel B: AMP vs. ICP plot, Panel C: RAP vs. ICP plot, Panel D: PRx vs. ICP plot, Panel E: PAx vs. ICP plot, Panel F: RAC vs. ICP plot 
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RAC and RAP/PRx/PAx – Inter-index Correlation  
 
Using grand mean data for the non-DC cohort of patients (ie. one data point per variable, per patient) 
we calculated the Pearson correlation coefficients to be:  0.718 for RAC and PRx (p<0.0001), with a linear 
relationship (Figure 4.5A).  The correlation between RAC and PAx was 0.816 (p<0.0001), with a linear 
relationship (Figure 4.5B).  Finally, the correlation between RAC and RAP was -0.594 (p<0.0001), with a 
negative linear relationship (Figure 4.5C). 
 
 
“Optimal CPP” Curves  
Given the interest in optimal CPP (CPPopt), and the application of PRx for this purpose, we plotted both:  
RAC vs. CPP (Figure 4.4F), PRx vs. CPP (Figure 4.4D) and PAx vs. CPP (Figure 4.4E); using 5 mm Hg bins of 
CPP and mean values for RAC and PRx for observations within those bins, using the minute-by-minute 
data for the entire non-DC cohort.  The optimal CPP is subsequently determined by finding the CPP 
values with the corresponding lowest PRx, PAx or RAC value (ie. the minimum of the parabola). The CPP 
optimum values from each of:  PRx vs. CPP, PAx vs. CPP and RAC vs. CPP, are similar (ie. ~65 to 70 mm 
Hg). In addition, of interest is the improved parabolic shape of the RAC vs. CPP curve, compared to both 
the PRx vs. CPP and PAx vs. CPP curves.  This is increasingly true for high values of CPP, where the PRx vs. 
CPP and PAx vs. CPP parabola appear to degenerate in shape, with this relationship appearing more 
preserved in the RAC vs. CPP curve.  Thus, for CPP optimum determination, RAC may prove to be 
applicable in this instance.  Further analysis of CPP optimum employing RAC is required. 
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Figure 4.5: Non-DC Cohort – RAC vs. PRx Plot, RAC vs. PAx Plot, and RAC vs. RAP Plot 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, mm Hg = millimeters of Mercury, PAx = pulse amplitude index (correlation between AMP 
and MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation coefficient between AMP and CPP, RAP = correlation between AMP and ICP. 
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4.4 Discussion 
 
Through the analysis of both the individual examples and the large non-DC TBI cohort, some interesting 
features have been identified regarding a new physiologic RAC index that describes the relationship 
between cerebral perfusion pressure and ICP pulse amplitude.  Several issues merit discussion. 
First, being derived from the correlation between CPP and AMP, RAC appears to represent physiologic 
information pertaining to both: the cerebrovascular system (similar to PRx and PAx) and cerebral 
compensatory reserve (similar to RAP).  This makes this index potentially unique and of importance.  It is 
unlike other indices in that it carries information regarding multiple aspects of cerebral physiology.  This 
aspect of RAC contributes to its potential usefulness clinically.  However, it also contributes to the 
complexity of its interpretation.  As outlined in the results section, the interpretation of RAC requires the 
assessment of not just RAC, but AMP, RAP and PRx/PAx.  Only through this comprehensive analysis of 
multiple aspects of cerebral physiology can RAC be properly interpreted, allowing for an assessment of 
both cerebrovascular responsiveness and cerebral compensatory reserve. RAC requires much further 
investigation regarding its relation to cerebral compensatory reserve and autoregulation.  It is too early 
to know the exact relationship between RAC with both cerebral autoregulation and cerebral 
compensatory reserve. 
Second, based on the examples of extreme physiology (Figures 4.1, and 4.2), RAC appears to be 
temporally responsive to changes in both ICP and CPP, as seen in data obtained from patients 
experiencing varied insults:  sustained intra-cranial hypertension and arterial hypotension.  As ICP 
increase (or CPP decreases), there is a gradual increase in RAC to more positive values.  An example of 
this is within the intracranial hypertension patients (Figure 4.1), where increased ICP and AMP (with 
corresponding decreases in CPP), results in increased RAC.  This indicates an increasing direct positive 
correlation between AMP and CPP.  Furthermore, in the patient with sustained intra-cranial 
hypertension (Figure 4.1), as ICP progressively increased towards ~60 mm Hg, AMP reaches a peak and 
subsequent break point, which has been previously described and is believed to potentially represent 
“exhaustion of cerebrovascular reserve” associated hypothetically with collapse of arterial bed.91,145  
After this break point in AMP is reached, and ICP remains elevated, RAC dramatically increases to values 
above +0.50, even approaching +1.0 in one example (Figure 4.1).  Thus, it appears that the dramatic 
change in the rate of increase of RAC may denote this area of “exhaustion of cerebrovascular reserve”.  
These changes occurred in concert with impaired cerebral compensatory reserve, as represented by RAP 
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values near +1.0.  RAP responded with a rapid decrease towards negative values after the break-point in 
AMP, indicating severely impaired cerebral compensatory reserve.  We must acknowledge that these 
observations are based on only case examples, and thus need further validation. However, both of these 
examples display RAC’s ability to display information regarding cerebral compensatory reserve.  Finally, 
the arterial hypotension case (Figure 4.2) displayed a progressive increase in PRx, PAx and RAC, during 
low ICP and “good” compensatory reserve (as per RAP).  This supports the concept that RAC may carry 
some similar information to PRx or PAx, regarding cerebrovascular responsiveness. 
Third, based on the non-DC TBI cohort, there is an increase in AMP, as ICP increases, to a peak at an ICP 
of ~50-60 (Figure 4.3B).  Similarly, as CPP decreases towards 50 mm Hg, AMP gradually increases and 
peaks at a CPP of ~40 mm Hg.  This is followed by a sharp decrease in AMP with further decreases in CPP 
(Figure 4.4B).  These two relations have both been previously described,145 with the current data 
supporting the previous literature.  However, of interest is the RAC response at these two points.  As ICP 
reaches ~50 to 60 mm Hg, and AMP peaks (Figure 4.3B), RAC begins to dramatically increase towards 
more positive values with further increases in ICP (Figure 4.3F).  Similarly, as CPP decreases towards 40 
mm Hg, RAC also increases dramatically towards more positive values (Figure 4.4F).  However, these 
inferences are limited given the limited data for ICP above 50 mm Hg, and CPP below 40 mm Hg, 
compared the large volume of data for ICP and CPP values within the “normal” range.  Within the results 
section the preliminary interpretation of these changes in RAC, with respect to AMP, RAP, PRx and PAx 
have been outlined.  It is likely that RAC represents both aspects of changing cerebral compensatory 
reserve and cerebrovascular responsiveness, yielding uniqueness and complexity in this new index.  
Interpretation of RAC requires the evaluation of AMP, RAP and PRx/PAx. 
Fourth, within the large non-DC TBI cohort, RAC appeared to respect the classic limits of the Lassen 
curve, with a trend to more positive RAC values when CPP was both below the LLA and above the ULA.  
As displayed in Figure 4.4F, RAC remains negative within the CPP range of ~50 to 140 mm Hg, with a 
trend to more positive RAC values as CPP approaches both thresholds (and in the case of the LLA, drops 
below it).   This relationship is based on the ~2.7 million data points from the non-DC TBI cohort of 358 
patients.  However, it must be acknowledged that the number of data points for CPP values less than 50 
mm Hg and close to/above the ULA were much less (ie. 1000’s), compared to CPP values between 50 to 
100 mm Hg (ie. 100,000’s).  Thus, strong conclusions on RAC’s ability to delineate the LLA and ULA 
cannot be made at this time.  It is unknown if RAC represents autoregulation at this time, though it 
appears to carry some similar information to PRx or PAx.  Ideally this would be confirmed in a well-
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controlled animal model, similar to PRx. As with extremes in ICP, RAC interpretation in relation to CPP 
changes requires evaluating response in AMP, RAP and PRx/PAx; given it seems to carry information 
regarding compensatory reserve and cerebrovascular responsiveness. 
Fifth, based on a Pearson correlation coefficient:  
A. RAC and PRx are strongly correlated (r=0.718, p<0.0001) with a linear relationship,  
B. RAC and PAx are strongly correlated (r=0.817, p<0.0001) with a linear relationship.  
In addition, comparing the mean RAC and PRx values across the entire non-DC TBI cohort, RAC is on 
average ~0.30 to 0.40 lower than PRx.  This is also seen in Figure 4.4.  It is clear that RAC carries similar 
information to both PRx and PAx (Figure 4.3D, 4.3E and 4.3F; Figure 4.4D, 4.4E and 4.4F), though we 
cannot confirm that the information regarding autoregulation in PRx or PAx is equally represented in 
RAC.  This requires further investigation.  It appears that RAC represents both cerebral compensatory 
reserve and cerebrovascular responsiveness. 
Finally, when comparing the RAC vs. CPP (Figure 4.4F), PRx vs. CPP (Figure 4.4D) and PAx vs. CPP (Figure 
4.4E) curves, using 5 mm Hg bins of CPP, some important features were seen.  The RAC vs. CPP plot 
appeared to display a similar parabolic relationship to both the PRx vs. CPP and PAx vs. CPP curves, with 
the minimum at ~65 to 70 mm Hg in all instances.  However, comparing the shape of the parabolic 
distributions, the RAC vs. CPP plot appears to retain the parabolic shape better at high CPP values, 
where both the PRx vs. CPP and PAx vs. CPP plots appear to degenerate.  Thus, given these observations, 
RAC could potentially be utilized for CPP optimum determination.  Furthermore, given the stronger 
parabolic relation displayed by CPP vs. RAC, RAC may prove superior for CPP optimum determination.  
However, substantial additional investigation of these issues is required before the RAC can be used to 
determine CPPopt. 
 
Limitations 
Despite the interesting results, there are some significant limitations which should be mentioned.   
The patient examples of extreme physiology and the non-DC cohort are retrospective patient 
populations.  Thus, within this population of patients, there is potential for significant heterogeneity in 
injury burden/pattern, co-morbidity and treatment.  Furthermore, all of these patients were admitted to 
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the NCCU at Addenbrooke’s Hospital, receiving therapies directed at maintaining ICP below 20 mm Hg 
and CPP greater than 60 mm Hg.  Thus, strong conclusions from this data set must be cautioned, given 
the constant manipulation of ICP and CPP during the recording of this data.  In addition, the impact of 
various vasopressor agents on the cerebrovascular pressure autoregulatory response is not well 
understood, and could potentially further impact the results seen. 
All of the relationships and conclusions regarding RAC and its response to changes in ICP and CPP are 
preliminary, requiring much further work and investigation.  As previously alluded to, the strength of 
conclusions related to RAC at CPP levels both below the LLA and above the ULAR must be tempered by 
the fact that the majority of data points are within the “normal” CPP range secondary to continuous CPP 
manipulation within the NCCU.   Similarly, inferences regarding the response of RAC to ICP values above 
30 mm Hg need to be cautious, given the relatively small number of data points for ICP’s above this 
threshold.  This is likely a consequence of ICP directed therapies within the NCCU, which may also 
account for the relative “discontinuity” in the RAC vs. CPP, PRx vs. CPP and PAx vs. CPP curves at CPP 
values below 30 mm Hg.  With this said, the “small” number of data points outside of the normal CPP 
and ICP range, number in the thousands.  Thus, despite hundreds of thousands of data points within the 
normal range for CPP and ICP, inferences drawn from thousands of data points recorded during extreme 
CPP and ICP values provide useful data regarding interesting trends in RAC, and allow to set hypotheses 
that can be tested in larger datasets. 
Finally, even though the results described above for RAC are promising, they do not clearly demarcate 
the potential role, if any, for RAC monitoring within moderate and severe TBI patients.  This important 
aspect has yet to be shown.  Future plans exist to analyze the potential clinical relevance of RAC, 
compared to the existing indices PRx and PAx.  Further to this, none of the patients included within this 
study underwent DC at any point during their hospital course, even for refractory ICP issues.  Thus, no 
comments can be made on the temporal changes in RAC, or other indices, as a result of the DC 
procedure in TBI patients.  Subsequent analysis of the value of monitoring RAC, among other physiologic 
indices, in patients undergoing DC is required.  Future plans exist to pursue such analysis.  In addition, 
the current population is unable to provide any information regarding the utility of RAC in predicting the 
need for subsequent craniotomy due to lesion progression, or new lesion development.  This also 
requires further investigation. 
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4.1 Conclusions 
 
A new continuous index of physiologic assessment in TBI is described, RAC, based on the moving 
Pearson correlation coefficient between AMP and CPP.  Based on both examples of extreme physiology, 
and in a large non-DC cohort, RAC appears to be responsive to changes in ICP and CPP, at the expected 
limits of normal autoregulation.  RAC appears to carry information regarding both:  cerebral 
compensatory reserve and cerebrovascular responsiveness. This contributes RAC’s uniqueness and 
complexity of interpretation. Validation of RAC as a means of potential autoregulation assessment is 
required. Further analysis of RAC in outcome prediction and CPP optimum estimation in TBI are 
required. 
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CHAPTER 5:   EXPERIMENTAL VALIDATION OF ICP DERIVED INDICES OF 
VASCULAR REACTIVITY 
 
*The studies described in Chapter 5.1 and 5.2 can also be found detailed in the following respective 
publications: 
1. Zeiler et al., J Neurotrauma. 2018; 35(23):2812-2819. doi: 10.1089/neu.2017.5604.171 
2. Zeiler et al., J Neurotrauma. 2018; 35(23):2803-2811. doi: 10.1089/neu.2017.5603.172 
 
5.1 Lower Limit of Autoregulation in Piglet Model of Arterial Hypotension 
 
5.1.1 Introduction 
 
To date, numerous indices of cerebrovascular reactivity have been derived.4  Given ICP monitoring is 
common in critically ill neurological patients, ICP-derived indices have received the most attention.  PRx 
is the most widely cited index, and is the correlation between slow waves recorded in ICP and MAP.3  
Numerous studies link PRx to patient outcome in TBI, with critical thresholds associated with morbidity 
and mortality defined within the literature.9  Furthermore, PRx has been validated in a piglet model 
against the LLA during arterial hypotension, one of only three indices to be validated in this type of 
model (the other being NIRS derived COx and HVx).14   
Aside from PRx, two other ICP-derived indices of cerebrovascular reactivity exist.  PAx, the correlation 
between AMP and MAP, has been demonstrated to be comparable to PRx in outcome prediction for TBI 
patients.15 In cases with low ICP (like for example after decompressive craniectomy) PAx is probably 
more useful than PRx. However, limited literature exists in the application of PAx clinically.  Similarly, 
RAC, the correlation (R) between AMP (A) and CPP (C), has been recently described within the TBI 
population and was highlighted in Chapter 4 of this thesis.21  It remains currently unknown whether PAx 
or RAC measure the LLA. 
This study was conducted to determine if PAx and RAC discriminate the LLA during arterial hypotension, 
as well as to provide validation for the previous PRx study14 in a larger cohort of animals. 
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5.1.2 Methods 
 
Animal Model 
The data from studies in neonatal piglets described here were retrospectively amalgamated from 3 
separate experiments. 14,147,148  Details regarding these models, including experimental treatment, has 
been outline in the general methodology section in Chapter 3.1. In brief, this cohort consisted of 3 
separate sham animal populations, totaling 22 piglets, where no cerebral insult had occurred (ie. ICP 
elevations, cardiac arrest or hypothermia).  All of these animals underwent similar anesthetic (see 
Chapter 3.1), and subsequently had an esophageal balloon within the IVC inflated to induce arterial 
hypotension over the course of 2 to 3 hours.  ICP, ABP and LDF-CBF were recorded continuously 
throughout the experiment using ICM+. 
 
Signal Acquisition and Processing 
All signals from the combined monitoring modalities described above were recorded and archived for 
subsequent retrospective use. All recorded signals were digitized via an A/D converter (DT9804, Data 
Translation, Marlboro, MA), sampled at frequency of 50 Hertz (Hz) or higher, using ICM+ software 
(Cambridge Enterprise Ltd, Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk).  Signal artifacts, such 
as transducer adjustments, were removed prior to further processing or analysis using tools available in 
ICM+. 
CPP was determined as: MAP – ICP.  AMP was determined by calculating the fundamental Fourier 
amplitude of the ICP signal over a 10 second window, updated every 10 seconds.  This was done over 
the range consistent with the normal range for piglet heart rate (ie. 100 – 350 bpm).  Finally, 10 second 
moving averages (without data overlap) were calculated for all recorded signals:  ICP, AMP, ABP (ie. 
producing MAP), CPP, and LDF-CBF. The piglets’ archived signals were retrospectively interrogated and 
analyzed.   
The following continuous indices of cerebrovascular reactivity were derived: PRx, PAx, RAC and LDF 
derived Lx.  All indices were derived via moving Pearson correlation coefficients between 30 consecutive 
10 second average values of relevant signals and their parameters (ie. 5 minute of data), updated every 
minute. 
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Statistics 
All statistical analysis was conducted utilizing R statistical software (R Core Team (2016). R: A language 
and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
https://www.R-project.org/).  The following packages were employed:  ggplot2, dplyr, tidyverse, 
lubridate, segmented, and pROC. Where significance is reported, alpha was set at 0.05.  The following 
analysis described is similar to that performed within previous studies on the LLA. This was done so as to 
allow comparison between the results, and potentially provide validation of the results seen within that 
study.14 
 
 Finding the LLA 
In order to determine the LLA of autoregulation in the 22 animals, piecewise linear regression of the CPP 
versus LDF-CBF plots was employed.  The LDF-CBF signal was standardized against the individual animal’s 
baseline LDF-CBF signal, producing “% change of LDF-CBF from baseline”.  This is similar to other studies 
evaluating LDF-CBF. 
The piecewise regression process employed a starting point for estimation of the break-point in LDF-CBF. 
This starting point was visually estimated from the ICM+ plots of CPP versus LDF-CBF.  The breakpoint 
identified by the piece wise regression process is one in which minimized the sum residual square error 
(SSE) of the two linear segments, above and below this point.  This was conducted for each animal, with 
piecewise regression plots produced denoting the 95% confidence interval (CI) for each fitted linear 
segment.  Finally, the mean LLA for the cohort of 22 piglets was determined by averaging all 22 LLA 
values obtained. 
 
 Binned Cohort Data and Plot 
After delineating the mean LLA for the cohort, cohort wide plots were produced to inspect the 
population trend of various physiologic measures against the LLA.  All data was binned across 5 mm Hg 
bins of CPP, using R statistical software.  The following error bar plots were then produced:  % change in 
LDF-CBF From Baseline vs. CPP, PRx vs. CPP, PAx vs. CPP, and RAC vs. CPP.   
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 Comparing CPP for Various Clinical Thresholds of PRx, PAx and RAC to LLA 
To conduct a rough comparison of the CPP for clinically defined thresholds of PRx, PAx and RAC to the 
CPP at the LLA, piecewise regression was performed in each animal.  To do so, a simplified piecewise 
linear regression was performed for PRx vs. CPP and PAx vs. CPP, using these models to determine the 
CPP in each animal for the following thresholds of PRx and PAx defined in TBI patients.9,152 For PRx, the 
thresholds of 0, +0.25 and +0.35 were tested, based on previous work in TBI. For PAx, the thresholds of 0 
and +0.25 were tested. Finally, for RAC, the thresholds of -0.10 and -0.05 were tested. CPP values at 
each threshold for PRx, PAx and RAC were compared with the CPP values at the LLA using a Pearson 
correlation coefficient and Bland-Altman analysis.  The Bland-Altman analysis was only conducted for 
those thresholds reaching statistically significant correlations with the LLA (ie. PRx 0, PRx +0.25, and PRx 
+0.35). 
 
 Prediction of Impaired Autoregulation using Continuous Indices  
As done in previous studies, receiver operating curve (ROC) analysis of PRx, PAx, RAC and Lx were 
performed across the cohort defined LLA.  This was conducted in order to determine the ability of these 
indices to predict being either above or below the LLA.  For each piglet, one mean value for each variable 
was obtained at each 5 mm Hg bin of CPP (ie. CPP = 40 mm Hg, 45 mm Hg, etc.).  Five mm Hg bins of CPP 
were used for the ROC analysis, given this was what was conducted within the previous study by Brady 
et al.14 
This data was then given the binary designation of being above the LLA, or below the LLA, based on the 
LLA defined previously.  The data from all 22 piglets was then used for the ROC analysis.  AUC for the 
ROC’s was reported and 95% CI reported via Delong method. Significance values (ie. p-values) for the 
AUC’s were derived from univariate logistic regression analysis. Comparison between AUC’s was 
conducted using Delong’s test. 
 
 Criteria for Measures of the LLA 
In order to be able to say that a specific index provides a measure of the LLA in this particular model, the 
following criteria needed to be met: 
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1. Demonstration of cerebrovascular reactivity indices to trend towards progressively more 
positive values at CPP levels below the LLA. 
2. Statistically significant logistic regression analysis for each cerebrovascular reactivity index in the 
prediction of having CPP values above or below the cohort defined LLA. 
 
 
5.1.3 Results 
 
Defining the LLA 
Through piecewise linear regression analysis of each piglet, the LLA was obtained for each animal.  
Figure 5.1 displays an example of the recorded MAP, ICP, CPP and LDF-CBF signal during the hypotension 
experiment.  While Figure 5.2 displays two examples of piecewise linear regression analysis of the LLA.  
The mean LLA was 36.2 +/- 10.5 mm Hg.   
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Figure 5.1: Example of Physiologic Signal Changes During Hypotension 
 
a.u. = arbitrary units, CPP = cerebral perfusion pressure, ICP = intracranial pressure, LDF-CBF = laser Doppler flowmetry cerebral blood flow, MAP = mean arterial pressure, mm Hg 
= millimeters of Mercury. 
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Figure 5.2: Examples of Piecewise Linear Regression Analysis of LLA 
 
CPP = cerebral perfusion pressure, LDF-CBF = laser Doppler flowmetry cerebral blood flow, mm Hg = millimeters of Mercury. Panel A + B = Piecewise linear regression and scatter 
plot for one piglet.  Panel C + D = piecewise linear regression and scatter plot for one piglet. NOTE: dashed line on piecewise linear regression plots represents the 95% confidence 
intervals for the fitted lines. 
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 Population-Wide Trends 
In order to provide a population-wide assessment of % change in LDF-CBF and the ICP derived indices 
during changes in CPP, various error bar plots were produced.  Figure 5.3 displays the plot of CPP versus 
% change in LDF-CBF from baseline, with the vertical dashed line indicating the approximate mean LLA, 
derived above.  This demonstrates that there is a precipitous drop in LDF-CBF below the LLA. 
Similarly, the ICP indices were plotted across 5 mm Hg bins of CPP, producing error bar plots.  Figure 5.4 
displays these plots.  It can be seen that PRx, PAx and RAC all correlated with the LLA, denoted by the 
vertical dashed line. 
 
Figure 5.3: Population-Wide – % Change in LDF From Baseline vs. CPP 
 
CPP = cerebral perfusion pressure, LDF = laser Doppler flowmetry, mm Hg = millimeters of Mercury. NOTE: vertical dashed line 
represents the approximate mean LLA for the population defined through piecewise linear regression in each animal. 
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Figure 5.4: Population-Wide Error Bar Plots – PRx vs. CPP, PAx vs. CPP and RAC vs. CPP 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary unite, CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, PAx = pulse amplitude index (correlation between AMP and 
MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation between AMP and CPP. NOTE: vertical dashed line represents the approximate mean 
LLA for the population, derived through piecewise linear regression in each animal. 
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Comparing CPP for Various Clinical Thresholds of PRx and PAx to LLA  
For each animal, the CPP at each threshold for PRx, PAx and RAC was roughly derived through a 
simplified piecewise linear model of PRx vs. CPP, PAx vs. CPP, and RAC vs. CPP in each individual animal.  
These CPP values were compared to the CPP for the LLA derived in each animal, as described above.  
Table 5.1 displays the results for Pearson correlation between the CPP at TBI defined critical thresholds 
and the LLA within the cohort of piglets. Only the PRx thresholds appeared to produce statistically 
significant correlations, though they are weak in strength.  Bland-Altman analysis comparing the CPP 
values at these PRx thresholds, and the CPP at the LLA, displayed poor agreement between the 
threshold CPP values and the CPP at the LLA. 
 
Table 5.1: Comparison of CPP at Index Threshold to LLA – Pearson Correlation and T-test 
Index Threshold Tested Against 
LLA 
Pearson Correlation Coefficient 
with LLA 
p-value for Pearson Correlation 
Coefficient 
PRx = 0 0.538 0.014 
PRx = +0.25 0.571 0.008 
PRx = +0.35 0.512 0.021 
PAx = 0 -0.078 0.745 
PAx = +0.25 0.294 0.208 
RAC = -0.10 0.394 0.077 
RAC = -0.05 0.350 0.120 
AMP = pulse amplitude of ICP, CPP = cerebral perfusion pressure, ICP = intracranial pressure, LLA = lower limit of autoregulation, 
PAx = pulse amplitude index (correlation between AMP and MAP), PRx = pressure reactivity index (correlation between ICP and 
MAP), RAC = correlation between AMP and CPP. *Note: Bolded values are those which reached statistical significance. 
 
LLA ROC Analysis 
Through ROC analysis across the LLA, using the data from the 22 piglets, the AUC’s for each continuous 
index were calculated.  The AUC for PRx, PAx and RAC was:  0.806 (95% CI: 0.750 – 0.863, p<0.0001), 
0.726 (95% CI: 0.664 – 0.789, p<0.0001), and 0.710 (95% CI: 0.646 – 0.775, p<0.0001), respectively.  
Finally, the AUC for Lx was 0.809 (95% CI: 0.754 – 0.863, p<0.0001).  Comparing AUC’s via Delong’s test, 
there was a statistically significant difference between the AUC’s generated, when comparing PRx to PAx 
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(p=0.0004), and PRx to RAC (p<0.0001). However, the AUC’s for PAx and RAC were not statistically 
different (p=0.214).  
 
5.1.4 Discussion 
 
Through retrospective analysis of archived experimental piglet data, a cohort of animals subjected to 
pure arterial hypotension, this allowed for the assessment of ICP derived continuous indices against the 
LLA.  A few important points deserve highlighting. 
First, for the first time, insight has been provided some evidence validating PAx and RAC against the LLA 
within a model of hypotension.  This suggests that both indices provide information regarding cerebral 
autoregulatory capacity with a moderate accuracy. However, inconclusive evidence exists to support 
that the index threshold values, as defined in a TBI population,152 measure the LLA within this current 
model.  The Pearson correlations between the LLA and the CPP at these thresholds were poor and not 
statistically significant.  It remains uncertain as to whether the TBI defined critical thresholds for PAx and 
RAC can be applied outside of the TBI population, given the poor performance of these thresholds within 
this model of arterial hypotension.  Further, it remains unclear as to whether these thresholds represent 
relevant aspects of cerebral autoregulation, aside from associations with patient outcome in TBI.  It is 
also likely that threshold values for reactivity indices may vary by individual. It must be acknowledged 
these results are preliminary. 
Finally, confirmatory evidence has been provided that PRx correlates with the LLA within a model of 
hypotension.  This was conducted using both the animal data from the initial publication documenting 
this relationship,14 plus another 14 sham control animals from other experiments.  A similar AUC (0.806, 
p<0.0001) in the prediction of the LLA using PRx was demonstrated.  Finally, evaluating clinically relevant 
thresholds for PRx, all thresholds fail to produce strong correlations with the LLA within a model of 
arterial hypotension.  This was confirmed via poor agreement with the LLA on Bland-Altman analysis for 
all PRx clinical thresholds tested. This is likely because these thresholds have been defined within adult 
TBI populations,9,152 and thus the underlying disease and influence of ICP elevation post-injury may 
produce these thresholds that are disease specific.  It is therefore not surprising that these thresholds do 
not necessarily respect the LLA in a model of pure hypotension.  As with PAx and RAC, it must be stated 
that given the small numbers of animals within the current study, strong conclusions regarding these 
clinical thresholds cannot be made at this time.  This work remains preliminary. 
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 Limitations 
Despite the interesting and promising results, a few limitations deserve emphasis.  First, this is a 
retrospective analysis of an amalgamated cohort of piglets from 3 separate experiments.  Though the 
anesthetic, procedures and experimental hypotension techniques were similar for all animals, the 
cohorts were not exactly identical.  For example, 8 of the animals were slightly older (ie. 5 to 10 days, 
versus 3 to 5 days), with higher weights.  This could influence the cerebrovascular response slightly.  
Second, despite have a sizable cohort of piglets for this retrospective analysis, it is still a relatively small 
number of animals, thus the conclusions drawn must be taken with caution.  Third, the clinically defined 
thresholds for PRx, PAx, and RAC tested are defined within a TBI population.9,152 Thus, exploring how 
they relate to the LLA in a model of arterial hypotension may explain why many of the thresholds for 
PRx, PAx and RAC don’t appear to be related to the LLA.  As mentioned above, the results of this analysis 
are preliminary and thus strong conclusions about the relationship between the clinical thresholds and 
the LLA cannot be made.  Further validation is required.  Further to this, even though the CPP at some of 
the clinically defined index thresholds appeared to be related to the LLA within this piglet model, one 
must interpret this with caution.  As the LLA represents the point at which cerebral autoregulation 
becomes impaired (ie. not the point at which vascular reactivity is completely lost), the lack of strong 
associations with CPP at thresholds defined by clinical outcome is not surprising.  These thresholds for 
the ICP defined indices were derived from TBI patient outcome at 6 months post injury.  As a result, 
these index thresholds may represent the severe end of the autoregulation spectrum, the point of 
complete failure of vascular reactivity. Hence, the relationship between the CPP at thresholds and the 
LLA may not be robust, as they could be representing different aspects of impaired cerebrovascular 
reactivity.  As well, one must assume that there are individual animal-based differences in vascular 
reactivity, introducing the influence of potential random effects. Much further interrogation of these 
clinically defined index thresholds is required, with the current analysis providing some preliminary 
insight. 
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5.1.5 Conclusions 
 
The three ICP derived continuous indices of cerebrovascular reactivity, PRx, PAx and RAC were evaluated 
against the LLA within this experimental model of arterial hypotension.  All three indices appear to 
respect the LLA within this model of pure arterial hypotension, with PRx being superior. 
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5.2 Lower Limit of Autoregulation in Rabbit Model of Intra-Cranial Hypertension 
 
5.2.1 Introduction 
 
Aside from literature supporting an association between continuous measures of cerebrovascular 
reactivity and patient outcome, there is a paucity of data to support the concept that these indices 
measure the limits of autoregulation (ie. become progressively more positive when CPP decreased 
below the LLA).14  To date, only PRx and two NIRS derived indices (COx and HVx) have been validated 
against the lower LLA in an animal model of arterial hypotension.14,173 Chapter 5.1 provides evidence to 
validate all ICP derived indices against the LLA in a piglet model of arterial hypotension. 
However, these continuous indices have never been validated against the LLA in a model of sustained 
intra-cranial hypertension. Thus, this study will explore the correlation between PRx, PAx and RAC with 
the LLA in a rabbit model of sustained IC hypertension. 
 
5.2.2 Methods 
 
Animals 
The animals described within this study have in part been described in previous studies related the 
physiologic response to intra-cranial hypertension.145,146 The details surrounding this NZ rabbit model of 
IC hypertension have been provided in Chapter 3.1 of the general methods, including anesthetic 
administered and CSF infusion protocol for the IC hypertension experiment.  In brief, all animals were 
placed under general anesthesia, with an isolated basilar artery fed circulation created two weeks prior 
to the experiment by ligation of common carotid arteries.  IC hypertension was induced through an 
infusion of Hartmann’s solution into the lumbar cistern, via intra-thecal catheter.  ICP was elevated until 
cessation of diastolic flow on TCD.  ICP, ABP, TCD CBFV from the basilar artery, and cortical LDF-CBF were 
recorded and linked in time-series. Arterial blood pressure (ABP) was measured through in the dorsal 
aorta after catheter insertion in the femoral artery (GaelTec, Dunvegan, UK). Cerebral blood velocity was 
measured using an 8MHz Doppler ultrasound probe (PCDop 842, SciMed, Bristol, UK) positioned over 
the basilar artery (accessed through a 7mm burr-hole at the bregma). ICP was monitored using an 
intraparenchymal microsensor (Codman and Shurtleff, Raynham, MA, USA) inserted through a right 
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frontal burr-hole, and a laser Doppler flowmetry (LDF) probe was placed epidurally through a further 
right frontal burr-hole (Moor Instruments, Axbridge, Devon, UK). The digitally recorded raw physiologic 
data from 12 animals from this experiment were accessed for the purpose of this study. Only 12 animals 
were used for this study, given the quality of the recorded LDF and TCD signals from the remaining 
animals were deemed unsuitable for derivation of piece-wise regression models to evaluate the LLA.  
Given technique related limitations for LDF and TCD during these experiments the recorded signals for 
animals, other than the selected 12, were:  noisy, non-continuous and contained various degrees of 
signal artefact.  As such, only the data from 12 animals were utilized.  
 
Data Acquisition 
All signals from the combined above invasive and non-invasive monitoring modalities were recorded and 
archived for future retrospective use. All recorded signals were digitized via A/D converters (DT300; Data 
Translation, Marlboro, MA), sampled at frequency of 100 Hertz (Hz), using WREC software (Warsaw 
University of Technology) and subsequently processed using ICM+ software (Cambridge Enterprise Ltd, 
Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk).  Signal artifacts were removed prior to further 
processing or analysis using tools available in ICM+. 
 
Signal Analysis 
CPP was determined as: MAP – ICP.  FVs was derived by calculated the maximum FV over a 0.5 second 
window, updated every 0.25 seconds.  FVm was calculated using the average FV over a 10 second 
window, updated every 10 seconds without data overlap. AMP was determined by calculating the 
fundamental Fourier amplitude of the ICP signal over a 10 second window, updated every 10 seconds.  
This was done over the frequency range consistent with the rabbits HR (ie. 100 – 400 bpm).  Finally, 10 
second moving averages (without data overlap) were calculated for all recorded signals:  ICP, AMP, ABP 
(ie. producing MAP), CPP, FVm, FVs, LDF based CBF (LDF-CBF).  Continuous indices of cerebrovascular 
reactivity were generated in a fashion consistent with that described in Chapter 3, deriving:  PRx, PAx, 
RAC, and Lx.  Update frequency for all physiologic variables was 10-seconds-by-10-seconds, given the 
short duration of recordings during the experiment. 
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The archived signals for all 28 of the animals were retrospectively interrogated and analyzed.  Utilizing 
ICM+ software, plots for LDF versus CPP and FVm/FVs versus CPP were constructed.  These were 
inspected visually for overall trend and the presence of a visible “break point” in LDF/FVm/FVs where 
future piecewise linear regression analysis would potentially be able to identify an accurate LLA. It was 
found that only 12 of the animals had sufficient recordings to allow for the accurate assessment of the 
LLA (given insufficient data after artifact removal to clearly identify an LLA), and thus only 12 animals 
were utilized for the remainder of the study. 
 
Statistics 
All statistical analysis was conducted utilizing R statistical software (R Core Team (2016). R: A language 
and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
https://www.R-project.org/).  The following packages were employed:  ggplot2, dplyr, tidyverse, 
lubridate, segmented, and pROC. Where significance is reported, alpha was set at 0.05.  The following 
analysis described is identical to that performed by Brady et al., the only study in existence validating 
PRx against the LLA.14  This was done so as to remain as to allow comparison between the results, and 
potentially provide validation of the results seen within that study. 
 
 Finding the LLA 
In order to determine the LLA of autoregulation in the 12 animals, piecewise linear regression of either 
LDF-CBF versus CPP plots, or FVs versus CPP plots, was employed.  In 3 of the 12 animals, the LDF-CBF 
signals were not adequate for piecewise regression, and thus CPP versus FVs plots were utilized to find 
the LLA.  The LDF-CBF signal was standardized against the individual animal’s baseline LDF-CBF signal, 
producing “% change of LDF-CBF from baseline”.  This is similar to other studies evaluating LDF-CBF. 
The piecewise regression process employed a starting point for estimation of the break-point in either 
LDF-CBF or FVs. This starting point was visually estimated from the ICM+ plots of LDF-CBF versus CPP or 
FVs versus CPP, described above.  The breakpoint identified by the piece wise regression process is one 
in which minimized the SSE of the two linear segments, above and below this point.  This was conducted 
for each animal, with piecewise regression plots produced denoting the 95% CI for each fitted linear 
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segment.  Finally, the mean LLA for the cohort of 12 rabbits was determined by averaging all 12 LLA 
values obtained. 
 
 Finding the “Cushing’s Response Point” 
Given this animal model involved sustained intra-cranial hypertension, the profound sympathetic surge 
seen during herniation could influence the relationship between MAP and ICP or AMP, leading to 
overwhelming positive trends in PRx, PAx and RAC below the LLA.145  Thus, it was important to see if 
there was a distinct separation between the LLA and when the Cushing’s response was seen.  A separate 
piecewise linear regression analysis of CPP versus MAP plots was performed, looking for a break point 
where as CPP continues to decrease, a dramatic increase in MAP is seen, corresponding the point where 
the Cushing’s response takes effect. The breakpoint identified by the piecewise regression process is one 
in which minimized the SSE of the two linear segments, above and below this point.  This was conducted 
for each animal, with piecewise regression plots produced denoting the 95% CI for each fitted linear 
segment.  Finally, the mean “Cushing’s Point” for the cohort of 12 rabbits was determined by averaging 
all 12 breakpoint values of MAP versus CPP.  The mean LLA was compared to the mean “Cushing’s Point” 
via student t-test, to assess statistical significance. 
 
 Binned Cohort Data and Plot 
After delineating the mean LLA for the cohort, cohort wide plots were produced to inspect the 
population trend of various physiologic measures against the LLA.  First all data was binned across 2.5 
mm Hg bins of CPP, using R statistical software.  The following error bar plots were then produced:  LDF-
CBF vs. CPP, FVs vs. CPP, PRx vs. CPP, PAx vs. CPP, RAC vs. CPP and AMP vs. CPP.   
 
 Comparing CPP for Various Clinical Thresholds of PRx and PAx to LLA 
A rough comparison of CPP for clinically defined thresholds of PRx and PAx to CPP at the LLA, defined via 
piecewise regression in each animal, was performed.  To do so, a simplified piecewise linear regression 
was performed of PRx vs. CPP and PAx vs. CPP, using these models to determine CPP in each animal for 
the following thresholds of PRx and PAx defined in TBI patients. For PRx, the thresholds of 0, +0.25 and 
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+0.35 were tested. For PAx, the thresholds of 0 and +0.25 were tests.  CPP values at each threshold for 
PRx and PAx were compared with the CPP values at the LLA, using a Bland-Altman analysis.  The Bland-
Altman analysis was only conducted for those index thresholds which displayed statistically significant 
correlation coefficients with the LLA. 
 Prediction of Continuous Indices for Impaired Autoregulation 
As done in Brady et al., ROC analysis of PRx, PAx and Lx across the cohort defined LLA was performed.  
This was conducted in order to determine the ability of these indices to predict being either above or 
below the LLA.  For each rabbit, 1 mean value for each variable was obtained at each 2.5 mm Hg bin of 
CPP (ie. CPP = 40 mm Hg, 45 mm Hg, etc.).  We utilized 2.5 mm Hg bins of CPP for the ROC analysis, to 
improve ROC prediction, given the short duration of experiments and noisy data recording available in 
this experiment. This is in contrast to the 5 mm Hg binned data utilized within the previous study by 
Brady et al.,14 where long duration of controlled induced experimental hypotension and data recording 
allowed for using such data binning.  
This data was then given the binary designation of being above the LLA, or below the LLA, based on the 
LLA defined previously.  The data from all 12 rabbits was then utilized for the ROC analysis.  AUC for the 
ROC’s was reported and 95% CI reported via Delong method. Significance values (ie. p-values) for the 
AUC’s were derived from univariate logistic regression analysis. Comparison between AUC’s was 
conducted utilizing Delong’s test. 
 Criteria for Measures of the LLA 
In order to be able to say that a specific index provides a measure of the LLA in this particular model, the 
following criteria needed to be met: 
3. Demonstration of cerebrovascular reactivity indices to trend towards progressively more 
positive values at CPP levels below the LLA. 
4. Statistically significant logistic regression analysis for each cerebrovascular reactivity index in the 
prediction of having CPP values above or below the cohort defined LLA. 
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5.2.3 Results 
 
Defining the LLA 
Piecewise linear regression was conducted in each rabbit.  Nine of the rabbits had this analysis 
conducted on the LDF-CBF vs. CPP plots, while in 3 animals it was conducted on the FVs plots vs. CPP.  
Across all rabbits, the mean LLA was determined to be 51.5 +/- 8.2 mm Hg. Figure 5.5 displays the 
piecewise linear regression for two animals, with their corresponding scatter plots.  Panel A displays and 
example of the plots for ICP, MAP, CPP, LDF and FVs over time during the experiment.  Panel B and C 
denote an example of piecewise regression using the LDF-CBF vs. CPP plot, and Panel D and E denote the 
same using the FVs vs. CPP plot.  Figure 5.6, displays the LDF-CBF vs. CPP error bar plot for the entire 
rabbit cohort, demonstrating a dramatic drop in LDF signal below the defined LLA (ie. ~50 mm Hg).   
 
 
 
Defining the “Cushing’s Point” 
Piecewise linear regression of MAP vs. CPP was conducted for each rabbit.  Across all rabbits the mean 
“Cushing’s Point”, where with further decrease in CPP we saw dramatic increases in MAP, was 42.4 +/- 
9.8 mm Hg.  Figure 5.7 displays an example of the piecewise regression between CPP and MAP, 
identifying the “Cushing’s Point”.  Comparing the LLA and the Cushing’s point across all animals, via the 
student’s t-test, the LLA and Cushing’s point were noted to be statistically different (t=2.396, p=0.027). 
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Figure 5.5: Examples of Piecewise Linear Regression Analysis 
 
a.u. = arbitrary units, cm = centimeters, CPP = cerebral perfusion pressure, FVs = systolic flow velocity, ICP = intra-cranial 
pressure, LDF-CBF = laser Doppler flowmetry cerebral blood flow, MAP = mean arterial pressure, mm Hg = millimeters of 
Mercury, sec = second. Panel A = example of ICP, MAP, CPP, LDF-CBF and FVs over time during the experiment. Panel B = 
piecewise regression using the LDF-CBF vs. CPP plot, Panel C = scatterplot of LDF-CBF vs.CPP, Panel D = piecewise regression 
using FVs vs. CPP plot, Panel E = scatterplot of FVs vs. CPP. Note: in piecewise regression plots, the hashed lines along the x-axis 
denote data point density. 
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Figure 5.6: Error Bar Plots – % Change in LDF-CBF vs. CPP – Entire Rabbit Cohort 
 
a.u. = arbitrary units, cm = centimeters, CPP = cerebral perfusion pressure, LDF-CBF = laser Doppler flowmetry cerebral blood 
flow, mm Hg = millimeters of Mercury. Vertical dashed line represents the approximate LLA for the entire cohort. Vertical solid 
line represents the approximate “Cushing’s Point” for the entire cohort. 
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Figure 5.7: Piecewise Linear Regression Identifying Cushing’s Point – Example 
 
CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, MAP = mean arterial pressure, mm Hg = millimeters of Mercury. Panel A = example of ICP, MAP and CPP over time 
during the experiment, Panel B = piecewise linear regression of MAP vs. CPP, Panel C = scatter plot of MAP vs. CPP. 
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Autoregulation/Cerebrovascular Reactivity across the LLA 
Various cohort-wide plots of continuous indices of autoregulation/cerebrovascular reactivity across the 
LLA were produced.  Figure 5.8 displays PRx and PAx error bar plots against binned CPP.  It can be seen 
that, as reported in Brady et al.,14 PRx correlates with the LLA, becoming progressively more positive 
(denoting “impaired” autoregulation) below the LLA of ~50 mm Hg (Panel A).  Similarly, we are able to 
demonstrate the PAx also correlates with the LLA within this model (Panel B).  Finally, given the LLA was 
mainly defined using LDF-CBF signal across a range of CPP, the LDF derived Lx also correlated with the 
LLA.  Of note for all of the above relationships, these trends can be seen between the LLA (vertical 
dashed line) and the Cushing’s point (vertical solid line), indicating that indeed these relationships to the 
LLA are seen before the Cushing’s response develops.   
RAC failed to produce reliable data within this model of intra-cranial hypertension to either confirm or 
refute their association with the LLA. This may be secondary to failure within this subset of animals to 
surpass the break-point in AMP, described in the adult TBI population of Chapter 4. Figure 5.9 displays 
the RAC and AMP vs. CPP error bar plots, panel B displays the failure to reach the AMP breakpoint. 
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Figure 5.8:  Cohort Based Error Bar Plots of ICP Derived Indices across the LLA 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, LLA = lower limit of autoregulation, MAP = mean arterial pressure, mm Hg = 
millimeters of Mercury, ICP = intracranial pressure, PAx = pulse amplitude index (correlation between AMP and MAP), PRx = pressure reactivity index (correlation 
between ICP and MAP). Panel A = PRx vs. CPP error bar plot, Panel B = PAx vs. CPP error bar plot. Note:  vertical hashed line denotes the approximate LLA, while the 
vertical solid line represents the approximate Cushing’s point. 
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Figure 5.9:  Cohort Based Error Bar Plots of RAC and AMP across the LLA 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary units, CPP = cerebral perfusion pressure, LLA = lower limit of autoregulation, mm Hg = millimeters of Mercury, ICP = intracranial 
pressure, RAC = correlation between AMP and CPP. Panel A = RAC vs. CPP error bar plot, Panel B = AMP vs. CPP error bar plot. Note:  vertical hashed line denotes the approximate 
LLA, while the vertical solid line represents the approximate Cushing’s point. 
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Comparing CPP for Various Clinical Thresholds of PRx and PAx to LLA  
For each animal, the CPP at each threshold for PRx and PAx was roughly derived through a simplified 
piecewise linear model of PRx vs. CPP and PAx vs. CPP in each individual animal.  These CPP values were 
compared to the CPP for the LLA derived in each animal, as described above.  They were compared via 
Pearson correlation coefficient.  Table 5.2 displays these results.  RAC was not interrogated given its 
poor performance in the above analysis and inability to produce reliable piecewise models for RAC vs 
CPP.  
 
Table 5.2: Comparison of CPP at Index Threshold to LLA – Pearson Correlation  
Index Threshold Tested Against 
LLA 
Pearson Correlation Coefficient 
with LLA 
p-value for Pearson Correlation 
Coefficient 
PRx = 0 0.037 0.9121 
PRx = +0.25 0.429 0.1881 
PRx = +0.35 0.600 0.0507 
PAx = 0 0.612 0.0454 
PAx = +0.25 0.689 0.0190 
AMP = pulse amplitude of ICP, CPP = cerebral perfusion pressure, ICP = intracranial pressure, LLA = lower limit of autoregulation, 
PAx = pulse amplitude index (correlation between AMP and MAP), PRx = pressure reactivity index (correlation between ICP and 
MAP). Note: bolded values indicate those which reached statistical significance. 
 
The Pearson correlation between the CPP values at a PRx threshold of +0.35, with the CPP at the LLA, 
demonstrates that this clinical threshold may represent the LLA.  Similarly, the Pearson correlation 
between the CPP values at PAx thresholds of 0 and +0.25, with the CPP at the LLA, demonstrate that 
these clinical thresholds may also represent the LLA. Bland-Altman analysis for the 3 statistically 
significant index thresholds (ie. PRx +0.35, PAx 0, and PAx +0.25) demonstrated poor agreement with 
bias, when comparing the CPP at each index thresholds to the CPP at the LLA.   
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LLA ROC Analysis 
Through ROC analysis across the LLA, using the data from the 12 rabbits, AUC’s for each continuous 
index were identified.  The AUC for PRx, PAx and RAC was:  0.795 (95% CI: 0.731 – 0.857, p<0.0001), 
0.703 (95% CI: 0.631 – 0.775, p<0.0001), and 0.558 (95% CI: 0.478 – 0.637, p=0.325), respectively.  
Finally, the AUC for Lx was 0.740 (95% CI: 0.668 – 0.812, p<0.0001).  Comparing AUC’s via Delong’s test, 
there was no significant difference between the AUC generated for PRx, PAx and Lx (all p>0.05). 
 
 
5.2.4 Discussion 
 
Through retrospective analysis of this experimental model data, validation has been provided for the 
previously described claims that PRx discriminates the LLA.  The previous study to provide the initial data 
for PRx and the LLA, was by Brady et al.14  This study focused on a piglet model of arterial hypotension, 
during both states of normal and slightly elevated ICP.  Within this previous model, it was clearly 
demonstrated that PRx identified the LLA (found to be between 30 and 40 mm Hg in this animal model).  
Further, it was demonstrated, that PRx was superior to all other indices in the ROC analysis for detecting 
the LLA.  This was replicated in Chapter 5.1 of this thesis. The above described study has been able to 
reproduce all of these results in a white NZ rabbit model of intra-cranial hypertension, which has not 
been described previously.  Thus, further evidence has been provided to support the use of PRx in 
monitoring autoregulatory capacity, particularly during instances of ICP elevation.  Finally, evaluation of 
the CPP at various clinically relevant thresholds of PRx, defined in TBI patients,9,152 was roughly 
conducted.  Interestingly, some preliminary results to support that the PRx threshold of +0.35 correlates 
with the LLA within this model of intra-cranial hypertension, though agreement on Bland-Altman was 
poor. 
Furthermore, validating evidence has been provided to support that the ICP index PAx, also correlates 
with the LLA, allowing for confidence in its application as a measure of autoregulatory 
capacity/cerebrovascular reactivity.  Thus, given the results of section 5.1 and 5.2 of this thesis, PAx 
measures the LLA during both arterial hypotension and IC hypertension. This has never been described 
previously for this index.  In addition, similar to PRx, some preliminary results are provided to support 
that the clinically relevant PAx thresholds152 of 0 and +0.25 correlate with the LLA within this model of 
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intra-cranial hypertension, though as with the PRx threshold of +0.35, the agreement on Bland-Altman 
analysis was poor. 
Of additional interest, the ICP derived index RAC failed to demonstrate any reliable evidence that it 
correlated with the LLA within this model of sustained intra-cranial hypertension, where the other ICP 
derived indices performed well.  RAC is derived from the correlation between AMP and CPP.  During this 
intra-cranial hypertension experiment, AMP was constantly increasing, with CPP decreasing secondary 
to elevated ICP (ie. not a drop in MAP).  Thus, the correlation derived between AMP and CPP during such 
a physiologic event will be negative in nature.  This was seen in the persistently negative values for RAC 
derived in every animal.  Thus, it isn’t that surprising that we didn’t see a dramatic response in RAC 
below the LLA.  It may be that the failure of RAC to display a significant relationship to the LLA is a 
function of the particular model used, not the index.  Furthermore, an upper break-point in AMP was 
not seen in this subpopulation of rabbits (n=12), as has been described in other animal and clinical 
studies.145  This is likely secondary to the Cushing’s sympathetic response seen within the animals during 
this experiment, which has been previously described.145 This Cushing’s response led to a preservation 
of, and increase in, MAP during elevation of ICP.  It is possible that if this break-point in AMP were 
observed it may lead to a rapid rise in RAC to more positive values.  Whether or not this potential 
physiologic event would have led to RAC correlating with the LLA is unknown, and requires further 
investigation. 
Finally, through the use of linear piecewise regression of CPP versus MAP, the point at which the 
sympathetic driven Cushing’s response occurred was identified, at a mean CPP of 42.4 +/- 9.8 mm Hg.  
This point was statistically below the mean LLA of 51.5 +/-8.2 mm Hg (p=0.027).  Thus, between the LLA 
and the Cushing’s point, the ICP derived indices were uninfluenced by the sympathetic response seen 
during a Cushing’s response.  Hence, the trend towards progressively more positive index values seen for 
PRx and PAx confirms that these indices respect the LLA in this model of IC hypertension. 
 
 Limitations 
Despite the interesting results found within this study, there are some important limitations which 
should be highlighted.  First, this study is a retrospective assessment of archived experimental data.  
Second, this rabbit model of IC hyptertension involved ligation of the common carotids bilaterally to 
produce an isolated basilar artery fed intra-cranial circulation.  Despite a 2 week rest period between 
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this arterial ligation and the IC hypertension experiments, the isolated circulation may have had an 
impact on cerebral autoregulatory function.  By ligating the common carotids, this left the entire 
anterior circulation dependant of posterior circulation flow and both the presence of adequate anterio-
posterior communicating vessels and collarteral flow.  Furthermore, the New Zealand white rabbit is also 
known to have significant variations in intra-cranial circulatory anatomy, with less than 30% of these 
rabbit cohorts displaying a normal circle of Willis.174 As such, much of the anterior circulation may have 
been exhausted in terms of autoregulatory capacity at the time of the IC hypertension experiements, 
leading to ischemia and/or infarction in the anterior territories, and have impacted the recorded signals 
and derived cerebrovascular reactivity indices. However, with that said, the relationship between 
frontally recorded LDF and CPP displayed a clearly identifiable LLA, with both PRx and PAx 
demonstrating trend towards progressively positive value at CPP levels below the LLA, with significan 
logistic regression analysis. Third, out of the 28 rabbits included in the original experiment, only 12 had 
sufficient quality archived signals for defining and interrogating the LLA.  Fourth, RAC, described within 
Chapter 4, failed to produce reliable data within this model of intra-cranial hypertension to either 
confirm or refute its association with the LLA.  This particular model of intra-cranial hypertension may be 
why the other index tested (RAC) failed to produce reliable data to confirm or refute their association 
with the LLA. Fourth, the rate of rise in ICP was fairly rapid within this model (ie. ~30 min), this may have 
played a part in the relatively noisy data and fluctuations seen within the error bar plots provided.  It is 
unknown if a longer period of rise in ICP would have led to “cleaner” data, and the ability to provide 
validation for the other indices.  There is much further work required to confirm these results during 
other physiologic conditions. Finally, even though the CPP at some of the clinically defined thresholds for 
PRx and PAx appeared to be related to the LLA within this rabbit model, one must interpret this with 
caution.  As the LLA represents the point at which cerebral autoregulation becomes impaired (ie. not the 
point at which vascular reactivity is completely lost), the lack of strong associations with CPP at 
thresholds defined by clinical outcome9,152 is not surprising.  These thresholds for the ICP defined indices 
were derived from TBI patient outcome at 6 months post injury.  As a result, these index thresholds may 
represent the severe end of the autoregulation spectrum, the point of complete failure of vascular 
reactivity. Hence, the relationship between the CPP at thresholds and the LLA may not be robust, as they 
could be representing different aspects of impaired cerebrovascular reactivity.  As well, one must 
assume that there are individual animal-based differences in vascular reactivity, introducing the 
influence of potential random effects. Much further interrogation of these clinically defined index 
thresholds is required, with the current analysis providing some preliminary insight.  These cautions are 
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in corollary with the lack of association between the TBI defined clinical thresholds and the LLA seen in 
the piglet model of arterial hypotension in Chapter 5.1. 
 
5.2.4 Conclusions 
 
Validation for the ICP derived indices, PRx and PAx, against the LLA within this experimental model of 
intracranial hypertension has been provided.  Given model limitations, it is unclear if RAC measures the 
LLA during extreme IC hypertension. 
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5.3 Upper Limit of Autoregulation in Piglet Model of Arterial Hypertension 
 
5.3.1 Introduction 
 
Chapter 5, subsection 5.1 and 5.2, highlight the ability of ICP derived indices of cerebrovascular reactivity 
to measure the LLA, during arterial hypotension and IC hypertension.  However, within the current 
literature surrounding these indices, there lacks data to support their ability to measure the ULA.  This 
likely stems from the fact that these physiologic indices are typically measured in adult TBI patients, 
where the main concern is ICP elevation with concomitant reductions in CPP, leading to hypoperfusion.  
Thus, the LLA has been the main interest in experimental validations studies using these indices. The 
focus of this study was to assess the ability of the ICP derived indices of cerebrovascular reactivity to 
measure the ULA, in a piglet model of arterial hypertension. 
 
5.3.2 Methods 
 
Animals 
The neonatal piglet data described within were retrospectively amalgamated from previous 
experiments.  Details regarding these models, including experimental treatment, has been outline in the 
general methodology section in Chapter 3.1. In brief, this cohort consisted of 6 sham piglets, where no 
cerebral insult had occurred (ie. ICP elevations, cardiac arrest or hypothermia).  All of these animals 
underwent similar anesthetic (see Chapter 3.1), and subsequently had an esophageal balloon within the 
distal aorta, inflated to induce arterial hypertension until fatality.  MAP increases were also supported 
with continuous infusions of intra-venous phenylephrine. ICP, ABP and LDF-CBF were recorded 
continuously throughout the experiment using ICM+. 
 
Signal Acquisition and Processing 
All signals from the combined above monitoring modalities were recorded and archived for future 
retrospective use. All recorded signals were digitized via A/D converter (DT9804, Data Translation, 
Marlboro, MA), sampled at frequency of 50 Hertz (Hz) or higher, using ICM+ software (Cambridge 
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Enterprise Ltd, Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk).  Signal artifacts, such as transducer 
adjustments, were removed prior to further processing or analysis using tools available in ICM+. 
CPP was determined as: MAP – ICP. AMP was determined by calculating the fundamental Fourier 
amplitude of the ICP signal over a 10 second window, updated every 10 seconds.  This was done over 
the range consistent with the normal range for piglet heart rate (ie. 100 – 350 bpm).  Finally, 10 second 
moving averages (without data overlap) were calculated for all recorded signals:  ICP, AMP, ABP (ie. 
producing MAP), CPP, and LDF-CBF. The piglets’ archived signals were retrospectively interrogated and 
analyzed.   
The following continuous indices of cerebrovascular reactivity were derived: PRx (correlation between 
ICP and MAP), PAx (correlation between AMP and MAP), RAC (correlation between AMP and CPP) and 
LDF derived Lx (correlation between LDF-CBF and CPP).  All indices were derived via moving Pearson 
correlation coefficients between 30 consecutive 10 second average values of relevant signals and their 
parameters (ie. 5 minute of data), updated every minute. 
 
Statistics 
All statistical analysis was conducted utilizing R statistical software (R Core Team (2016). R: A language 
and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
https://www.R-project.org/).  The following packages were employed:  ggplot2, dplyr, tidyverse, 
lubridate, segmented, and pROC. Where significance is reported, alpha was set at 0.05.  The following 
analysis described is similar to that performed within previous studies on the LLA. This was done so as to 
allow comparison between the results. 
 
 Finding the ULA 
In order to determine the ULA of autoregulation in the 6 animals, piecewise linear regression of the LDF-
CBF vs. CPP plots was employed.  The LDF-CBF signal was standardized against the individual animal’s 
baseline LDF-CBF signal, producing “% change of LDF-CBF from baseline”.  This is similar to other studies 
evaluating LDF-CBF, and that analysis conducted in Chapter 5, subsections 5.1 and 5.2. 
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The piecewise regression process employed a starting point for estimation of the break-point in LDF-CBF. 
This starting point was visually estimated from the ICM+ plots of LDF-CBF vs. CPP.  The breakpoint 
identified by the piece wise regression process is one in which minimized the SSE of the two linear 
segments, above and below this point.  This was conducted for each animal, with piecewise regression 
plots produced denoting the 95% CI for each fitted linear segment.  Finally, the mean ULA for the cohort 
of 6 piglets was determined by averaging all 6 ULA values obtained. 
 
 Binned Cohort Data and Plot 
After delineating the mean ULA for the cohort, cohort wide plots were produced to inspect the 
population trend of various physiologic measures against the ULA.  First all data was binned across 2.5 
mm Hg bins of CPP, using R statistical software.  The following error bar plots were then produced:  % 
change in LDF-CBF From Baseline vs. CPP, PRx vs. CPP, PAx vs. CPP, and RAC vs. CPP.   
 
 Prediction ability of Continuous Indices for Impaired Autoregulation 
As done in previous studies, ROC analysis of PRx, PAx, RAC and Lx were performed across the cohort 
defined ULA.  This was conducted in order to determine the ability of these indices to predict being 
either above or below the ULA.  For each piglet, 1 mean value for each variable was obtained at each 2.5 
mm Hg bin of CPP (ie. CPP = 40 mm Hg, 45 mm Hg, etc.).  Five mm Hg bins of CPP were used for the ROC 
analysis, given this was what was conducted within the previous study by Brady et al. 
This data was then given the binary designation of being above the ULA, or below the ULA, based on the 
ULA defined previously.  The data from all 6 piglets was then used for the ROC analysis.  AUC for the 
ROC’s was reported and 95% CI reported via Delong method. Significance values (ie. p-values) for the 
AUC’s were derived from univariate logistic regression analysis.  
 
 Criteria for Measures of the ULA 
In order to be able to say that a specific index provides a measure of the ULA in this particular model, 
the following criteria needed to be met: 
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3. Demonstration of cerebrovascular reactivity indices to trend towards progressively more 
positive values at CPP levels above the ULA. 
4. Statistically significant logistic regression analysis for each cerebrovascular reactivity index in the 
prediction of having CPP values above or below the cohort defined ULA. 
 
 
5.3.3 Results 
 
Defining the ULA 
Through piecewise linear regression analysis of each piglet, the ULA was obtained for each animal.  The 
mean ULA was 83.1 +/- 17.8 mm Hg, with a wide inter-piglet variation in individual ULA values seen 
(range: 63.4 to 109.3 mm Hg).  Figure 5.10 displays the piece-wise linear regression of the % Change in 
LDF from baseline versus CPP, attempting to identify the ULA. All animals died secondary to heart failure 
during the aggressive increases in MAP using the aortic balloon and intra-venous phenylephrine. 
 
Population-Wide Trends 
In order to provide a population-wide assessment of % change in LDF-CBF and the ICP derived indices 
during changes in CPP, various error bar plots were produced.  Figure 5.11 displays the plot of CPP 
versus % change in LDF-CBF from baseline, with the vertical dashed line indicating the approximate 
mean ULA, derived above.  This demonstrates that there is initially a precipitous rise in LDF-CBF above 
the ULA. However, this signal subsequently saturates, failing to display the classic characteristics of 
pressure, or flow, passivity to increases in CPP when above the ULA.  
Similarly, the ICP indices were plotted across 5 mm Hg bins of CPP, producing error bar plots.  Figure 
5.12 displays these plots.  It can be seen that PRx, PAx and RAC initially display a trend to more positive 
values above the ULA (denoted by the vertical dashed line), with subsequent rapid tapering of this 
increase at the point of LDF-CBF saturation. 
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ULA ROC Analysis 
Through ROC analysis across the ULA, using the data from the 6 piglets, the AUC’s for each continuous 
index were calculated.  The AUC for PRx, PAx and RAC was:  0.575 (95% CI: 0.500 – 0.651, p=0.164), 
0.580 (95% CI: 0.507 – 0.653, p=0.035), and 0.716 (95% CI: 0.651 – 0.782, p<0.0001), respectively.  
Comparing AUC’s via Delong’s test, there was no statistically significant difference between the AUC’s 
generated, when comparing PRx to PAx (p=0.877). However, the AUC for RAC was statistically different 
than both PRx (p<0.0001) and PAx (p<0.0001). 
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Figure 5.10: Piecewise Linear Regression Analysis of ULA for 6 Piglets 
 
The above 6 panels depict the piecewise linear regression analysis of % LDF Change from Baseline versus CPP, attempting to 
determine the inflection point in LDF CBF signifying the ULA. As can be seen, there was significant heterogeneity in the identified 
ULA, with varying shapes and slope to the piecewise regression, highlighting the difficulting in accurately determining the ULA in 
this particular model of arterial hypertension.  
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Figure 5.11: Error Bar Plots – % Change in LDF-CBF vs. CPP – Entire Cohort 
 
a.u. = arbitrary units, cm = centimeters, CPP = cerebral perfusion pressure, LDF-CBF = laser Doppler flowmetry cerebral blood 
flow, mm Hg = millimeters of Mercury. Vertical dashed line represents the approximate ULA for the entire cohort.  
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Figure 5.12: Cohort Based Error Bar Plots of ICP Derived Indices across the ULA 
 
AMP = pulse amplitude of ICP, a.u. = arbitrary unite, CPP = cerebral perfusion pressure, ICP = intra-cranial pressure, PAx = pulse amplitude index (correlation between AMP and 
MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation between AMP and CPP. NOTE: vertical dashed line represents the approximate mean 
ULA for the population, derived through piecewise linear regression in each animal. 
 
120 
 
5.3.4 Discussion 
 
Through the retrospective analysis of the raw physiologic data from 6 piglets during induced arterial 
hypertension, some interesting comments/limitations should be highlighted.  First, the data from this 
model provides no strong conclusions regarding the ability of ICP derived indices to measure the ULA.  It 
was difficult to clearly identify the ULA in the 6 piglets for which data was available. As seen in the piece-
wise regression plots, there was significant heterogeneity in the LDF response to increases in CPP, 
leading to a large range in ULA values determined through this regression technique (range: 63.4 to 
109.3 mm Hg).  Given the saturation of the LDF-CBF signal at CPP levels just past the ULA, this suggests 
the breakpoint in % LDF-CBF signal identified through piecewise linear regression was not the ULA.  One 
would expect pressure/flow passivity to progressively increasing CPP values, however, this was not the 
case in these 6 animals.  This failure to identify the ULA could be secondary to these specific animals not 
having a readily identifiable ULA, or inability to reach high enough MAP values to identify the ULA. This 
difficulty with identifying the ULA has been noted by other researchers investigating piglet CBF.  Under 
the setting of normal ICP, it appears difficult to delineate the ULA despite aggressive increases with 
MAP, as most animals perish secondary to heart failure. However, sustained ICP elevations during 
arterial hypertension appear to shift the ULA to lower CPP values, thus allowing to identify the ULA.175,176  
Future studies of the ULA may benefit from this technique. Second, all ICP derived indices also seem to 
plateau during this saturation phase in LDF-CBF signal, also suggesting that this point was not the ULA.  
However, even if this is not the ULA, it is reasonable to accept that we use this threshold as a point at 
which there is a change in physiological behavior of the cerebral circulation.  If so, the ROC analysis 
showed that both PRx and PAx were extremely poor at predicting this threshold for altered physiological 
response, regardless of whether it represents the ULA or not.  This is in contrast to their strong 
performance at predicting the LLA seen in Chapter 5.1 and 5.2 of this thesis.  This may indicate that 
these indices are poor at assessing the ULA, or just confirming that this threshold of ~83 mm Hg was not 
the ULA. Finally, RAC displayed the most uniform association with this threshold of 83 mm Hg.  The error 
bar plots displayed a clear trend towards more positive index values, and the ROC analysis provided the 
strongest statistical significance with this index.  It still remains unclear based on this small study as to 
whether RAC can measure the ULA, despite it showing promise over both PRx and PAx.  Further 
experimental models for interrogating these indices with respect to the ULA are required. 
One final aspect of all of the experimental models outlined in Chapters 5.1, 5.2 and 5.3 is related to the 
anesthetic administered.  All animals were administered volatile inhalational anesthestic agents during 
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the induction, and also during maintanence. The rabbit models were exposed to halothane, while the 
piglet models were exposed to isoflurane. Both of these inhalational anesthetics have a well-
documented literature body related to alteration of CBF control, leading to either hypoperfusion or 
hyperperfusion states.177–179  It is unknown as to the impact that these agents had on the recorded 
physiology during the respective experiments, or the impact on the derived cerebrovascular reactivity 
indices.  Such an impact related to halothane or isoflurane may have led to alterations in the observed 
LLA or ULA in the animal models, and thus impacted the results of the analysis related to individual 
cerebrovascular reactivity indices and their ability to measure the LLA or ULA. As such, future 
experimental models in this area will need to pay particular attention to the anesthetic agents 
employed, so as to avoid this potential confounding factor in the assessment of the LLA or ULA.  
 
 
5.3.5 Conclusions 
 
It is currently unclear as to whether the ICP derived indices of cerebrovascular reactivity can measure 
the ULA, based on this experimental model of arterial hypertension. Further investigation is required. 
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CHAPTER 6: MULTI-MODAL MONITORING INTER-INDEX RELATIONSHIPS IN 
ADULT TBI 
*The information presented within this chapter can also be found detailed within the following 
publications: 
1. Zeiler et al., J Neurotrauma. 2017; 34(22):3070-3080. doi: 10.1089/neu.2017.5129.180 
2. Zeiler et al., Neurocrit Care. 2018; 28(2):194-202. doi: 10.1007/s12028-017-0472-x.181 
3. Zeiler et al., J Neurotrauma. 2018; 35(2):314-322. doi: 10.1089/neu.2017.5364.182 
 
6.1 Multi-Modal Monitoring Cohort 
 
6.1.1 Introduction 
 
Numerous continuous indices of cerebrovascular reactivity exist, and are derived from the different 
MMM devices employed for cranial monitoring within the ICU.4,10  These devices include, but are not 
limited to:  ICP, PbtO2, TCD and NIRS.  As alluded to within previous sections of this thesis, the majority 
of current literature on these continuous indices focuses on the ICP derived index PRx, with limited 
information on others.  Furthermore, inter-index association studies currently are limited to the 
assessment of individual indices, using Pearson correlation coefficients and basic linear regression.20,83  
Thus, it can be confusing to the treating clinician as to which indices are related, and which co-vary.  This 
information is crucial, as understanding which indices are closely associated provides the potential for 
future modelling of invasive indices using non-invasive surrogates.  This chapter focuses on assessing the 
inter-index relationships between various MMM derived continuous indices of cerebrovascular 
reactivity, with subsection 6.1 focusing on an adult TBI population with the highest number of different 
monitoring devices simultaneously recording.  
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6.1.2 Methods 
 
Patient Population 
The patients included in this study represent a sub-population of a cohort that provide the substrate for 
previous publications which assessed specific NIRS based autoregulatory indices and their association 
with PRx.19,20  A review of this dataset revealed that it contained raw monitoring signals which permitted 
the measurement of additional indices of cerebrovascular reactivity.  The majority of patients in this 
cohort had the following monitoring:  ICP, CPP, ABP, NIRS, bilateral TCD of the MCA, and PbtO2. Thus, 
this population provided us the largest number of monitoring devices, and hence allowed assessment of 
relationships between the largest range of autoregulatory indices. This study was conducted as a 
retrospective analysis of a prospectively maintained database cohort.  
 All patients suffered mild to severe TBI and were admitted to the NCCU at Addenbrooke’s Hospital, 
Cambridge.  Those with mild and moderate TBI, displayed progressive deterioration in clinical status, 
necessitating multi-modal monitoring via a combination of invasive and non-invasive techniques. 
Treatment received during the recording periods included standard ICP-directed therapy, with an ICP 
goal of less than 20 mm Hg and CPP goal of greater than 60 mm Hg.   
 
Signal Acquisition 
ABP was measured through either radial or femoral arterial lines connected to pressure transducers 
(Baxter Healthcare Corp. CardioVascular Group, Irvine, CA).  ICP was acquired via an intra-parenchymal 
strain gauge probe (Codman ICP MicroSensor; Codman & Shurtleff Inc., Raynham, MA).  NIRS signals 
were recorded bilaterally over the frontal lobes utilizing the NIRO 200 monitoring.  The following NIRS 
signals were recorded: HbO, HHb, TOI, THI and Hb. 
PbtO2 monitoring occurred via invasive parenchymal monitoring (Licox probe; Integra, Licox Brain 
Oxygen Monitoring System, Plainboro, NJ), typically placed in the right frontal lobe via a triple lumen 
bolt (Technicam Ltd).   
TCD assessment of MCA CBFV was conducted via Doppler Box (DWL Compumedics, Singen, Germany).  
Two separate recording sessions were obtained for each patient with TCD, lasting ~60 minutes each.  
Bilateral MCA recordings were obtained in every patient during these sessions.   
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Signal Processing 
All recorded signals were recorded using digital data transfer or digitized via A/D converters (DT9801; 
Data Translation, Marlboro, MA), where appropriate, sampled at frequency of 50 Hz or higher, using 
ICM+ software (Cambridge Enterprise Ltd, Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus).  
Signal artifact were removed manually prior to further processing or analysis. 
Post-acquisition processing of the above signals was conducted using ICM+ software.  CPP was 
determined using the formula:  CPP = MAP – ICP.  Of note, the data recorded from the left TCD probe 
had a large amount of artifact, impeding the ability to include it in the majority of patients.  
Consequently, signals from the left TCD probe were excluded, and only right sided NIRS based indices 
are reported.   
FVs was determined by calculating the maximum FV over a 1.5 second window, updated every second.  
FVd was calculated using the minimum FV over a 1.5 second window, updated every second. FVm was 
calculated using average FV over a 10 second window, updated every 10 seconds (ie. without data 
overlap).  AMP was determined by calculating the fundamental Fourier amplitude of the ICP pulse 
waveforms over a 10 second window, updated every 10 seconds. 
Ten second moving averages (updated every 10 seconds to avoid data overlap) were calculated for all 
recorded signals:  ICP, ABP (which produced MAP), CPP, FVm, FVs, FVd, TOI, and THI.  For the PbtO2 
signal, 30 second means were calculated, as previously described by Jaeger et al.   
Autoregulation indices were derived in a similar fashion across modalities, as detailed in Chapter 3, table 
3.3.  The following continuous indices were derived:  PRx, PAx, RAC, Mx, Mx_a, Sx, Sx_a, Dx, Dx_a, TOx, 
TOx_a, THx, THx_a, ORx-5, ORx-30 and ORx-60.   
Data for this analysis were provided in the form of a minute by minute time trends of the parameters of 
interest for each patient.  This was extracted from ICM+ in to CSV datasets, which were collated into one 
continuous data sheet (compiled from all patients). Thirty-minute moving averages (non-overlapping) 
for every index, and individual patient grand means for each index, were determined.  The statistical 
analysis was performed on all 3 data sheets for each data sheet:  minute-by-minute, 30 minute moving 
averaged, and grand means. Three separate data sheets were employed given the currently unknown 
autocorrelative structure within each of these physiologic indices.  Furthermore, given PbtO2 based 
indices are typically calculated over varying window lengths (such as 30 minutes or longer), which are 
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longer than all other ICP/TCD/NIRS based indices, multiple data sheets were utlizedto ensure that there 
was no difference in the results based on the calculation windows and averaging process of the data. 
  
Statistics 
 General Statistics 
Statistics were performed utilizing XLSTAT (Addinsoft, New York, United States; 
https://www.xlstat.com/en/) add-on package to Microsoft Excel (Microsoft Office 15, Version 
16.0.7369.1323) and R statistical software (R Core Team (2016). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/).   
Tests for normality were performed using the Shapiro-Wilks test for all indices and measured variables.  
All indices and variables were determined to be non-parametric in nature.  Alpha was set at 0.05 for all 
results describing a p-value.   All statistical tests were performed on each of these data sheets, resulting 
in three sets of results.   
We employed a Pearson correlation coefficient matrix to assess correlation between the various indices, 
which was conducted after performing a Fisher transformation (formula 6.1) to the data set (which 
normalizes the correlation coefficient distribution).  This was the only test in which transformed data 
was utilized within the analysis. 
Grouped variance between different combinations of indices was assessed using the Friedman test with 
and without multiple sampling, to account for within subject variation. The main assumption for the use 
of this test was that all indices were measuring the same physiologic variable (ie. autoregulation). The 
Friedman test was performed on the following combinations of data:  all indices, ICP derived indices 
(PRx, PAx, RAC), PbtO2 derived indices (ORx-5, ORx-30, ORx-60), NIRS derived indices (THx, TOx, THx_a, 
TOx_a), and TCD derived indices (Mx, Sx, Dx, Mx_a, Sx_a, Dx_a).  The results for both the with and 
without multiple comparisons were identical, hence only the Friedman test with multiple sampling is 
mentioned within the results section. 
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 Multivariate Clustering and Assessment of Co-variance 
Finally, multivariate statistics were performed to delineate further the associations between the various 
indices.  Currently, it is unclear as to which multivariate clustering technique is superior in the 
exploration of time series based physiologic variables.  Consequently, an array of testing techniques 
were chosen.  Three different multi-variate methods were employed in order to assess the co-variance 
within various combinations of indices.  This was done, so as to be comprehensive and to provide 
confirmation of the potential clustering seen in any individual given test.   
First, Principal Component Analysis (PCA) was performed using a Spearman type PCA, chosen to account 
for the non-parametric data distribution in the dataset (with significance set at p<0.05).  PCA has been 
described in detail in other publications, and is ideally suited as an “exploratory” statistic for small 
patient cohorts with large numbers of variables.  The purpose of PCA is to highlight which combinations 
of variables explain the overall variance within the entire dataset, and thus which variables may be 
related and of further interest to study via other methods. 159–161  
Second and third, agglomerative hierarchal clustering (AHC) and k-means based cluster analysis (KMCA) 
(using Euclidean distance) were also performed.159 These tests provide an overall assessment of the 
similarity between variables, grouping them into clusters (or stems on a dendrogram, as seen within 
AHC) based on the mean distance away from one another, as assessed by Euclidean distance.   
For the AHC, the statistical strength of the correlation between the clusters produced in the 
dendrograms was quantified using cophenetic correlation coefficients.  Cophenetic correlations 
coefficients were produced by the Spearman correlation between the original Euclidean distance matrix 
calculated for the ACH, and the cophenetic distance matrix.  The cophenetic distance is defined as the 
distance between two clusters that contain two indices individually and the point where both clusters 
are merged (ie. it represents the height on the dendrogram at which the branch points occur).  The 
cophenetic correlation coefficient is believe to be an estimate of how well the AHC dendrogram 
maintains pairwise distances when compared with the original data set (ie. the baseline distance matrix 
between variables).162 
With the KMCA, the number of clusters can be set by the investigator.  The “Elbow method” of KMCA 
was utilized in order to determine the appropriate number of clusters for the final analysis.159  The Elbow 
method consists of computing all possible k-means clusters.  Subsequently, a plot of the within-group 
sum of squares versus cluster number, allowed selection of an inflection point (or “elbow”) at which the 
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plot showed the most dramatic slope change.  This is deemed the “most appropriate” cluster number for 
the final analysis. 
 
6.1.3 Results 
 
Patient Demographics 
 The median age of the patients within this retrospective TBI cohort was 33 years (range: 16 to 76 years), 
with a median admission GCS of 7 (range: 3 to 14).  Three patients underwent surgical evacuation of 
mass lesions upon admission to hospital.  There were a total of 37 patients included in the final analysis.   
 
Inter-Index Correlation 
 The Pearson correlation coefficient matrix for the grand mean data set can be seen in Table 6.1.  The 
Pearson correlation matrices for the 30-minute average and minute-by-minute data sheets provided 
very similar results and are hence not shown.  In the grand mean data set, PRx was noted to display 
strong correlations with PAx, RAC and Sx/Sx_a.  PRx displayed weak correlations with the remaining 
indices, with r-values less than 0.3 (p<0.0001 for all).  PAx and RAC displayed similar correlation patterns 
to PRx. 
PbtO2 based indices (ORx-5/ORx-30/ORx-60) failed to display strong correlations with any of the other 
indices of autoregulatory assessment within the grand mean data set.  However, strong correlations 
were seen between ORx-30 and ORx-60. All r-values were 0.250 or less, with most failing to reach 
statistical significance.  The only exception to this was with the correlation between ORx-60 and THx (r= -
0.341, p=0.039). This raises the question as to whether ORx-30 or ORx-60 can safely be utilized as a 
surrogate for cerebrovascular reactivity assessment. 
The TCD based indices (Mx, Sx and Dx) displayed interesting correlation patterns within the grand mean 
data set.  Robust correlations were observed for Mx vs. Dx (r=0.911, p<0.0001), and Mx vs Sx (r=0.726, 
p<0.0001) were seen.  Furthermore, the TCD indices derived using correlations against CPP (Mx, Sx, and 
Dx) were strongly correlated with those derived using MAP (Mx_a, Sx_a, and Dx_a). Mx displayed a 
moderate correlation with the ICP derived indices (PRx, PAx, and RAC) with r-values ranging from 0.3 to 
0.4.  Mx was strongly correlated with the spatially resolved NIRS indices (TOx and THx):  TOx (r=0.618, 
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p<0.0001) and THx (r=0.487, p=0.002).   Sx and Sx_a were correlated with the ICP derived indices, Mx 
and Dx (as previously mentioned), with the remaining correlations being weak.  Finally, Dx and Dx_a only 
displayed strong correlations between Mx and Sx, with the remaining index correlations being weak. 
The NIRS based spatially resolved indices displayed strong intra-technique correlations.  Only the 
statistically significant strong correlations are reported, with the remaining displaying weak correlations 
(r-values <0.3) (the exact r-values can be seen in Table 6.1).  TOx displayed moderate-to-strong 
correlations with THx, PRx, Mx, Sx and Dx.  THx displayed moderate-to-strong correlations with TOx, 
RAC, Mx, Sx and Dx.  Of note, most NIRS based autoregulatory indices displayed weak, or absent, 
correlation to ICP derived indices (such as PRx, PAx or RAC).  Importantly, NIRS based indices displayed 
moderate-to-weak correlation with PRx, with most r-values around 0.3 or less. 
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Table 6.1:  Pearson Correlation Coefficient Matrix – Grand Mean Data Set 
 
The described indices are Pearson correlation coefficients between various variables:  PRx (between ICP and MAP), PAx (between AMP and MAP), RAC (between AMP and CPP), 
ORx (between PbtO2 and CPP; 5 = 5 minutes calculation window, 30 = 30 minute calculation window, 60 = 60 minute calculation window),  Mx (between FVm and CPP), Mx_a 
(between FVm and MAP), Sx (between FVs and CPP), Sx_a (between FVs and MAP), Dx (between FVd and CPP), Dx_a (between FVd and MP), TOx (between TOI and CPP), TOx_a 
(between TOI and MAP), THx (between THI and CPP) and THx_a (between THI and MAP).  *Values in bold typeface are those which reached statistical significance (p<0.05). 
Variables PRx PAx RAC Mx Mx_a Sx Sx_a Dx Dx_a TOx TOx_a THx THx_a ORx_5 ORx_30 ORx_60
PRx 1 0.682 0.677 0.356 0.412 0.531 0.538 0.119 0.168 0.393 0.217 0.257 0.058 -0.013 -0.135 -0.054
PAx 0.682 1 0.825 0.296 0.479 0.554 0.668 0.014 0.160 0.255 0.227 0.159 0.025 0.188 0.038 0.111
RAC 0.677 0.825 1 0.368 0.349 0.584 0.507 0.133 0.110 0.288 0.183 0.342 0.150 0.164 -0.009 0.031
Mx 0.356 0.296 0.368 1 0.723 0.726 0.373 0.911 0.695 0.618 0.460 0.487 0.434 0.316 0.085 0.053
Mx_a 0.412 0.479 0.349 0.723 1 0.490 0.552 0.531 0.825 0.551 0.524 0.332 0.326 0.322 0.089 0.148
Sx 0.531 0.554 0.584 0.726 0.490 1 0.791 0.626 0.426 0.558 0.346 0.284 0.158 0.253 -0.024 0.012
Sx_a 0.538 0.668 0.507 0.373 0.552 0.791 1 0.242 0.422 0.347 0.221 -0.015 -0.139 0.196 -0.026 0.115
Dx 0.119 0.014 0.133 0.911 0.531 0.626 0.242 1 0.732 0.518 0.303 0.421 0.389 0.275 0.154 0.100
Dx_a 0.168 0.160 0.110 0.695 0.825 0.426 0.422 0.732 1 0.454 0.352 0.289 0.326 0.348 0.277 0.306
TOx 0.393 0.255 0.288 0.618 0.551 0.558 0.347 0.518 0.454 1 0.863 0.516 0.456 0.172 -0.096 -0.140
TOx_a 0.217 0.227 0.183 0.460 0.524 0.346 0.221 0.303 0.352 0.863 1 0.412 0.473 0.133 -0.085 -0.088
THx 0.257 0.159 0.342 0.487 0.332 0.284 -0.015 0.421 0.289 0.516 0.412 1 0.885 0.009 -0.264 -0.341
THx_a 0.058 0.025 0.150 0.434 0.326 0.158 -0.139 0.389 0.326 0.456 0.473 0.885 1 -0.012 -0.216 -0.260
ORx_5 -0.013 0.188 0.164 0.316 0.322 0.253 0.196 0.275 0.348 0.172 0.133 0.009 -0.012 1 0.654 0.529
ORx_30 -0.135 0.038 -0.009 0.085 0.089 -0.024 -0.026 0.154 0.277 -0.096 -0.085 -0.264 -0.216 0.654 1 0.920
ORx_60 -0.054 0.111 0.031 0.053 0.148 0.012 0.115 0.100 0.306 -0.140 -0.088 -0.341 -0.260 0.529 0.920 1
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Friedman Test (with multiple sampling) for Grouped Similarity Between Indices 
A Friedman test, with multiple sampling, was conducted on different groups of indices, in order to assess 
if similar variance existed between the means in each group.  The main assumption made for this 
statistical test was that each index measured the same physiologic parameter (ie. cerebrovascular 
reactivity) with the same range of measurement.   
In the grand mean sheet, the Friedman test on the whole group of indices (ie. 16 variables in total), 
indicated that these indices were dissimilar (p<0.0001, Q = 249.797).  Testing of clusters of indices based 
on the modality they were derived from showed that, even within clusters, there was clear lack of 
similarity between the ICP based indices (ie. PRx, PAx and RAC; p<0.0001, Q = 48.054), the TCD based 
indices (ie. Mx, Mxa, Sx, Sxa, Dx and Dxa; p<0.0001, Q = 141.046), and the NIRS-based indices (p<0.0001, 
Q = 38.849). However, the PbtO2 based indices (ORx-5, ORx-30 and ORx-60) were found to share 
substantial commonality based on the Friedman test (p=0.155, Q = 3.722). Similar results were found for 
the 30-minute mean and minute-by-minute data sheets. 
 
Inter-Index Relationships - Multivariate Tests (PCA, AHC and KMCA) 
 Principal Component Analaysis (PCA) 
For the grand mean data, the PCA test was performed utilizing a Spearman type PCA (given the non-
parametric nature of the dataset).  Twenty principal components (PC) (also referred to as factors (F)) 
were identified, with the first 8 PC’s composing ~90% of the overall variance in the dataset.  PC 
eigenvalue data, Scree plots, and variable specific loadings can be seen in Appendix A.   
A loading biplot for PC1 (denoted F1) and PC2 (denoted F2) can be seen in Figure 6.1. As can be seen in 
Figure 6.1, the ICP derived indices (PRx, PAx and RAC) are clustered in the same quadrant of the biplot, 
contributing to the overall variance of both PC’s.  Furthermore, PRx/PAx/RAC appeared to be associated 
with TCD based Sx and Sx_a, in terms of their contributions to the variance of the whole data set.  
Similarly, the TCD based indices (Mx, Mx_a, Dx and Dx_a) were co-located within the area of the biplot 
most associated with PC1.  NIRS based spatially resolved THx, THx_a, TOx and TOx_a were co-located 
with the Sx/Sx_a TCD indices.  Of note, ORx-/ORx-30/ORx-60 were all co-located, but separated from the 
other variables, indicating they are essentially unrelated to all the other indices.  Furthermore, ORx-
5/ORx-30/ORx-60 were located close to the origin of the biplot, indicating that they contribute little 
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variance to the two main principal components of the data sheet.  The 30-minute mean and minute-by-
minute data sets displayed similar results, and can be found in Appendix A. 
 
Figure 6.1: PCA Loading Biplot of F1 (PC1) vs. F2 (PC2) – Minute-by-Minute Data Set 
 
PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal component #1, F2 = PC2 = 
principal component #2. PC1 and PC2 are the two components which contribute the largest amount of variance to the entire 
data set.  The above biplot of PC1 vs. PC2 displays which variables contribute variance to PC1 and PC2.  The longer the arm 
connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  Similarly, the quadrant on the biplot 
in which the variable falls correlates to its contribution to a particular PC. The upper left quadrant is primarily PC2; lower left 
quadrant is neither PC1 or PC2; the upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1.  
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Agglomerative Hierarchal Clustering (AHC) 
To further assess the inter-index relationships, AHC was applied to see if different associations 
appeared.  Figure 6.2 displays the hierarchal dendrogram generated from this analysis on the minute-by-
minute data.  As can be seen within the dendrogram, the TCD based indices, ICP based indices, PbtO2 
based indices and NIRS based indices seem to co-cluster under similar branches.  Another relation of 
interest is that of Sx/Sxa with PRx/PAx/RAC, where these indices arise from the same limb of the 
dendrogram.  This is concordant with the results of the Pearson correlation matrix and the PCA.  In 
addition, the spatially resolved NIRS indices (THx, THx_a, TOx and TOx_a) appear to co-localize with the 
Sx/Sx_a TCD indices on the dendrogram (similar to the Pearson correlation testing and PCA).    
An interesting association was observed between the NIRS indices and PRx and PAx.  This was seen in 
the PCA (and KMCA; see next section), but was not robustly demonstrated by the Pearson correlation 
coefficients.  Finally, ORx-5/ORx-30/ORx-60 clustered on a separate limb of the dendrogram, having little 
association with the other indices.  The cophenetic correlation coefficient derived for the AHC 
dendrogram displayed in Figure 6.2 was 0.822, indicating a statistically robust clustering.  Applying AHC 
to the 30 minute and grand mean data sets resulted in similar hierarchical dendrograms with similar 
clustering of indices (cophenetic correlation coefficients of r=0.812 and r=0.746 respectively), confirming 
the relations/clustering seen in the minute-by-minute data set
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Figure 6.2: AHC Dendrogram - Minute by Minute Data 
 
AHC = agglomerative hierarchal clustering;  The described indices are Pearson correlation coefficients between various variables:  
PRx (between ICP and MAP), PAx (between AMP and MAP), RAC (between AMP and CPP), ORx (between PbtO2 and CPP; 5 = 5 
minutes calculation window, 30 = 30 minute calculation window, 60 = 60 minute calculation window),  Mx (between FVm and 
CPP), Mx_a (between FVm and MAP), Sx (between FVs and CPP), Sx_a (between FVs and MAP), Dx (between FVd and CPP), Dx_a 
(between FVd and MAP), TOx (between TOI and CPP), TOx_a (between TOI and MAP), THx (between THI and CPP) and THx_a 
(between THI and MAP).  
 
 
 K-Mean Cluster Analysis (KMCA) 
KMCA was employed, using seven centers of cluster (based on Euclidean distance and the Elbow method 
of cluster number determination).  Table 6.2 displays the KMCA cluster groupings based on 
cerebrovascular reactivity index from the grand mean data sheet, with the clusters displaying similar 
patterns to the AHC described above.  Figure 6.3 displays the “elbow method” plot confirming the 
selection of 7 centroids within the KMCA. Identical findings were seen with the 30-minute mean and 
minute-by-minute data sheets. 
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Table 6.2: KMCA Clusters – Grand Mean Data Set 
Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Cluster 7 
PRx RAC Mx Mx_a TOx THx ORx-5 
PAx  Dx Dx_a TOx_a THx_a ORx-30 
Sx      ORx-60 
Sx_a       
       
       
KMCA = k-means cluster analysis, PRx (between ICP and MAP), PAx (between AMP and MAP), RAC (between AMP and CPP), ORx 
(between PbtO2 and CPP; 5 = 5 minutes calculation window, 30 = 30 minute calculation window, 60 = 60 minute calculation 
window),  Mx (between FVm and CPP), Mx_a (between FVm and MAP), Sx (between FVs and CPP), Sx_a (between FVs and MAP), 
Dx (between FVd and CPP), Dx_a (between FVd and MAP), TOx (between TOI and CPP), TOx_a (between TOI and MAP), THx 
(between THI and CPP) and THx_a (between THI and MAP). 
 
 
Figure 6.3:  KMCA “Elbow Method” Plot for Centroid Confirmation – Grand Mean Data Set 
 
Plot denotes sequential KMCA performed on grand mean data set.  For each number of centroids/clusters, the within group sum 
of square distance is calculated.  The “elbow method” involves evaluating this plot and selecting the centroid/cluster number 
where there is an “elbow”, transitioning to a relative plateau in the within group sum of square distance.  Hence in this figure, 
centroid/cluster number of 7 fits these criteria, and is subsequently the most appropriate cluster number for final KMCA. 
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6.1.4 Discussion 
 
This retrospective analysis of a small cohort of adult TBI patients with ICP, MAP, TCD, NIRS and PbtO2 
monitoring provides interesting insights into these inter-index associations, with concordant results 
across three distinct data sheets.  A few important relationships are highlighted below. 
First, and most importantly, these indices are not all related.  This is clear based on all forms of analysis 
performed:  Pearson correlation test, Friedman test (with and without multiple sampling), PCA, AHC and 
KMCA. Thus, for the treating clinician, it is critical to understand that these indices are derived from 
different invasive/non-invasive cranial and systemic monitoring metrics and may measure different 
aspects of physiology.  One cannot simply substitute a less commonly described index for one that has 
been well defined, such as PRx.  With that said, the analysis produced some interesting relationships 
which could drive further study.   
Second, PRx displayed strong correlations with PAx and RAC across Pearson correlation test, PCA, AHC 
and KMCA.  It is not surprising that these indices are related, since they are all derived from ICP or AMP.  
Of note, PRx was not found to be strongly correlated to Mx (r=0.356, p<0.0001), a finding confirmed in 
all three data sheets across the short recordings.  This is in contradiction to a previously defined 
moderate correlations between PRx and Mx.83  The reason for this may be related to the small patient 
numbers, short monitoring duration and impact of injury/treatment heterogeneity.   
Third, TCD based indices (regardless if calculated via CPP or MAP) are associated and co-cluster during 
formal cluster analysis.  This is unsurprising, and has been previously described in larger cohorts.83 What 
was interesting was the strong association of Sx/Sx_a with the ICP derived indices across all of the 
analyses.  This strong relationship with PRx/PAx/RAC may stem from the contribution of systolic peaks in 
CBF to ICP and its derivatives (ie. AMP), suggesting Sx/Sx_a may be closely associated with PRx/PAx/RAC.  
This is in contrast to Mx/Dx (and their MAP derivatives), which may more closely relate to CBV, and 
therefore do not strongly associate with PRx/PAx/RAC on Pearson test, PCA, AHC and KMCA.  These 
relationships require further investigation and physiologic validation.  However, the strong association 
between Sx/Sx_a with PRx/PAx/RAC may imply that Sx/Sx_a might be the best surrogate for 
PRx/PAx/RAC, compared to the other invasive/non-invasive indices. 
Fourth, PbtO2 based indices (ORx-5/ORx-30/ORx-60) all failed to display strong correlations with any of 
the other indices, as assessed through Pearson correlation, KW, PCA, AHC and KMCA.  This was 
confirmed across the minute-by-minute, 30 minute, and grand mean data.  Notably, but not surprisingly, 
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ORx-5, ORx-30, and ORx-60 were found to be co-related on Pearson correlation, PCA, ACH and KMCA 
across all data sheets and recording lengths.  The divergence of ORx from the other indices measured 
likely stems from the fact the PbtO2 is a slowly changing parameter, at a frequency that is lower than 
most slow waves. Taking all of this into consideration, ORx may be a questionable tool for assessment of 
autoregulatory capacity, and should be utilized with caution in the clinical setting.  Derivation of patient 
specific CPP optimal values based on ORx, as described in some studies,128,183 should be interpreted with 
caution, as PbtO2 can be greatly influenced by many systemic factors, and since these indices do not 
appear to be associated strongly with any of the other indices, including the thoroughly studied PRx/Mx.  
Moreover, using thresholds defined by other indices (ie. PRx or Mx)8,9 with ORx should be avoided 
entirely, since it appears that this index is not the same as PRx or Mx.   
Finally, NIRS based indices displayed variable correlation with indices derived from ICP, PbtO2 and TCD 
signals, especially PRx and Mx.  The NIRS indices display intra-modality correlation of varying degrees 
(increasing in the 30 minute and grand mean data sets).  Further, these NIRS indices seem to co-cluster 
on PCA, AHC and KMCA.  Of interest, with both PCA and AHC, TOx/THx (and their MAP based 
equivalents) appear to cluster with the ICP derived indices.  Based on the animal studies validating PRx 
and TOx against the lower limit of the Lassen curve, the association between ICP derived indices and 
TOx/TOx_a is not that surprising.  The cluster of THx and THx_a with the ICP derived indices has not been 
well documented.  It is possible that the spatially resolved NIRS indices, with parent signals designed to 
exclude the contamination of extracranial blood flow, may represent frontal lobe pulsatile cortical blood 
flow through the small arteries/arterioles.  This may explain the clustering and association with 
PRx/PAx/RAC/Sx/Sx_a, and not Mx/Dx which are potentially more representative of CBV.  In addition, 
the 'classic' clustering of these indices has been to group TOx/Mx group together (CBF effects) and 
THx/PRx together (CBV effects).  The multi-technique analysis performed in this study provides inference 
that are not concordant with these classical views, and suggest that the NIRS based spatially resolved 
indices are more closely related to ICP (for both THx and TOx).  These NIRS indices may therefore both 
be metrics of CBV (perhaps oxygenated and deoxygenated versions).  This relation was confirmed on 
every test (PCA, ACH and KMCA) across all data sheets.  Further to this, the relationships described 
within the manuscript are statistically robust.  The ACH dendrogram, for example, is a statistically 
significant and robust outcome based on a strong cophenetic correlation coefficient (r=0.822).  This 
indicates a quite strong AHC intra-cluster association, and essentially means the clusters on this test are 
not by chance.  This was of course confirmed with the grouped variances within PCA and grouped 
clustering on KMCA testing.  However, despite these results, further exploration of these relationships is 
 
137 
 
required in order to better understand the physiology and associations between indices of 
autoregulation.   
 
Limitations 
Despite these interesting results, some critical limitations within this study must be addressed.  First, this 
is a retrospective cohort study.  The patient population is composed of those with heterogenous injury 
patterns, ICU/hospital courses and potentially varied ICU therapies during the recorded signals.  This 
impacts the inter-patient signal variability and potentially the results of the analysis.  This may be 
exemplified by the lack of “strong” correlation between PRx and Mx, which has been previously seen in 
larger cohorts of TBI patients with TCD recordings.83  Therefore, the results are only hypothesis 
generating and by no means definitive in terms of the relationships between the various autoregulatory 
indices.  
Second, the population was small, consisting of only 37 patients.  Third, the duration of signal recording 
was quite limited for each patient within the short recording cohort, with typically only two sessions 
lasting one hour each in duration.  Thus, depending on the individual patient events (ie. suctioning, ICP 
therapies, etc.) during these period, various segments of data were either too artefactual to include in 
the final analysis (such as during suctioning or turning), or significantly impacted by administered 
therapies (such as hypertonic saline boluses). Furthermore, weaker correlation was demonstrated 
between THx_a and PRx, than in a previously published study, based on similar recordings. The reason 
for the weaker correlation coefficient stems from the fact that the population of this current study is 
only a sub-population the original group (i.e. those with all the monitoring modalities available).  Also, 
we only used the short (1-2 hour) recordings, given these were the only recordings available with TCD.   
Third, the instability of spontaneous slow waves may be the main driving factor as to why some indices 
failed to produce reproducible relationships. It may be that in the continuous measure of these indices 
within the ICU, we should apply filters related to slow wave power,129 focusing only on those periods in 
which power and signal coherence meet a certain threshold.  This could potentially improve some of the 
relationships seen.  Longer recording sessions would be required for this, ideally throughout the entirety 
of the patient’s ICU stay.  
Fourth, even the metric of cerebrovascular reactivity provided by individual indices are dissimilar, it is 
important to highlight that this does not indicate that CPP-optimum derived from these indices is 
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divergent as well.  This would need to be explored in patients with all of the above monitoring 
modalities, across much longer recording intervals.   
Fifth, the use of multivariate statistical tests, such as PCA, are meant as “exploratory” methods of 
analyzing small patient cohorts with many recorded variables.  PCA, AHA and KMCA are not definitive 
tests, in that they do not indicate statistically significant associations or correlations between various 
combinations of variables.  These tests are merely designed to provide some idea on groupings of 
variables across the entire data set and serve only to drive further directed studies of specific 
relationships identified. Thus, the associations of Sx/Sx_a and the NIRS indices with PRx/PAx/RAC require 
further investigation in order to better understand the physiologic link between these indices. 
 
6.1.5 Conclusions 
 
Continuously indices of cerebrovascular reactivity, derived from various MMM devices, are different, 
and can be poorly correlated with one another.  However, these indices cluster in several groupings, 
which provide insights regarding the pathophysiology that underlies their production.  Caution must be 
advised when utilizing less commonly described autoregulation indices (such as ORx) for the clinical 
assessment of autoregulatory capacity, as they appear to not be related to commonly 
measured/establish indices, such as PRx.   
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6.2 Laser Doppler, ICP and Transcranial Doppler Indices 
 
6.2.1 Introduction 
 
PRx and Mx are the two most commonly quoted continuous indices of cerebrovascular reactivity in TBI, 
with moderate inter-index correlation (r values quoted up to 0.58).83  Given the different monitoring 
techniques utilized to produce these indices, these carry different physiologic information, and may not 
provide similar information regarding cerebral autoregulation/vessel reactivity (as demonstrated in the 
previous study, section 6.1).180 
Though no longer employed clinically, cortical LDF affords the ability to obtain continuous direct 
measure of small vessel/microvascular CBF.  This device requires insertion of a fibreoptic probe into the 
subdural space, and uses the Doppler shift in the reflected light signal to calculate cortical CBF in the 
region of the probe.122  Given the availability of this direct measure of cerebral cortical microvascular 
flow, it becomes possible to ask a key question:  How do Mx and other TCD derived indices of 
cerebrovascular reactivity relate to cortical microvascular autoregulatory capacity?  
A previous study displayed interesting differences between Lx and Mx,125 but did not address 
relationships with other TCD- based indices (such as Sx or Dx). Further, the existing data provide no 
guidance on how PRx (and other ICP derived indices of cerebrovascular reactivity based on “global” ICP), 
relate to cortical microvascular autoregulatory capacity?  While focal continuous measurement of 
microvascular cerebral blood flow is possible with thermal diffusion catheters, their use in the 
assessment of microvascular behavior over extended periods is limited, given the need for repeated re-
calibration and moderate noise in the parent signal.142  However, given that, of all the continuous 
bedside monitors available, the microvascular flow best approximates nutritive perfusion, such 
relationships are critically important in helping validate and interpret less direct metrics of vascular 
biology in the injured brain. 
The goal of this study was to explore the relationship between various commonly used bedside 
autoregulatory/cerebrovascular reactivity indices in order to determine which indices best approximate 
cortical small-vessel/microvascular autoregulatory capacity.  Various tests of multi-variate assessment of 
co-variance were employed in order to assess these relationships, identical to the previous study in 
section 6.1.  
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6.2.2 Methods 
 
Patient Population 
The patient population included in this study is a sub-population of a cohort that has been previously 
described.122,125  This patient cohort was one in which the main goal of the initial prospective study was 
to assess regional CBF via LDF in TBI patients, where local Cambridge Health Authority research ethics 
committee approval was obtained.  Through retrospective analysis of this cohort, it was identified that 
the raw monitoring signals included data that would allow the determination of various indices of 
cerebrovascular reactivity, assessing the relationship between those derived from different monitoring 
devices.  All recording sessions included in this study had the following monitors:  ICP, MAP, CPP, LDF-
CBF and TCD based CBFV of the MCA ipsilateral to the ICP and LDF monitors.   
This study was conducted as a retrospective analysis of a prospectively maintained database cohort, in 
which 61 separate recordings were analyzed. Most recordings were approximately 30 minutes to 1 hour 
in duration. All patients in both cohorts suffered moderate-severe TBI, or deteriorated after an initial 
admission with mild TBI and required sedation and mechanical ventilation for clinical care in the NCCU at 
Addenbrooke’s Hospital, Cambridge.  Treatment received during the recording periods included 
standard ICP-directed therapy, with an ICP goal of less than 20 mm Hg and CPP goal of greater than 60 
mm Hg.   
 
Signal Acquisition 
Various signals were obtained through a combination of invasive and non-invasive methods.  ABP was 
obtained through either radial or femoral arterial lines connected to pressure transducers (Baxter 
Healthcare Corp. CardioVascular Group, Irvine, CA).  ICP was acquired via an intra-parenchymal strain 
gauge probe (Codman ICP MicroSensor; Codman & Shurtleff Inc., Raynham, MA).   
LDF based CBF was obtained via placement of a MBF3D dual channel laser LDF (Moor Instrument Ltd, 
Devon UK) in the subdual space, ipsilateral to the ICP monitor.  The LDF probe employed a low energy 
laser (0.5 to 1.5 mW) with light generated in the near infrared spectrum (780 to 820 nm).  LDF signals 
were recorded at a frequency of 14.6 kHz.  All probes were pre-calibrated prior to insertion.    
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Finally, TCD assessment of MCA CBFV was conducted via Doppler Box (DWL Compumedics, Singen, 
Germany) or Neuroguard (Medasonic, Fremont, CA, USA).  Unilateral MCA recordings (ipsilateral to the 
ICP and LDF monitors) were obtained in every patient during these sessions.   
All recorded signals were digitized via A/D converters (DT9801; Data Translation, Marlboro, MA), 
sampled at frequency of 50 Hz or higher and recorded using WREC software (Warsaw University of 
Technology) and analyzed retrospectively using ICM+ software (Cambridge Enterprise Ltd, Cambridge, 
UK, http://www.neurosurg.cam.ac.uk/icmplus).  All signal artifacts were removed prior to further 
processing or analysis. 
 
Signal Processing 
Post-acquisition processing of the above described signals was conducted utilizing ICM+ software.  CPP 
was determined utilizing the virtual signals by:  CPP = MAP – ICP.  FVs was determined by calculating the 
maximum FV over a 1.5 second window, updated every second.  FVd was calculated using the minimum 
FV over a 1.5 second window, updated every second. FVm was calculated using average FV over a 10 
second window, updated every 10 seconds (ie. without data overlap).  AMP was determined by 
calculating the fundamental amplitude of the ICP signal over a 10 second window, updated every 10 
seconds.  Ten second moving averages (updated every 10 seconds to avoid data overlap) were 
calculated for all recorded signals:  ICP, ABP (which produced MAP), CPP, FVm, FVs, FVd, and LDF-CBF.  
 
Cerebrovascular Reactivity Indices 
The cerebrovascular reactivity indices were derived in an identical fashion to the description in Chapter 
3, and in the previous study (section 6.1.2). The following cerebrovascular reactivity indices were 
derived: PRx, PAx, RAC, Mx, Mx_a, Sx, Sx_a, Dx, Dx_a, Lx, and Lx_a.  A 10 second update period was 
chosen given the short duration of the recordings.  
 
Statistics 
The analysis conducted is identical to that performed in the previous study, outlined in section 6.1.2.  
The only difference for this study is that there are slightly larger patient/recording numbers, no PbtO2 or 
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NIRS monitoring, and the availability of LDF signal.  As well, given the short recording duration, instead 
of 3 data sheets utilized in chapter 6.1, only 2 were employed (ie. grand mean data, and 10-second-by-
10-second data). For more details on the statistical methods please see 6.1.2 “Statistics” section. 
 
6.2.3 Results 
 
Patient Demographics 
A total of 40 patients, with 61 recordings, were included within this study.  The average age was 31.1 +/- 
15.3 years, with a median admission GCS of 5 (IQR: 4 to 7). The median 6-month Glasgow Outcome 
Score (GOS) for these patients was 2 (range: 1 to 5).   
 
Cerebrovascular Reactivity Index Analysis 
 Inter-Index Correlation 
We compared the inter-index correlation via a Pearson correlation matrix, for both the 10 second-by-10 
second data and the grand mean data.  Of note, the ICP derived indices (PRx, PAx and RAC) display 
moderate to strong inter-technique correlation (r~ >0.5 in all, p<0.05 in all).  A similar trend was noted 
with the TCD derived indices (Mx, Mx_a, Dx, Dx_a, Sx, Sx_a).  Mx and PRx were not strongly correlated 
(r=0.346, p=0.006).  Sx and Sx_a were moderately correlated with the ICP derived indices.  Finally, the 
LDF derived indices were correlated more with TCD indices (Mx: r=0.561, p<0.0001; Dx: r=0.492, 
p<0.0001).  Thus, it appears that cortical small-vessel/microvascular autoregulatory capacity may be 
better approximated by TCD derived Mx/Mx_a and Dx/Dx_a, then other indices.  These relationships 
were confirmed in both data sheets. Table 6.3 displays the grand mean Pearson correlation matrix. 
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Table 6.3:  Pearson Correlation Coefficient Matrix for Autoregulatory Indices – Grand Mean Data 
 
AMP = fundamental amplitude of ICP, CPP = cerebral perfusion pressure, Dx = diastolic flow index (between FVd and CPP), Dx_a = arterial diastolic flow index (between FVd and 
MAP), FVd = diastolic flow velocity, FVm = mean flow velocity, FVs = systolic flow velocity, ICP = intracranial pressure, Lx = laser Doppler flow index (between LDF-CBF and CPP), 
Lx_a = arterial laser Doppler flow index (between LDF-CBF and MAP), Mx = mean flow index (between FVm and CPP), Mx_a = arterial mean flow index (between FVm and MAP), 
PAx = between AMP and MAP, PRx = pressure reactivity index (between ICP and MAP), RAC = between AMP and CPP. *Note: all values in bold type face are those which reached 
statistical significance (ie. p<0.05). 
Variables PRx PAx RAC Mx Mx_a Sx Sx_a Dx Dx_a Lx Lx_a
PRx 1 0.496 0.600 0.356 0.433 0.382 0.393 -0.203 -0.204 0.139 0.189
PAx 0.496 1 0.644 0.077 0.379 0.279 0.612 -0.161 0.076 -0.067 0.182
RAC 0.600 0.644 1 0.119 0.319 0.352 0.369 -0.230 -0.017 0.051 0.167
Mx 0.356 0.077 0.119 1 0.707 0.670 0.398 0.753 0.473 0.561 0.171
Mx_a 0.433 0.379 0.319 0.707 1 0.469 0.717 0.486 0.713 0.400 0.250
Sx 0.382 0.279 0.352 0.670 0.469 1 0.646 0.301 0.178 0.255 0.062
Sx_a 0.393 0.612 0.369 0.398 0.717 0.646 1 0.158 0.417 0.095 0.107
Dx -0.203 -0.161 -0.230 0.753 0.486 0.301 0.158 1 0.739 0.492 0.095
Dx_a -0.204 0.076 -0.017 0.473 0.713 0.178 0.417 0.739 1 0.329 0.165
Lx 0.139 -0.067 0.051 0.561 0.400 0.255 0.095 0.492 0.329 1 0.556
Lx_a 0.189 0.182 0.167 0.171 0.250 0.062 0.107 0.095 0.165 0.556 1
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Grouped Variance Analysis – Friedman Test 
Similarity between various groups of autoregulatory indices was assessed by the Friedman test (with and 
without multiple sampling), with the pre-test assumption that each index was assessing the same aspect 
of physiology, autoregulation.  In both the 10 second-by-10 second and grand mean data sheets, 
Friedman testing confirmed that the indices were not all the same (p<0.0001, Q = 301.204).  Further 
Friedman tests were applied to groups of monitor specific indices (ie. derived indices were grouped 
based on their monitoring signal source: ICP, TCD, etc).  The within monitor Friedman testing also 
confirmed each index was in fact demonstrably different.   
 
 Principal Component Analysis (PCA) 
Spearman PCA was conducted on both data sheets, with similar results.  Eleven principal components 
(PC) (also referred to as factors (F)) were identified, with the first 5 PC’s composing ~90% of the overall 
variance in the dataset.  PC eigenvalue data, Scree plots, and variable specific loadings can be seen in 
Appendix B of the supplementary materials.   
A loading biplot for PC1 (denoted F1) and PC2 (denoted F2) can be seen in Figure 6.4. As can be seen 
within the biplot, the ICP derived indices (PRx, PAx and RAC) are clustered in the same quadrant of the 
biplot, contributing to the overall variance of both PC1 and PC2.  Furthermore, PRx/PAx/RAC appeared 
to be associated with TCD based Sx and Sx_a, in terms of their contributions to the variance of the whole 
data set.  Similarly, the TCD based indices (Mx, Mx_a, Dx and Dx_a) were co-located within the area of 
the biplot most associated with PC1.  LDF indices (Lx, Lx_a) co-varied with TCD derived 
Mx/Mx_a/Dx/Dx_a, confirming the correlations seen in the Pearson test analysis. 
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Figure 6.4: Spearman Type Principal Component Analysis of Autoregulatory Indices – Biplot of PC1 vs. PC2 (Grand Mean Data) 
 
PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal component #1, F2 = PC2 = 
principal component #2. PC1 and PC2 are the two components which contribute the largest amount of variance to the entire 
data set.  The above biplot of PC1 vs. PC2 displays which variables contribute variance to PC1 and PC2.  The longer the arm 
connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  Similarly, the quadrant on the biplot 
in which the variable falls correlates to its contribution to a particular PC. The upper left quadrant is primarily PC2; lower left 
quadrant is neither PC1 or PC2; the upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1.  
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Agglomerative Hierarchal Clustering (AHC) 
AHC was performed on both data sheets, yielding identical results.  Figure 6.5 demonstrates the 
dendrogram produced.  Of note is the clustering of ICP, TCD and LDF based indices.  ICP indices co-
cluster with Sx and Sx_a, as displayed in both Pearson and PCA testing.  Similarly, TCD based Mx/Mx_a 
and Dx/Dx_a co-cluster with Lx/Lx_a, as seen in the Pearson and PCA testing.  The cophenetic correlation 
coefficient for the grand mean AHC was 0.77, indicating moderate-to-strong significance of the 
clustering.   
 
Figure 6.5:  AHC Dendrogram of Cerebrovascular Reactivity Indices – Grand Mean Data 
 
AHC = agglomerative hierarchal clustering, AMP = fundamental amplitude of ICP, CPP = cerebral perfusion pressure, Dx = 
diastolic flow index (between FVd and CPP), Dx_a = arterial diastolic flow index (between FVd and MAP), FVd = diastolic flow 
velocity, FVm = mean flow velocity, FVs = systolic flow velocity, ICP = intracranial pressure, Lx = laser Doppler flow index 
(between LDF-CBF and CPP), Lx_a = arterial laser Doppler flow index (between LDF-CBF and MAP), Mx = mean flow index 
(between FVm and CPP), Mx_a = arterial mean flow index (between FVm and MAP), PAx = between AMP and MAP, PRx = 
pressure reactivity index (between ICP and MAP), RAC = between AMP and CPP. 
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 K-Means Cluster Analysis (KMCA) 
KMCA was performed on both data sheets, producing identical clustering results.  Based on the “Elbow 
Method”, the optimal number of centroids for the KMCA was determined to be 4.  The clustering of the 
indices was similar to that seen in the AHC, PCA and Pearson correlation testing and hence not discussed 
further. 
 
6.2.4 Discussion 
 
Through the analysis of this TBI LDF data set, the relationships between various ICP/TCD/LDF 
cerebrovascular reactivity indices in humans have been better defined.    First, intra-technique 
correlations were seen for ICP, TCD and LDF-CBF derived indices across a using a range of statistical 
approaches, including the Pearson correlation test, PCA, ACH and KMCA.  This result isn’t surprising, 
given indices derived from the same signals would be expected to be inter-related.  Second, LDF-CBF 
based Lx and Lx_a were found to be more closely associated with TCD based Mx/Mx_a and Dx/Dx_a, 
than with Sx/Sx_a or the ICP derived indices.  This was confirmed on all forms of the analysis.  This 
suggests that TCD “vascular” based measures (Mx/Mx_a and Dx/Dx_a) are a better approximation of 
cortical small-vessel/microcirculatory autoregulation. Further to this, Lx and Lx_a were not correlated 
with ICP-derived indices of cerebrovascular reactivity (ie. including PRx) in any of the analyses 
conducted.  This is another important finding as it suggests that that ICP-derived indices may not 
measure cortical pial/microcirculatory vascular reactivity. This lack of association with metrics derived 
from continuously measured CBF requires further evaluation. Third, Sx/Sx_a appear to be more closely 
associated with the ICP derived indices (PRx, PAx and RAC), as confirmed on all forms of the analysis. 
This was also seen in the study in section 6.1. This likely stems from the peak pulsatile systolic 
component of CBFV yielding a stronger contribution to the ICP signal, than mean or diastolic CBFV’s.  
Further, it isn’t surprising that by the time that CBF reaches the small cortical vessels, that the peak 
systolic pulsatile component has less of an impact on regional LDF-CBF signal, where it is more likely to 
be dependent on mean flow or diastolic flow parameters.  This requires confirmation however. 
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 Limitations 
Some important limitations should be highlighted.  First, this is a small retrospective cohort of patients 
that were studied.  The patients had heterogeneous injury patterns and were subject to variations in ICU 
therapies/treatments during the short recording sessions.  This could have impacted signal 
heterogeneity and quality, leading to a direct influence on both the results of the slow wave and 
autoregulatory index analysis.  Therefore, the strength of conclusions that can be drawn from the 
analysis is limited.  However, with that said, the analysis conducted provides more than anecdotal 
insight into the co-variance and inter-index relationship, providing valuable information all involved in 
the critical care management of moderate/severe TBI patients.  
Second, LDF-CBF probes are no longer in clinical use in humans.  Consequently, despite interesting 
results in this chapter, it will be difficult to confirm the analysis with newer and larger patient cohorts.  
Therefore, unfortunately, only retrospective data sets exist to analyze relationships between LDF based 
cortical/small-vessel CBF and common monitors in current use.  The decline in the use of LDF stemmed 
from cost, maintenance, invasive placement and focality of measure, as well as the relatively noisy signal 
generated from red blood cell flux measurements.  With that said, the technique provided useful and 
unique information on cortical cerebral blood flow, and subsequent cerebrovascular reactivity.  
Finally, the statistics utilized within the autoregulatory index analysis are mainly exploratory and not 
confirmatory of the relationships described.  The use of PCA, AHC and KMCA are exploratory multi-
variate statistical techniques designed to highlight potential relationships of interest within an entire 
dataset, which would then drive further prospective focused assessment of the individual relationships 
identified.  Given the limitations mentioned around the clinical use of LDF, the analysis will have to 
remain “exploratory” for human data.  With that said, the relationships were all confirmed across 
Pearson correlation test, PCA, AHC and KMCA, potentially indicating that the various 
clustering/correlations are more than just by chance within an individual multi-variate test.  Further to 
this, future prospective evaluation of the index relations can be carried out within controlled animal 
studies, given the continued application of LDF within this setting.   
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6.2.5 Conclusions 
 
Mx is most closely related to LDF derived measures of microvascular flow (Lx/Lx_a).  Both Sx/Sx_a and 
the ICP derived indices appear to be dissociated from LDF based cortical small vessel cerebrovascular 
reactivity, leaving Mx/Mx_a/Dx/Dx_a as a better surrogate for the assessment of cortical small 
vessel/microvascular cerebrovascular reactivity.  Sx/Sx_a co-cluster/co-vary with ICP derived indices, as 
seen in previous work described in this thesis. 
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6.3 Relationships between ICP and Transcranial Doppler Indices 
 
6.3.1 Introduction 
 
Based on the results of the studies detailed in sections 6.1 and 6.2,180,181 it is apparent within these small 
patient cohorts that Sx/Sx_a preferentially co-vary with the ICP derived indices of cerebrovascular 
reactivity.  Confirming that Sx/Sx_a do indeed co-cluster with the ICP derived indices would provide 
confidence in utilizing them as a potential surrogate for the more invasive ICP indices.  Furthermore, 
given Sx_a can be derived through entirely non-invasive means (ie. with MAP recording by non-invasive 
finger-cuff techniques), ICP indices (such as PRx), could be estimated or even forecasted (ie. predicted) if 
this relationship with Sx/Sx_a is validated.  Thus, the goal of this study was to provide validation for the 
ICP and TCD derived inter-index relationships seen in sections 6.1 and 6.2, using a substantially larger 
adult TBI cohort with both continuous high-frequency ICP and TCD recordings. 
 
6.3.2 Methods 
 
Patient Population and Demographic Data Acquisition 
A large retrospective database cohort of TBI patients with simultaneous TCD and ICP recording was 
utilized.  TCD signal acquisition in TBI patients was conducted intermittently within the NCCU at 
Addenbrooke’s Hospital, Cambridge between the period from January 1992 up to and including 
September 2011.  The timing to application of TCD based monitoring varied from patient to patient, 
typically initiated between 24 hours to 10 days post-TBI.  The duration of recording also varied between 
patients, subject to the technical limitations of long-term TCD monitoring. 
TCD based CBFV, ICP and ABP were all linked in time series and prospectively stored.   We performed a 
retrospective analysis of this prospectively maintained database. A large portion of this population was 
previously utilized in the determination of critical thresholds for Mx and Mx_a.8 
Most patients included in this analysis had sustained moderate/severe TBI, but also included a few 
patients who were initially classified as mild TBI (as defined by the admission GCS), but experienced 
subsequent clinical deterioration leading to invasive monitoring and admission to the NCCU.  Treatment 
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received during the recording periods included standard ICP-directed therapy, with an ICP goal of less 
than 20 mm Hg and CPP goal of greater than 60 mm Hg.   
 
For the purpose of confirming the co-variance and co-clustering relationships previously discovered, 
minimum recording lengths of 30 minutes were utilized for analysis.  A total of 347 patients were 
included, with 410 recordings of 30 minutes or greater in duration. The following patient demographic 
data was obtained from the database:  age, sex, admission GCS, and patient outcome at 6 months.   
 
 
Signal Acquisition 
Various signals were obtained through a combination of invasive and non-invasive methods.  ABP was 
obtained through either radial or femoral arterial lines connected to pressure transducers (Baxter 
Healthcare Corp. CardioVascular Group, Irvine, CA).  ICP was acquired via an intra-parenchymal strain 
gauge probe (Codman ICP MicroSensor; Codman & Shurtleff Inc., Raynham, MA).  Finally, TCD 
assessment of MCA CBFV was conducted via Doppler Box (DWL Compumedics, Singen, Germany) or 
Neuroguard (Medasonic, Fremont, CA, USA).   
All recorded signals were digitized via A/D converters (DT9801; Data Translation, Marlboro, MA), 
sampled at frequency of 50 Hz or higher, using ICM+ software (Cambridge Enterprise Ltd, Cambridge, 
UK, http://www.neurosurg.cam.ac.uk/icmplus).  All signal artifact was removed prior to further 
processing or analysis. 
 
Signal Processing 
Post-acquisition processing of the above described signals was conducted utilizing ICM+ software.  CPP 
was determined as:  CPP = MAP – ICP.  FVs was determined by calculating the maximum FV over a 1.5 
second window, updated every second.  FVd was calculated using the minimum FV over a 1.5 second 
window, updated every second. FVm was calculated using average FV over a 10 second window, 
updated every 10 seconds (ie. not data overlap).  AMP was determined by calculating the fundamental 
Fourier amplitude of the ICP signal over a 10 second window, updated every 10 seconds.  Ten second 
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moving averages (updated every 10 seconds to avoid data overlap) were calculated for all recorded 
signals:  ICP, ABP (which produced MAP), CPP, FVm, FVs, and FVd.  
 
Cerebrovascular Reactivity Indices 
The autoregulation/cerebrovascular reactivity indices were derived in a similar fashion, as highlighted in 
Chapter 3.  The following indices of cerebrovascular reactivity were derived:  PRx, PAx, RAC, Mx, Mx_a, 
Sx, Sx_a, Dx, and Dx_a.   
 
Statistics 
The analysis conducted is identical to that performed in the previous studies, outlined in section 6.1.2.  
The only difference for this study is that there are larger patient/recording numbers, with ICP and TCD 
signals.  Three data sheets were employed for the analysis (ie. grand mean, 30-minute mean and 
minute-by-minute data). For more details on the statistical methods please see 6.1.2 “Statistics” section. 
 
6.3.3 Results 
 
Patient Demographics 
A total of 347 patients, with 410 recordings, constituting 419.6 hours of monitoring, were included for 
the co-variance/cluster analysis.  The mean age was 33.7 +/- 16.4 years, with 250 males.  The median 
admission GCS was 6 (IQR: 4 to 8). The mean length of recording was 1.02 hours (range: 0.50 to 3.26 
hours).  
 
Cerebrovascular Index Co-Variance/Clustering Analysis 
Inter-index correlation was compared via a Pearson correlation matrix, for all three data sheets: grand 
mean, 30-minute mean and minute-by-minute data.  Table 6.4 displays the Pearson correlation matrix 
for the grand mean data sheet.  Of note is the strong inter-index correlation of the ICP indices.  In 
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addition, Sx and Sx_a display stronger correlation with the ICP indices, compared to Mx/Mx_a/Dx/Dx_a.  
This was confirmed across all 3 data sheets.   
 
Table 6.4: Pearson Correlation Coefficient Matrix for Autoregulatory/Cerebrovascular Reactivity Indices – Entire TBI TCD Cohort – 
Grand Mean Data 
Variables PRx PAx RAC Mx Mx_a Dx Dx_a Sx Sx_a 
PRx 1 0.665 0.490 0.434 0.440 0.303 0.365 0.448 0.488 
PAx 0.665 1 0.631 0.234 0.357 0.085 0.197 0.368 0.562 
RAC 0.490 0.631 1 0.332 0.277 0.176 0.156 0.544 0.344 
Mx 0.434 0.234 0.332 1 0.777 0.934 0.732 0.738 0.479 
Mx_a 0.440 0.357 0.277 0.777 1 0.728 0.898 0.599 0.695 
Dx 0.303 0.085 0.176 0.934 0.728 1 0.805 0.580 0.340 
Dx_a 0.365 0.197 0.156 0.732 0.898 0.805 1 0.446 0.487 
Sx 0.448 0.368 0.544 0.738 0.599 0.580 0.446 1 0.754 
Sx_a 0.488 0.562 0.344 0.479 0.695 0.340 0.487 0.754 1 
AMP = fundamental amplitude of ICP, CPP = cerebral perfusion pressure, Dx = diastolic flow index (between FVd and CPP), Dx_a 
= arterial diastolic flow index (between FVd and MAP), FVd = diastolic flow velocity, FVm = mean flow velocity, FVs = systolic flow 
velocity, ICP = intracranial pressure, Mx = mean flow index (between FVm and CPP), Mx_a = arterial mean flow index (between 
FVm and MAP), PAx = between AMP and MAP, PRx = pressure reactivity index (between ICP and MAP), RAC = between AMP and 
CPP. *all values in bold type face are those which reached statistical significance (ie. p<0.05) 
 
Grouped Variance Analysis – Friedman Test  
Similarity between various groups of indices was assessed by the Friedman test (with and without 
multiple sampling), with the pre-test assumption that each index was assessing the same aspect of 
physiology, cerebrovascular reactivity.  Friedman testing showed significant inter-index differences, 
indicating that these indices were non-identical.  Further Friedman tests were applied to groups of 
monitor specific indices (ie. Separately within the two clusters of ICP- and TCD-derived indices).  This 
within-modality Friedman testing also confirmed that each index was in fact different.   
 
 
Principal Component Analysis (PCA) – Entire TBI TCD Cohort 
Spearman PCA was conducted on all three data sheets, all with similar results. Nine principal 
components (PC) (also referred to as factors (F)) were identified, with the first 5 PC’s composing ~96% of 
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the overall variance in the dataset.  PC eigenvalue data, Scree plots, and variable specific loadings can be 
seen in Appendix C of the supplementary materials.  A loading biplot for PC1 (denoted F1) and PC2 
(denoted F2) can be seen in Figure 6.6, based on the grand mean data. The ICP derived indices (PRx, PAx 
and RAC) are clustered in the same quadrant of the biplot, contributing to the overall variance of both 
PC1 and PC2.  Furthermore, PRx/PAx/RAC appeared to be associated with TCD based Sx and Sx_a, in 
terms of their contributions to the variance of the whole data set.  Similarly, the TCD based indices (Mx, 
Mx_a, Dx and Dx_a) were co-located within the area of the biplot most associated with PC1.  This was 
confirmed on all 3 data sheets.   
 
Agglomerative Hierarchal Clustering (AHC) – Entire TBI TCD Cohort 
AHC was performed on all three data sheets, yielding similar results.  Figure 6.7 demonstrates the AHC 
dendrogram for the grand mean data from the entire TBI TCD cohort. As was seen in the two previous 
sections, Sx/Sx_a co-clustered with the ICP derived indices. The cophenetic correlation coefficient for the 
grand mean data AHC analysis was 0.76, indicating a moderate-to-strong significance of the clustering. 
 
K-Means Cluster Analysis (KMCA)  
KMCA was performed on all data sheets for both cohorts, producing identical clustering results.  For the 
entire TBI TCD cohort, based on the “Elbow Method”, the optimal number of centroids for the KMCA 
was determined to be 3. This was also similar to that seen in the AHC, PCA and Pearson correlation 
testing.  
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Figure 6.6: Spearman Type Principal Component Analysis of Autoregulatory/Cerebrovascular Reactivity Indices – Biplot of PC1 vs. 
PC2 (Entire TBI TCD Cohort - Grand Mean Data) 
 
 
PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal component #1, F2 = PC2 = 
principal component #2. PC1 and PC2 are the two components which contribute the largest amount of variance to the entire 
data set.  The above biplot of PC1 vs. PC2 displays which variables contribute variance to PC1 and PC2.  The longer the arm 
connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  Similarly, the quadrant on the biplot 
in which the variable falls correlates to its contribution to a particular PC. The upper left quadrant is primarily PC2; lower left 
quadrant is neither PC1 or PC2; the upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1.  
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Figure 6.7:  Entire TBI TCD Cohort – AHC Dendrogram – Grand Mean Data 
 
AHC = agglomerative hierarchal clustering, AMP = fundamental amplitude of ICP, CPP = cerebral perfusion pressure, Dx = 
diastolic flow index (between FVd and CPP), Dx_a = arterial diastolic flow index (between FVd and MAP), FVd = diastolic flow 
velocity, FVm = mean flow velocity, FVs = systolic flow velocity, ICP = intracranial pressure,, Mx = mean flow index (between FVm 
and CPP), Mx_a = arterial mean flow index (between FVm and MAP), PAx = between AMP and MAP, PRx = pressure reactivity 
index (between ICP and MAP), RAC = between AMP and CPP. 
 
6.3.4 Discussion 
 
These results replicate the previously described multi-variate clustering analysis of continuous 
autoregulation indices in a larger cohort of TBI patients with TCD, providing confirmatory evidence for 
the co-clustering/co-variance of Sx/Sx_a with the ICP derived indices (PRx, PAx, RAC).  The current 
results based on 410 recordings of at least 30 minutes duration, provide this confirmatory evidence.  
Thus, it appears that Sx/Sx_a may be more representative of the ICP derived indices, compared to 
Mx/Mx_a/Dx/Dx_a.  This was confirmed with the Pearson correlation test, PCA, AHC and KMCA in all 
three data sheets analyzed.  This may stem from the peak pulsatile systolic component of CBFV yielding 
a stronger contribution to the ICP signal, than mean or diastolic CBFV’s.  This concept requires 
confirmation.  
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It is important to identify which TCD-based indices are associated with ICP derived indices, in particular 
PRx.  Only a few indices have been validated in animal models with respect to the lower limit of 
autoregulation (such as PRx). Thus, strong co-variance and association between “non-validated” indices 
with PRx potentially allow for the use of these indices as a “surrogate” measure for the validated PRx.  Sx 
and Sx_a may be these surrogate measures, with Sx_a potentially derived through entirely non-invasive 
means.   
 
Limitations 
Despite the interesting results, some important limitations should be highlighted.  First, a retrospective 
cohort of patients were studied.  The patients had heterogeneous injury patterns and were subject to 
variations in ICU therapies/treatments during the short recording sessions.  This could have impacted 
signal heterogeneity and quality, leading to a direct influence on both the results of the slow wave and 
autoregulatory/cerebrovascular reactivity index analysis.  Further, these varying treatments may have 
impacted patient outcomes seen at 6 months.  Adding to this, given the varied time frame to application 
of TCD monitoring within this population, it limits the ability to make definitive comments regarding the 
“time-dependent” change in predictive power for these indices with respect to 6-month outcome.  This 
aspect would definitively benefit from a prospective study, analyzing the application of TCD recording 
throughout the course of the patient’s ICU stay, leading to standardized and longer recording periods.  
With this type of data, one would be able to comment on the whether there exists a variation in the 
predictive power of the TCD based indices, based on the time frame post-injury from which the 
recordings were obtained. 
Second, given this was a retrospective analysis of a database, data was limited to that recorded at the 
time of entry.  Details regarding patient co-morbidities and CT based injury patterns/burden were not 
recorded in these patients.  These details may prove important in terms of an individual patient’s 
cerebrovascular response to injury and the development of impaired autoregulatory capacity.  Further 
prospective studies would benefit from a detailed account of these variables in order to determine their 
impact on cerebrovascular reactivity post-TBI. 
Third, the statistics utilized within the index co-variance/cluster analysis are mainly exploratory and not 
100% confirmatory of the relationships described.  The use of PCA, AHC and KMCA are exploratory 
multi-variate statistical techniques designed to highlight potential relationships of interest within an 
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entire dataset, which would then drive further prospective focused assessment of the individual 
relationships identified.  With that said, the relationships were all confirmed across Pearson correlation 
test, PCA, AHC and KMCA, potentially indicating that the various clustering/correlations are more than 
just by chance within an individual multi-variate test.   
Finally, as mentioned in previous studies (6.1 and 6.2), the erratic nature of spontaneous slow waves 
may impact the strength of the relationships seen.  Thus, future prospective analysis will require longer 
recording sessions to allow for the application of slow wave power filters.  Ideally this would take place 
over the course of a patient’s ICU stay, in order to confirm that these relationships hold true throughout 
the acute phase of illness. 
 
6.3.5 Conclusions 
 
TCD based Sx, and Sx_a, are both more closely associated with the ICP derived indices (PRx, PAx and 
RAC), compared to Mx (or Mx_a) and Dx (or Dx_a).  Thus, Sx and Sx_a likely provide a better 
approximation of PRx and other ICP derived indices, compared to Mx/Mx_a/Dx/Dx_a. 
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CHAPTER 7: NON-INVASIVE MODELLING OF PRESSURE REACTIVITY USING 
TCD IN ADULT TBI 
*The results of the studies detailed in section 7.1, 7.2 and 7.3 can also be found detailed in the following 
publications: 
1. Zeiler et al., J Neurotrauma. 2018; 35(14):1559-1568. doi: 10.1089/neu.2017.5596.184 
2. Zeiler et al., Crit Ultrasound J. 2018; 10(1):16. doi: 10.1186/s13089-018-0097-0.185 
3. Zeiler et al., Acta Neurochir (Wein). 2018; 60(11):2149-2157. doi: 10.1007/s00701-018-3687-5.186 
4. Zeiler et al., J Neurotrauma. 2018 Sep 27. doi: 10.1089/neu.2018.5987. [Epub ahead of print]187 
 
7.1 Estimation of Pressure Reactivity Index Using TCD 
 
7.1.1 Introduction 
 
PRx is the one continuous measure of autoregulatory capacity that has received the most attention in 
the TBI population.3,11  Numerous studies have been published linking abnormal PRx values to poor 
outcome in TBI.  Further to this, thresholds associated with 6-month outcomes have been defined for 
PRx in the TBI population.9,152  Finally, PRx is one of few indices that have been validated in an animal 
model against the LLA.14 
Despite the promising nature of PRx, the major limitation in its acquisition is the need for invasive 
measure of ICP.  Non-invasive autoregulatory indices based on transcranial Doppler (TCD) exist, 
including: Mx_a and Sx_a.  These TCD-derived indices display a positive linear relationship with PRx.  In 
addition, based on the studies performed in Chapter 6 in three separate patient populations, robust 
statistical co-variance and co-clustering of the non-invasively derived Sx_a with the invasively derived 
PRx has been demonstrated.180–182  Thus, the question remains:  Can we estimate PRx using non-invasive 
TCD based autoregulatory indices? 
The main issues with modelling PRx are the fact that the high frequency data used are autocorrelated 
violating the assumption of statistical independence implicit in simple linear regression techniques and 
limiting the literature in this area to date. The goal of this study was to provide for the first time, a non-
invasive method of estimating PRx using formal time series analysis and linear mixed effects modelling. 
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7.1.2 Methods 
 
Patient Population 
A large retrospective database of TBI patients with simultaneous TCD and ICP recording were studied.  
All high frequency signals from monitoring devices were archived prospectively between the periods for 
January 1992 up to and including September 2011, with all patients being admitted to the neurosciences 
critical care unit (NCCU) at Addenbrooke’s Hospital, Cambridge.  This was the identical TCD cohort 
described in section 6.3.182 For further details refer to section 6.3.2. 
Similar to the previous study on co-variance (Chapter 6.3), we were only interested in continuous 
recording lengths of 30 minutes or longer, for use in linear mixed effects (LME) modelling of PRx.  A total 
of 410 recordings from 347 patients were included.  Details of the study population are provided in the 
results section. 
 
Signal Acquisition, Processing and Definitions of Cerebrovascular Reactivity Indices 
This was conducted identically to the methods described in section 6.3.2. 
 
Statistics 
Minute-by-minute time series data were utilized for the entirety of the analysis described below.  
Statistical significance was set at an alpha of less than 0.05.  All statistical analysis was conducted using R 
statistical software (R Core Team (2016). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/). The following 
packages were utilized during the analysis: dplyr, ggplot2, ggthemes, tseries, forecast, lubridate and 
lme4. 
The statistical methods sections to follow will outline the techniques employed to:  A. estimate the 
autocorrelative structure of PRx in time series, B. estimate PRx using non-invasive TCD indices of 
cerebrovascular reactivity via application of linear mixed effects (LME) modelling (with embedded PRx 
ARIMA error structure) to, and C. assess the correlation and agreement between model based estimated 
PRx and the observed PRx values. 
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Autocorrelative Structure of PRx 
Prior to being able to model PRx using TCD based indices, it was necessary to determine the 
autocorrelation structure of PRx.  We used autoregressive integrative moving average (ARIMA) 
modelling PRx to determine:  the autoregressive structure of order “p”, the differencing factor or order 
“d”, and the moving average component of order “q”; commonly denoted “(p,d,q)”.163,164,166  The 
autoregressive structure refers to the dependence of PRx at time t (denoted PRxt) on previous measures 
of PRx (ie. called “lags”), say at time t-1 (ie. PRxt-1), and so forth (ie. say to PRxt-p), with the order “p” 
indicating how many previous PRx measures PRxt is dependent on.  The differencing component refers 
to the need to make a non-stationary signal stationary, with seasonal or trending structure within a time 
series indicating non-stationary character.  Stationarity is defined as the presence of a stable variance, 
autocorrelative structure and mean over time.  Stationarity can be introduced by differencing previous 
PRx measures from current measures, thus removing seasonality or trending structure to a time series 
and allowing further modelling to occur.  The differencing order “d” refers to how many previous terms 
should be included in the differencing process.  Finally, the moving average term refers to the need to 
include the error in the model at time “t” (ie. et) based on its association in previous measured error 
terms (ie. et-q).  The order “q” for the moving average component refers to how many previous error 
terms are to be included within the ARIMA model.  Assuming stationarity (ie. no “d” order), a general 
ARMA model can be represented by the following formula: 
 
PRxt = c + εt +  ∑ 𝜑𝑃𝑅𝑥
𝑝
𝑖=1 t-i + ∑ 𝜃𝜀
𝑞
𝑖=1 t-i  (7.1) 
 
Where:  PRxt = PRx at time t, PRxt-i = PRx at time t-i, εt = error at time t, εt-i = error at time t-i, c = constant, 
φ and θ are coefficient parameters at time t, p = autoregressive order, and q = moving average order. 
Initially, the following process was conducted on 10 representative patient recordings (I.e. the longest 
continuous recordings), in order to derive the optimal ARIMA structure for PRx time series. The following 
process was only conducted on the 10 longest representative patient recordings, so as to provide insight 
into the approximate best ARMA structure for future population wide LME models. 
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 First, data had already been artifact cleared and had a 10-second moving average filter applied to the 
data, leading to some data smoothing (as described above in the signal processing section).  Thus, the 
initial step for the ARIMA modelling focused on determining stationarity of the signal.  This was 
assessed, and confirmed, using 3 methods.  First, the autocorrelation function (ACF) correlogram for PRx 
was assessed, looking for a rapid decline in significant lags, indicating a stationary signal.  Second, the 
Augmented Dickey Fuller (ADF) test was applied to assess for stationarity.  Finally, the auto.arima 
function in R was employed to see if the automated process confirmed the results of the above two 
steps.  All above process confirmed stationarity within the patient examples.159,163,164 
Second, the autoregressive structure of PRx was assessed using the ACF correlograms and partial 
autocorrelation function (PACF) correlograms.  ACF correlograms were assessed to see how many 
previous consecutive terms (ie. “lags”) PRx may be dependent upon.  Similarly, the PACF correlograms 
were assessed to see how many non-consecutive previous lags, PRx may be dependent upon. Significant 
level on ACF/PACF correlograms is set at a correlation level of +/-(2/N1/2), where N = sample size. 
Sequential ARMA models were run for PRx by varying the order “p” from 0 to 3, while also varying the 
moving average order “q” from 0 to 3.  Given the analysis for stationarity confirming a stationary signal 
within the 10 patient examples, the differencing order “d” was fixed at 0. In doing so 16 separate ARMA 
models for PRx were generated within the 10 patient examples.  Model superiority was assessed by 
Akaike Information Criterion (AIC) and Log-Likelihood (LL), with the lowest AIC and highest LL indicating 
the best ARMA model for PRx.  In addition, model superiority was assessed via residuals, model ACF and 
PACF correlograms, with an adequate model represented by random residuals, and ACF/PACF failing to 
display any lags reaching significance.  Finally, the auto.arima function was employed to assess if there 
would be a difference in the automated ARIMA structure process from the manual process.  The 
auto.arima algorithm within R produced the same final ARIMA model for PRx as identified by the manual 
iterative process. 
 
LME Modelling of PRx Using TCD Derived Indices 
LME modelling was conducted in a step-wise fashion on the entire patient population.159,163,165  Initially 
LME modelling involved a fixed linear model represented by PRx ~ Sx_a, and a random component 
introduced into the intercept only (based on individual patient).  The PRx ARIMA structure was 
embedded within the LME model.  This model (ie. PRx ~ Sx_a) was used to confirm the ARMA model 
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structure identified in the 10 patient examples.  Iterative LME models were run with various 
permutations of embedded ARIMA structure for PRx.  Again, 16 separate models were run, varying 
autoregressive order “p” from 0 to 3, and the moving average order “q” from 0 to 3.  Given stationarity 
of signal identified within the patient examples, no differencing order “d” was introduced. 
Having confirmed that the LME model residuals structure follows the PRx ARIMA model, this model was 
used in the subsequent search for a parsimonious model of the relationship between various TCD 
derived parameters and PRx.  This analysis was done on the full data set, deriving LME models for each 
patient as well as for the entire population. The following LME models were assessed, initially with 
random intercept only (stratified by patient), as above:  PRx ~ Sx_a, PRx ~ Mx_a, PRx ~ Dx_a, PRx ~ Sx_a 
+ Mx_a, PRx ~ Sx _a + Dx_a, PRx ~ Sx_a + Mx_a + Dx_a.  Finally, these LME models were run again, 
introducing random effects into the slope parameters for each of the included independent variables: 
Sx_a, Mx_a and Dx_a.  All models were corrected using maximum likelihood estimation method.  
Adequacy of the LME model was assessed via QQ plots and the residuals distribution plot, with linear 
shape to the QQ plots and normally distributed residuals confirming validity of the model.   
Models were compared using AIC, Bayesian Information Criterion (BIC), LL and ANOVA testing.  Superior 
models were attributed to the lowest AIC, lowest BIC and highest LL.  Significance between models as 
assessed by ANOVA testing was set at a p < 0.05. The top two LME models were reported in detail, with 
a final assessment of model adequacy through ACF/PACF plots of the model residuals, observing for a 
minimal number of significant lags which decay rapidly.159,163   
Generalized fixed effect model versions of the two superior LME models were evaluated by removing 
the random components of the LME model. This was conducted via generating models for each patient, 
with the ARMA structure coefficients determined per patient.  Finally, a generalized model was also 
determined for population. Generalized fixed effects models were compared to their LME versions via 
AIC, BIC, LL and ANOVA testing. 
 
Observed versus Estimated PRx 
Finally, the correlation between the observed (minute-by-minute) PRx values in the population versus 
those estimated from the optimal two LME models were evaluated using Pearson correlation coefficient.  
Linear regression plots were then produced between observed and estimated PRx for the best two LME 
models, using grand mean data (ie. mean value per patient).  Finally, Bland-Altman plots were produced 
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to assess agreement between the observed and estimated PRx values, using grand mean Fisher 
transformed data (ie. Fisher transform applied to both observed and estimated PRx). Bland-Altman 
determination was conducted via the following method:  estimated PRx – observed PRx. 
Generalized fixed effects model estimated PRx was compared against the observed PRx in a similar 
fashion, however are not reported given the results were poor. 
 
7.1.3 Results 
 
The results are described in three sections.  The first of these ([A]) characterizes the study population, 
the second ([B]) the building blocks used for developing TCD based PRx modelling, and the third ([C]) 
addressing the development and testing of the accuracy of modelled PRx. 
 
A. Study Population 
Patient Demographics  
As in section 6.3, there were 347 patients with 410 recordings analyzed.  The mean age was 33.7 +/- 16.4 
years, 250 male subjects.  Median admission GCS was 6 (IQR: 4 to 8).  Mean recording length was 1.02 
hours (range: 0.50 to 3.26 hours).   
 
B. Building the Model to Estimate PRx 
The initial step was to confirm the expected relationship between TCD flow indices and PRx in the data, 
understand the autocorrelative structure of PRx time series data in order to provide a rigorous 
framework for modelling PRx from TCD data, and then confirm that the models for PRx time series data 
were generalizable across the populations of study.  These results are addressed in the next three 
sections of results 
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 Linear Relation between PRx, Sx_a and Mx_a – Population Level 
In order to confirm the linear relationship between PRx, Sx_a and Mx_a, simple linear regression was 
employed using grand mean data (ie. one average value for each index per patient over the entire 
recording period), allowing the use of linear principals (ie. ensuring independence of measures).  Figure 
7.1 displays the linear relationship between PRx versus Sx_a (panel A) and PRx versus Mx_a (panel B). 
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Figure 7.1: Linear Relationship between PRx vs. Sx_a and PRx vs. Mx_a – Grand Mean Population Data 
 
a.u. = arbitrary units, FVm = mean velocity, FVs = systolic flow velocity, ICP = intra-cranial pressure, MAP = mean arterial pressure, Mx_a = mean flow index (correlation between 
FVm and MAP), p = p-value, PRx = pressure reactivity index (correlation between ICP and MAP), R = Pearson correlation coefficient, Sx_a = systolic flow index (correlation between 
FVs and MAP). 
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ARIMA Modelling of PRx – Patient Example 
Ten patients, with the longest continuous recordings, were initially analyzed to determine the ARIMA 
structure of PRx.  All patients were deemed to display stationary signals for PRx, as assessed by ACF 
correlograms, ADF testing and auto.arima algorithmic testing.  Thus, no differencing factor was 
employed.  Figure 7.2 displays a patient example of the ACF and PACF correlograms on the raw PRx data, 
indicating rapid decay of significant lags on the ACF (panel A) and PACF (panel B) correlograms, 
confirming stationarity (ADF test = -4.456, p-value = 0.01).   
Running sequential iterative ARIMA models for PRx within the patient examples, the appropriate 
autoregressive order “p” and moving average order “q” for the PRx ARIMA model were assessed.  
Autoregressive order, “p”, varied from 0 to 3, and moving average order, “q”, varied from 0 to 3, 
assessing 16 separate ARIMA models for PRx.  All models and their AIC’s and LL can be seen in Appendix 
D. The most robust ARIMA structure for PRx, across the 10 patient examples, was deemed to be (2,0,2), 
with p = 2, d = 0, and q = 2.  This model had the lowest AIC of -69.3, and amongst the highest LL of 39.65.  
Furthermore, the residuals for this PRx ARIMA model appear random, with ACF/PACF correlograms 
indicating a lack of significant lags (Figure 7.3).  This ARIMA structure was confirmed with the auto.arima 
algorithm in R across all patient examples. 
 
 
 
 
 
 
 
 
 
 
 
 
168 
 
 
 
 
 
Figure 7.2: PRx ACF and PACF Correlograms - Patient Example 
 
ACF = autocorrelation function, a.u. = arbitrary units, ICP = intracranial pressure, MAP = mean arterial pressure, PACF = partial autocorrelation function, PRx = pressure reactivity 
index (correlation between ICP and MAP). Panel A = ACF correlogram, Panel B = PACF correlogram.  Confidence intervals on correlograms (dotted lines) = +/-(2/N1/2), where N = 
sample size. 
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Figure 7.3:  PRx ARIMA Model (2,0,2) Residual Plot, ACF and PACF Correlograms – Patient Example 
 
ACF = autocorrelation function, a.u. = arbitrary units, ARIMA = autoregressive integrative moving average, MAP = mean arterial 
pressure, PACF = partial autocorrelation function, PRx = pressure reactivity index (correlation between ICP and MAP) 
 
 
 Confirmation of PRx ARIMA Structure Via Sequential LME Modelling 
In order to confirm that the PRx (2,0,2) ARIMA model structure was adequate for the modeling across 
the entire dataset, sequential LME models were employed based on the fixed effects PRx ~ Sx_a, and 
random effects within the intercept (based on patient), with varied embedded PRx ARIMA structures.  
The same 16 ARIMA model structures utilized within the patient examples were then run, assessing the 
AIC, BIC and LL of the LME models, with the goal of parsimony in the ARIMA structure.  The data for AIC, 
BIC and LL in each LME with the varied embedded PRx ARIMA error structures can be found in Appendix 
D. The best model was again deemed to be that with a PRx ARIMA error structure of (2,0,2), with an AIC 
of -9797.294, BIC of -9735.699 and LL of 4906.647.  The residual density for this model was normally 
distributed. 
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C. Model Development and Accuracy Assessment 
 
Modelling of PRx using TCD derived variables was conducted in two stages.  First, modelling of PRx using 
the optimal autocorrelative structure that we identified in the previous section of results was conducted. 
Then measured (ie. observed) and estimated PRx were compared to determine how well te observed 
PRx values correlated with estimates from the top two models.  
 
 LME Modelling of PRx Using TCD Indices 
After confirming that ARIMA (2,0,2) error structure was adequate for continued LME modelling of PRx of 
the population, several different LME models were fitted to the whole data set, first varying the fixed 
effects model structure and then the random effects, as described within the methods section.  The AIC, 
BIC and LL values for each LME model tested is presented in Table 7.1.  The two best models, based on 
lowest AIC/BIC values, highest LL, and normally distributed residuals were:  PRx ~ Sx_a, and PRx ~ Sx_a + 
Mx_a, with random effects (based on patient) introduced into both the independent variables and 
intercept.  In addition, ANOVA testing indicated these two models were superior, with the multi-variable 
model (with Sx_a and Mx_a) performing significantly better.  The QQ plots and residual density plots for 
both models can be seen in Figure 7.4, indicating adequacy of the model.  ACF and PACF plots of the 
residuals form each of these models displayed a number of significant lags each LME model (ie. ~10).   
To evaluate further the impact of patient-by-patient variation on the LME model, random effects were 
removed from these models.  Doing so produced inferior models, with larger AIC and BIC values.  
Furthermore, comparing these population wide generalized fixed effects models to the LME models via 
ANOVA, the LME models described above were statistically superior.   
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Figure 7.4: QQ Plot and Residual Density Plot for Two Superior LME Models 
 
QQ = quantile quantile. Panel A = QQ plot for LME model PRx ~ Sx_a, Panel B = residual density plot for LME PRx ~ Sx_a, Panel C = QQ plot for LME PRx ~ Sx_a + Mx_a, Panel D = 
residual density plot for LME PRx ~ Sx_a + Mx_a. QQ and Density plots for both models indicate normally distributed residuals, and thus model adequacy. 
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Table 7.1:  LME Models with PRx (2,0,2) ARIMA Structure – Entire Population 
LME Model  PRx ARIMA Structure AIC BIC  LL 
Fixed Effects Random Effects p q 
PRx ~ Sx_a intercept 2 2 -9797.294 -9735.699 4906.647 
PRx ~ Mx_a intercept 2 2 -8530.042 -8468.447 4273.021 
PRx ~ Dx_a intercept 2 2 -7865.311 -7803.716 3940.655 
PRx ~ Sx_a + Mx_a intercept 2 2 -9821.206 -9751.912 4919.603 
PRx ~ Sx_a + Dx_a intercept 2 2 -9804.395 -9735.101 4911.198 
PRx ~ Sx_a + Mx_a + Dx_a intercept 2 2 -9822.731 -9745.737 4921.365 
PRx ~ Sx_a Intercept + Sx_a 2 2 -10806.43 -10729.44 5413.404 
PRx ~ Mx_a Intercept + Mx_a 2 2 -9928.451 -9851.458 4974.226 
PRx ~ Dx_a Intercept + Dx_a 2 2 -9239.414 -9162.420 4629.707 
PRx ~ Sx_a + Mx_a Intercept + Sx_a + Mx_a 2 2 -11798.81 -11691.02 5913.404 
PRx ~ Sx_a + Dx_a Intercept + Sx_a + Dx_a 2 2 FTC FTC FTC 
PRx ~ Sx_a + Mx_a + Dx_a Intercept + Sx_a + Mx_a + Dx_a 2 2 FTC FTC FTC 
AIC = Akaike Information Criterion, ARIMA = auto-regressive integrative moving average, BIC = Bayesian Information Criterion, Dx_a = diastolic flow velocity (correlation between 
TCD based FVd and MAP), FTC = “failure to converge” for the model, FVd = TCD based diastolic flow velocity, FVm = mean TCD flow velocity, FVs = TCD based systolic flow velocity, 
ICP = intra-cranial pressure, LL = log likelihood, LME = linear mixed effects model, p = auto-regression parameter for ARIMA model, MAP = mean arterial pressure, PRx = pressure 
reactivity index (correlation between ICP and MAP), q = moving average parameter for ARIMA model, Sx_a = systolic flow index (correlation between TCD based FVs and MAP), 
TCD = transcranial Doppler. *Note: bolded value represents the most appropriate ARIMA structure and LME model for the patient population tested, based on principal of 
parsimony, lowest AIC and BIC.   There was no integrative parameter (ie. “d” parameter) included within the ARIMA models, given stationarity testing during patient examples 
(see appendix A and Methodology section of manuscript). 
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Population Based Estimation of PRx Using Sx_a and Mx_a 
Assessing the correlation between observed PRx and estimated PRx using the various models, it 
confirmed that the above-mentioned superior LME models, with embedded PRx ARIMA structure of 
(2,0,2), displayed the best correlation between observed and estimated values.  The model based on 
fixed effects of PRx ~ Sx_a (with random effects in the slope and intercept based on patient) had a 
correlation of 0.794 (p<0.0001, CI = 0.788 to 0.799).  The model based on fixed effects of PRx ~ Sx_a + 
Mx_a (with the same random effects) displayed a correlation of 0.814 (p<0.0001, CI = 0.809 to 0.819).  
All correlations between observed and estimated PRx for the LME models tested can be seen in Table 
7.2.  
 
Table 7.2: Correlation Between Observed PRx and LME Model Based Predicted PRx 
LME Model  Correlation Between 
Observed PRx and Model 
Predicted PRx 
Fixed Effects Random Effects 
PRx ~ Sx_a intercept 0.770 
PRx ~ Sx_a + Mx_a intercept 0.770 
PRx ~ Sx_a + Dx_a intercept 0.770 
PRx ~ Sx_a + Mx_a + Dx_a intercept 0.770 
PRx ~ Sx_a Intercept + Sx_a 0.794 
PRx ~ Sx_a + Mx_a Intercept + Sx_a + Mx_a 0.814 
PRx ~ Sx_a + Dx_a Intercept + Sx_a + Dx_a NA 
PRx ~ Sx_a + Mx_a + Dx_a Intercept + Sx_a + Mx_a + Dx_a NA 
Dx_a = diastolic flow velocity (correlation between TCD based FVd and MAP), FTC = “failure to converge” for the model, FVd = 
TCD based diastolic flow velocity, FVm = mean TCD flow velocity, FVs = TCD based systolic flow velocity, ICP = intra-cranial 
pressure, LL = log likelihood, LME = linear mixed effects model, p = auto-regression parameter for ARIMA model, MAP = mean 
arterial pressure, PRx = pressure reactivity index (correlation between ICP and MAP), q = moving average parameter for ARIMA 
model, Sx_a = systolic flow index (correlation between TCD based FVs and MAP), TCD = transcranial Doppler. *Note: bolded 
value represents the most appropriate ARIMA structure and LME model for the patient population tested, based on principal of 
parsimony, lowest AIC and BIC.    
 
Figure 7.5 displays the linear relationship between observed and estimated grand mean PRx (ie. average 
per patient) from the two optimal models:  PRx ~ Sx_a (Figure 7.5A), and PRx ~ Sx_a + Mx_a (Figure 
7.5B).  As can be seen, each model shows a strong linear correlation between observed PRx and model 
estimated PRx, with a slope almost equal to that of line “y = x” (dotted straight line in Figure 7.5A and 
7.5B). 
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Figure 7.5: Linear Regression Between Observed and Estimated PRx – Using Estimated PRx From Two Best LME Models 
 
a.u. = arbitrary units, ICP = intracranial pressure, LME = linear mixed effects, MAP = mean arterial pressure, PRx = pressure reactivity index (correlation between ICP and MAP). 
Panel A: LME model – PRx ~ Sx_a (random effects with intercept and Sx_a), Panel B: LME model – PRx ~ Sx_a + Mx_a (random effects with intercept, Sx_a and Mx_a).  Coef = 
coefficients, form linear model between observed PRx and model estimated PRx.  Dotted straight line – represents the relationship “y = x”, for comparison the two models. 
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Finally, Figure 7.6 displays the Bland-Altman plots for Fisher transformed grand mean data (ie. average 
per patient), assessing the difference between observed and estimated PRx for each model (Figure 7.6A 
and Figure 7.6B). Both plots display good agreement between the observed and estimated PRx values 
for each model, within limits.  Of note, that the model estimates PRx well for values between +0.50 and -
0.50 (approximately +0.46 and -0.46 in un-transformed data; the common clinical range), where outside 
of that the agreement deteriorates. 
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Figure 7.6: Bland-Altman Plots – Top Two LME Models – Observed versus Estimated PRx (FT Grand Mean Data) 
 
FT = Fisher transformed, LME = linear mixed effects. Panel A: Bland-Altman plot comparing observed versus estimated PRx for LME model – PRx ~ Sx_a (random effects in 
intercept and Sx_a), Panel B: Bland-Altman plot comparing observed versus estimated PRx for LME model – PRx ~ Sx_a + Mx_a (random effects in intercept, Sx_a and Mx_a). 
Horizontal bold dotted lines represent +/- 2 standard deviations in difference. Arrows denote margins of acceptable agreement between observed and estimated PRx, where 
outside of this range the agreement deteriorates.  *NOTE:  These values are FT values, where a transformed value of 0.5 is ~0.46 in un-transformed data. 
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7.1.4 Discussion 
 
Through the application of linear mixed effects modelling and accounting for the autocorrelative 
structure of PRx, via employing ARIMA modeling, models were produced which theoretically estimated 
PRx using non-invasive TCD autoregulation indices in TBI patients, Sx_a and Mx_a.  Furthermore, PRx 
was estimated with a correlation between observed and estimated of ~0.80, with acceptable agreement 
on linear regression and Bland-Altman analysis.  This is the first attempt at applying time series and 
linear mixed effects modelling of PRx, and has laid the ground for further exploration of complex time 
series analysis of high frequency data in TBI patients.   
Some important points should be highlighted in this study.  First, this is the first attempt at estimating an 
invasive autoregulation index, PRx, using non-invasive TCD measures, Sx_a and Mx_a.  This is preliminary 
attempt at incorporating the complexities of time series analysis in the modelling of PRx.  Models have 
been produced for estimating PRx, however, these are very preliminary and should be interpreted with 
caution. These results are promising for the future ability to estimate the “gold standard” PRx via non-
invasive means. Further, a strong relationship between non-invasive TCD derived measures of 
cerebrovascular reactivity and the invasive derived “gold-standard” PRx has been displayed, 
demonstrating that in fact PRx may be expressed in terms of these non-invasive measures.  As well, this 
paper identifies the strong link between two aspects of cerebral autoregulation, measures of cerebral 
blood flow (ie. TCD based CBFV) and measures of cerebral blood volume (ie. ICP).  Previous literature has 
displayed variable correlation between these measures. This study provides a highly important evidence 
of a strong link between the two and offers explanation of that relatively poor correlation. Second, the 
complexity of these models displays the difficulties in incorporating time series “real-time” analysis of 
high frequency physiological data from ICU monitoring.  The application of ARIMA modelling is complex 
and labor intensive to find the most parsimonious model for the variable of interest, PRx.  In order to 
ensure the appropriate modeling was applied, various iterative techniques were employed in both 
representative patient examples and a basic LME in the entire dataset.  Third, given the poor 
performance of the generalized fixed effects versions of the models, it is clear that there exists patient-
by-patient variability that impacts the ability to model PRx, supporting the application of LME modelling.  
This cannot be ignored, as see within the analysis.  This was confirmed via AIC, BIC, LL, ANOVA and 
correlation with observed PRx values. An important point for those wishing to employ generalized fixed 
effects models.  Thus, the application of a generalized fixed effects model is limited, based on the results 
from this dataset. Fourth, the BA analysis provided further confirmation that the estimated PRx from the 
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top 2 models, were in good agreement with the observed PRx values in the patients.  However, there is 
some bias evident within the BA plots (ie. the negative linear pattern seen), despite being within 
agreement throughout the normal range of PRx values typically encountered within the clinical setting 
(ie. -0.5 to +0.5). This particular bias indicates that the models slightly underestimate PRx. Thus, the 
model is not perfect, but still closely estimates PRx within acceptable degrees of agreement. Finally, 
again this is preliminary work and these models should not be employed clinically at this time to 
estimate PRx using non-invasive TCD measures.  Further analysis of these models and improvements 
need to occur before the reliability of their estimation can be determined. 
 
Limitations 
Some important limitations need to be highlighted.  First, this is a retrospective analysis of a 
heterogeneous patient cohort.  Thus, patient co-morbidity, injury pattern/burden and treatment 
heterogeneity may have impacted the recorded and archived high frequency signals utilized in the 
derivation of these autoregulation indices.   
Second, the ARIMA structure identified for PRx is only valid in this TBI patient sample.  The (2,0,2) ARIMA 
structure may not apply to other cohorts of TBI patients, or even other, perhaps longer recordings in the 
same patients.  It is possible that the autoregressive order “p” as well as the moving average order “q” 
may be much higher in other cohorts, depending on dynamical composition of time series.  
Furthermore, the ARIMA structure of PRx based on different update periods, averaging process and 
grouped averages (ie. mean hourly values, mean daily values, etc.) has not been explored within this 
study.   
Third, this cohort the signals appeared to fulfill the criteria for stationarity, based on various aspects of 
assessment.  Thus, a differencing order “d” was not applied in the ARIMA structure for PRx.  However, 
stationarity was only assessed within the 10 longest patient recordings, generalizing the results of the 
stationarity assessment to the rest of the patient dataset.  Thus, the short recordings not assessed could 
potentially have seasonality/trend which we did not account for.  Futhermore, it is possible that 
different populations of TBI patients, different methods of acquiring PRx and different averaging of the 
PRx data may introduce seasonality and trend to the data such that the signals become non-stationary.  
As well, the recordings were short, it may be that seasonality and trend were not appreciated in such 
short duration recordings, and longer recordings may display the need for a differencing order within 
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the ARIMA structure for PRx.  Much further evaluation of the autocorrelative structure for PRx and other 
high frequency physiologic variables in TBI is required.   
Fourth, the inclusion of PRx ARIMA structure within the LME modelling adds significant complexity to 
the final models derived for the general population.  This is a significant limitation to the application of 
these models broadly at this time.  If further studies confirm and improve upon the preliminary results 
displayed here, there is potential to automate this modelling and PRx estimation so that it is may 
become more accessible.  
Fifth, one could argue that the top 2 LME models displaying approximately 10 significant residual lags on 
the ACF plot indicates the model isn’t perfect.  This is correct, and possible a consequence of the short 
nature of the TCD recordings.  However, with p-values less than 1 X10-16, there exists confidence that 10 
residual lags would not inflate the p-values so much that statistical significance could be questioned 
within the LME models. 
Finally, the fact the generalized fixed effects models fail to display superiority to the LME models is a 
major limitation.  This indicates that there is substantial patient-to-patient variability, limiting the ability 
to apply these models to other patients and datasets.  Thus, at the current time, no general model can 
be offered for widespread use.  
 
7.1.5 Conclusions 
 
Through employing linear mixed effects modelling and accounting for the autocorrelative structure of 
PRx with ARIMA modelling, one can theoretically estimate PRx using non-invasive TCD based indices of 
cerebrovascular reactivity.  
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7.2 Application of New Robotic Doppler Technology 
 
Introduction 
The results of the studies detailed in 6.1, 6.2 and 6.3 provide a comprehensive assessment of the inter-
index relationships between cerebrovascular reactivity indices derived from MMM. Importantly, the 
association between Sx/Sx_a and the invasive ICP derived indices (PRx, PAx, and RAC) was highlighted in 
the relevant chapters.180–182  Furthermore, the results of 7.1 further confirm the strong relationship 
between PRx and Sx_a.184 
Based on these results, the only major limitation regarding this identified relationship is that the TCD 
recordings were short in nature, limited by the technique.  One potential last aspect to explore is the 
relationship between ICP and TCD derived indices in longer recordings, in order to assess the impact of 
recording length on the co-variance and improve our models of PRx estimation using non-invasive TCD 
indices.  Finally, such data could allow for prediction of PRx using non-invasive TCD measures.   
Recent advances in robotics have led to the development of robotically driven TCD probes for extended 
duration recordings, integrated with automated algorithms for MCA CBFV detection and optimization of 
recorded signal intensity.  To date, these devices have not been applied the neurocritically ill. To obtain 
longer recordings, this technology was applied in moderate/severe TBI patients within the NCCU at 
Addenbrooke’s Hospital for the purpose of this thesis.  This section highlights this newly applied 
technology, with the results of the prospective validation study of PRx and Sx_a inter-index 
relationships/modelling found in the section to follow, section 7.3. 
 
Methods: 
From of November 2017 to April 2018, in place of the regular TCD devices (Doppler Box (DWL 
Compumedics, Singen, Germany) or Neuroguard (Medasonic, Fremont, CA, USA)), the Delica EMS 9D 
robotic TCD (Delica EMS 9D System, Shenzen Delica Medical Equipment Co. Ltd., China; 
http://www.delicasz/com) system was applied for bilateral MCA CBFV recording in moderate and severe 
TBI patients within the NCCU at Addenbrooke’s Hospital, University of Cambridge.  TCD monitoring is 
considered part of standard NCCU patient care, as such formal patient or proxy consent was not 
required. The timing to application of TCD based monitoring varied from patient to patient, typically 
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initiated between 24 hours to 10 days post-TBI. A total of 20 patients were able to be recorded with the 
device during the 6-month trial period. 
All patients were intubated and sedated given the severity of their TBI, with ICP target of less than 20 
mm Hg, and CPP greater than 60 mm Hg. ABP was obtained through radial arterial lines connected to 
pressure transducers (Baxter Healthcare Corp. CardioVascular Group, Irvine, CA).  All patients had a 
frontally situated cranial bolt (Technicam Ltd, Newton Abbot, UK), for parenchymal ICP monitoring 
(Codman ICP MicroSensor; Codman & Shurtleff Inc., Raynham, MA), and cerebral microdialysis (M 
Dialysis AB, Stockholm, Sweden).  Finally, bifrontal near infrared spectroscopy was also applied (NIRO-
200 or NIRO-200NX, Hamamatsu Photonics Ltd, Japan). 
We recorded all physiologic signals in digital high frequency format (50 Hertz (Hz) or higher) using ICM+ 
software (Cambridge Enterprise Ltd, Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk). This was 
installed and run directly off the Delica monitor. 
The following sections will describe the device and outline the advantages/disadvantages of the system 
within the moderate/severe TBI population.  Finally, summary conclusion regarding the device are 
made. 
 
The Device – An Overview: 
 The Probes/Robotic Drive 
The Delica EMS 9D robotic TCD system is a portable TCD system allowing for bilateral simultaneous MCA 
insonation.  The standard probes available with the system are 1-2 MHz Doppler ultrasound probes, 
each attached to a separate robotic drive.  The entire drive/probe construct is encased within a tough 
plastic shell and supported using a head-band type frame (Figure 7.7A).  An option exists for the probes 
to be surrounded by a small rubber ring around its periphery, which is designed to hold ultrasound gel 
for longer, allowing for preserved signal quality. Figure 7.7 displays various pictures of the Delica EMS 9D 
system.  
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Figure 7.7: Delica EMS 9D Robotic TCD Probe and Headband 
 
TCD = transcranial Doppler. Panel A: TCD probe (black circular object) held with robotic drive as one construct within plastic 
casing.  Medial view – where probe contacts patient for transtemporal insonation of the middle cerebral artery. Neoprene pad is 
also seen on medial aspect of head-band. Panel B: Lateral view of robotic drive/TCD probe construct. Displays wing-nut 
attachment to head-band holder, via “inverted U-shaped” plastic bracket.  Panel C: Anterior view of head-band displaying plastic 
component and wheel ratchet system for tightening.  Panel D: Full view of head-band with bilateral robotic drive/TCD probes 
attached.   
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The head-band frame is a composite of plastic and Velcro straps with fabric (Figure 6.8C and 6.8D).  The 
diameter of the head-band may be adjusted using either the Velcro straps, or the ratcheting wheel 
located on the front of the head band (Figure 7.7C).  Ideal location of the band is just above the orbital 
margins.  Near the temporal windows, the head-band frame contains plastic inverted “U-shaped” pieces 
following the course of the superior temporal line, meant for mounting the robotic drive/TCD probe 
construct (Figure 7.7B).  The is accomplished using wing-nut fasteners.  The entire head-band is padded 
with exchangeable Neoprene inserts, for comfort (Figure 7.7A). 
 
 The Delica TCD Software 
The Delica EMS 9D comes with its own specially design software for recording TCD signal.  This provides 
both an easy to use interface with the robotic drive system, and continuously updating CBFV waveforms 
and M-mode signals.  Furthermore, the left side of the screen provides both simultaneous left and right 
CBFV waveforms at various depths of insonation, allowing for selection of the optimal depth for 
recording.  Various other more complex functions are available within the software, such as microemboli 
detection, however focus will not be on these, given the goal was to assess the basic ability to record in 
critically ill TBI patients.  Figure 7.8 Displays the software interface. 
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Figure 7.8: Delica EMS 9D TCD Software Interface 
 
TCD = transcranial Doppler. Panel A: Displays right middle cerebra artery real time blood flow velocity waveform.  Panel B: 
Displays sequential “look ahead” view of right middle cerebral artery, providing sequential real time cerebral blood flow velocity 
waveforms at various depths of insonation.  Panel C: Search robotic signal acquisition function window, displaying the pattern at 
which the TCD probe is automatically moved.  Panel D: Directional robotic signal acquisition function window, displaying the 
patter which the TCD probe is moved, changing the angle of insonation.  Note: panel C and D, the various points of insonation 
are color coded to represent strength of signal, this can be appreciated via different shadings in this greyscale picture. 
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Finally, the robotic drive system carries 4 main functions:  scan, search, direction, and track. Scan is an 
automated algorithm which moves the TCD probe position in a square grid pattern, insonating at each 
spot, assessing for MCA CBFV signal intensity and providing a color code for its findings (black = poor/no 
signal found, red = good; with colors ranging from blue, to green, to yellow, to orange, to red).  It must 
be acknowledged that the amount that the probe can change in position is limited, so large position 
corrections still required manual manipulation. After completion of the grid, the proprietary automated 
algorithm then chooses the best position.  The search function provides an automated circular search 
pattern around the initial starting point, changing both probe position and insonation angle.  As with the 
scan function, it insonates each spot, finding the optimal signal intensity for a final position.  The 
directional function alters the TCD probe angle, using an automated algorithm, with the goal of finding 
the optimal insonation angle. It should be noted, at any point, the operator can manually change the 
probe position using the direction touch pad on the screen.  
Finally, the track function is enabled after the user selects the optimal position of insonation.  This 
function is designed to automatically detect any deterioration in signal quality/intensity, and then 
automatically adjust the TCD probe (both via position and angle), using a proprietary algorithm, to 
restore optimal signal.  Figure 7.9, demonstrates TCD CBFV signal recorded over a 4-hour period, 
displaying continuous uninterrupted acquisition of maximum envelope flow velocity signal which 
retained good quality without the need of any manual adjustments over the whole duration of 
recording. 
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Figure 7.9: TCD CBFV Signal – Over 4 Hour Recording Session 
 
CBFV = cerebral blood flow velocity, cm = centimeter, FV = flow velocity, sec = seconds, TCD = transcranial Doppler.  *Diagram 
depicts continuous uninterrupted FV signal over 4+ hours of recording.  Two windows on bottom of image depict signal 
waveforms from beginning (bottom left) and end (bottom right) of the recording, demonstrating preserved high-quality signal 
throughout the duration of the lengthy recording period. 
 
Application in Moderate/Severe TBI – Initial Impression - Advantages and Disadvantages 
The Delica EMS 9D system was applied in moderate/severe TBI patients who were intubated, sedated 
and had other multi-modal monitoring in situ (ie. both invasive and non-invasive).  The typical patient 
set-up can be seen in Figure 7.10, including a triple-bolt (ICP, Licox, and microdialysis) with bifrontal 
NIRS.  
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Figure 7.10: Application of Robotic TCD System in TBI Patient with Multi-modal monitoring 
 
Patient has triple bolt located in left frontal area, with bifrontal NIRS pads applied (all images).  Delica TCD head-band can be 
seen crossing the forehead, just above the orbital rims.  Wheel for ratchet tightening of headband can be seem (both upper left 
and right images).  Robotic drive/TCD probe can be seen over transtemporal window, insonating the MCA (upper right and lower 
left images). 
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Advantages 
With above described set-up, extended length recordings were possible, with non-interrupted, good 
quality TCD signals.  The TCD probe held ultrasound gel for 4 hours without any drying issues or need for 
re-application. Both the recording length and gel integrity duration are far longer than most standard 
TCD systems can provide.  Furthermore, bilateral MCA TCD was captured, in the presence of all other 
multi-modal monitoring devices described, confirming its applicability in the multi-monitoring 
moderate/severe TBI patient.     
The head-band appeared to be comfortable, with the padding protecting surgical wounds from injury, 
and rarely moving once secured.  Once in situ, the head-band, with attached robotic drive/TCD probes 
tolerated patient turning in each patient, without loss of CBFV waveform or intensity.  Furthermore, two 
patients underwent portable chest x-ray while recording, with no change in signal intensity throughout 
this procedure.  Finally, one patient underwent a bedside chest-tube insertion without change in signal 
quality. 
The robotic drive system worked well, with the search and directional functions aiding with set-up and 
re-acquisition of signal if it needed to be optimized.  The algorithms for these two functions appeared to 
work well, finding the optimal angle and position of insonation.   
 
Disadvantages 
The system suffered from a few important initial issues/limitations, which require highlighting.  The main 
issues stemmed from initial poor real-time functioning of certain aspects of the robotic drive system.  As 
mentioned above, the search and direction functions appear to work satisfactorily.  However, the two 
other functions (scan and track), within the initial version of the system, were less useful.  The scan 
function, within all patients recorded, failed to select automatically the appropriate optimal position for 
insonation.  This occurred during repeated attempts.  As a result, it was elected to manually position the 
probe using the CBFV waveform and M-mode, selecting an appropriate starting position and depth for 
insonation.  The search and direction functions were then applied, which provided improvement and 
overall optimization of the signal acquired.  This issue was raised with the manufacturer, who responded 
promptly with a software update, leading to a remedy to the scan function. This was subsequently 
trialed on additional patients, confirming its functionality and fix to the previous issues.  
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As well, with the initial software version, the track function rarely appeared to work.  This was a 
disappointment, as the hope with this function is that the drive would automatically correct for any shift 
in the probe during recording.  There were two issues we found with this function in the initial software 
version.  First, despite being enabled, it was rarely triggered, even in the rare case when the 
headframe/probe shifted and lost signal.  Second, when the track function was triggered, one could 
audibly identify that the robotic drive was attempting to move the TCD probe, however it never 
appeared to accurately correct the probe for signal loss.  Both issues were likely a result of inefficiencies 
in the embedded algorithm for the track function.  As with the scan function, concerns were raised with 
the manufacturer and resolved with a subsequent, more recent version of the software.  Trialing this 
updated software version on additional patients, the track function was correctly engaged during shift of 
the probe, and corrected the probe position/angle, optimizing the CBFV signal. 
Finally, as observed that in one patient with scalp soft tissue bruising, the ratcheting head-band 
triggered a sustained intra-cranial pressure elevation above 20 mm Hg lasting 5 minutes, with an initial 
baseline ICP of 10 to 15 mm Hg. This was promptly resolved by re-adjusting the head-band.  In this one 
patient however, the sedation was relatively light, and thus the ICP elevation was likely secondary to 
pain experienced during the head-band tightening. Nevertheless, this is an important potential 
complication to highlight. 
 
Summary of Experience: 
The current Delica EMS 9D robotic TCD system provides the ability to obtain 4+ hours of continuous, 
uninterrupted bilateral TCD recordings in critically ill TBI patients, undergoing other various 
invasive/non-invasive multi-modal monitoring.  Further, the automated algorithms aid in TCD set-up and 
optimization of signal intensity.   
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7.3 Predicting Pressure Reactivity Index Using TCD 
 
7.3.1 Introduction 
 
Given the results of section 7.1 of this thesis,184 the next natural step is to explore the ability to predict 
PRx using non-invasive TCD measures, such as Sx_a and/or Mx_a. This has never been attempted before, 
given complexity of analysis and limitations surrounding acquisition of continuous longer uninterrupted 
TCD recordings.  The goal of this study was to outline the first experience at predicting PRx using non-
invasive Sx_a, derived from extended duration robotic TCD recordings (see section 7.2 for description of 
set-up). 
 
7.3.2 Methods 
 
Patient Population 
The data utilized in study consisted of part of a prospective observational study conducted over a 6-
month period.  All patients suffered from moderate to severe TBI and were admitted to the 
neurosciences critical care unit (NCCU) at Addenbrooke’s Hospital, Cambridge, during the period of 
November 2017 to May 2018.  Patients were intubated and sedated given the severity of their TBI.  
Invasive ICP monitoring was conducted in accordance with the BTF guidelines.150  Therapeutic measures 
were directed at maintaining ICP less than 20 mm Hg and CPP greater than 60 mm Hg.   
 
Ethics 
TCD monitoring is a part of standard intermittent cerebral monitoring within the NCCU.  The application 
of the newer robotic TCD device (see description below) was therefore in alignment with usual care, 
negating the need for formal direct or proxy consent.  All data related to patient admission 
demographics and high frequency digital signals from monitoring devices were collected in an entirely 
anonymous format, negating the need for formal consent, as in accordance with institutional research 
committee policies.  
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Signal Acquisition 
This was conducted identically to the methods described in section 6.3.2.  TCD assessment of MCA CBFV 
was conducted via a robotic TCD system, the Delica EMS 9D (Delica, Shenzhen, China, 
www.delicasz.com). This system allows for continuous extended duration recording of MCA CBFV, using 
robotically controlled TCD probes, with automated correction algorithms for probe shift.   
The goal of the initial study from which this data was analyzed was to obtain extended duration 
recording of ICP, near infrared spectroscopy (NIRS) and TCD.  This study aimed to record 3 to 4 hours of 
continuous data from all devices simultaneously, given the previous work on inter-index relationships 
focused on recording durations of only 0.5 to 1-hour duration due to limitation of conventional TCD.  As 
such, this data set also proved to be ideal for complex time series modelling and forecasting analysis.  
Only patients with 3 or more hours of continuous, uninterrupted, ICP and TCD recordings were utilized 
for this study.  Thus, only a sub-population of the group from the original study were utilized for this 
analysis. 
 
Signal Processing 
This was conducted identically to the methods described in section 6.3.2. 
 
Cerebrovascular Reactivity Indices 
This was conducted identically to the methods described in section 6.3.2.  Diastolic flow index (Dx_a) 
was not derived in this study, given the previous work documenting poor time series and linear mixed 
effects (LME) model performance in relation to PRx (section 7.1.3).  Data for this analysis were provided 
in the form of a minute by minute time trends of the parameters of interest for each patient.  This was 
extracted from ICM+ in to comma separated values (CSV) datasets, which were collated into one 
continuous data sheet (compiled from all patients).   
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Statistical Analysis 
Similar statistical modelling approach as seen in the previous work for time series data and LME model 
creation were followed with this data set (section 7.1.2), and almost identical statistical description to 
this work will be found below.184  Minute-by-minute time series data was utilized for the entirety of the 
analysis described below.  Statistical significance was set at an alpha of less than 0.05.  All statistical 
analysis was conducted using R statistical software (R Core Team (2016). R: A language and environment 
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/). The following packages were utilized during the analysis: dplyr, ggplot2, ggthemes, tseries, 
forecast, lubridate and lme4. 
The statistical methods sections to follow will outline the techniques employed to:  A. estimate the 
autocorrelative structure of PRx in time series, B. create an accurate model estimating PRx using non-
invasive TCD indices of cerebrovascular reactivity via application of linear mixed effects (LME) modelling 
(with embedded PRx autocorrelative error structure) , C. assess the correlation and agreement between 
model based estimated PRx and the observed PRx values, and D. forecast PRx using the derived LME 
models and estimated PRx time series data.  For LME model creation/training the 1st 80% of the data 
was utilized for each patient, with the remaining 20% utilized for the prediction of PRx using the LME 
models. 
 
 Autocorrelative Structure of PRx 
Prior to being able to model PRx using TCD based indices, it was necessary to determine the 
autocorrelation structure of PRx.  Box-Jenkin’s autoregressive integrative moving average (ARIMA) 
modelling was employed for PRx  to determine:  the autoregressive structure of order “p”, the 
differencing factor or order “d”, and the moving average component of order “q”; commonly denoted 
“(p,d,q)”.163,164  The autoregressive structure refers to the dependence of PRx at time t (denoted PRxt) on 
previous measures of PRx (ie. called “lags”), say at time t-1 (ie. PRxt-1), and so forth (ie. say to PRxt-p), 
with the order “p” indicating how many previous PRx measures PRxt is dependent on.  The differencing 
component refers to the need to make a non-stationary signal stationary, with seasonal or trending 
structure within a time series indicating non-stationary character.  Stationarity is defined as the presence 
of a stable variance, autocorrelative structure and mean over time.  Stationarity can be introduced by 
differencing previous PRx measures from current measures, thus removing seasonality or trending 
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structure to a time series, and allowing further modelling to occur.  The differencing order “d” refers to 
how many previous terms should be included in the differencing process.  Finally, the moving average 
term refers to the need to include the error in the model at time t (ie. εt) based on its association in 
previous measured error terms (ie. εt-q).  The order “q” for the moving average component refers to how 
many previous error terms are to be included within the ARIMA model.  Assuming stationarity (ie. no “d” 
order), a general ARMA model can be represented by the following formula: 
 
PRxt = c + εt +  ∑ 𝜑𝑝𝑖=1 𝑃𝑅𝑥t-i + ∑ 𝜃𝜀
𝑞
𝑖=1 t-i     (7.1) 
Where:  PRxt = PRx at time t, PRxt-i = PRx at time t-i, εt = error at time t, εt-i = error at time t-i, c = 
constant, φ and θ are parameters at time t-i, p = autoregressive order, and q = moving average order. 
The following process was conducted on all patient recordings, in order to derive the optimal ARIMA 
structure for PRx time series. This would provide insight into the approximate best ARMA structure for 
future LME models. 
 First, data had already been artifact cleared and had a 10-second moving average filter applied to the 
data, leading to some data smoothing (as described above in the signal processing section).  Thus, the 
initial step for the ARIMA modelling focused on determining stationarity of the signal.  This was 
assessed, and confirmed, using 3 methods.  First, the autocorrelation function (ACF) correlogram was 
assessed for PRx, looking for a rapid decline in significant lags, indicating a stationary signal.  Second, the 
Augmented Dickey Fuller (ADF) test was employed to assess for stationarity. Third, seasonal 
decomposition was employed using the like-named function in R for each PRx time series, which 
employs locally weighted scatterplot smoothing (LOESS) to identify seasonal and trend components to a 
time series. All above processes confirmed stationarity within the patient examples. 
Second, the autoregressive structure of PRx was assessed using the ACF correlograms and partial 
autocorrelation function (PACF) correlograms.  ACF correlograms were assessed to see how many 
previous consecutive terms (ie. “lags”) PRx may be dependent upon.  Similarly, the PACF correlograms 
were assessed to see how many non-consecutive previous lags, PRx may be dependent upon. Significant 
level on ACF/PACF correlograms is set at a correlation level of +/-(2/N1/2),163 where N = sample size. 
Sequential ARMA models for PRx we run, by varying the order “p” from 0 to 3, while also varying the 
moving average order “q” from 0 to 3.  Given the analysis for stationarity confirmed a stationary signal 
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within the 10 patient examples, we fixed the differencing order “d” at 0. In doing so, 16 separate ARMA 
models were generated for PRx within each patient.  Model superiority was assessed by Akaike 
Information Criterion (AIC) and Log-Likelihood (LL), with the lowest AIC and highest LL indicating the best 
ARMA model for PRx.159,163,164,166,188  In addition, model superiority was assessed via residuals, model ACF 
and PACF correlograms, with an adequate model represented by random residuals, and ACF/PACF failing 
to display any lags reaching significance.   
 
LME Modelling of PRx Using TCD Derived Indices 
LME modelling was conducted on the entire patient population. LME modelling involved various fixed 
linear models, and a random component introduced into the intercept and independent variable 
coefficient (based on individual patient).  The PRx ARIMA structure was embedded within the LME 
models (ie. (2,0,2)).  This analysis was done on the full data set, deriving LME models for each patient as 
well as for the entire population. The following LME models were assessed, initially with random 
intercept only (stratified by patient), as above:  PRx ~ Sx_a, PRx ~ Mx_a, and PRx ~ Sx_a + Mx_a.  All 
models were corrected using maximum likelihood estimation method.  Adequacy of the LME model was 
assessed via QQ plots and the residuals distribution plot, with linear shape to the QQ plots and normally 
distributed residuals confirming validity of the model.   
Models were compared using AIC, Bayesian Information Criterion (BIC), LL and analysis of variance 
(ANOVA) testing.  Superior models were attributed to the lowest AIC, lowest BIC and highest LL.  
Significance between models as assessed by ANOVA testing was set at a p < 0.05. The top 2 superior LME 
models were reported in detail, with a final assessment of model adequacy through ACF/PACF plots of 
the model residuals, observing for a minimal number of significant lags which decay rapidly.163,164,166   
Generalized fixed effects models were also created based on the top two LME models. However, these 
models performed poorly, with substantially inferior AIC, BIC and LL values.  In addition, these general 
fixed effects models maintained continuous significant lags in the residuals, further indicating poor 
modelling of PRx.  Hence, these models will not be discussed further.  
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Observed versus Estimated PRx 
The correlation between the observed (minute-by-minute) PRx values in the population versus those 
estimated from our optimal two LME models was assessed using Pearson correlation coefficient.  Linear 
regression plots were then produced between observed and estimated PRx for the best two LME 
models, using grand mean data (ie. mean value per patient).  Finally, Bland-Altman plots were produced 
to assess agreement between the observed and estimated PRx values, using grand mean Fisher 
transformed data (ie. Fisher transform applied to both observed and estimated PRx). Bland-Altman 
determination was conducted via the following method:  estimated PRx – observed PRx. 
 
Predicting PRx  
PRx was then predicted based on the top two LME models from the above discussed methods. Using the 
LME models themselves and the remaining 20% patient data not used in LME creation, predicted PRx 
(pPRx) values were derived from observed Sx_a and Mx_a values within this data subset. The predicted 
values were then compared to the actual observed PRx values during this period using Pearson 
correlation, linear modelling and Bland-Altman analysis. Bland- Altman determination was conducted via 
the following method:  pPRx – observed PRx. 
 
 
7.3.3 Results 
 
a. Patient Demographics 
A total of 10 patients with moderate/severe TBI had sufficient quality TCD signals (ie. at least 3 – 4 hours 
duration and uninterrupted).  The mean age for this population was 34.5 +/- 17.0 years, with 8 patients 
being male.  The median admission GCS was 7 (IQR 4 to 8), with median admission GCS motor score of 4 
(IQR 2 to 5). The mean duration of ICP/TCD recording was 223.2 +/- 38.4 minutes. Only 80% of the total 
recording duration for each patient was utilized for model formation and training, with the remaining 
20% reserved for predictive testing. 
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b. Building the Model to Estimate PRx 
 
ARIMA Modelling of PRx  
In all 10 patients the ARIMA structure of PRx was investigated in order to determine the appropriate 
structure for future LME modelling of the entire population.  Upon inspection of the ACF/PACF plots, 
ADF test results and seasonal decomposition techniques, it was determined that no significant trend or 
seasonality were present in any of the 10 patient recordings. Thus, no differencing order “d” was 
introduced.  Next, sequential ARMA models were produced for each patient, varying the autoregressive 
order “p” and moving average order “q”, from 0 to 3.  Across all patients the optimal ARMA model for 
PRx was deemed to be a p of 2 and q or 2 (ie. (2,0,2)), based on the principal of parsimony, and the 
lowest AIC and highest LL. Figure 7.11 displays the ACF and PACF plots of PRx for one patient with 4 
hours of continuous recording, demonstrating a rapid decay in significant lags (implying stationarity). 
Figure 7.12 demonstrates the ARMA model for PRx in the same patient, with an ARMA structure of 
(2,0,2).  This figure demonstrates a lack of significant lags on ACF and PACF plots, with randomly 
distributed residuals, confirming adequacy of the model.  
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Figure 7.11: ACF and PACF for PRx – Patient Example 
 
ACF = autocorrelation function, a.u. = arbitrary units, PACF = autocorrelation function, PRx = pressure reactivity index (correlation between intracranial pressure and mean arterial 
pressure). Panel A: ACF plot displaying a rapid decay of significant PRx lag, suggesting stationarity. Panel B: PACF plot, also displaying rapid decay of significant PRx lags.  
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Figure 7.12: ACF, PACF and Residual Plots for PRx (2,0,2) ARIMA Model – Patient Example 
 
ACF = autocorrelation function, PACF = autocorrelation function, PRx = pressure reactivity index (correlation between 
intracranial pressure and mean arterial pressure). Panel A: displays the residual plot for the ARIMA model in this patient 
example. Panel B: ACF plot displaying no significant lags with (2,0,2) ARIMA model for PRx. Panel C: PACF plot, also no significant 
lags with (2,0,2) ARIMA model for PRx.  
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c. Model Development and Accuracy Assessment 
LME Modelling of PRx Using TCD Indices 
Using the (2,0,2) PRx ARMA structure identified within the individual patients, various LME models 
were produced, embedding the PRx ARMA structure within. Table 7.3 displays the model 
characteristics for those LME models derived from Sx_a and Mx_a, introducing random effects by 
patient into the intercept and coefficients. Model superiority was confirmed via ANOVA testing, with 
the lowest AIC/BIC and highest LL, indicating superiority. The top two LME models were:  PRx ~ Sx_a 
(AIC = -1564.957, BIC = -1510.159, LL = 792.4786) and PRx ~ Sx_a + Mx_a (AIC = -1597.345, BIC = -
1520.627, LL = 812.6726); with random effects by patient introduced into both the coefficients and 
intercept.  The QQ and residual density plots for these top two LME models can be seen in Appendix 
E, displaying normally distributed residuals, indicating model adequacy. The ACF and PACF plots for 
these two models can also be found in Appendix E, displaying acceptable rapid decay of significant 
lags.  
 
Population Based Estimation of PRx Using Sx_a and Mx_a 
Using the top two LME models described above, PRx was estimated using the available Sx_a and 
Mx_a measures in the training data set. Grand mean values were calculated per patient and plotted 
against the observed PRx values from the data.  A strong linear relationship was seen between 
estimated and observed PRx using both LME models.  Figure 7.13 displays estimated versus 
observed PRx plots for each model. The PRx ~ Sx_a model displayed a correlation between 
estimated and observed values of 0.998 (95% CI = 0.990 – 0.999; p<0.0001), while the PRx ~ Sx_a + 
Mx_a model had a correlation between estimated and observed PRx values of 0.997 (95% CI = 0.988 
– 0.999; p<0.0001).  Bland-Altman analysis on Fisher transformed results displayed acceptable 
agreement, with slight underestimation bias in the estimated PRx for both models.  This bias in the 
Bland-Altman plots was seen in our previous work as well.  Appendix E contains the results of the 
Bland-Altman analysis comparing the estimated to observed PRx for both LME models. 
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Table 7.3:  LME Models with PRx (2,0,2) ARIMA Structure – Entire Population 
LME Model  PRx ARIMA Structure AIC BIC  LL 
Fixed Effects Random Effects P q 
PRx ~ Sx_a intercept 2 2 -1543.672 -1499.833 779.8362 
PRx ~ Mx_a intercept 2 2 -1502.348 -1458.509 759.1738 
PRx ~ Sx_a + Mx_a intercept 2 2 -1550.704 -1501.385 784.3520 
PRx ~ Sx_a Intercept + Sx_a 2 2 -1564.957 -1510.159 792.4768 
PRx ~ Mx_a Intercept + Mx_a 2 2 -1516.367 -1461.569 768.1836 
PRx ~ Sx_a + Mx_a Intercept + Sx_a + Mx_a 2 2 -1597.345 -1520.627 812.6726 
AIC = Akaike Information Criterion, ARIMA = auto-regressive integrative moving average, BIC = Bayesian Information Criterion,  FVm = mean TCD flow velocity, FVs = TCD based 
systolic flow velocity, ICP = intra-cranial pressure, LL = log likelihood, LME = linear mixed effects model, p = auto-regression parameter for ARIMA model, MAP = mean arterial 
pressure, PRx = pressure reactivity index (correlation between ICP and MAP), q = moving average parameter for ARIMA model, Sx_a = systolic flow index (correlation between TCD 
based FVs and MAP), TCD = transcranial Doppler. *Note: bolded value represents the most appropriate ARIMA structure and LME model for the patient population tested, based 
on principal of parsimony, lowest AIC and BIC.   There was no integrative parameter (ie. “d” parameter) included within the ARIMA models, given stationarity testing during 
patient examples (see appendix A and Methodology section of manuscript). 
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Figure 7.13: Linear Regression Between Observed and Estimated PRx – Using Estimated PRx From Two Best LME Models 
 
 
a.u. = arbitrary units, ICP = intracranial pressure, LME = linear mixed effects, MAP = mean arterial pressure, PRx = pressure reactivity index (correlation between ICP and MAP). 
Panel A: LME model – PRx ~ Sx_a (random effects with intercept and Sx_a), Panel B: LME model – PRx ~ Sx_a + Mx_a (random effects with intercept, Sx_a and Mx_a).  Coef = 
coefficients, form linear model between observed PRx and model estimated PRx.  Dotted straight line – represents the relationship “y = x”, for comparison to our two models. 
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d. Predicting PRx Using Non-Invasive TCD Parameters 
Using the top two LME models derived above, predicted PRx (pPRx) was derived via the 20% of data not 
used in model construction/training.  Each patient had 20% of their recording data excluded from the 
prior model formation/training, each with ICP and TCD derived variables, amounting to ~30 to 60 
minutes of minute-by-minute data per patient. For each LME model, the Sx_a and Mx_a values from this 
new data were entered into the models to derive pPRx. Grand mean values were then calculated per 
patient.  For the model PRx ~ Sx_a, the correlation between predicted and observed PRx values was 
0.797 (95% CI = 0.336 – 0.949; p=0.006). Similarly, for the model PRx ~ Sx_a + Mx_a, the correlation 
between predicted and observed PRx was 0.763 (95% CI = 0.258 – 0.941; p=0.011). Predicted and 
observed PRx values displayed a linear association, though not 1:1.  Figure 7.14 displays the predicted 
versus observed PRx plots for the top two LME models. Bland-Altman analysis of Fisher transformed 
data demonstrated acceptable agreement between predicted and observed PRx values, with similar 
underestimation of the predicted PRx values as seen in the training data previously. All Bland-Altman 
test results for comparing pPRx to observed PRx can be found in Appendix E.  
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Figure 7.14: Linear Regression Between Observed and Predicted PRx – Using Predicted PRx From Two Best LME Models 
 
 
a.u. = arbitrary units, ICP = intracranial pressure, LME = linear mixed effects, MAP = mean arterial pressure, PRx = pressure reactivity index (correlation between ICP and MAP). 
Panel A: LME model – PRx ~ Sx_a (random effects with intercept and Sx_a), Panel B: LME model – PRx ~ Sx_a + Mx_a (random effects with intercept, Sx_a and Mx_a).  Coef = 
coefficients, form linear model between observed PRx and model estimated PRx.   
 
204 
 
7.2.4 Discussion 
 
Through the application of time-series ARMA and LME modelling in this pilot study, for the first time the 
prediction of PRx using non-invasive TCD measures (ie. Sx_a and Mx_a) has been described.  Some 
important aspects of this preliminary pilot work require highlighting. 
First, through the application of ARMA modelling of PRx, and LME modelling of PRx using TCD measures, 
in this unique cohort of patients with extended duration continuous TCD recordings, LME models that 
accurately estimate observed PRx can be produced.  This is similar to prior retrospective work in a large 
TB population with TCD.184  Further, the superior two models from this current cohort were of similar 
ARMA and mixed-effects structure to those discovered in the prior work, as confirmed through the 
principal of parsimony.  This provides some validation of the previous work, and also provides some 
evidence to support these models regardless of the duration of TCD recording analyzed. In addition, the 
bias on Bland-Altman analysis comparing observed to estimated PRx displayed the same 
underestimation bias seen in the previous work, with acceptable agreement. Finally, is provides 
prospective confirmatory evidence of the strong relationship between PRx and Sx_a in longer duration 
recordings. 
Second, as with the previous work,184 the general fixed effects versions of the top two models performed 
poorly in estimating PRx, with continuous significant autocorrelation in the model residuals. As 
mentioned within the methods section, these models were subsequently not reported further. This 
again confirms patient-by-patient heterogeneity, limiting the extrapolation of this work to other general 
TBI populations.  
Third, for the first time in the literature the ability to predict PRx using non-invasive TCD surrogates has 
been demonstrated.  Comparing pPRx to the observed PRx values in the top two models, the correlation 
is of moderate strength with a linear relationship between the two and acceptable agreement on Bland-
Altman analysis. However, a similar underestimation bias for pPRx is present on Bland-Altman analysis. 
Further, the relationship between pPRx and the observed PRx was not 1:1, indicating the prediction is 
not perfect.  Further work is required to optimize the prediction models. 
Finally, this work is based on only 10 patients and is entirely preliminary with results that are not 
generalizable at this time. Thus, this type of modelling and prediction of PRx should not be conducted 
outside of a research setting.  Much further work is required for validation.  
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Limitations 
Despite the interesting results of this analysis, there are some important limitations which require 
highlighting. 
First, as with the previous work in this area, the patient population was heterogeneous in terms of age, 
intra-cranial injury patterns and therapies directed at ICP/CPP goals.  These heterogeneities could impact 
signal fluctuations and the results obtained for the time series modelling conducted.  Though in 
comparison to the larger time series work in TBI, the results of the modelling within this preliminary pilot 
study were similar, as described above.184 
Second, patient numbers were small, at only 10.  For the purpose of this type of analysis the desire was 
to only look at patients with 3 to 4 hours of completely uninterrupted ICP and TCD recordings.  This 
limited the size of this unique patient population, given technical limitations around TCD.  Thus, the 
results here are quite preliminary and should be considered experimental at this point.  This 
requirement for interrupted continuous TCD is a significant limitation with the described modelling and 
forecasting processes, as conventional TCD is currently heavily limited by artifact and signal loss. The 
application of robotic TCD mitigated this in the study, however this technology is relatively new and not 
without limitations, including patient eligibility (ie. no decompressive craniectomy, no cervical spine 
immobilisation collars, etc.) and substantial cost. Furthermore, even with the application of robotic TCD, 
it still posed difficult to obtain continuous extended duration recordings.  As robotic and automatic TCD 
technology improves, it is expected to be able to obtain extended duration uninterrupted recordings 
throughout a patient’s ICU stay.  Thus, even though the current results are limited given patient 
numbers, they provide the platform for future applications once technology catches up with the 
demands of this type of modelling/prediction. 
Third, the ARIMA structure highlighted for PRx, and the LME models within this study may not be widely 
applied outside this population.  This was also mentioned in the previous publication on this topic.184  
There exists the potential for patient specific ARIMA structures, and thus the models described in these 
studies should not be applied clinically. Furthermore, as mentioned above, the general fixed effects 
versions of the top two models performed poorly in the estimation of PRx, with continuous significant 
residual lags.  This also suggests significant patient-by-patient heterogeneity, negating the extrapolation 
of these results to other general TBI populations at this time. Much further work on PRx, amongst other 
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physiologic measures in TBI, is required in larger patient populations in order to determine the exact 
high frequency time series behavior.  This is a work in progress for us currently.  
Finally, the statistical methodology employed within this study is quite complex, requiring numerous 
steps, and is fraught with difficulties. Thus, the wide spread applicability of these techniques is currently 
limited.  However, based on the results of this work with time series data in TBI, the plan is to develop 
custom functions for ICM+ software, allowing for a much more user-friendly application of such 
modelling and forecasting/prediction techniques.  Such functions will automate much of the analysis 
described in these works on time series (ie. sections 7.1 and 7.3), requiring limited user input.  This will 
hopefully bring this type of work to the wider clinical world for future multi-center validation studies.  
 
7.2.5 Conclusions 
 
Through the application of ARMA and LME modelling, it is possible to predict PRx using non-invasive TCD 
measures, such as Sx_a and Mx_a.  This is the first preliminary attempts at doing so.  Much further work 
is required prior to application within a clinical setting, as this the current work should be considered 
experimental at this time. 
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CHAPTER 8: CRITICAL THRESHOLDS FOR CEREBROVASCULAR REACTIVITY 
INDICES AND OUTCOME PREDICTION IN ADULT TBI 
 
*The study results described in sections 8.1 and 8.2 can also be found detailed in the following 
respective publications: 
1. Zeiler et al., J Neurotrauma. 2018; 35(10):1107-1115. doi: 10.1089/neu.2017.5472.152 
2. Zeiler et al., J Neurotrauma. 2018; 35(2):314-322. doi: 10.1089/neu.2017.5364.182 
 
8.1 ICP Derived Indices of Cerebrovascular Reactivity 
 
8.1.1 Introduction 
 
ICP derived continuous indices of cerebrovascular autoregulation are currently employed in some ICU’s, 
particularly in the MMM of TBI patients.11,12  The two most quoted ICP derived indices are PRx3 and 
PAx.15 As well, within Chapter 4 of this thesis, a new index of cerebrovascular reactivity, RAC, was 
explored.21  All three of these ICP based indices have been interrogated in experimental models, as 
described in Chapter 5 of this thesis, with some preliminary evidence to suggest they provide some 
measure of the LLA. 
To date, PRx has received most attention, both in terms of published literature and clinical application.  
PRx has displayed strong associations with patient outcome, with published thresholds of PRx associated 
with mortality and morbidity at 6 months in a mixed TBI population.9  The use of PRx as a surrogate 
assessment of cerebral autoregulatory status has received support from recent multi-modal monitoring 
consensus statements,11 and has been applied in the estimation of individual patient “optimal” CPP.144  
However, the basis for such use of PRx leaves some issues unanswered.  The PRx thresholds for poor 
functional outcome at 6-months (ie. PRx > 0) and mortality (ie. PRx > +0.25) were derived from a large 
cohort or heterogenous TBI patients, including some who were post-DC.9  PRx calculation is known to be 
impacted by craniectomy in TBI, making its reliability uncertain, at least initially, after removal of the 
calvarium.22  Furthermore, recent literature supports a potential superior capability of PAx over PRx in 
the prediction of patient outcome, within the subgroup of patients with “low” ICP (defined as less than 
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15 mm Hg).15  However, the literature addressing PAx in TBI is limited, with few studies suggesting an 
association with outcome, and no definition of clear threshold values that predict outcome. Finally, 
based on the results from Chapters 4 and 5 of this thesis, RAC shows promise as an index of 
cerebrovascular reactivity.21  
Most critically for clinical use, there is no documented comparison of these three ICP-derived indices as 
they relate to mortality and functional outcome at 6 months, and the critical thresholds of each of these 
indices which are associated with poor outcome.  Furthermore, all descriptions of outcome associations 
and threshold values for these indices is confounded inclusion of patients following DC, and their 
performance has not been described in a purely non-DC TBI patient population, potentially mitigating 
the poorly understood impact of craniectomy on these continuous indices of cerebrovascular reactivity.   
The goal of this study in non-DC TBI patients was to:  A. compare the association to outcome of all three 
ICP derived indices (PRx, PAx and RAC), B. compare the thresholds of each index which are most 
associated with morbidity and mortality, C. conduct both outcome and threshold analysis for these 
indices across various timeframes/lengths of signal recording. 
 
8.1.2 Methods 
 
Patient Population and Demographic Data Acquisition 
This population is identical to the one described in Chapter 4.21 All patients (n=358) were admitted to 
the NCCU at Addenbrooke’s Hospital, Cambridge, during the period of March 2005 to December 2016.  
In addition, only patients with at least 6 hours of recorded signals were included in this study. Patients 
suffered either moderate to severe TBI, or mild TBI and subsequently deteriorated to a point where they 
required ICP monitoring and sedation and mechanical ventilation as part of ICP management.  
Treatment received during the recording periods included standard ICP-directed therapy, with an ICP 
goal of less than 20 mm Hg and CPP goal of greater than 60 mm Hg.   
The following patient demographic data was obtained from the database:  age, sex, admission Glasgow 
Coma Scale (GCS), and patient outcome at 6 months.  Patient outcome was assessed via the Glasgow 
Outcome Score (GOS) at 6 months and stored prospectively within the database.  For purpose of the 
outcome and threshold analysis, we dichotomized the GOS into two binary outcomes of interest: A. 
Favourable (GOS of 4 or 5) vs. Unfavourable (GOS of 3 or less), and B. Alive vs. Dead. 
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Signal Acquisition 
See Chapter 4.2 for details on signal acquisition. 
 
Signal Processing 
See Chapter 4.2 for details on signal processing.  The following variables were derived: ICP, MAP, AMP, 
PRx, PAx, RAC and RAP.  
Finally, data for this analysis were provided in the form of a minute by minute time trends of the 
parameters of interest for each patient.  This was extracted from ICM+ in to CSV datasets, which were 
collated into one continuous data sheet (compiled from all patients).  From this, separate data sheets 
for:  entire recording period for each patient (n=358), 1st 24 hours of recording (n= 340), 1st 72 hours of 
recording (n=277), 1st 5 days of recording (n=217), 1st 7 days of recording (n=163), and 1st 10 days of 
recording (n=101) were produced in order to assess the association to outcome, and thresholds, across 
various durations of recording.  The difference in patient numbers between time periods of analysis is 
secondary to both death and discontinuation of high-resolution physiologic recording.  
This staged analysis was conducted in order to determine if the outcome relationships and thresholds 
seen in the total recording period (as used in previous works on PRx and PAx), continue to hold true 
within various recording periods after TBI. Within these separate data sheets, a grand mean per patient 
was calculated for each index across the duration of that recording period and subsequently utilized for 
the final statistical analysis. 
 
Statistics 
Statistics were performed utilizing XLSTAT (Addinsoft, New York, United States; 
https://www.xlstat.com/en/) add-on package to Microsoft Excel (Microsoft Office 15, Version 
16.0.7369.1323) and R statistical software (R Core Team (2016). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/).  For all statistical tests described, alpha was set at 0.05 for significance. 
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General Statistics 
Simple descriptive statistics for the non-DC cohort were utilized to summarize the patient demographics. 
Outcome Analysis 
First, a univariate binary logistic regression (ULR) analysis was performed utilizing the three indices (PRx, 
PAx, and RAC) and two binary outcomes of interest:  A. Favourable vs. Unfavourable, and B. Alive versus 
Dead; both at 6 months post-TBI.  
Second, multi-variate binary logistic regression (MLR) was performed using a “baseline” model, 
including: age, sex, admission GCS, mean ICP, mean AMP, MAP and mean CPP.  This “all inclusive” 
baseline model was selected in order to include all physiologic variables monitored during the patient’s 
ICU stay.  This multi-variate analysis was exploratory only, designed to determine which ICP derived 
cerebrovascular reactivity index was superior in outcome prediction when all other physiologic variables 
were taken into account.  Database records did not contain information regarding pupillary response, 
GCS motor response, extra-cranial injury burden or admission CT scan injury characteristics.  Thus, in the 
absence of this data, used in current TBI prognostic models, we focused on the demographic data 
available to us (ie. Age, cumulative GCS and Sex) in addition to the physiologic variables. The goal was 
not to produce the most significant model for overall outcome prediction, with the minimum number of 
variables. The goal was, based on the available data, determine which ICP derived index of 
cerebrovascular reactivity was superior, taking into account as much demographic and physiologic 
information available.  Subsequently, each index was added individually to the baseline model in order 
to see the difference in both outcomes of interest.  Then all indices were added to the baseline model in 
order to determine which indices remained statistically significant. Finally, PAx and RAP were added to 
the baseline model, to allow for comparison with the RAC based model – given it is believed that RAC 
contains both information pertaining to cerebrovascular reactivity and compensatory reserve, based on 
the results from Chapter 4. 
Both of ULR and MLR techniques described above were performed for each recording period:  entire 
recording, 1st 24 hours, 1st 72 hours, 1st 5 days, 1st 7days and 1st 10 days.  Strength of relationship to 
the outcomes of interest were reported via AUC, with bold AUC’s reaching a p<0.05.    For ULR, 
statistically significant differences in AUC’s between PRx, PAx and RAC were tested via Delong’s test. 
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Threshold Analysis 
A sequential chi-square method of thresholding was conducted.  This technique for threshold analysis 
has been described in detail within other publications on continuous autoregulation/cerebrovascular 
reactivity indices in TBI, including PRx.  Sequential 2 by 2 binary outcome contingency tables were 
constructed for each outcome:  6-month dichotomized Favourable vs. Unfavourable GOS, and 6 month 
Alive vs. Dead.  Patients were grouped by Favourable vs. Unfavourable GOS, and Alive vs. dead status 
based on PRx, PAx or RAC index values above or below sequential thresholds (in 0.05-point steps in the 
index value).  Pearson chi-square was then determined for each 2 by 2 table.   
The chi-square test statistic value was then plotted against index threshold (PRx, PAx or RAC).  The index 
threshold value with the largest statistically significant (p<0.05) Chi-square value was then deemed the 
threshold for that outcome of interest (ie. 6-month Favourable vs. Unfavourable outcome, or 6-month 
mortality).  Patients with index values above these thresholds are at highest risk of worse outcome 
(Unfavourable GOS or mortality).  
This entire process was repeated for each index (PRx, PAx and RAC) during each monitoring period:  
entire recording period, 1st 24hours, 1st 72 hours, 1st 5 days, 1st 7 days and 1st 10 days.  This was done 
to determine the potential variation in PRx, PAx and RAC thresholds associated with different lengths of 
recording. 
 
8.1.3 Results 
 
Patient Demographics 
In total, there were 358 patients included for analysis.  All patients suffered mild to severe TBI.  In 
addition, all patients had at least 6 hours of high frequency signals recorded.  The mean age was 40.6 +/-
17.2 years (range: 16 to 89) with a median admission Glasgow Coma Scale score of 7 (IQR = 3 to 9; range: 
3 to 13).  There were 272 males (76.0%), and the mean length of signal recording was 189.1 +/-151.1 
hours (range: 8.5 to 1033.0 hours; median = 152.7 hours).  The mean ICP, MAP, CPP, AMP, PRx and RAC 
were:  14.057 +/-7.6 mm Hg, 91.3 +/- 7.9 mm Hg, 77.5 +/- 8.5 mm Hg, 2.3 +/- 1.4 mm Hg, 0.046 +/-0.173, 
and -0.350 +/- 0.254; respectively.  A further breakdown of patient demographics can be seen in Table 
8.1, based on the recording period analyzed. 
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Table 8.1:  Patient Demographics by Recording Length Analyzed 
 Recording Period 
 Total  1st 24hr 1st 72hr 1st 5d 1st 7d 1st 10d 
N 358 340 277 217 163 101 
Mean Age 
(yrs) 
40.6 +/- 
17.2 
40.6 +/- 
17.2 
40.2 +/- 
17.0 
38.78 +/- 
15.8 
39.2 +/- 
15.1 
38.4 +/- 
14.0 
Number of 
Males 
272 258 212 169 124 83 
Median 
Admission 
GCS (IQR) 
7.0 (3 to 9) 7.0 (3 to 10) 7.0 (3 to 9) 6.0 (3 to 9) 7.0 (3 to 
9.5) 
7.0 (3 to 9) 
Mean ICP 
(mm Hg) 
14.1 +/-7.6 15.6 +/- 8.6 14.9 +/- 7.4 15.1 +/- 6.2 15.4 +/- 4.5 15.9 +/- 4.2 
Mean AMP 
(mm Hg) 
2.34 +/- 
1.39 
2.63 +/- 
1.67 
2.68 +/- 
1.43 
2.44 +/- 
1.15 
2.48 +/- 
1.12 
2.41 +/- 
0.96 
Mean CPP 
(mm Hg) 
77.5 +/- 8.5 75.2 +/- 9.0 76.3 +/- 7.4 77.4 +/- 7.3 78.8 +/- 5.9 80.2 +/- 5.8 
MAP (mm 
Hg) 
91.2 +/- 7.9 90.5 +/- 9.3 91.2 +/- 1.4 92.5 +/- 7.7 94.2 +/- 7.4 96.1 +/- 7.2 
Mean PRx 0.05 +/- 
0.17 
0.01 +/- 
0.22 
0.00 +/- 
0.19 
0.00 +/- 
0.16 
0.01 +/- 
0.15 
0.00 +/- 
0.12 
Mean PAx -0.06 +/-
0.20 
-0.07 +/- 
0.24 
-0.07 +/- 
0.20 
-0.08 +/- 
0.18 
-0.07 +/- 
0.16 
-0.07 +/- 
0.14 
Mean RAC -0.35 +/- 
0.25 
-0.36 +/- 
0.29 
-0.38 +/- 
0.26 
-0.38 +/- 
0.23 
-0.38 +/- 
0.20 
-0.40 +/- 
0.18 
AMP = pulse amplitude of ICP, CPP = cerebral perfusion pressure, d = day, GCS = Glasgow Coma Scale, hr = hours, ICP = intra-
cranial pressure, MAP = mean arterial pressure, mm Hg = millimeters of Mercury, N = number, yrs = years, PAx = pulse amplitude 
index (correlation between AMP and MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation 
between AMP and CPP. 
 
 
Association with 6-Month Outcome – PRx, PAx and RAC 
 Univariate Binary Logistic Regression (ULR) 
A summary of the ULR AUC’s for each index, during each recording period can be seen in Table 8.2 
(bolded AUC’s indicate a p<0.05).  In summary, RAC demonstrated superior AUC’s for prediction of both 
unfavourable outcome and for mortality; across all periods of recording analyzed.  In analyzing the entire 
recording period, the AUC’s for prediction of unfavourable outcome were:  PRx (0.573, p<0.0001), PAx 
(0.606, p<0.0001), and RAC (0.655, p<0.0001).  Similarly, the AUC’s for mortality were:  PRx (0.651, 
p<0.0001), PAx (0.705, p<0.0001), and RAC (0.722, p<0.0001).  The AUC differences between RAC vs. 
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PRx, and PAx vs. PRx reached statistical significance (ie. p<0.05) in all recording periods (except the “1st 
10 days” recording group) tested, using Delong’s test.  However, the difference in AUC between RAC and 
PAx, failed to reach statistical significance, regardless of the recording period analyzed. The “1st 10 days” 
recording group failed to display statistically significant relationships between the indices and the two 
binary outcomes. 
 
Multivariate Binary Logistic Regression (MLR) 
Table 8.3 displays the AUC’s for the various prognostic models tested: baseline model, baseline + PRx, 
baseline + PAx, baseline + RAC and baseline + “All Indices”; across all time periods of recording that were 
analyzed (bold AUC’s indicate p<0.05).  In summary, the baseline model demonstrated significance for 
ICP, Age and admission GCS for both binary outcomes, across the majority of the recording periods 
analyzed.  This also held true in the majority of the models in which one or more of the cerebrovascular 
reactivity indices was added, across all time periods. Only the “1st 10 days” recording group failed to 
reach statistical significance between any of the models and the binary outcomes analyzed. 
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Table 8.2:  Univariate Binary Logistic Regression – A/D and F/U AUC’s Based on Various Recording Periods 
Recording 
Period 
PRx PAx RAC 
A/D 
AUC 
p-value F/U 
AUC 
p-
value 
A/D 
AUC 
p-value F/U 
AUC 
p-value A/D 
AUC 
p-value F/U 
AUC 
p-value 
Total  0.651 <0.0001 0.573 0.002 0.705 <0.0001 0.606 0.0001 0.722 <0.0001 0.655 <0.0001 
1st 24hr 0.650 <0.0001 0.580 0.002 0.688 <0.0001 0.612 0.0001 0.677 <0.0001 0.632 <0.0001 
1st 72hr 0.613 0.0001 0.517 0.144 0.671 <0.0001 0.579 0.011 0.693 <0.0001 0.603 0.001 
1st 5d 0.596 0.003 0.508 0.279 0.667 0.001 0.591 0.007 0.700 <0.0001 0.621 0.001 
1st 7d 0.583 0.038 0.550 0.221 0.660 0.009 0.621 0.006 0.704 0.0001 0.660 0.0001 
1st 10d 0.546 0.643 0.519 0.793 0.585 0.265 0.548 0.186 0.630 0.086 0.612 0.050 
A/D = alive/dead, AMP = pulse amplitude of ICP, AUC = area under the receiver operating curve, CPP = cerebral perfusion pressure, d = day, F/U = favourable/unfavourable GOS 
(Favourable = 4 or 5; Unfavourable = 3 or less), hr = hour, ICP = intracranial pressure, MAP = mean arterial pressure, PAx = pulse amplitude index (moving correlation coefficient 
between AMP and MAP), PRx = pressure reactivity index (moving correlation coefficient between ICP and MAP), RAC = moving correlation coefficient between AMP and CPP. 
*NOTE:  bold values are those p-values which reached the threshold of statistical significance (p<0.05). 
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Table 8.3:  Multivariate Logistic Regression – A/D and F/U AUC’s Based on Various Recording Periods 
MODEL Recording Period 
Total (n=358) 1st 24hr (n=340) 1st 72hr (n=277) 1st 5d (n=217) 1st 7d (n=163) 1st 10d (n=101) 
A/D AUC F/U AUC A/D 
AUC 
F/U 
AUC 
A/D 
AUC 
F/U 
AUC 
A/D 
AUC 
F/U 
AUC 
A/D 
ACU 
F/U 
AUC 
A/D 
AUC 
F/U 
AUC 
Baseline  0.802 0.718 0.765 0.716 0.759 0.710 0.780 0.720 0.755 0.730 0.741 0.743 
+ PRx 0.822 0.727 0.804 0.732 0.802 0.717 0.807 0.718 0.803 0.734 0.741 0.752 
+ PAx 0.836 0.728 0.798 0.728 0.797 0.720 0.796 0.723 0.790 0.740 0.739 0.744 
+ RAC 0.863 0.745 0.811 0.742 0.821 0.725 0.820 0.733 0.817 0.764 0.744 0.740 
+ All 
Indices 
Included 
0.862 0.748 0.816 0.738 0.823 0.723 0.825 0.735 0.819 0.763 0.751 0.761 
+PAx 
and RAP 
0.847 0.741 0.806 0.739 0.819 0.722 0.803 0.727 0.803 0.760 0.743 0.743 
A/D = alive/dead, AMP = pulse amplitude of ICP, AUC = area under the receiver operating curve, CPP = cerebral perfusion pressure, d = day, F/U = favourable/unfavourable GOS 
(Favourable = 4 or 5; Unfavourable = 3 or less), hr = hour, ICP = intracranial pressure, MAP = mean arterial pressure, n= number, PAx = pulse amplitude index (moving correlation 
coefficient between AMP and MAP), PRx = pressure reactivity index (moving correlation coefficient between ICP and MAP), RAC = moving correlation coefficient between AMP 
and CPP, RAP = moving correlation coefficient between AMP and ICP. *NOTE:  bold values are those p-values which reached the threshold of statistical significance (p<0.05). **All 
“MODEL’s” contained:  Age, Sex, admission Glasgow Coma Scale (GCS), mean ICP, mean CPP, MAP, mean AMP. ***All Indices Included model – despite including PRx, PAx and 
RAC, RAC was the only index to reach statistical significance in the model across all recording periods (except 1st 10d – given nothing reached significance secondary to patient 
numbers in this cohort), with PRx and PAx both dropping out of the model. 
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In evaluating the baseline model with the addition of PRx, PAx or RAC, RAC displayed superior AUC’s for 
both binary outcomes, across all periods analyzed.  Furthermore, when all indices were added into the 
MLR, both PRx and PAx failed to reach significance, with RAC being the only ICP derived cerebrovascular 
reactivity index that remained significant.  Finally, the RAC multivariate model also outperformed the 
PAx + RAP multivariate model across all time periods analyzed. This held true across all time periods 
analyzed.  
 
Critical Thresholds Associated with Morbidity and Mortality – PRx, PAx and RAC 
 
The sequential chi-square thresholding was conducted for each index with each binary outcome, across 
all recording periods.  Appendix F displays the chi-square versus index threshold plots for each index, in 
each recording period.  In summary, using the entire recording period, PRx displayed a threshold of 
+0.35 for both unfavourable outcome (p=0.0001) and mortality (p<0.0001). This is contradictory to the 
previous thresholding study (which included DC patients), displaying thresholds of +0.05 and +0.25, 
respectively.9   For the same recording period, PAx displayed a threshold of +0.05 for unfavourable 
outcome (p<0.0001) and +0.25 for mortality (p<0.0001).  Finally, for the same recording period, RAC 
displayed a threshold of -0.10 for unfavourable outcome (p<0.0001), and -0.05 for mortality (p<0.0001).  
Figure 8.1 displays the chi-square value vs. index threshold plots for PRx, PAx and RAC, using data from 
the entire recording period. 
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Figure 8.1:  Threshold Plots for PRx, PAx and RAC – Entire Recording Period 
 
A/D = Alive/Dead outcome (black line), AMP = pulse amplitude of ICP, CPP = cerebral perfusion pressure, F/U = favourable/unfavourable outcome (grey line), ICP = intra-cranial 
pressure, MAP = mean arterial pressure, P = p-value, PAx = pulse amplitude index (correlation between AMP and MAP), PRx = pressure reactivity index (correlation between ICP 
and MAP), RAC = correlation between AMP and CPP. 
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Critical Thresholds of PRx, PAx and RAC Based on Length of Recording Analyzed 
 
Given that the duration of signal recording varies significantly between patients, we were interested to 
explore differences in critical thresholds of PRx, PAx and RAC across various durations of recording.  
Figure 8.2 displays the critical thresholds for PRx, PAx and RAC (for both binary outcomes) plotted 
against the duration of recording used for analysis.  Of interest is the significant variation in thresholds of 
both PRx (Figure 8.2A) and PAx (Figure 8.2B), with loss of significance of some threshold values using 7 
and 10 days of recording.  In contrast, RAC (Figure 8.2C) displayed more consistent and stable critical 
thresholds, for both binary outcomes, regardless of the length of recording period utilized within the 
analysis. 
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Figure 8.2:  Critical Thresholds of PRx, PAx and RAC – Based on Length of Recording Analyzed 
 
A/D = Alive/Dead outcome, AMP = pulse amplitude of ICP, CPP = cerebral perfusion pressure, F/U = favourable/unfavourable 
outcome, ICP = intra-cranial pressure, MAP = mean arterial pressure, P = p-value, PAx = pulse amplitude index (correlation 
between AMP and MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation between AMP 
and CPP. *NS = not statistically significant threshold value for this period of recording analyzed. Number of patients in each time 
period analyzed:  Total = 358, 1st 24 hours = 340, 1st 72 hours = 277, 1st 5 days = 217, 1st 7 days = 163, 1st 10 days = 101. 
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8.1.4 Discussion 
 
Using both univariate logistic regression and multi-variate logistic regression, and critical threshold 
analysis of PRx, PAx and RAC in a solely non-DC TBI cohort, some important relationships have been 
identified which need to be emphasized.   
First, RAC, explored in Chapter 4, displays the highest AUC for prediction of both mortality and 
unfavourable outcome, when compared to PRx and PAx.  This was replicated across all periods of 
recording that were analyzed. This finding is critical, given that PRx is the most commonly quoted 
continuous autoregulation index in TBI.  The fact that RAC may be superior to PRx for outcome 
prediction warrants its consideration for further evaluation in terms of clinical application.   
Second, RAC also displayed superior AUC’s for both binary outcomes using MLR, compared to the 
models including PRx or PAx.  This was again replicated across all recording periods analyzed.  
Furthermore, when all three indices were added into the MLR modelling, RAC was the only one to 
remain statistically significantly associated with both mortality and unfavourable outcome, across all 
recording periods analyzed.  Finally, the RAC model also outperformed the PAx + RAP model across all 
time periods analyzed.  RAP is the moving correlation coefficient between AMP and ICP, and is believed 
to represent pure compensatory reserve and not cerebrovascular reactivity.  RAC is believed to 
represent an index which carries information regarding both cerebrovascular reactivity and cerebral 
compensatory reserve, as demonstrated in Chapter 4.  Thus, the multivariate model including PAx (an 
index of cerebrovascular reactivity) and RAP (an index of compensatory reserve) should theoretically 
carry similar or superior outcome prediction capacity compared to a multivariate model with RAC alone.  
The MLR model with RAC alone outperformed all other multi-variate models tested, including the model 
with PAx and RAP, indicating that RAC appears superior and carries additional outcome predictive 
capabilities.  These models with RAP alone are not discussed in detail given they do not focus on 
cerebrovascular reactivity/autoregulation, as the goal of this study was to explore the outcome 
predictive capabilities of ICP derived indices of cerebrovascular reactivity/autoregulation. 
Third, critical thresholds of cerebrovascular reactivity indices for both mortality and unfavourable 
outcome vary depending on the length of recording utilized.  This holds true for all three indices.  Using 
the entire recording period (which has been described in previous autoregulation index thresholding 
studies), the thresholds for both Favourable/Unfavourable and Alive/Dead were: +0.35/+0.35 for PRx, 
0/+0.25 for PAx, and -0.10/0 for RAC.  The ~0.34 to 0.45 lower value for the threshold of RAC, compared 
 
221 
 
to PRx, is not surprising given previous literature demonstrating this approximate relationship across 
~2.7 million data points.  
Fourth, the important point of these thresholds, regardless of which time period is utilized, is the fact 
that DC patients were excluded.  The literature supporting aberrations in PRx post-craniectomy22 raise 
concerns around the previously defined critical thresholds.9  Thus, these new thresholds may be more 
reliable for outcome prediction in those patients not undergoing a decompressive craniectomy.  For DC 
patients, it still remains unclear the utility of PRx, at least in the initial phases, post-craniectomy and the 
reliability of the critical thresholds in this population. 
Fifth, the chi-square critical threshold analysis indicated that RAC had more consistent and stable critical 
thresholds for favourable/unfavourable and Alive/Dead binary outcomes at 6 months.  Compared to PRx 
and PAx, which display greater variation in critical threshold values based on the duration of recordings 
analyzed, RAC may prove to be more stable, at least in the non-DC TBI population, for the application of 
critical thresholds for mortality and unfavourable outcome.  In addition, PRx and PAx had issues with 
statistical significance of their critical thresholds for recording lengths of 7 and 10 days, while RAC did 
not.  Thus, for critical threshold analysis of long recording periods (ie. greater than 7 days), RAC may be 
superior.  However, it must be acknowledged that the number patients who had at least 7 days or 10 
days of recording, in order to be included in those analysis groups, were much less than the “all comers” 
entire recording, or 1st 24 hours of recording, groups.  Thus, it is possible that we were underpowered 
to reach significance in these specific recording periods. 
Finally, the “grey” zone of PRx, as defined by previous thresholding analysis as the index value range 
between the two critical thresholds of +0.05 and +0.25, was not identified within this cohort of 358 non-
DC patients.  This raises suspicion of the potential influence that the DC patients had on the previous 
critical threshold analysis.9  Thus, the thresholds identified for PRx within this current study, may 
represent the true thresholds for non-DC patients.   
  
Limitations 
Despite the interesting results, there are some important limitations to highlight.  First, this study was 
conducted retrospectively on a prospectively collected database of mild to severe TBI patients, with 
archived high frequency signal data.  Thus, there exists significant heterogeneity in injury pattern, 
systemic injury, co-morbidities and treatment within the NCCU, all of which could significantly impact 
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the outcome and threshold analysis.  Furthermore, while on the NCCU, patients were actively 
undergoing ICP and CPP directed therapies which would influence both the parent recorded signals, and 
the subsequently derived autoregulatory indices.   
Second, the results of both the outcome and threshold analysis for the “1st 10 days” recording period 
should be interpreted with caution.  This analysis was underpowered in this sub-group of patients, with 
only 101 included.  This would account for the failure to reach statistical significance in the ULR, MLR 
and thresholding studies described.   
Third, the study presents promising results related to RAC in both ULR/MLR outcome prediction and 
consistency/stability in critical thresholds, with better prognostic associations in the cohort.  However, 
the exploration of RAC in this context is very limited, and the definitive superiority of RAC over either 
PRx or PAx remains unproven and requires further confirmation.  Similarly, while the data suggest that 
RAC may have benefits for measurement of optimum CPP, its performance needs to be formally 
compared to PRx.  
Fourth, the use of the sequential chi-square technique for critical threshold analysis could be considered 
controversial.  It was elected to proceed with this method for two main reasons.  First, sharply defined 
thresholds for the indices were desired, which is not afforded through standard ROC analysis.  Second, 
given the previous work on critical thresholds for continuous autoregulation indices in TBI, similar 
threshold analysis was conducted to allow for comparison with prior results. 
 
8.1.5 Conclusions 
 
In this cohort of non-DC TBI patients, RAC appears to be superior to PRx and PAx in 6-month outcome 
prediction, using both univariate and multivariate logistic regression; across all time periods of recording 
analyzed.  Further, RAC displayed more consistent and stable critical thresholds associated with 
mortality and unfavourable outcomes at 6 months, compared to PRx and PAx.   
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8.2 TCD Systolic Flow Index  
 
8.2.1 Introduction 
 
Chapters 6 and 7 detailed the strong association between TCD based Sx/Sx_a and the ICP derived indices 
of cerebrovascular reactivity.180–182,184 Regardless of the ability to model the “gold standard” PRx via 
Sx_a, there still exists the potential to utilize Sx/Sx_a as a primary measure of cerebrovascular reactivity.  
Currently, the only TCD index with defined critical thresholds is Mx, despite previous literature 
suggesting Sx has a stronger association with 6-month outcome in adult TBI.  Thus, the aim of this study 
was to explore and provide critical thresholds for 6-month outcomes in adult TBI patients. 
 
8.2.2 Methods 
 
Patient Population and Demographic Data Acquisition 
The identical patient cohort described in sections 6.3 and 7.1 was utilized for this study.182,184  Details 
surrounding this cohort can be found in these sections.  Only 281 patients had outcome information 
available for this study. The following patient demographic data was obtained from the database:  age, 
sex, admission GCS, and patient outcome at 6 months.  Patient outcome was assessed using the GOS at 
6 months, and stored prospectively within the database.   For purpose of the outcome and threshold 
analysis, we dichotomized the GOS into two binary outcomes of interest: A. Favourable (GOS of 4 or 5) 
vs. Unfavourable (GOS of 3 or less), and B. Alive vs. Dead. 
 
Signal Acquisition 
Refer to section 6.3 and 7.1 for details. 
 
Signal Processing 
Refer to section 6.3 and 7.1 for details.   
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Cerebrovascular Reactivity Indices 
The cerebrovascular reactivity indices were derived in a similar fashion, as described in Chapter 3. The 
following indices were used for this outcome analysis:  PRx, PAx, RAC, Mx, Mx_a, Sx, Sx_a, Dx and Dx_a.  
 
Statistics 
General Statistics 
Data were provided on a minute-by-minute basis for the duration of the recordings, for each recording.  
Data was also extracted into CSV documents.  We then produced individual recording grand means for 
each index. Statistical analyses were performed in XLSTAT (Addinsoft, New York, United States; 
https://www.xlstat.com/en/) add-on package to Microsoft Excel (Microsoft Office 15, Version 
16.0.7369.1323) and R statistical software (R Core Team (2016). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/).  Tests for normality were performed using the Shapiro-Wilks test for all indices and 
measured variables.  All indices and variables were determined to be non-parametric in nature.  Alpha 
was set at 0.05 for all results describing a p-value.    
 
Outcome Analysis and Critical Thresholds 
To assess the association with patient 6-month outcome, two binary outcomes were of interest:  A. 
Favourable (GOS 4 or 5) vs. Unfavourable (3 or less), and B. Alive vs. Dead.  Initially simple univariate 
logistic regression was performed, comparing each of the ICP indices (PRx, PAx, RAC) and the TCD indices 
(Mx, Mx_a, Sx, Sx_a, Dx, and Dx_a) to both binary outcomes. We reported area under the receiver 
operating curve (AUC) and p-values for each. 
Next, to define critical thresholds for Sx and Sx_a, a sequential chi-square method of thresholding was 
conducted.  This technique for threshold analysis has been described in detail within other publications 
on continuous autoregulation indices in TBI, including PRx and Mx.  It was conducted identical to that 
described in section 8.1.2.  
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8.2.3 Results 
Univariate Logistic Regression 
A univariate logistic regression analysis was performed for each index with both binary outcomes.  A 
summary of the AUC’s and p-values for each index and binary outcome can be seen in Table 8.4.  
These results support previously described univariate logistic regression analysis results for TCD based 
indices.   Sx displayed AUC’s of 0.630 (p=0.005) and 0.646 (p=0.001) for its association with alive/dead 
and favourable/unfavourable outcomes at 6 months, respectively.  Sx_a displayed AUC’s of 0.582 
(p=0.068) and 0.632 (p=0.001) for its association with alive/dead and favourable/unfavourable outcomes 
at 6 months.  Thus, Sx is superior to Mx and Dx, and Sx_a is superior to Mx_a and Dx_a. Further, Sx_a 
appears worse at outcome prediction, compared to Sx.  Finally, Sx displayed broadly similar AUC 
magnitude to the ICP derived indices for both binary outcomes. 
Dx displayed an AUC of 0.592 (p=0.012) for unfavourable outcome at 6 months. Dx failed to reach 
significance in univariate logistic regression for its association with 6-month mortality (AUC = 0.560, p = 
0.215).  Similarly, Dx_a failed to reach significance in logistic regression for both 6-month mortality and 
unfavourable outcome (AUC = 0.494, p = 0.792; AUC = 0.563, p = 0.116, respectively). 
Table 8.4:  Binary Univariate Logistic Analysis – Comparing Indices of Autoregulation to Dichotomized Outcomes 
 “Favourable” vs. 
“Unfavourable” 
Outcome – AUC 
“Favourable” vs. 
“Unfavourable” 
Outcome – p value 
“Alive” vs. 
“Dead” 
Outcome – AUC 
“Alive” vs. 
“Dead” 
Outcome – p 
value 
“Invasive” 
Indices 
    
PRx 0.560 0.035 0.593 0.004 
PAx 0.613 0.002 0.648 0.001 
RAC 0.579 0.028 0.640 0.002 
Mx 0.640 0.001 0.614 0.010 
Sx 0.646 0.001 0.630 0.005 
Dx 0.592 0.013 0.560 0.216 
“Non-invasive” 
Indices 
    
Mx_a 0.617 0.001 0.559 0.213 
Sx_a 0.632 0.001 0.582 0.068 
Dx_a 0.563 0.118 0.494 0.792 
AUC = area under the receiver operating curve, The described indices are Pearson correlation coefficients between various 
variables:  PRx (between ICP and MAP), PAx (between AMP and MAP), RAC (between AMP and CPP Mx (between FVm and CPP), 
Mx_a (between FVm and MAP), Sx (between FVs and CPP), Sx_a (between FVs and MAP), Dx (between FVd and CPP), Dx_a 
(between FVd and MP). 
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Critical Thresholds for Sx and Sx_a 
The sequential chi-square thresholding was conducted for both Sx and Sx_a, with each binary outcome.  
Using the entire recording period, Sx displayed a threshold of -0.15 for unfavourable outcome 
(p<0.0001) and -0.20 for mortality (p<0.0001). This is a much lower threshold compared to those 
described for Mx/Mx_a in previous publications. Figure 8.3 displays the chi-square vs. threshold plot for 
Sx. 
Similarly, Sx_a displayed thresholds of +0.05 (p=0.019) and -0.10 (p=0.0001) for alive/dead and 
favourable/unfavourable outcomes, respectively.   Of note, the chi-square test statistic and p-values for 
Sx_a were much worse across the entire sequential threshold analysis for Sx_a, compared to Sx.  This 
indicates that the strength of relationships for the thresholds defined for Sx_a are much less than those 
described for Sx. Figure 8.4 displays the chi-square value vs. index threshold plot for Sx_a, using data 
from the entire recording period. 
 
Figure 8.3:  6 Month Outcome Thresholds – Sx 
 
A/D = Alive/Dead outcome, CPP = cerebral perfusion pressure, FVs = systolic flow velocity, F/U = favourable/unfavourable 
outcome, MAP = mean arterial pressure, P = p-value, Sx = systolic flow index (correlation between FVs and CPP). 
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Figure 8.4: 6 Month Outcome Thresholds – Sx_a 
 
A/D = Alive/Dead outcome, CPP = cerebral perfusion pressure, FVs = systolic flow velocity, F/U = favourable/unfavourable 
outcome, MAP = mean arterial pressure, P = p-value, Sx_a = systolic flow index based on MAP (correlation between FVs and 
MAP). 
 
8.2.4 Discussion 
 
Univariate Logistic Regression Outcome Analysis 
Univariate logistic regression analysis displayed that Sx is superior to Mx and Dx in its association with 
both binary 6-month outcomes.  Similarly, Sx_a displayed superiority to Mx_a and Dx_a in its association 
with both binary 6-month outcomes.  This confirms previously described results.84,180  Of further interest, 
Sx displayed similar AUC’s to the ICP derived indices (PRx, PAx, and RAC) for both binary 6 month 
outcomes.  This univariate regression analysis confirms similarity in outcome prediction between Sx and 
the ICP derived indices, PRx/PAx/RAC. 
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Critical Thresholds Analysis 
Critical thresholds associated with 6-month outcome have been defined for both Sx and Sx_a. Some 
important points require highlighting. First, the thresholds for mortality and unfavourable outcome with 
Sx is -0.20 and -0.15 respectively.  These are lower than those previously describe for Mx, with mortality 
and unfavourable outcome thresholds defined at +0.05 and +0.30, using an identical process.  Thus, one 
cannot apply the same Mx based thresholds8 to other TCD based autoregulation indices. Furthermore, 
the threshold for worse outcomes with Sx are not located near zero or in positive values, meaning 
disrupted autoregulatory capacity of a magnitude likely to impact outcome may be present even with 
negative values for Sx. This is not seen in the two commonly quoted indices, PRx and Mx, where negative 
values are believed to denote “preserved autoregulation”, and thresholds for outcome association are 
always at or above zero. This emphasizes that “intact” cerebral autoregulation in TBI is a spectrum, not a 
binary phenomenon, with varying degrees of “intact” and “impared” autoregulation which may be 
detected differently via different MMM based measures.  
Second, there is a difference between the thresholds for Sx and Sx_a, with Sx_a displaying thresholds for 
mortality and unfavourable outcome at +0.05 and -0.10, respectively.  It appears the use of MAP during 
the calculation of Sx_a, shifts the thresholds for 6-month outcome towards more positive index values.  
Thus, even within Sx and Sx_a, we cannot assume that the thresholds associated with 6-month outcome 
are interchangeable.  However, it must be acknowledged that the chi-square test statistic and p-values 
for the Sx_a threshold analysis were less significant for all thresholds tested, compared to Sx.  Thus, the 
strength of the relationship with respect to the Sx_a thresholds is not as robust as those described for 
Sx.  This difference between Sx and Sx_a was mirrored within the univariate logistic regression analysis, 
which revealed that Sx was superior in both mortality and unfavourable outcome prediction at 6 
months.  The results from the logistic regression analysis for Sx and Sx_a mirror those previously 
published.84,180 
 
Limitations 
Despite having 281 patients included for the outcome and critical threshold analysis, the length of TCD 
recordings are relatively short.  “Short” recordings, defined as less than 30 minutes duration, were 
removed from the analysis in order to prevent limited recording periods from confounding the outcome 
and threshold analysis. Thus, the grand mean calculations for all indices were based on recordings 
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ranging from 30 minutes up to 2 or 3 hours in maximum duration.  However, despite using only the 
“longer” recordings, they only provide a “snap-shot” into autoregulation/cerebrovascular reactivity.  
Thus, using these limited recordings for outcome association studies is fraught with issues since the 
global outcomes used for threshold analysis reflect the constellation of physiologic and pathologic 
events suffered during the patient’s entire hospital course. 
 
 
8.2.5 Conclusions 
 
Sx and Sx_a provide superior 6-month outcome prediction, compared to Mx and Mx_a, with defined 
critical thresholds different than those described for Mx. Both systolic indices better differentiate 
between favourable-unfavourable outcome than alive-deead. 
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CHAPTER 9: INJURY BURDEN AS A DRIVER OF IMPAIRED 
CEREBROVASCULAR REACTIVITY IN ADULT TBI 
 
*The results of this study can also be found detailed in the publication:  Zeiler et al., J Neurotrauma. 
2018, 35(14):1569-1577. doi: 10.1089/neu.2017.5595..189 
9.1 Introduction 
 
Chapter 8 focuses on the association between various MMM derived cerebrovascular reactivity indices 
and thresholds with patient outcome in adult TBI.152,182 These thresholds may therefore characterize 
critical points in the loss of autoregulatory capacity/cerebrovascular reactivity, beyond which the burden 
of abnormal physiology impacts outcome.  However, despite a growing body of literature on these 
continuous ICP derived indices of cerebrovascular reactivity, very little is understood with regards to 
what drives impaired vascular reactivity after TBI.  Potential drivers of such a relationship include the 
severity and type of IC injury, the severity of EC injury, and/or the physiological response to injury.   
As mentioned in Chapter 2, one past study from Cambridge evaluated the association between 
intracranial injury burden and autoregulatory function in 126 patients post-TBI, and showed that PRx 
was more commonly abnormal in patients with Diffuse Injury Grade III, as compared to other diffuse and 
focal injury classifications, on the Marshall Scale.107 However, the Marshall grading system is just one of 
many available, and its summary descriptions do not provide a full characterization of the type, extent 
and severity of intracranial injury.  Further, the PRx outcome threshold of >0 used in this analysis may 
have been non-optimal, since a recent re-analysis suggests that its derivation may have been heavily 
confounded by inclusion of patients with decompressive craniectomy where different intracranial 
conditions apply. Consequently, there exists an imperfect understanding of how intracranial injury 
impacts on autoregulation following TBI, and there are no publications relating the severity of 
extracranial injury or post-injury physiology to the incidence of abnormal cerebral autoregulation.   
Understanding such relationships is important, since their elucidation could allow early patient 
stratification, and potentially reveal mechanistic targets for therapy.  Therefore, this study details 
exploration of these relationships in a large non-DC TBI patient population with archived high frequency 
digital ICU signals.  There were two main goals of this study:   
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1. Determine the association between admission IC injury burden (assessed by recognized CT 
scoring systems in TBI and an extensive CT based IC lesion database) and impaired cerebrovascular 
reactivity. 
2. Determine how the burden of EC injury relates to impaired cerebrovascular reactivity. 
 
9.2 Methods 
 
Patient Population and Demographic Data Acquisition 
This population is identical to that described in Chapters 4 and 8.1.21,152  Details regarding the population 
specifics can be found there. 
 
Intra-Cranial (IC) Injury Burden Data Acquisition 
All admission CT-head scans were accessed and archived retrospectively.  These scans were assessed by 
a qualified specialist neurosurgeon (the author of this thesis) for a variety of injury characteristics.  There 
was a vast amount of admission CT scoring systems and injury scales determined from the admission CT 
scans.  As such, this study was designed to be a very preliminary analysis into admission injury 
characteristics associated with impaired vascular reactivity, with the described associations to be 
considered exploratory in nature. This image analysis will be assessed in future prospective studies as 
part of CENTER-TBI.190 This IC CT injury database has been described in detail within Chapter 3.4 of the 
general methods. 
 
Extra-Cranial (EC) Injury Burden Data Acquisition 
As part of standard trauma and NCCU care, the admission total Injury Severity Score (ISS)191 and Acute 
Physiology And Chronic Health Evaluation II (APACHE II)192 score were determined for each patient as 
part of national audit requirements and were retrospectively available for this study. 
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Signal Acquisition 
See Chapter 4.2 for details on signal acquisition. 
 
Signal Processing 
See Chapter 4.2 for details on signal processing. PRx, PAx and RAC were derived for every patient. 
Finally, data for this analysis were provided in the form of a minute by minute time trends of the 
parameters of interest for each patient.  From this, data was extracted for; entire recording period for 
each patient (n=358), 1st 24 hours of recording (n= 340), and 1st 72 hours of recording (n=277) were 
produced in order to assess the association between IC and EC injury burden and cerebrovascular 
reactivity, across various durations of recording.  Within these separate datasets, a grand mean was 
calculated per patient for each index across the duration of that recording period and subsequently 
utilized for the final statistical analysis.  Furthermore, in each of these sheets we evaluated the following 
binary thresholds for PRx, PAx and RAC:  A. PRx: >0, >0.25, >0.35; B. PAx: >0, >0.25; and C. RAC: > -0.05, > 
-0.10.  These are the critical thresholds associated with patient outcome previously defined in the 
literature and within Chapter 8.1. Finally, for the entire recording dataset, we calculated the percentage 
of recording time (% time) spent above each threshold for every patient. 
 
Statistics 
Statistics were performed utilizing XLSTAT (Addinsoft, New York, United States; 
https://www.xlstat.com/en/) add-on package to Microsoft Excel (Microsoft Office 15, Version 
16.0.7369.1323) and R statistical software (R Core Team (2016). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/).  For all statistical tests described, alpha was set at 0.05 for significance, with correction for 
multiple comparisons. 
 
General Statistics 
Simple descriptive statistics were utilized to summarize the patient demographics.  Box plots were also 
employed to summarize the cerebrovascular reactivity indices, with respect to IC and EC injury scoring 
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systems.  A Shapiro Wilks test found significant non-normality in the distributions of all continuous 
variables of interest and non-parametric tests were used. 
 
The burden of IC and EC injury, quantified using widely accepted scoring systems,153–156 were related to 
differences in PRx, PAx and RAC based on category of injury burden.  All scoring systems are summarized 
in Chapter 3, section 3.5.1. Using the entire recording period datasets, first correlations between ICP 
derived indices (PRx, PAx and RAC) and the IC and EC injury scores were examined using Spearman’s 
test.  Similarly, the % time spent above index threshold was correlated with IC and EC injury scores. 
Finally, mean PRx, PAx and RAC values across each category of IC injury scoring system were compared 
for:  Marshall,153 Rotterdam,154 Helsinki155 and ordinal Stockholm156 scores; using the Kruskal-Wallis (KW) 
test for the Marshall CT grade, and a one-way Jonckheere-Terpstra (JT) test for the ordinal Rotterdam, 
Helsinki and Stockholm (converted from continuous) scores. This was repeated for % time above 
thresholds of PRx, PAx and RAC.  The KW test was chosen for the Marshall system, given this system is 
not an ordinally arranged grading system.  The JT test was chosen for the Rotterdam, Helsinki and 
ordinal Stockholm graded, given these systems are ordinal in nature and we wished to test if there was 
statistically significant increase in mean values as the ordinal IC CT score increased.  The JT test was 
performed in a one-way method, testing for increasing mean values, running 1000 permutations, 
yielding a p-value.  
Next, the difference between individual patient demographics and injury characteristics for those 
patients above and below various thresholds in PRx, PAx and RAC (using above defined thresholds) were 
evaluated.  Using the entire recording period data sheet, continuous variables were compared using the 
Mann-Whitney U test, while categorical variables were compared via chi-square testing. 
 
Injury Burden Association with Impaired Cerebrovascular Reactivity 
Impaired cerebrovascular reactivity was defined using the above-mentioned critical thresholds for PRx, 
PAx, and RAC.  Each threshold was tested, for every demographic and injury variable.   
First, a univariate binary logistic regression (ULR) analysis was performed utilizing the three datasets; 
evaluating all patient demographics and injury characteristics, comparing to the following binary 
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outcomes of interest:  A. PRx Above 0, B. PRx above +0.24, C. PRx above +0.35, D. PAx above 0, E. PAx 
above +0.25, F. RAC above -0.05, and G. RAC above -0.10.  
Second, multivariable binary logistic regression (MLR) was performed using the above thresholds for 
PRx, PAx and RAC as binary outcomes.  Any variables reaching statistical significance (or close to it:  p-
values <=0.100) in the ULR were entered into the initial MLR model, yielding unique multivariable 
models for each index threshold tested. Running sequential multivariable models, through a backward 
elimination method, deleting those variables which were grossly insignificant (ie. p>0.100), the best 
potential model was derived (based on highest AUC, statistical significance p<0.05, and individual 
component variables reaching p<0.100 within the model).  This was conducted for each index threshold 
tested. 
Both of ULR and MLR techniques described above were performed for each recording period:  entire 
recording, 1st 24 hours, and 1st 72 hours. Only the results of the entire recording period are reported, 
given the other two periods displayed confirmatory results.  Strength of relationship to the outcomes of 
interest were reported via AUC, with bold AUC’s reaching a p<0.05.     
 
9.3 Results 
 
Patient Demographics 
Patient demographics for each of the 3 data sheets are summarized in Table 9.1.  A total of 358 patients 
were included in the entire recording period cohort, with a mean recording period length of 189.1 +/- 
151.1 hour (range: 8.5 to 1033.0 hours duration).  There were 340 and 277 patients in the 1st 24 hours 
of recording and 1st 72 hours of recording cohorts, respectively.  Injury data are summarized in 
Appendix G for the entire cohort. 
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Table 9.1:  Patient Demographics by Recording Length Analyzed 
 Total  1st 24hr 1st 72hr 
N 358 340 277 
Mean Age (yrs) 40.6 +/- 17.2 40.6 +/- 17.2 40.2 +/- 17.0 
Number of Males 272 258 212 
Median Admission GCS 
(IQR) 
7.0 (3 to 9) 7.0 (3 to 10) 7.0 (3 to 9) 
Mean ICP (mm Hg) 14.1 +/-7.6 15.6 +/- 8.6 14.9 +/- 7.4 
Mean AMP (mm Hg) 2.34 +/- 1.39 2.63 +/- 1.67 2.68 +/- 1.43 
Mean CPP (mm Hg) 77.5 +/- 8.5 75.2 +/- 9.0 76.3 +/- 7.4 
MAP (mm Hg) 91.2 +/- 7.9 90.5 +/- 9.3 91.2 +/- 1.4 
Mean PRx 0.05 +/- 0.17 0.01 +/- 0.22 0.00 +/- 0.19 
Mean PAx -0.06 +/-0.20 -0.07 +/- 0.24 -0.07 +/- 0.20 
Mean RAC -0.35 +/- 0.25 -0.36 +/- 0.29 -0.38 +/- 0.26 
AMP = pulse amplitude of ICP, CPP = cerebral perfusion pressure, d = day, GCS = Glasgow Coma Scale, hr = hours, ICP = intra-
cranial pressure, MAP = mean arterial pressure, mm Hg = millimeters of Mercury, N = number, yrs = years, PAx = pulse amplitude 
index (correlation between AMP and MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = correlation 
between AMP and CPP. 
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IC Injury Scores and Cerebrovascular Reactivity  
No significant correlation was detected between any of the ICP indices (PRx, PAx and RAC) and any of 
the IC injury burden scores (Spearman’s correlation).  Comparing the indices to the IC injury scores, all 
coefficients were positive, however failed to reach r-values greater than 0.250 (however with most 
reaching p<0.05).  When comparing the % time spent above threshold for PRx, PAx and RAC with the IC 
injury scores, we found identical trends.   
Given the non-ordinal nature of the Marshall CT grading system, Kruskal Wallis (KW) test was used to 
compare the mean PRx, PAx and RAC values across individual IC score categories.  For the Rotterdam, 
Helsinki and ordinal Stockholm score we compared the mean PRx, PAx and RAC values across each 
ordinal category using a one-way JT test.  Marshall CT grade displayed no statistically significant 
association with the mean PRx, PAx or RAC on KW testing.  Similarly, the Marshall CT grade was not 
significantly associated with % time above thresholds for PRx, PAx and RAC, with the only exception 
being the percentage of time spent with a PRx threshold above 0. 
The Rotterdam CT score displayed some statistically significant association with mean PRx (p=0.001), PAx 
(p=0.001) and RAC (p=0.001).  Similar results were seen for the % time spent above threshold, with most 
PRx and RAC % times above threshold reaching significance. The JT testing confirmed a statistically 
significant increase in the mean values of the indices and % time above threshold, with increasing 
Rotterdam score. 
The Helsinki CT score displayed the most significant association, comparing mean index values and % 
time above threshold across score categories using the JT test. All mean index values and % times above 
threshold were significantly different between ordinal Helsinki score categories (all p<0.002), with 
increasing mean values seen with increasing Helsinki score values.  The mean PRx, PAx, and RAC vs 
Helsinki CT score can be seen in Figure 9.1.   
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Figure 9.1:  Box Plots of PRx, PAx and RAC versus Helsinki CT Score 
 
a.u. = arbitrary units, CT = computed tomography, PAx = pulse amplitude index (correlation between pulse amplitude of ICP (AMP) and MAP), PRx = pressure reactivity index 
(correlation between ICP and MAP), RAC = correlation between AMP and CPP. Panel A:  PRx vs. Helsinki Score (p=0.01 on JT testing), Panel B:  PAx vs. Helsinki Score (p=0.001 on JT 
testing), Panel C: RAC vs. Helsinki Score (p=0.001 on JT testing).  
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Finally, the ordinally arranged Stockholm score seemed to display significant association between mean 
index values and % time above thresholds for RAC only.  The JT testing confirmed a statistically 
significant increase in the mean values of RAC with increasing ordinal Stockholm score value. All mean 
values for indices and % time above thresholds, for each IC scoring system category can be seen in 
Appendix H of the Supplementary Materials. 
 
EC Injury Scores and Cerebrovascular Reactivity 
We evaluated the EC injury scores (ISS and APACHE) in a similar manner.  As with the majority of the IC 
injury scores, the ISS EC injury score failed to reach any statistically significant relationship with any of 
the ICP indices of cerebrovascular reactivity. Out of all IC and EC injury scores, the APACHE score 
displayed the strongest correlation with PRx (p = 0.016), PAx (p=0.001) and RAC (p=0.001), with r-values 
up to 0.285.  Similar trends were found when comparing the % time spent above threshold for PRx, PAx 
and RAC with the IC and EC injury scores.  Figure 9.2 displays box plots of the PRx, PAx and RAC values 
compared to ISS and APACHE scores.  
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Figure 9.2:  Box Plots of PRx, PAx and RAC versus APACHE and ISS Scores 
 
APACHE = APACHE injury score, a.u. = arbitrary units, ISS = injury severity score, PAx = pulse amplitude index (correlation 
between pulse amplitude of ICP (AMP) and MAP), PRx = pressure reactivity index (correlation between ICP and MAP), RAC = 
correlation between AMP and CPP. Panel A:  PRx vs. APACHE (r=0.130; p=0.016), Panel B:  PRx vs. ISS (r=0.-0.018; p= 0.762), 
Panel C: PAx vs. APACHE (r=0.257; p=0.001), Panel D: PAx vs. ISS (r=-0.064; p=0.264), Panel E: RAC vs. APACHE (r=0.285; 
p=0.001), Panel F: RAC vs. ISS (r=0.027; p=0.644). 
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Patient Demographics and Injury Characteristics – Across Binary Index Thresholds 
Table 9.2 displays the results of the Mann-Whitney U testing for across the various binary outcome 
thresholds for RAC, with similar results found for PRx and PAx (Appendix I).  Various variables displayed 
statistical significance between those below versus above threshold.  Of note, age and APACHE scores 
were the two variables consistently different between those patients below and above the index 
thresholds, with higher age and APACHE scores seen in those above the thresholds.  
The ISS and IC scoring systems were rarely statistically different between those patients below and 
above threshold. Those patients with PRx, PAx, and RAC values above threshold were most likely to 
display significantly higher Helsinki CT score values.   
Patients with PRx values above 0 displayed more contusions, higher largest lesion volume, higher total 
contusion volume and more midline shift. A similar pattern was seen for patients with PAx values above 
0.  The other index thresholds tested rarely displayed a statistically significant difference in the 
continuous variable IC injury characteristics.   
 
241 
 
Table 9.2: RAC Thresholds – Non-Binary Demographics and Injury Characteristics 
 
Demo (Mean and 
Medians with 
Std Dev/IQR) 
RAC p-value RAC p-value 
<-0.05 ≥-0.05 <-0.10 ≥-0.10  
N 314 44 - 302 56 - 
Age 39.2 (16.7) 50.6 
(17.5) 
<0.0001 38.9 (16.7) 49.7 (17.0) <0.0001 
GCS 7 (4-10) 5 (3-8.25) 0.078 7 (4-10) 6 (3-8.25) 0.143 
Marshall 2 (2-3) 3 (2-4) 0.433 2 (2-3) 3 (2-3.25) 0.455 
Rotterdam 2 (2-3) 2 (2-4) 0.252 2 (2-3) 2 (2-4) 0.135 
Helsinki 2 (0-4.75) 4 (2-6.25) 0.016 2 (0-4.75) 4 (2-6) 0.005 
Stockholm 2.06 (0.89) 2.35 (0.95) 0.055 2.05 (0.89) 2.32 (0.91) 0.034 
Stockholm Range 2 (2-3) 3(2-3) 0.088 2 (2-3) 3 (2-3) 0.041 
ISS 32.6 (11.2) 35.2 (12.3) 0.384 32.8 (11.2) 33.9 (12.2) 0.829 
APACHE II 11.7 (5.5) 14.4 (5.7) 0.006 11.6 (5.5) 14.6 (5.6) 0.001 
MLS (mm) 1.6 (3.4) 3.0 (5.2) 0.051 1.6 (3.4) 2.6 (4.7) 0.166 
Largest Lesion 
Volume 
12.3 (22.1) 18.7 (32.1) 0.055 12.4 (22.4) 17.0 (29.2) 0.091 
# Contusions 0.44 (0.87) 0.43 (0.73) 0.684 0.42 (0.85) 0.52 (0.83) 0.204 
# DAI Lesions 1.1 (2.8) 0.5 (1.6) 0.021 1.2 (2.9) 0.43(1.4) 0.005 
Total Contusion 
Volume 
4.0 (8.7) 6.3 (17.2) 0.797 5.9 (17.0) 6.1 (13.3) 0.257 
# = number, N = number of patients, CPP = cerebral perfusion pressure, DAI = diffuse axonal injury, MLS = midline shift, mm = millimeters, ISS = injury severity score, GCS = 
Glasgow Coma Scale, RAC = correlation between pulse amplitude of ICP (AMP) and cerebral perfusion pressure (CPP).
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Univariate Logistic Regression (ULR) Analysis – Prediction of Impaired Cerebrovascular Reactivity 
Further evaluation of the association between all patient demographics, EC injury and IC injury 
characteristics with the development of impaired cerebrovascular reactivity was undertaken.  Using the 
defined thresholds for PRx, PAx and RAC for impaired cerebrovascular reactivity, we employed ULR 
techniques to evaluate each variable in relation to its ability to predict impairment in the entire 
recording period dataset.  Each threshold was evaluated against each variable.  Table 9.3 displays the 
ULR AUC’s and p-values for the patient demographic data and both the IC and EC scoring systems tested, 
while Appendix J displays the ULR AUC’s and p-values for the individual IC injury characteristics tested.  
Similar results were seen for the 1st 24 hours and 1st 72 hours recording datasets. 
Various patterns of statistically significant relationships with impaired cerebrovascular reactivity were 
seen.  Of note, the most commonly seen statistically significant association (with the highest AUC’s and 
lowest p-values) with impaired cerebrovascular reactivity was patient age (AUC = 0.606 to 0.783; 
p<0.025 for all) and the APACHE score (AUC = 0.619 to 0.704; p<0.032 in all except the PRx >0 
threshold).  IC CT scores were mostly not significantly associated with impaired cerebrovascular 
reactivity, although some evidence for association was detected for the Stockholm CT score being the 
most significant scoring system for PAx >0.25, RAC > -0.10 and RAC > -0.05 thresholds.  Of note, for most 
thresholds tested, admission GCS, sex, ISS and pupillary reactivity were not related to impaired 
cerebrovascular reactivity. 
There were some noteworthy patterns from the evaluation of the individual IC CT-based lesions.  
Associations depended on the threshold chosen, but in general, across all index thresholds tested, the 
most commonly seen associations were between markers of diffuse IC injury, rather than macroscopic 
parenchymal damage.  The following injury characteristics were most commonly statistically associated 
with impaired cerebrovascular reactivity:  presence of convexity SDH, presence of falcine SDH, presence 
of bilateral SDH, thickness of tSAH and the presence of SC DAI lesions.  Some important characteristics 
rarely associated with impaired cerebrovascular reactivity: MLS, largest lesion volume, # of contusions, 
total contusion volume, basal cistern compression, lateral ventricle compression, 4th ventricle 
compression and gyral compression.   
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Table 9.3: Univariate Logistic Regression of Admission Demographics and Scores with ICP Index – Grand Mean Data 
 PRx >0 PRx >0.25 PRx >0.35 PAx >0 PAx >0.25 RAC >-0.05 RAC>-0.10 
 AUC P AUC P AUC P AUC P AUC P AUC P AUC P 
Age  0.606 0.001 0.637 0.007 0.655 0.025 0.720 <0.0001 0.783 <0.0001 0.685 <0.0001 0.679 <0.0001 
Sex 0.495 0.850 0.640 0.040 0.663 0.204 0.555 0.526 0.699 0.073 0.586 0.335 0.534 0.621 
Admission 
GCS 
0.592 0.551 0.633 0.983 0.722 0.977 0.621 0.374 0.620 0.994 0.651 0.723 0.625 0.773 
Admission 
Pupil 
Reactivity 
0.564 0.241 0.628 0.012 0.675 0.003 0.558 0.648 0.695 0.013 0.600 0.050 0.577 0.098 
Admission 
Marshall 
CT Grade 
0.584 0.029 0.596 0.537 0.656 0.361 0.581 0.392 0.665 0.192 0.562 0.748 0.531 0.905 
Admission 
Rotterdam 
CT Grade 
0.562 0.157 0.656 0.032 0.689 0.107 0.569 0.443 0.689 0.140 0.628 0.149 0.570 0.332 
Admission 
Helsinki 
CT Score 
0.634 0.335 0.685 0.540 0.773 0.488 0.644 0.213 0.709 0.577 0.661 0.525 0.656 0.396 
Admission 
Stockholm 
CT Score 
0.544 
 
0.072 0.519 0.601 0.650 0.063 0.550 0.147 0.640 0.022 0.594 0.045 0.585 0.030 
Admission 
Stockholm 
CT 
“Range” 
0.556 0.473 0.578 0.754 0.675 0.324 0.557 0.875 0.670 <0.0001 0.642 0.152 0.612 0.192 
ISS 0.518 0.734 0.598 0.027 0.560 0.375 0.545 0.393 0.565 0.521 0.553 0.192 0.514 0.545 
APACHE II 0.526 0.406 0.619 0.032 0.702 0.002 0.652 <0.001 0.704 0.001 0.633 0.004 0.651 0.001 
AUC = area under the receiver operative curve, p = p-value, GCS = Glasgow Coma Scale, CT = computed tomography, ISS = injury severity score, PRx = pressure reactivity index 
(correlation between ICP and MAP), PAx = pulse amplitude index (correlation between pulse amplitude of ICP (AMP) and MAP), RAC = correlation between AMP and CPP. *NOTE: 
bolded values are those which have reached statistical significance (p<0.05). 
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Multivariable Logistic Regression (MLR) Analysis 
Based on the results of the ULR analysis, we created individualized multivariable models for each binary 
threshold outcome, performing a sequential “elimination method” of MLR analysis in order to arrive at 
the best predictive model for each index threshold (see methods section).  For each model, we included 
only those variables reaching statistical significance (or close to it: p<=0.100) in ULR, as highlighted in 
Tables 9.3 and Appendix J. Similar results were seen for the 1st 24 hours and 1st 72 hours recording data 
sheets. 
The MLR models for the binary PRx threshold outcomes displayed similar trends to those mentioned in 
the ULR section, markers of systemic injury and diffuse IC injury seem to predominate over those of IC 
parenchymal damage. For the binary threshold outcome of PRx above 0, the best model was that 
composed of age (p=0.093), presence of bilateral SDH (p=0.009), convexity tSAH thickness over 5mm 
(p=0.049) and the presence of subcortical (SC) DAI lesions (p=0.001); with an AUC for the model of 0.670 
(p<0.0001).  For the binary threshold outcome of PRx above +0.25, the best model was composed of sex 
(p=0.015), APACHE II score (p=0.032), presence of convexity SDH (p=0.016), presence of falcine SDH 
(p=0.051) and the presence of bilateral convexity SDH (p=0.023); with an AUC for the model of 0.758 
(p=<0.0001).  Finally, for the binary threshold outcome of PRx above +0.35, the best model was 
composed of APACHE II score (p=0.003), presence of convexity SDH (p=0.072), presence of bilateral 
convexity SDH (p=0.062) and complete filling of the basal cisterns with tSAH (p=0.025); with an AUC for 
the model of 0.791 (p<0.0001). 
For the binary threshold outcome of PAx above 0, the best model contained age (p<0.0001), presence of 
any basal cistern compression (p=0.011), presence of bilateral contusions (p=0.062) and the presence of 
SC DAI lesions (p=0.019); with an AUC for the model of 0.752 (0<0.0001).  For the binary threshold 
outcome of PAx above +0.25, the best model contained age (p=0.001), presence of convexity SDH 
(p=0.099), presence of falcine SDH (p=0.067) and the presence of bilateral SDH (p=0.015); with an AUC 
for the model of 0.871 (p<0.0001). 
Finally, the multi-variate models for the binary RAC threshold outcomes displayed similar results to 
those of PRx and PAx. For the binary threshold outcome of RAC above -0.05, the best model contained 
age (p=0.016), APACHE II (0.092), presence of tentorial SDH (p=0.048), presence of tSAH filling the basal 
cisterns (p=0.028) and the presence of SC DAI lesions (p=0.051); with an AUC for the model of 0.744 
(p<0.0001). Similarly, for the model with RAC above -0.10 as an outcome, the best model contained age 
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(p=0.027), Stockholm Score (0.062), APACHE II score (p=0.032), any gyral compression (p=0.017), tSAH 
amount in the basal cisterns (p=0.087) and the presence of SC DAI lesions (p=0.009); with an AUC for the 
model of 0.756 (p<0.0001). 
 
9.4 Discussion 
 
Through a detailed analysis of both admission IC and EC injury burden, as it relates to cerebrovascular 
reactivity during the ICU phase of TBI care, some interesting and important trends have been identified 
for the first time. 
First, whilst the admission IC CT scores (Marshall,153 Rotterdam,154 Helsinki,155 Stockholm156) are well 
validated as predictors of outcome, overall, they appear to show little association with impaired 
cerebrovascular reactivity after TBI.  Some statistically significant differences between categories of the 
IC scoring systems for both: A. raw mean values of PRx, PAx and RAC; and B. mean % time spent above 
index threshold; using KW and JT testing were seen.  The Helsinki and Rotterdam scoring systems appear 
to display the strongest relationship to some of the indices of cerebrovascular reactivity.  Similarly, 
through JT testing, it appears that the various scoring categories for the Helsinki score display 
statistically different mean values for the indices and % time above threshold, with increasing values 
seen as the ordinal score increases. Among the CT scoring systems, the Helsinki score provides the 
greatest role for large mass lesions as both basal cistern compression and mass lesions >25 cm3 greatly 
increase the score, suggesting that these space occupying lesions may affect cerebral autoregulation. 
However, when evaluating the ability of the Helsinki score to predict “impairment” of cerebrovascular 
reactivity, ULR and MLR analysis display that the Helsinki score falls out of statistical significance.  This 
was also seen with the Marshall, Rotterdam and Stockholm score in ULR and MLR analysis. The 
Stockholm CT score had the strongest correlations to RAC and PAx. The tSAH burden is the main 
outcome predictor in the Stockholm CT score, as recently shown in comparison to the other CT scoring 
systems. This could indicate that RAC and PAx are more strongly associated with wide spread tSAH which 
presumably is a driver for several secondary injury cascades following TBI.  
Secondly, the EC injury scores (ISS and APACHE) displayed interesting trends.   The ISS failed to be 
associated with either the indices or impaired cerebrovascular reactivity.  Thus, the combined IC and EC 
trauma burden, as assessed by the ISS does not appear to be associated with impairment of 
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autoregulation/cerebrovascular reactivity. In contrast, the APACHE score was the most strongly, out of 
both the IC and EC scoring systems, associated with both raw index values and % time spent above 
thresholds.  Furthermore, the APACHE reaches statistical significance in ULR for its association with all 
thresholds of ICP indices of cerebrovascular reactivity (except for the PRx >0 threshold).   This predictive 
value for impaired reactivity is even maintained in some the multi-variate models tested for the 
thresholds of:  PRx > +0.35 and RAC > -0.10.  Examining the differences between the ISS and APACHE, it 
can be seen that the APACHE provides a much more robust assessment of the patient’s systemic 
response to injury, including accounting for: A. age, B. hemodynamic response, C. core temperature, and 
D. laboratory values.  Thus, the patient’s individual “host response” to injury, appears to be most 
associated with impaired cerebrovascular reactivity, not the tallied gross injury burden.  This raises the 
question of systemic host response to injury, not cumulative injury burden, as a potential driver of 
autoregulatory failure/cerebrovascular dysfunction post-TBI. This requires investigation.  It is possible 
that diffuse IC injury patterns, which were more associated with impaired cerebrovascular reactivity, are 
also more likely to be associated with severe systemic multi-system trauma, and hence worse APACHE 
scores.  Thus, the association between APACHE and impaired autoregulation/cerebrovascular reactivity 
may be reflective of this relationship, and not necessarily the host systemic biochemical/metabolic or 
inflammatory response, driving impaired vascular reactivity.  As discussed in a recent review of 
literature, these relationships may be modulated by host genotype.28,193 Much further work is required 
to explore this relationship. 
Thirdly, diffuse IC injury patterns, not gross macroscopic parenchymal injury, appear to be most 
associated with impaired cerebrovascular reactivity. This was seen in both the ULR and MLR analysis of 
the detailed admission IC injury characteristics.  The presence of a convexity SDH, falcine SDH, bilateral 
convexity SDH, thickness of convexity tSAH, amount of tSAH in the basal cisterns and presence of SC DAI 
lesions, appear to be the most significant predictors of impaired cerebrovascular reactivity, regardless of 
the ICP-related autoregulatory index threshold tested.  All of these markers are those of diffuse injury, 
implicating a mechanism of high energy, with both acceleration/deceleration and angular 
acceleration/shearing forces applied to the parenchyma.  This implies that “diffuse” injury, other than 
what is captured by the CT scoring systems, is more predictive of impaired reactivity. Furthermore, all 
markers of gross macroscopic parenchymal injury failed to be associated with autoregulatory failure. In 
aggregate, this could explain the lack of significance of IC CT scoring systems in predicting impaired 
cerebrovascular reactivity.  Given these results, diffuse microscopic injury burden, not visible on 
admission CT scans, may be a driver of impaired cerebrovascular reactivity.  Magnetic resonance imaging 
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(MRI) based assessment of IC injury in the acute phase may shed light on this injury pattern, and 
requires further investigation. 
Finally, age appears to be robustly associated with both the raw indices and % time spent above index 
thresholds.  In addition, age was a strong predictor of impaired cerebrovascular reactivity in both ULR 
and MLR analysis.  This relationship between advancing age and impairment of autoregulatory capacity 
has been described in part before, and the analysis in this non-DC cohort confirms this variable as a key 
player in an individual patient’s cerebrovascular reactivity post-TBI.  Age is also included within the 
APACHE score calculation, and thus may play a role in why the APACHE scores were statistically 
significant in their associations with impaired cerebrovascular reactivity.  From this data set, it cannot be 
determined if this was that case given the amalgamated single score that was stored within the NCCU 
database.  Age may play a role in the baseline ability of the cerebrovascular tree to autoregulate, and/or 
the host response to injury.  Further investigation into local and global biochemical/metabolic response 
and inflammatory response to TBI is required, in order to fully understand how age impacts 
autoregulatory function/cerebrovascular reactivity post-TBI.   
 
Limitations 
Despite the interesting results, there are some important limitations to highlight.  First, this is a 
retrospective cohort of non-DC patients.  The treatments received during the patient’s ICU phase 
directly influenced the physiologic variables and signals recorded.  Furthermore, this treatment may not 
have been homogenous throughout all patients included in this study.  This could not be taken into 
account within the analysis, given the lack of information available on treatments received.   
Second, this cohort is a non-DC cohort only.  This was chosen specifically to avoid the confounding 
introduced post-DC, during which ICP and ICP derived indices of cerebrovascular reactivity are impacted.  
Thus, the results of this analysis only apply to non-DC patients.  Similar analysis is required for DC 
patients, analyzing the associations while taking into account the influence of craniectomy on the 
physiologic variables measured.  
Thirdly, the ISS included in this study is the total ISS, thus including injury to the body as well as the head 
and brain, not making it an exclusive score for the EC injury burden. Head ISS is based on anatomical 
localization of lesions on admission head CT scans, similar to many of the CT scoring systems included 
and, depending on the presence of polytrauma, will contribute significantly to the total ISS variable used 
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in this study. Moreover, APACHE II contains admission GCS which is commonly used to assess the 
severity of brain injury, similar to the IC CT scoring systems. Thus, the EC injury variables used in this 
study will to different degrees be influenced by the IC injury burden. Future studies may avoid this by 
only using non-head ISS components, unfortunately not available for the current cohort. 
 
9.5 Conclusions 
 
Diffuse IC injury markers (such as thickness of SAH, presence of sub-cortical DAI lesions, and the 
presence of a SDH) and systemic injury response (as assessed via APACHE II) are most associated with 
dysfunction in cerebrovascular reactivity after TBI. Standard IC CT scoring systems and evidence of 
macroscopic parenchymal damage are poor predictors, implicating potentially both microscopic injury 
patterns and host response as drivers of dysfunctional cerebrovascular reactivity.  Age remains a major 
variable associated with cerebrovascular reactivity.
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CHAPTER 10: SUMMARY AND CONCLUSIONS 
 
Through the studies and data presented in Chapters 4 through 9 of this thesis, some important new 
insights into continuous MMM of cerebrovascular reactivity in adult TBI have been made.  The following 
questions were addressed: A. Do other ICP derived indices exist? B. Do ICP derived indices actually 
measure autoregulation? C. What are the inter-index relationships between various MMM techniques? 
D. Can one estimate/predict the “gold standard” invasive PRx using non-invasive means? E. What are the 
critical thresholds associated with outcome for ICP derived indices? F. Which ICP derived index is 
superior for outcome prediction? and G. What role does IC and EC injury burden play in driving 
autoregulatory function in TBI?  These questions were addressed using data from various experimental 
models and populations of adult TBI patients. 
 
The following hypotheses were addressed: 
 
Hypothesis I: The moving correlation coefficient between slow-wave fluctuations in AMP and CPP, 
defined as RAC, will provide information regarding cerebrovascular reactivity, and may be used in 
place of existing ICP based reactivity indices in adult TBI patients. 
Chapter 4 provided the first description of this new index in adult TBI, providing confirmatory evidence 
that it provides information regarding cerebrovascular reactivity.  Furthermore, RAC appears to carry 
additional information regarding cerebral compensatory reserve (similar to RAP).  The interpretation of 
this index is somewhat complex, however it appears to have a clearer parabolic relationship with CPP 
over the range of clinically seen CPP values, compared to PRx and PAx.  Thus, RAC can potentially be 
utilized for monitoring cerebrovascular reactivity. 
 
Hypothesis II: PRx, PAx and RAC will measure the LLA in an experimental piglet model of arterial 
hypotension. 
Chapter 5.1 outlined the experimental validation of PRx, PAx and RAC as a measure of the LLA in a model 
of arterial hypotension.  This study provided very preliminary confirmatory evidence for PRx.  In 
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addition, for the first time in the literature, this study provided a similar validation for PAx and RAC.  
These results provide some degree of confidence in the clinical use of these indices for monitoring 
cerebral autoregulation, though further experimental validation of these indices is required. As such 
Hypothesis II is not fully confirmed. 
 
Hypothesis III: PRx, PAx and RAC will measure the LLA in an experimental rabbit model of sustained IC 
hypertension. 
 
Chapter 5.2 outlined the experimental validation of PRx and PAx as a measure of the LLA in and 
experimental model of IC hypertension.  This study, for the first time, provides preliminary confirmation 
that PRx and PAx measure autoregulation during sustained ICP elevations.  These results provide some 
further confidence in the clinical use of these indices to measure autoregulation, particularly in 
pathologic states prone to elevated ICP, such as TBI.  RAC, however, failed to conclusively measure the 
LLA within this model, which is likely a limitation of the model and failure to reach the break-point in 
AMP within the 12 animals. Despite the promsing results from this analysis, further experimental 
evaluation of these indices as measures of the LLA during IC hypertension is required. As such 
Hypothesis III is not fully confirmed. 
 
Hypothesis IV: PRx, PAx and RAC will measure the ULA in an experimental piglet model of arterial 
hypertension. 
Chapter 5.3 outlined the attempts at experimental validation of the ICP derived indices against the ULA 
in a piglet model of arterial hypertension.  The results of the analysis within the 6 animals were 
inconclusive.  Saturation of LDF-CBF signal, with failure to display pressure/flow passivity with increasing 
CPP, questions the CPP values identified as the ULA via piecewise regression.  Currently it remains 
unclear as to whether these indices can accurately measure the ULA. 
 
Hypothesis V: Continuous indices derived from MMM are not all the same, and display specific 
covariance structure between monitoring devices used, which is reproducible across populations. 
Chapter 6.1, 6.2, and 6.3 outlined the studies into MMM inter-index relationships, explored via 
multivariate clustering and co-variance analysis techniques.  The strong relationships between PRx and 
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Sx_a seen in these sections were echoed in the results from section 7.1 and 7.3. This work, for the first 
time, explores the inter-index relationships of all concomitantly monitored continuous indices of 
cerebrovascular reactivity, across four separate adult TBI populations.  Several specific relationships 
were seen amongst the indices examined.  First, we observed intra-technique clustering, suggesting than 
different metrics provided by a single technique provide shared information.  Second, the results 
demonstrate a strong, and recurrent, association between TCD based Sx/Sx_a and the ICP derived 
indices (PRx, PAx, and RAC).  Third, the data show an association between measures of cortical 
pial/microvascular cerebrovascular reactivity indices and TCD based Mx/Mx_a., implicating Mx/Mx_a as 
potential surrogate measures of cortical vessel reactivity.  Finally, the stong PRx and Sx_a relationships 
also hold up during extended duration recordings, as seen with the modelling in chapter 7.1 and 7.3. 
 
Hypotheses VI and VII: PRx can be accurately estimated and predicted via non-invasive TCD 
alternatives, systolic flow index (Sx_a) and mean flow index (Mx_a). 
 
Chapters 7.1 and 7.3 outlined the studies into the estimation of PRx via non-invasive TCD based 
surrogates (Sx_a and Mx_a).  Employing complex time-series ARMA models and LME modelling, it was 
demonstrated that PRx can be estimated using non-invasive TCD surrogates.  Furthermore, this 
estimation closely follows observed PRx values. Further, even if the data are preliminary, given 
limitations with extended duration TCD recording, using time-series ARMA and LME modelling, it was 
demonstrated in a small pilot cohort that PRx can be predicted non-invasively with an acceptable degree 
of agreement.  Despite these promising results, it must be acknowledged that these analyses are some 
of the first of their type in the literature and require substantial validation. Further, large scale, studies 
need to be conducted to confirm these results. As such, the results should be considered very 
preliminary and exploratory in nature, with Hypotheses VI and VII not fully yet confirmed. 
 
Hypothesis VIII: Outcome prediction with ICP-derived indices are not equal, with RAC providing 
superior predictive capabilities for 6-month patient outcomes. 
 
Chapter 8.1 outlined the studies into outcome prediction and critical thresholds of ICP derived indices of 
cerebrovascular reactivity in adult TBI.  It was demonstrated that RAC provides superior 6-month 
outcome prediction over both PRx and PAx, via both univariate and multivariate models.  This was 
 
252 
 
observed for both mortality and favourable/unfavourable outcomes.  These results confirm the 
superiority of RAC over PRx and PAx for outcome assessment.  
 
Hypothesis IX: Critical thresholds for 6-month outcome in adult TBI in ICP derived reactivity indices are 
not all the same, with some indices displaying more “stable” thresholds over time. 
 
As studied in Chapter 8.1, critical thresholds associated with outcome at 6-months were evaluated for all 
ICP indices in a non-DC cohort.  Thresholds for mortality and unfavourable outcome were provided for 
PRx, PAx and RAC.  It has demonstrated that the PRx thresholds for these outcomeswere substantially 
different compared to previous work on a heterogenous TBI population (which included DC patients), 
suggesting that alterations in post-DC cerebrovascular physiology may have confounded previous 
results.  Furthermore, RAC consistently provided significant predictive thresholds for outcome, 
regardless of time period analyzed, which was not the case for PRx or PAx.  Finally, RAC displayed the 
most stable critical thresholds over time, when compared to those for PRx and PAx. These results 
implicate RAC as a having potentially more reliable critical thresholds for outcome in adult TBI. 
 
Hypothesis X: Both Sx and Sx_a have well defined critical thresholds associated with 6-month outcome 
in adult TBI. 
Chapter 8.2 outlined the studies to determine critical thresholds for Sx/Sx_a.  The results of this analysis 
demonstrate, for the first time, significant thresholds for Sx/Sx_a to predict both 6-month mortality and 
unfavourable outcome, based on GOS.  Furthermore, these thresholds are drastically different 
compared to thresholds previously defined for Mx/Mx_a. These results provide a framework and 
clinically relevant outcome prediction thresholds derived from monitoring of Sx/Sx_a in adult TBI. 
 
Hypothesis XI: Specific patterns of IC injury are associated with impaired cerebrovascular reactivity in 
TBI. 
Chapter 9 outlined the studies conducted to evaluate the link between IC injury pattern/burden and its 
link with impaired cerebrovascular reactivity.  The results, for the first time, suggest that IC markers of 
diffuse injury are linked to impaired reactivity.  These markers included: thickness of SAH, presence of 
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SDH, and presence of DAI.  This implicates acceleration/deceleration or angular forces suffered by the 
brain to be a potential driver of impaired vascular reactivity in adult TBI. 
 
Hypothesis XII: EC injury burden will be associated with cerebral vascular reactivity in polytrauma 
patients. 
 
Chapter 9 also attempted to address the association between EC injury burden and vascular reactivity 
post-TBI.  Given out access to records and data on EC injury was limited, the conclusions are also limited.  
The results did demonstrate a strong link with impaired reactivity and both age and APACHE II.  The link 
with age has been previously documented.  The association with APACHE II has never been described 
previously.  The ISS failed to demonstrate a significant association with impaired reactivity.  This 
implicates systemic host response (ie. APACHE II), and not the tallied systemic injury burden (ie ISS), as a 
potential driver of impaired cerebrovascular reactivity in adult TBI. 
 
Clinical Implications 
 
Clinically, the results of this thesis carry some potentially important implications which may lead to 
changes in future patient care.  First, the results of these studies suggest RAC may:  provide information 
regarding both cerebrovascular reactivity and cerebral compensatory reserve, have some ability of 
measure the LLA and appears to display stronger associations with global patient outcome. This may 
translate to improve prognostic models with the inclusion of such an index.  This index carries some 
complexity in interpretation, as outlined in Chapter 4, which highlights difficulties with its 
implementation as a continuously displayed and interpreted bedside physiologic metric in TBI.  
However, the strong outcome association and stability in critical thresholds supports its promising role in 
the development of next generation prognostic models in moderate and severe TBI, which will be the 
focus of upcoming studies from CENTER-TBI.190  Further to this, RAC appears to have a clearer parabolic 
relationship with CPP at the population level.  This implies that RAC carries potential to be superior in 
the determination of individual patient optimal CPP values, improving percent yield of these CPP 
estimations.  With future work, if such superiority of RAC based optimal CPP estimation is confirmed, 
this will lead to improved continuity in individualized CPP optimum estimation and potential confidence 
in the derived optimal CPP value that is being suggested as a target.   
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Second, the preliminary results of the experimental models, despite requiring much future validation, do 
provide some added confidence that some of these metrics of cerebrovascular reactivity employed 
clinically, do in fact measure aspects of the LLA.  This is important, as previously, there was limited 
literature to suggest metrics such as PRx, do indeed provide surrogate measures for the LLA.14 
 
Third, some further clarity regarding the various MMM derived cerebrovascular reactivity indices has 
been provided.  The previous literature base suffered from small individual index comparisons between 
monitoring modalities.  This was insufficient and led to confusion as to if all of these metrics were 
measuring the same aspect of cerebral physiology.  Through the various analytical techniques applied in 
Chapters 6 and 7, it was demonstrated the certain modalities provide specific information regarding 
cerebrovascular reactivity, which may be carried forward in the future to guide clinical assessment.  ICP, 
NIRS and TCD systolic flow indices appear to carry similar information regarding cerebrovascular 
reactivity.  These were distinct from TCD mean flow-based indices which appear to provide more 
information regarding cortical pial/microcirculatory cerebrovascular reactivity. Finally, uncertainty 
regarding the utility of PbtO2 derived cerebrovascular reactivity indices was provided, suggesting 
extreme caution in the clinical application of such measures. 
 
Fourth, non-invasive estimation and prediction of invasively derived cerebrovascular reactivity measures 
has been demonstrated as feasible.  These are the first preliminary attempts at such work, but provide 
great promise if further validated.  Such non-invasive estimation carries important implications for long-
term follow-up assessment using TCD, and confidence in systolic flow-derived metrics in the non-
invasive assessment of cerebrovascular reactivity.  Further, with the delineation of critical thresholds 
associated with global outcome for these TCD metrics, there now exists defined values of systolic flow 
indices which are associated with negative outcomes.  Overall, though preliminary and exploratory in 
nature, this thesis work provides important implications for the future potential transition to more non-
invasive monitoring modalities in adult TBI, without the sacrifice in critical information related to 
cerebrovascular physiology or prognostication. 
 
Fifth, previous studies on ICP-derived indices of cerebrovascular reactivity may have been clouded by 
included heterogeneous populations consisting of both DC and non-DC TBI patients.  The results of the 
ICP index critical threshold studies in this thesis suggest that DC may have had significant impacts on 
previously defined, and current clinically applied, critical thresholds associated with outcome.9,152  This 
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implies there is a need to re-evaluate our current clinical thresholds and spend time to better 
understand the impact of DC on cerebrovascular physiology, raising questions as to the applicability of 
cerebrovascular reactivity monitoring in the setting of a craniectomy. 
 
Finally, the association between IC and EC admission injury metrics and impaired cerebrovascular 
reactivity is an important finding.  Though preliminary findings, requiring further validation, they suggest 
that specific injury characteristics predispose patients to the development of impaired vascular 
reactivity.  This carries important implications for future ability to predict those at highest risk, and 
stratify them accordingly for any potential future therapies that may be directed at prevention and 
treatment of impaired autoregulation in TBI. 
 
Conclusions 
In conclusion, this thesis provides important results which fill in many current holes in the knowledge 
regarding continuous measures of cerebrovascular reactivity in adult TBI.  The data and results 
presented in this thesis describe a new ICP derived index of cerebrovascular reactivity in adult TBI, 
provide validation for ICP indices as measures of the LLA, highlight important inter-index relationships, 
demonstrate the ability to non-invasively model invasive measures, accurately define critical thresholds 
for 6-month outcome, demonstrate superiority of the new ICP index, and provide the first evidence to 
suggest a link between specific IC injury patterns, and physiological markers of the host response, with 
impaired cerebrovascular reactivity.  These results will provide confidence in the clinical application of 
MMM measures of vascular reactivity in adult TBI, while laying the platform for future exploration into 
drivers of impaired reactivity.  
 
256 
 
CHAPTER 11: FUTURE DIRECTIONS 
 
11.1 Experimental Validation – LLA and ULA 
 
The studies within this thesis provided validation of the ICP indices as measures of the LLA.  However, 
this was conducted using the two extremes of CPP change:  pure arterial hypotension, and pure IC 
hypertension.  There still exists the possibility that these indices fail to measure the LLA when ICP is 
moderately elevated (ie. 20 to 40 mm Hg) – the context in which most clinical care is undertaken.  Thus, 
further models are required to explore physiology when ICP is moderately elevated and/or arterial 
hypotension is present.  
Regarding the ULA, this thesis failed to validate the ICP indices of cerebrovascular reactivity as measures 
of the ULA.  Thus, it remains unclear as to whether these indices actually measure the ULA, despite some 
of them being employed clinically for calculation of the optimal CPP (CPPopt).  Experimental models of 
arterial hypertension are required for to address this question, both in the setting of normal and 
elevated ICP.  One might consider models of sustained ICP elevation during arterial hypertension, so as 
to shift the ULA to lower CPP values, allowing to interrogate these indices across the ULA prior to 
animals succumbing to cardiac failure.175  Further, given the inability to determine the ULA easily within 
piglets suggests the need for a different animal model.  
 
11.2 Validation for RAC 
 
Despite the promising results presented in this thesis, further work is required to validate the findings 
for the newly defined index RAC.  First, the assessment of RAC in experimental models IC hypertension 
requires further evaluation, given the inconclusive results seen from the studies in this thesis.  It is 
possible that the failure to demonstrate that RAC can provide measure of the LLA during IC hypertension 
(as seen in Chapter 5.2) may be secondary to limitations of the model. The rate of increase in ICP was 
precipitous and may have led to the lack of AMP break-point seen in the 12 animals studied. 
Furthermore, the Cushing’s response seen within these animals may have driven AMP to increase 
without an identifiable break point.145  If this break point was reached, RAC would likely have measured 
the LLA within this model.  Hence, further evaluation in this context is required, where ICP is elevated in 
a more controlled and prolonged fashion. 
 
257 
 
Regarding the clinical application of RAC, validation studies are required to confirm the superiority of 
RAC over PRx and PAx.  These studies would require similar univariate and multivariate models 
evaluating 6-month outcomes in adult TBI, as employed in this thesis.  However, added value would be 
found in evaluating the additional variance when each of these indices is added to the IMPACT-core194 
variables.  One would expect the IMPACT + RAC to provide superior outcome prediction capabilities.  
However, this has yet to be demonstrated.   This assessment of IMPACT plus vascular reactivity 
monitoring would also provide much need information regarding the overall additional benefit of 
monitoring cerebrovascular reactivity in adult TBI.  This is currently planned using the CENTER-TBI190 high 
resolution patient cohort. 
Finally, the calculation of CPPopt using PRx, PAx and RAC needs further assessment.  The results from 
this thesis displayed a more symmetric parabolic relationship between RAC vs. CPP, compared to PRx vs. 
CPP or PAx vs. CPP, suggesting RAC may be superior in CPPopt estimation.  This requires investigation.  
Further, evaluating the association between the percentage of time spent outside of CPPopt and 
outcome, requires investigation (comparing PRx, PAx and RAC). This study is also planned using the 
CENTER-TBI190 high resolution patient cohort. 
 
11.3 Time-Series Techniques for Cerebrovascular Reactivity 
 
This thesis provided the first described attempts at modelling cerebrovascular reactivity indices using 
time-series analysis techniques.  Despite being adapted from the financial sector;163,164,166 these 
techniques have wide reaching implications for monitoring in TBI.  Applications exist for based 
forecasting/predictions of physiologic events, and for Bayesian state space models166 of the entire 
patients clinical “state”.  Given the complexity of these forms of statistical modelling, the application of 
artificial neural networks is a natural avenue to explore with this type of modelling.  The implications of 
these techniques could mean accurate future forecasting of events and clinical states for patients. 
 
11.4 Critical Thresholds for DC Populations 
 
Results from this thesis defined critical thresholds for 6-month outcomes in non-DC adult TBI patients.152  
These results provide thresholds for PRx that are substantially different compared to those that have 
 
258 
 
previously been defined, and are currently clinically used.9  It is highly likely that these discrepancies 
arise from the inclusion of physiologic data from DC patients in earlier studies on the outcome 
associations of PRx thresholds.  The physiologic response to DC likely led to the overall thresholds for the 
entire population (DC and non-DC) to be lower than that found in the studies of this thesis.  Thus, future 
work is required to both better understand the changes in PRx, PAx and RAC after DC, and also define 
critical thresholds for DC patients. 
 
11.5 Drivers of Impaired Cerebrovascular Reactivity 
 
Injury Burden 
IC and EC injury burden were explored as drivers of impaired cerebrovascular reactivity in adult TBI.  It 
was demonstrated in this thesis that specific IC injury patterns were associated with impaired reactivity.  
This analysis is the first to explore this relationship, and needs replication.  This is currently planned 
using the CENTER-TBI high resolution cohort.  
EC injury burden was only preliminarily assessed in this thesis, with the results suggesting that the 
burden of abnormal physiology measured by APACHE II (which probably integrates injury severity and 
systemic host response) as a potential diver of impaired reactivity.  This requires much further 
investigation.  Additional assessment of systemic markers of inflammation and biomarkers of injury 
would prove useful.  Similarly, a breakdown of organ system injury burden and its association with 
cerebrovascular reactivity might prove interesting.  These studies are currently planned using the 
CENTER-TBI190 high resolution cohort. 
Understanding the IC and EC injury associations to impaired reactivity will allow us to properly risk 
stratify patients and improve outcome prediction capabilities.  
 
Genetics 
Recent review of literature has outlined the current literature addressing the association between 
genetic variation and impaired reactivity post-TBI.28,193  More specifically, published data suggest a link 
between NOS3 polymorphisms and impaired reactivity,195  and literature outside of TBI has implicated 
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numerous SNP’s associated with systemic vascular reactivity.  A theoretical framework for candidate 
genetic polymorphisms linked to cerebrovascular biology has been outlined in one of the publications 
associated with literature review for this thesis.28  These candidate genes are currently being 
investigated as part of the genome wide association analysis for the CENTER-TBI190 high resolution 
cohort. Potential associations with cerebrovascular reactivity will be analyzed.   
If specific genes are identified, the study will be underpowered to make significant conclusions.  
However, this will provide the platform for future directed genetics studies related to cerebrovascular 
reactivity.  These genetic associations will provide insight into the mechanisms involved in impaired 
vascular reactivity. These analyses will provide insights into potential molecular mechanisms that 
underpin impaired cerebrovascular reactivity, and allow the design of therapeutic interventions aimed at 
improving autoregulation with the aim of reducing mortality and improving patient outcome in TBI. 
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Appendix A – Section 6.1 - PCA Eigenvalues Table, Scree Plot and Factor 
Loadings Table 
 
* PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal 
component #1, F2 = PC2 = principal component #2. PC1 and PC2 are the two components which 
contribute the largest amount of variance to the entire data set.   
*Biplots of PC1 vs. PC2 display which variables contribute variance to PC1 and PC2.  The longer the 
arm connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  
Similarly, the quadrant on the biplot in which the variable fallscorrelates to its contribution to a 
particular PC. The upper left quadrant is primarily PC2; lower left quadrant is neither PC1 or PC2; the 
upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1. 
*Eigenvalue tables display the eigenvalue for each principal component (PC) (also denoted F), with the 
% variability and cumulative variability for each factor/principal component. 
*Scree plot displays the same information form the eigenvalue table in a histogram format, with each 
F (or PC) along the x-axis, the eigenvalue along the left side y-axis and the % variability along the right 
y-axis.  Furthermore, the red line on the graph displays the cumulative variability with the addition of 
each F (or PC) moving from F1 to F18. 
*Factor loading tables display the loading of each variable (ie. PRx, etc.) for each principal component.  
Loading varies from -1 to +1, with negative values indicating that particular variable is less likely to 
contribute to the variance in that particular factor (F). Similarly, positive loadings indicate that 
particular variable likely contribute to the variance in that corresponding factor (F). 
*Contribution % of Variables tables displays the % contribution to the variance of each individual 
variable for each individual factor (F). 
 
Summary of 30-minute mean and Minute-by-minute Data - PCA 
Using the 30-minute mean data sheet, PCA analysis displayed similar results for the PC’s and biplot, 
supporting our results described for the minute-by-minute analysis.  Finally, using the grand mean 
data sheet, similar PCA results were displayed with the exception of the PbtO2 based indices (ORx-5, 
ORx-30 and ORx-60).  Within the grand mean PCA, ORx-5/ORx-30/ORx-60 contributed more to the 
variance of the data set, with positive loadings towards PC1 and PC2.  The PbtO2 indices still displayed 
a lack of association with other indices in the minute-by-minute data sheet. These can be seen in 
Appendix B of the supplementary materials. 
 
 
 
 
 
278 
 
1. Minute-by-Minute Data Set: 
 
 
Eigenvalues Table 
 
 
 
 
 
 
 
Scree Plot 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 F16
Eigenvalue 4.293 2.945 2.055 1.803 1.386 0.863 0.805 0.520 0.360 0.252 0.194 0.180 0.155 0.097 0.077 0.016
Variability (%) 26.833 18.408 12.842 11.269 8.664 5.393 5.032 3.250 2.251 1.578 1.209 1.124 0.966 0.603 0.478 0.099
Cumulative % 26.833 45.241 58.083 69.352 78.016 83.409 88.441 91.691 93.942 95.520 96.730 97.854 98.819 99.423 99.901 100.000
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Factor Loading Table 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8
PRx 0.493 0.660 -0.163 0.040 -0.129 0.112 -0.262 -0.199
PAx 0.438 0.730 -0.234 0.107 -0.156 0.098 -0.276 -0.026
RAC 0.443 0.636 -0.080 0.071 -0.278 0.099 -0.148 0.417
Mx 0.783 -0.492 -0.083 -0.060 -0.033 -0.004 0.025 0.213
Mx_a 0.781 -0.404 -0.123 -0.157 -0.047 0.024 -0.186 -0.220
Sx 0.698 0.143 -0.372 0.163 0.036 -0.156 0.489 0.142
Sx_a 0.641 0.269 -0.443 0.142 0.053 -0.148 0.373 -0.296
Dx 0.668 -0.648 0.018 -0.065 -0.071 -0.003 -0.065 0.211
Dx_a 0.657 -0.593 -0.007 -0.151 -0.102 0.023 -0.270 -0.155
TOx 0.499 0.233 0.447 0.105 0.623 -0.120 -0.082 0.073
TOx_a 0.429 0.258 0.481 0.073 0.646 -0.123 -0.089 -0.019
THx 0.336 0.191 0.737 -0.164 -0.403 0.042 0.229 0.020
THx_a 0.311 0.175 0.755 -0.199 -0.374 0.027 0.180 -0.162
ORx_5 0.142 -0.178 0.059 0.411 0.218 0.831 0.184 -0.036
ORx_30 0.006 -0.190 0.178 0.869 -0.155 -0.105 -0.102 -0.015
ORx_60 -0.027 -0.214 0.179 0.822 -0.255 -0.225 -0.065 -0.046
F9 F10 F11 F12 F13 F14 F15 F16
0.320 -0.047 0.109 0.129 -0.144 0.001 -0.029 -0.001
0.036 -0.068 -0.131 -0.188 0.178 0.029 0.086 -0.002
-0.293 0.075 0.040 0.039 -0.073 -0.025 -0.070 0.002
0.160 -0.088 -0.187 0.101 0.036 0.027 -0.042 0.069
-0.197 0.029 -0.131 0.194 0.036 -0.042 0.034 -0.055
0.066 0.013 0.029 -0.008 -0.086 -0.081 0.149 -0.012
-0.122 0.041 0.037 -0.051 0.063 0.074 -0.137 0.011
0.168 -0.041 0.075 -0.161 -0.008 0.056 -0.073 -0.068
-0.131 0.083 0.191 -0.124 -0.048 -0.020 0.068 0.055
0.050 -0.004 0.130 0.048 0.178 -0.132 -0.034 0.002
-0.095 -0.012 -0.109 -0.052 -0.174 0.131 0.032 -0.001
0.009 0.033 0.112 0.113 0.110 0.147 0.065 -0.002
0.017 -0.018 -0.131 -0.126 -0.080 -0.144 -0.055 0.002
-0.037 -0.038 0.012 -0.008 -0.003 -0.004 0.001 0.000
0.117 0.335 -0.071 0.003 0.009 0.003 -0.004 -0.001
-0.121 -0.325 0.051 0.025 -0.017 -0.005 0.005 0.000
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% Contribution of Variables 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8
PRx 5.666 14.805 1.291 0.090 1.202 1.445 8.535 7.626
PAx 4.462 18.109 2.666 0.641 1.748 1.120 9.440 0.135
RAC 4.568 13.735 0.310 0.280 5.579 1.131 2.738 33.378
Mx 14.272 8.226 0.335 0.198 0.078 0.002 0.075 8.766
Mx_a 14.194 5.555 0.732 1.363 0.162 0.064 4.292 9.284
Sx 11.362 0.690 6.748 1.478 0.093 2.805 29.712 3.885
Sx_a 9.573 2.462 9.532 1.126 0.205 2.549 17.289 16.820
Dx 10.402 14.269 0.015 0.238 0.362 0.001 0.519 8.583
Dx_a 10.056 11.927 0.003 1.257 0.758 0.064 9.043 4.607
TOx 5.797 1.840 9.733 0.616 27.971 1.678 0.837 1.019
TOx_a 4.279 2.259 11.241 0.297 30.143 1.746 0.973 0.067
THx 2.624 1.233 26.412 1.498 11.714 0.203 6.523 0.074
THx_a 2.254 1.042 27.709 2.201 10.113 0.084 4.029 5.049
ORx_5 0.472 1.077 0.169 9.361 3.440 79.974 4.191 0.247
ORx_30 0.001 1.224 1.541 41.886 1.742 1.286 1.280 0.045
ORx_60 0.017 1.548 1.563 37.470 4.693 5.847 0.523 0.416
F9 F10 F11 F12 F13 F14 F15 F16
28.501 0.879 6.138 9.267 13.456 0.001 1.085 0.013
0.352 1.824 8.824 19.693 20.416 0.850 9.691 0.029
23.756 2.201 0.837 0.849 3.477 0.644 6.482 0.034
7.105 3.064 18.132 5.705 0.826 0.764 2.310 30.141
10.807 0.332 8.849 20.883 0.834 1.869 1.553 19.227
1.202 0.063 0.445 0.033 4.776 6.796 28.947 0.964
4.133 0.656 0.703 1.465 2.577 5.624 24.522 0.764
7.797 0.668 2.914 14.468 0.043 3.280 7.054 29.386
4.760 2.755 18.909 8.539 1.478 0.400 6.087 19.358
0.686 0.008 8.679 1.279 20.397 17.957 1.478 0.025
2.515 0.054 6.194 1.506 19.529 17.811 1.375 0.010
0.023 0.439 6.465 7.049 7.835 22.434 5.453 0.023
0.079 0.124 8.876 8.878 4.112 21.515 3.910 0.023
0.380 0.558 0.073 0.033 0.008 0.015 0.002 0.000
3.823 44.475 2.602 0.005 0.058 0.010 0.018 0.002
4.082 41.898 1.359 0.347 0.177 0.029 0.031 0.001
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2. 30 Minute Mean Data Set: 
 
 
Eigenvalue Table 
 
 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 F16
Eigenvalue 4.765 3.083 2.144 1.901 1.294 0.815 0.572 0.457 0.288 0.173 0.145 0.128 0.116 0.064 0.047 0.009
Variability (%) 29.780 19.268 13.402 11.883 8.086 5.093 3.576 2.854 1.798 1.083 0.903 0.800 0.722 0.403 0.295 0.055
Cumulative % 29.780 49.048 62.449 74.332 82.418 87.511 91.087 93.941 95.739 96.822 97.726 98.525 99.248 99.651 99.945 100.000
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Scree Plot 
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Factor Loading 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8
PRx 0.522 0.653 0.001 0.112 -0.116 -0.331 0.085 -0.127
PAx 0.496 0.724 0.130 0.128 -0.165 -0.268 0.039 -0.037
RAC 0.451 0.570 0.013 0.286 -0.440 0.143 0.061 -0.262
Mx 0.796 -0.383 -0.072 -0.287 -0.108 0.203 -0.010 -0.182
Mx_a 0.767 -0.259 -0.044 -0.377 -0.010 -0.334 0.053 0.084
Sx 0.679 0.365 0.246 -0.214 -0.057 0.477 -0.158 0.093
Sx_a 0.569 0.536 0.324 -0.253 0.059 0.039 -0.189 0.396
Dx 0.702 -0.562 -0.084 -0.280 -0.077 0.171 -0.047 -0.176
Dx_a 0.655 -0.502 -0.054 -0.349 -0.046 -0.357 0.008 0.027
TOx 0.651 0.057 -0.059 0.347 0.598 0.104 0.006 -0.144
TOx_a 0.526 0.095 -0.131 0.370 0.704 -0.037 -0.011 0.002
THx 0.406 -0.249 -0.481 0.574 -0.350 0.111 -0.030 0.167
THx_a 0.394 -0.347 -0.515 0.575 -0.189 -0.045 -0.035 0.216
ORx_5 0.288 -0.282 0.631 0.184 -0.039 0.145 0.590 0.168
ORx_30 0.076 -0.428 0.747 0.390 -0.021 -0.091 -0.078 -0.095
ORx_60 0.045 -0.384 0.687 0.390 -0.135 -0.137 -0.371 -0.027
F9 F10 F11 F12 F13 F14 F15 F16
-0.339 -0.085 -0.076 -0.067 -0.099 0.002 -0.015 0.003
0.057 0.263 0.093 0.056 0.069 0.007 0.072 0.001
0.284 -0.131 0.001 0.032 -0.022 -0.024 -0.060 0.001
-0.047 0.140 -0.091 -0.090 0.043 -0.038 -0.032 -0.054
0.160 -0.064 -0.109 -0.132 0.127 0.037 0.007 0.033
-0.023 -0.053 0.046 -0.076 -0.059 0.119 0.079 0.003
-0.024 -0.013 0.013 0.058 0.027 -0.093 -0.090 -0.004
-0.093 0.076 0.057 0.084 -0.071 -0.072 -0.008 0.057
0.054 -0.123 0.129 0.133 -0.087 0.033 0.029 -0.036
-0.086 -0.050 -0.020 0.142 0.145 0.080 -0.036 0.000
0.160 0.010 0.000 -0.097 -0.130 -0.088 0.045 -0.003
-0.098 -0.107 -0.003 0.015 0.105 -0.086 0.091 -0.005
0.023 0.121 0.029 -0.039 -0.086 0.100 -0.090 0.005
-0.002 0.021 -0.061 0.043 -0.038 -0.001 0.009 0.000
-0.062 -0.042 0.211 -0.141 0.071 -0.015 -0.034 0.000
0.043 0.028 -0.195 0.080 -0.053 0.014 0.031 0.000
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% Contribution of Variables 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8
PRx 5.725 13.833 0.000 0.660 1.048 13.413 1.253 3.528
PAx 5.170 17.008 0.787 0.868 2.113 8.783 0.262 0.292
RAC 4.272 10.523 0.007 4.299 14.954 2.506 0.652 15.061
Mx 13.296 4.769 0.244 4.340 0.905 5.047 0.017 7.253
Mx_a 12.360 2.184 0.090 7.490 0.008 13.723 0.483 1.532
Sx 9.669 4.315 2.817 2.403 0.253 27.971 4.362 1.910
Sx_a 6.802 9.319 4.907 3.358 0.265 0.184 6.264 34.361
Dx 10.331 10.254 0.328 4.120 0.453 3.572 0.383 6.761
Dx_a 9.015 8.176 0.136 6.414 0.161 15.617 0.012 0.163
TOx 8.903 0.104 0.162 6.338 27.651 1.331 0.005 4.546
TOx_a 5.817 0.292 0.805 7.212 38.356 0.171 0.023 0.001
THx 3.468 2.006 10.799 17.325 9.491 1.515 0.158 6.079
THx_a 3.264 3.915 12.353 17.367 2.773 0.254 0.216 10.182
ORx_5 1.744 2.575 18.539 1.774 0.117 2.591 60.789 6.205
ORx_30 0.123 5.938 26.043 8.019 0.035 1.012 1.066 1.968
ORx_60 0.042 4.788 21.982 8.013 1.416 2.309 24.056 0.159
F9 F10 F11 F12 F13 F14 F15 F16
39.827 4.149 4.009 3.466 8.500 0.006 0.471 0.112
1.117 39.980 5.927 2.478 4.112 0.083 10.998 0.022
28.100 9.968 0.001 0.819 0.414 0.879 7.535 0.010
0.779 11.334 5.778 6.364 1.626 2.252 2.122 33.875
8.859 2.382 8.287 13.644 14.000 2.086 0.094 12.779
0.179 1.613 1.483 4.530 3.058 22.031 13.276 0.127
0.196 0.097 0.114 2.661 0.644 13.420 17.233 0.175
2.982 3.371 2.254 5.513 4.338 8.040 0.126 37.173
1.027 8.777 11.472 13.923 6.555 1.721 1.806 15.026
2.550 1.420 0.289 15.837 18.225 9.854 2.780 0.002
8.870 0.058 0.000 7.356 14.643 12.032 4.236 0.128
3.354 6.642 0.007 0.172 9.517 11.560 17.632 0.275
0.179 8.487 0.579 1.186 6.432 15.364 17.155 0.293
0.002 0.246 2.578 1.442 1.228 0.000 0.169 0.001
1.337 1.016 30.807 15.565 4.306 0.370 2.395 0.000
0.641 0.457 26.416 5.045 2.402 0.300 1.973 0.001
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3. Grand Mean Data Set: 
 
 
 
Eigenvalue Table 
 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 F16
Eigenvalue 6.062 2.779 2.542 1.294 0.844 0.672 0.561 0.395 0.263 0.180 0.133 0.107 0.088 0.037 0.028 0.015
Variability (%) 37.889 17.366 15.887 8.088 5.277 4.201 3.507 2.468 1.644 1.123 0.833 0.666 0.551 0.232 0.174 0.094
Cumulative % 37.889 55.255 71.142 79.230 84.507 88.708 92.215 94.683 96.327 97.450 98.283 98.949 99.500 99.732 99.906 100.000
 
286 
 
Scree Plot 
 
 
Factor Loadings 
 
 
F1 F2 F3 F4 F5 F6 F7 F8
PRx 0.631 0.131 0.628 0.181 0.050 -0.080 -0.140 0.059
PAx 0.620 0.233 0.636 0.215 0.063 -0.123 0.014 -0.126
RAC 0.602 0.136 0.552 0.388 -0.167 -0.013 -0.008 -0.259
Mx 0.843 -0.020 -0.285 -0.212 -0.257 -0.059 0.144 -0.206
Mx_a 0.798 0.072 -0.079 -0.234 0.406 -0.205 0.029 -0.135
Sx 0.790 0.211 0.165 -0.226 -0.396 0.193 0.032 0.185
Sx_a 0.581 0.451 0.430 -0.323 0.062 0.025 -0.079 0.347
Dx 0.691 0.072 -0.492 -0.260 -0.406 -0.026 0.018 -0.095
Dx_a 0.623 0.161 -0.471 -0.235 0.245 -0.377 -0.202 0.037
TOx 0.821 -0.246 -0.122 0.052 0.221 0.346 0.022 0.003
TOx_a 0.677 -0.373 -0.179 0.004 0.298 0.478 -0.041 -0.055
THx 0.511 -0.615 -0.161 0.438 -0.164 -0.140 -0.056 0.212
THx_a 0.489 -0.558 -0.380 0.422 -0.053 -0.148 -0.157 0.105
ORx_5 0.323 0.514 -0.326 0.380 0.156 -0.068 0.570 0.149
ORx_30 -0.078 0.798 -0.439 0.312 -0.042 0.119 -0.124 -0.013
ORx_60 0.013 0.783 -0.399 0.270 0.001 0.128 -0.319 -0.038
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% Contribution of Variables 
 
 
F9 F10 F11 F12 F13 F14 F15 F16
0.299 0.123 0.057 -0.020 -0.130 -0.020 -0.027 -0.013
-0.055 -0.070 0.196 0.093 0.135 -0.021 0.027 -0.001
-0.093 -0.141 -0.179 -0.072 -0.043 0.038 -0.009 0.004
-0.043 0.127 0.043 -0.013 -0.043 -0.050 -0.005 0.076
-0.118 0.219 -0.067 -0.005 0.026 0.054 0.011 -0.039
-0.022 0.028 -0.067 0.086 -0.031 -0.005 0.096 -0.027
-0.171 -0.036 0.003 -0.045 0.019 0.027 -0.067 0.033
0.088 -0.080 0.081 -0.036 0.042 0.033 -0.069 -0.055
0.116 -0.213 -0.036 -0.015 -0.026 -0.020 0.049 0.017
0.180 -0.012 -0.142 0.085 0.125 -0.038 -0.037 0.014
-0.076 -0.080 0.140 -0.084 -0.089 0.026 0.027 -0.003
0.012 0.078 0.007 -0.170 0.108 0.008 0.033 0.006
-0.158 -0.003 0.009 0.183 -0.083 0.014 -0.038 -0.002
0.001 -0.045 0.006 -0.015 -0.045 -0.023 -0.007 -0.013
0.115 0.058 0.029 0.041 0.027 0.117 0.019 0.037
-0.136 0.060 -0.012 -0.052 0.009 -0.104 -0.009 -0.025
F1 F2 F3 F4 F5 F6 F7 F8
PRx 6.569 0.616 15.491 2.523 0.298 0.961 3.499 0.871
PAx 6.347 1.960 15.931 3.562 0.477 2.249 0.035 3.993
RAC 5.984 0.661 11.966 11.624 3.308 0.026 0.011 17.016
Mx 11.716 0.014 3.197 3.478 7.849 0.522 3.678 10.778
Mx_a 10.503 0.187 0.246 4.214 19.515 6.231 0.151 4.598
Sx 10.287 1.609 1.067 3.940 18.575 5.552 0.177 8.689
Sx_a 5.565 7.314 7.265 8.063 0.453 0.090 1.100 30.498
Dx 7.869 0.188 9.538 5.237 19.505 0.103 0.059 2.284
Dx_a 6.406 0.930 8.744 4.278 7.102 21.096 7.283 0.341
TOx 11.122 2.172 0.590 0.207 5.782 17.818 0.085 0.002
TOx_a 7.567 5.020 1.257 0.001 10.511 33.954 0.295 0.769
THx 4.301 13.632 1.016 14.848 3.187 2.900 0.562 11.355
THx_a 3.942 11.208 5.669 13.732 0.335 3.272 4.416 2.806
ORx_5 1.718 9.515 4.193 11.140 2.894 0.694 57.808 5.601
ORx_30 0.101 22.936 7.579 7.520 0.208 2.113 2.731 0.041
ORx_60 0.003 22.037 6.251 5.631 0.000 2.420 18.109 0.357
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F9 F10 F11 F12 F13 F14 F15 F16
33.964 8.376 2.399 0.391 19.145 1.075 2.711 1.110
1.166 2.735 28.923 8.110 20.704 1.138 2.657 0.013
3.275 11.020 23.920 4.924 2.096 3.796 0.288 0.083
0.689 8.995 1.387 0.167 2.071 6.613 0.081 38.766
5.253 26.756 3.404 0.028 0.753 7.721 0.430 10.011
0.188 0.440 3.400 6.919 1.088 0.062 33.100 4.905
11.147 0.737 0.005 1.877 0.429 1.999 16.348 7.112
2.940 3.599 4.930 1.200 2.020 2.930 17.287 20.310
5.158 25.270 0.980 0.201 0.788 1.033 8.555 1.835
12.384 0.083 15.149 6.720 17.631 3.980 5.022 1.252
2.215 3.544 14.614 6.655 9.070 1.825 2.629 0.076
0.058 3.422 0.041 27.085 13.233 0.160 3.930 0.269
9.502 0.007 0.067 31.417 7.761 0.552 5.286 0.027
0.000 1.132 0.028 0.211 2.318 1.413 0.162 1.173
5.048 1.863 0.638 1.591 0.801 36.612 1.250 8.969
7.014 2.022 0.115 2.502 0.094 29.091 0.265 4.091
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Appendix B: Section 6.2 - Spearman Principal Component Analysis (PCA) – 
Supplementary Material 
 
* PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal 
component #1, F2 = PC2 = principal component #2. PC1 and PC2 are the two components which 
contribute the largest amount of variance to the entire data set.   
*Biplots of PC1 vs. PC2 display which variables contribute variance to PC1 and PC2.  The longer the 
arm connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  
Similarly, the quadrant on the biplot in which the variable falls correlates to its contribution to a 
particular PC. The upper left quadrant is primarily PC2; lower left quadrant is neither PC1 or PC2; the 
upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1. 
*Eigenvalue tables display the eigenvalue for each principal component (PC) (also denoted F), with the 
% variability and cumulative variability for each factor/principal component. 
*Scree plot displays the same information form the eigenvalue table in a histogram format, with each 
F (or PC) along the x-axis, the eigenvalue along the left side y-axis and the % variability along the right 
y-axis.  Furthermore, the red line on the graph displays the cumulative variability with the addition of 
each F (or PC) moving from F1 to F18. 
*Factor loading tables display the loading of each variable (ie. PRx, etc.) for each principal component.  
Loading varies from -1 to +1, with negative values indicating that particular variable is less likely to 
contribute to the variance in that particular factor (F). Similarly, positive loadings indicate that 
particular variable likely contribute to the variance in that corresponding factor (F). 
*Contribution % of Variables tables displays the % contribution to the variance of each individual 
variable for each individual factor (F). 
*Correlation between variables and factor table – denotes the strength of association between 
various autoregulatory indices and the individual factors 
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1. Grand Mean Data Set 
 
Loading Biplot:  PC1 vs. PC2 
Spearman Type Principal Component Analysis of Autoregulatory Indices – Biplot of PC1 vs. PC2 (Grand Mean Data) 
 
PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal component #1, F2 = PC2 = 
principal component #2. PC1 and PC2 are the two components which contribute the largest amount of variance to the entire 
data set.  The above biplot of PC1 vs. PC2 displays which variables contribute variance to PC1 and PC2.  The longer the arm 
connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  Similarly, the quadrant on the biplot 
in which the variable falls correlates to its contribution to a particular PC. The upper left quadrant is primarily PC2; lower left 
quadrant is neither PC1 or PC2; the upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1.  
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Spearman Correlation Matrix 
 
 
 
Eigenvalue Table 
 
 
 
 
 
 
 
 
 
 
 
 
Variables PRx PAx RAC Mx Mx_a Sx Sx_a Dx Dx_a Lx Lx_a
PRx 1 0.639 0.595 0.192 0.384 0.334 0.504 -0.145 0.008 -0.143 0.052
PAx 0.639 1 0.706 0.026 0.311 0.264 0.573 -0.186 0.018 -0.139 0.124
RAC 0.595 0.706 1 0.104 0.237 0.310 0.401 -0.119 -0.023 -0.026 0.037
Mx 0.192 0.026 0.104 1 0.676 0.610 0.360 0.746 0.494 0.464 0.408
Mx_a 0.384 0.311 0.237 0.676 1 0.376 0.629 0.501 0.742 0.279 0.433
Sx 0.334 0.264 0.310 0.610 0.376 1 0.668 0.271 0.084 0.113 0.083
Sx_a 0.504 0.573 0.401 0.360 0.629 0.668 1 0.140 0.338 -0.030 0.145
Dx -0.145 -0.186 -0.119 0.746 0.501 0.271 0.140 1 0.778 0.416 0.322
Dx_a 0.008 0.018 -0.023 0.494 0.742 0.084 0.338 0.778 1 0.257 0.360
Lx -0.143 -0.139 -0.026 0.464 0.279 0.113 -0.030 0.416 0.257 1 0.814
Lx_a 0.052 0.124 0.037 0.408 0.433 0.083 0.145 0.322 0.360 0.814 1
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
Eigenvalue 4.197 2.827 1.291 0.972 0.584 0.457 0.255 0.206 0.115 0.078 0.019
Variability (%) 38.152 25.699 11.735 8.835 5.310 4.154 2.320 1.877 1.044 0.705 0.169
Cumulative % 38.152 63.852 75.587 84.422 89.733 93.886 96.206 98.082 99.126 99.831 100.000
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Scree Plot 
 
 
 
Factor Loading Table 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
PRx 0.449 0.694 0.101 -0.078 0.112 0.493 0.053 -0.201 -0.020 -0.016 0.001
PAx 0.416 0.748 0.237 -0.215 -0.003 -0.198 0.312 0.144 -0.057 -0.075 -0.007
RAC 0.391 0.681 0.256 -0.045 0.442 -0.244 -0.235 -0.016 0.053 0.055 0.003
Mx 0.813 -0.294 -0.150 0.307 0.215 0.174 0.062 0.208 -0.025 0.091 -0.063
Mx_a 0.876 -0.039 -0.116 -0.278 -0.144 0.156 -0.198 0.220 -0.004 -0.063 0.061
Sx 0.626 0.253 -0.252 0.654 -0.084 -0.101 0.005 -0.063 0.124 -0.126 0.007
Sx_a 0.708 0.456 -0.206 0.047 -0.419 -0.157 -0.055 -0.106 -0.114 0.135 -0.006
Dx 0.629 -0.597 -0.299 -0.049 0.294 -0.110 0.184 -0.124 -0.046 0.043 0.073
Dx_a 0.672 -0.403 -0.271 -0.518 -0.001 -0.103 -0.037 -0.130 0.069 -0.077 -0.071
Lx 0.445 -0.552 0.626 0.209 0.012 -0.047 -0.098 -0.076 -0.190 -0.090 -0.012
Lx_a 0.551 -0.374 0.680 -0.039 -0.199 0.021 0.093 -0.022 0.191 0.082 0.013
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% Contribution 
 
 
 
Correlation Between Variables and Factors 
 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
PRx 4.812 17.052 0.793 0.620 2.154 53.259 1.112 19.525 0.335 0.333 0.004
PAx 4.114 19.775 4.352 4.757 0.002 8.545 38.122 10.035 2.836 7.208 0.255
RAC 3.641 16.384 5.061 0.205 33.495 13.044 21.724 0.121 2.430 3.844 0.052
Mx 15.744 3.058 1.735 9.697 7.884 6.597 1.483 20.993 0.536 10.582 21.691
Mx_a 18.284 0.053 1.047 7.928 3.555 5.360 15.441 23.412 0.012 5.051 19.857
Sx 9.337 2.265 4.933 44.040 1.203 2.221 0.009 1.940 13.423 20.328 0.302
Sx_a 11.953 7.352 3.280 0.230 30.103 5.397 1.187 5.393 11.241 23.638 0.226
Dx 9.417 12.593 6.931 0.247 14.787 2.655 13.293 7.408 1.826 2.350 28.493
Dx_a 10.752 5.745 5.673 27.633 0.000 2.342 0.541 8.127 4.139 7.571 27.477
Lx 4.713 10.786 30.346 4.483 0.023 0.484 3.732 2.806 31.508 10.362 0.758
Lx_a 7.233 4.938 35.850 0.159 6.794 0.096 3.357 0.240 31.714 8.734 0.885
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
PRx 0.449 0.694 0.101 -0.078 0.112 0.493 0.053 -0.201 -0.020 -0.016 0.001
PAx 0.416 0.748 0.237 -0.215 -0.003 -0.198 0.312 0.144 -0.057 -0.075 -0.007
RAC 0.391 0.681 0.256 -0.045 0.442 -0.244 -0.235 -0.016 0.053 0.055 0.003
Mx 0.813 -0.294 -0.150 0.307 0.215 0.174 0.062 0.208 -0.025 0.091 -0.063
Mx_a 0.876 -0.039 -0.116 -0.278 -0.144 0.156 -0.198 0.220 -0.004 -0.063 0.061
Sx 0.626 0.253 -0.252 0.654 -0.084 -0.101 0.005 -0.063 0.124 -0.126 0.007
Sx_a 0.708 0.456 -0.206 0.047 -0.419 -0.157 -0.055 -0.106 -0.114 0.135 -0.006
Dx 0.629 -0.597 -0.299 -0.049 0.294 -0.110 0.184 -0.124 -0.046 0.043 0.073
Dx_a 0.672 -0.403 -0.271 -0.518 -0.001 -0.103 -0.037 -0.130 0.069 -0.077 -0.071
Lx 0.445 -0.552 0.626 0.209 0.012 -0.047 -0.098 -0.076 -0.190 -0.090 -0.012
Lx_a 0.551 -0.374 0.680 -0.039 -0.199 0.021 0.093 -0.022 0.191 0.082 0.013
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2. 10 Second by 10 Second Data 
 
Loading Biplot:  PC1 vs. PC2 
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Spearman Correlation Matrix 
 
Eigenvalue Table 
 
 
 
 
 
 
 
 
 
 
 
 
Variables PRx PAx RAC Mx Mx_a Sx Sx_a Dx Dx_a Lx Lx_a
PRx 1 0.704 0.481 0.144 0.286 0.248 0.416 -0.089 0.036 -0.011 0.154
PAx 0.704 1 0.565 0.002 0.168 0.234 0.497 -0.153 -0.002 -0.143 0.049
RAC 0.481 0.565 1 0.044 0.071 0.369 0.248 -0.152 -0.112 0.034 0.063
Mx 0.144 0.002 0.044 1 0.705 0.536 0.310 0.815 0.535 0.380 0.175
Mx_a 0.286 0.168 0.071 0.705 1 0.332 0.565 0.561 0.796 0.244 0.286
Sx 0.248 0.234 0.369 0.536 0.332 1 0.650 0.266 0.097 0.101 0.002
Sx_a 0.416 0.497 0.248 0.310 0.565 0.650 1 0.147 0.351 -0.016 0.071
Dx -0.089 -0.153 -0.152 0.815 0.561 0.266 0.147 1 0.733 0.338 0.088
Dx_a 0.036 -0.002 -0.112 0.535 0.796 0.097 0.351 0.733 1 0.183 0.188
Lx -0.011 -0.143 0.034 0.380 0.244 0.101 -0.016 0.338 0.183 1 0.737
Lx_a 0.154 0.049 0.063 0.175 0.286 0.002 0.071 0.088 0.188 0.737 1
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
Eigenvalue 3.870 2.586 1.559 0.993 0.709 0.472 0.321 0.203 0.183 0.086 0.018
Variability (%) 35.184 23.513 14.174 9.027 6.441 4.292 2.915 1.847 1.665 0.778 0.164
Cumulative % 35.184 58.697 72.871 81.898 88.339 92.632 95.546 97.394 99.058 99.836 100.000
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Scree Plot 
 
 
Factor Loading Table 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
PRx 0.398 0.698 0.170 -0.268 -0.169 -0.382 -0.189 0.204 0.052 0.005 0.000
PAx 0.309 0.809 0.063 -0.262 -0.107 -0.062 0.350 -0.182 -0.033 -0.081 -0.004
RAC 0.244 0.693 0.210 0.212 -0.398 0.444 -0.096 0.028 -0.010 0.065 0.003
Mx 0.831 -0.278 -0.116 0.253 -0.236 -0.215 -0.075 -0.189 -0.054 0.055 0.073
Mx_a 0.875 -0.118 -0.106 -0.280 0.097 0.091 -0.264 -0.141 -0.136 -0.049 -0.065
Sx 0.600 0.316 -0.187 0.651 0.193 -0.025 -0.023 0.027 0.151 -0.137 -0.017
Sx_a 0.661 0.442 -0.218 0.014 0.516 0.057 0.105 0.089 -0.095 0.150 0.016
Dx 0.698 -0.533 -0.216 0.053 -0.309 -0.061 0.227 0.088 0.088 0.095 -0.066
Dx_a 0.722 -0.376 -0.214 -0.430 -0.013 0.250 0.041 0.135 0.105 -0.100 0.059
Lx 0.408 -0.360 0.754 0.205 0.000 -0.020 0.114 0.148 -0.230 -0.072 0.003
Lx_a 0.360 -0.153 0.845 -0.110 0.214 0.028 -0.019 -0.125 0.233 0.062 -0.003
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% Contribution 
 
 
Correlation Between Variables and Factors 
 
 
 
 
 
 
 
 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
PRx 4.098 18.813 1.849 7.224 4.018 30.839 11.181 20.482 1.461 0.034 0.001
PAx 2.471 25.277 0.258 6.890 1.610 0.824 38.117 16.271 0.582 7.599 0.102
RAC 1.537 18.591 2.841 4.531 22.397 41.785 2.897 0.389 0.057 4.929 0.046
Mx 17.838 2.999 0.865 6.429 7.887 9.748 1.757 17.645 1.617 3.555 29.660
Mx_a 19.761 0.536 0.715 7.871 1.337 1.735 21.667 9.775 10.061 2.750 23.792
Sx 9.315 3.873 2.246 42.647 5.237 0.130 0.161 0.352 12.408 22.054 1.578
Sx_a 11.287 7.564 3.045 0.020 37.566 0.699 3.416 3.862 4.885 26.158 1.500
Dx 12.585 10.978 2.990 0.283 13.448 0.796 16.074 3.808 4.270 10.616 24.153
Dx_a 13.459 5.463 2.937 18.649 0.025 13.195 0.534 8.914 6.058 11.679 19.088
Lx 4.304 5.007 36.451 4.233 0.000 0.088 4.083 10.821 28.845 6.123 0.046
Lx_a 3.344 0.901 45.805 1.224 6.474 0.161 0.113 7.681 29.757 4.503 0.035
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
PRx 0.398 0.698 0.170 -0.268 -0.169 -0.382 -0.189 0.204 0.052 0.005 0.000
PAx 0.309 0.809 0.063 -0.262 -0.107 -0.062 0.350 -0.182 -0.033 -0.081 -0.004
RAC 0.244 0.693 0.210 0.212 -0.398 0.444 -0.096 0.028 -0.010 0.065 0.003
Mx 0.831 -0.278 -0.116 0.253 -0.236 -0.215 -0.075 -0.189 -0.054 0.055 0.073
Mx_a 0.875 -0.118 -0.106 -0.280 0.097 0.091 -0.264 -0.141 -0.136 -0.049 -0.065
Sx 0.600 0.316 -0.187 0.651 0.193 -0.025 -0.023 0.027 0.151 -0.137 -0.017
Sx_a 0.661 0.442 -0.218 0.014 0.516 0.057 0.105 0.089 -0.095 0.150 0.016
Dx 0.698 -0.533 -0.216 0.053 -0.309 -0.061 0.227 0.088 0.088 0.095 -0.066
Dx_a 0.722 -0.376 -0.214 -0.430 -0.013 0.250 0.041 0.135 0.105 -0.100 0.059
Lx 0.408 -0.360 0.754 0.205 0.000 -0.020 0.114 0.148 -0.230 -0.072 0.003
Lx_a 0.360 -0.153 0.845 -0.110 0.214 0.028 -0.019 -0.125 0.233 0.062 -0.003
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Appendix C: Section 6.3 - Spearman Principal Component Analysis (PCA) – 
Supplementary Material – Entire TBI TCD Cohort 
 
* PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal 
component #1, F2 = PC2 = principal component #2. PC1 and PC2 are the two components which 
contribute the largest amount of variance to the entire data set.   
*Biplots of PC1 vs. PC2 display which variables contribute variance to PC1 and PC2.  The longer the 
arm connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  
Similarly, the quadrant on the biplot in which the variable fallscorrelates to its contribution to a 
particular PC. The upper left quadrant is primarily PC2; lower left quadrant is neither PC1 or PC2; the 
upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1. 
*Eigenvalue tables display the eigenvalue for each principal component (PC) (also denoted F), with the 
% variability and cumulative variability for each factor/principal component. 
*Scree plot displays the same information form the eigenvalue table in a histogram format, with each 
F (or PC) along the x-axis, the eigenvalue along the left side y-axis and the % variability along the right 
y-axis.  Furthermore, the red line on the graph displays the cumulative variability with the addition of 
each F (or PC) moving from F1 to F18. 
*Factor loading tables display the loading of each variable (ie. PRx, etc.) for each principal component.  
Loading varies from -1 to +1, with negative values indicating that particular variable is less likely to 
contribute to the variance in that particular factor (F). Similarly, positive loadings indicate that 
particular variable likely contribute to the variance in that corresponding factor (F). 
*Contribution % of Variables tables displays the % contribution to the variance of each individual 
variable for each individual factor (F). 
*Correlation between variables and factor table – denotes the strength of association between 
various autoregulatory indices and the individual factors 
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1. Grand Mean Data Set 
 
Loading Biplot 
Spearman Type Principal Component Analysis of Autoregulatory/Cerebrovascular Reactivity Indices – Biplot of PC1 vs. PC2 
(Entire TBI TCD Cohort - Grand Mean Data) 
 
 
PCA = principal component analysis, F = factor, PC = principal component, F1 = PC1 = principal component #1, F2 = PC2 = 
principal component #2. PC1 and PC2 are the two components which contribute the largest amount of variance to the entire 
data set.  The above biplot of PC1 vs. PC2 displays which variables contribute variance to PC1 and PC2.  The longer the arm 
connecting (0,0) to the variable (such as PRx), the larger the contribution of that variable.  Similarly, the quadrant on the biplot 
in which the variable falls correlates to its contribution to a particular PC. The upper left quadrant is primarily PC2; lower left 
quadrant is neither PC1 or PC2; the upper right quadrant is PC1 and PC2; the lower right quadrant is primarily PC1.  
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Spearman Correlation Matrix 
Variables PRx PAx RAC Mx Mx_a Dx Dx_a Sx Sx_a 
PRx 1 0.715 0.507 0.338 0.409 0.232 0.304 0.430 0.495 
PAx 0.715 1 0.651 0.191 0.305 0.047 0.141 0.363 0.526 
RAC 0.507 0.651 1 0.340 0.224 0.191 0.109 0.545 0.339 
Mx 0.338 0.191 0.340 1 0.755 0.934 0.715 0.716 0.458 
Mx_a 0.409 0.305 0.224 0.755 1 0.713 0.886 0.508 0.654 
Dx 0.232 0.047 0.191 0.934 0.713 1 0.801 0.561 0.327 
Dx_a 0.304 0.141 0.109 0.715 0.886 0.801 1 0.361 0.444 
Sx 0.430 0.363 0.545 0.716 0.508 0.561 0.361 1 0.743 
Sx_a 0.495 0.526 0.339 0.458 0.654 0.327 0.444 0.743 1 
 
 
Eigenvalue Table 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
Eigenvalue 4.862 1.938 0.788 0.678 0.368 0.202 0.100 0.048 0.016 
Variability 
(%) 54.027 21.533 8.752 7.529 4.084 2.246 1.116 0.531 0.182 
Cumulative 
% 54.027 75.560 84.311 91.841 95.925 98.171 99.287 99.818 100.000 
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Scree Plot 
 
 
 
Factor Loading Table 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 0.629 0.525 -0.296 -0.200 -0.418 -0.159 0.013 -0.015 0.000 
PAx 0.534 0.731 -0.224 -0.130 0.110 0.314 -0.030 0.047 -0.006 
RAC 0.538 0.594 0.379 -0.308 0.293 -0.176 0.000 -0.048 0.002 
Mx 0.865 -0.349 0.250 -0.128 -0.106 0.129 0.130 -0.018 0.080 
Mx_a 0.861 -0.287 -0.305 0.052 0.180 -0.069 0.199 0.032 -0.050 
Dx 0.778 -0.524 0.167 -0.217 -0.101 0.115 -0.100 -0.086 -0.068 
Dx_a 0.765 -0.475 -0.319 -0.134 0.150 -0.107 -0.171 0.064 0.043 
Sx 0.800 0.133 0.451 0.322 -0.124 -0.038 -0.042 0.130 -0.023 
Sx_a 0.757 0.229 -0.130 0.582 0.061 -0.004 -0.045 -0.116 0.019 
 
 
 
 
 
302 
 
% Contribution 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 8.148 14.237 11.151 5.906 47.458 12.469 0.170 0.459 0.002 
PAx 5.858 27.569 6.389 2.496 3.315 48.627 0.921 4.620 0.205 
RAC 5.956 18.223 18.228 13.956 23.295 15.399 0.000 4.909 0.035 
Mx 15.380 6.275 7.964 2.409 3.067 8.263 16.740 0.665 39.238 
Mx_a 15.256 4.254 11.791 0.406 8.774 2.324 39.431 2.193 15.570 
Dx 12.444 14.165 3.542 6.948 2.781 6.569 9.860 15.417 28.274 
Dx_a 12.033 11.659 12.940 2.653 6.121 5.640 29.126 8.498 11.331 
Sx 13.154 0.908 25.849 15.266 4.161 0.701 1.718 35.107 3.135 
Sx_a 11.772 2.710 2.146 49.960 1.027 0.008 2.035 28.132 2.211 
 
 
 
Correlation Between Variables and Factors 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 0.629 0.525 -0.296 -0.200 -0.418 -0.159 0.013 -0.015 0.000 
PAx 0.534 0.731 -0.224 -0.130 0.110 0.314 -0.030 0.047 -0.006 
RAC 0.538 0.594 0.379 -0.308 0.293 -0.176 0.000 -0.048 0.002 
Mx 0.865 -0.349 0.250 -0.128 -0.106 0.129 0.130 -0.018 0.080 
Mx_a 0.861 -0.287 -0.305 0.052 0.180 -0.069 0.199 0.032 -0.050 
Dx 0.778 -0.524 0.167 -0.217 -0.101 0.115 -0.100 -0.086 -0.068 
Dx_a 0.765 -0.475 -0.319 -0.134 0.150 -0.107 -0.171 0.064 0.043 
Sx 0.800 0.133 0.451 0.322 -0.124 -0.038 -0.042 0.130 -0.023 
Sx_a 0.757 0.229 -0.130 0.582 0.061 -0.004 -0.045 -0.116 0.019 
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2. 30 Minute Mean Data 
 
Loading Biplot:  PC1 vs. PC2 
 
 
 
Spearman Correlation Matrix 
Variables PRx PAx RAC Mx Mx_a Dx Dx_a Sx Sx_a 
PRx 1 0.721 0.508 0.290 0.381 0.171 0.235 0.404 0.473 
PAx 0.721 1 0.671 0.187 0.297 0.040 0.110 0.371 0.500 
RAC 0.508 0.671 1 0.357 0.280 0.187 0.114 0.556 0.356 
Mx 0.290 0.187 0.357 1 0.796 0.919 0.715 0.707 0.442 
Mx_a 0.381 0.297 0.280 0.796 1 0.726 0.868 0.551 0.623 
Dx 0.171 0.040 0.187 0.919 0.726 1 0.813 0.530 0.290 
Dx_a 0.235 0.110 0.114 0.715 0.868 0.813 1 0.358 0.396 
Sx 0.404 0.371 0.556 0.707 0.551 0.530 0.358 1 0.765 
Sx_a 0.473 0.500 0.356 0.442 0.623 0.290 0.396 0.765 1 
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Eigenvalue Table 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
Eigenvalue 4.807 2.018 0.745 0.688 0.356 0.200 0.121 0.050 0.015 
Variability 
(%) 53.407 22.424 8.279 7.649 3.954 2.219 1.345 0.557 0.166 
Cumulativ
e % 53.407 75.831 84.110 91.759 95.714 97.933 99.277 99.834 
100.00
0 
 
Scree Plot 
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Factor Loading Table 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 0.587 0.566 -0.381 0.101 -0.394 -0.155 -0.003 -0.012 0.000 
PAx 0.527 0.732 -0.260 0.000 0.135 0.312 -0.008 0.047 -0.003 
RAC 0.564 0.573 0.076 -0.499 0.247 -0.184 -0.022 -0.053 0.001 
Mx 0.868 -0.355 0.082 -0.237 -0.133 0.102 0.152 -0.023 0.076 
Mx_a 0.877 -0.278 -0.161 0.195 0.178 -0.089 0.215 0.026 -0.053 
Dx 0.765 -0.544 -0.057 -0.240 -0.129 0.129 -0.119 -0.084 -0.062 
Dx_a 0.748 -0.500 -0.319 0.116 0.173 -0.093 -0.178 0.068 0.043 
Sx 0.809 0.139 0.533 -0.030 -0.137 -0.023 -0.049 0.136 -0.020 
Sx_a 0.738 0.254 0.324 0.513 0.081 0.012 -0.051 -0.117 0.017 
 
 
% Contribution 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 7.168 15.871 19.502 1.481 43.714 11.984 0.007 0.274 0.000 
PAx 5.781 26.572 9.082 0.000 5.143 48.881 0.055 4.435 0.052 
RAC 6.623 16.288 0.779 36.184 17.077 17.008 0.402 5.625 0.014 
Mx 15.677 6.261 0.895 8.158 4.945 5.184 18.989 1.099 38.791 
Mx_a 16.008 3.830 3.475 5.507 8.919 3.926 38.361 1.300 18.674 
Dx 12.169 14.657 0.440 8.371 4.655 8.356 11.751 14.160 25.440 
Dx_a 11.625 12.364 13.634 1.943 8.406 4.325 26.257 9.131 12.314 
Sx 13.628 0.961 38.124 0.128 5.279 0.266 2.019 36.804 2.793 
Sx_a 11.322 3.197 14.069 38.229 1.863 0.071 2.159 27.171 1.921 
 
 
Correlation Between Variables and Factors 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 0.587 0.566 -0.381 0.101 -0.394 -0.155 -0.003 -0.012 0.000 
PAx 0.527 0.732 -0.260 0.000 0.135 0.312 -0.008 0.047 -0.003 
RAC 0.564 0.573 0.076 -0.499 0.247 -0.184 -0.022 -0.053 0.001 
Mx 0.868 -0.355 0.082 -0.237 -0.133 0.102 0.152 -0.023 0.076 
Mx_a 0.877 -0.278 -0.161 0.195 0.178 -0.089 0.215 0.026 -0.053 
Dx 0.765 -0.544 -0.057 -0.240 -0.129 0.129 -0.119 -0.084 -0.062 
Dx_a 0.748 -0.500 -0.319 0.116 0.173 -0.093 -0.178 0.068 0.043 
Sx 0.809 0.139 0.533 -0.030 -0.137 -0.023 -0.049 0.136 -0.020 
Sx_a 0.738 0.254 0.324 0.513 0.081 0.012 -0.051 -0.117 0.017 
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3. Minute-by-Minute Data 
Loading Biplot:  PC1 vs. PC2 
 
 
 
Spearman Correlation Matrix 
Variables PRx PAx RAC Mx Mx_a Dx Dx_a Sx Sx_a 
PRx 1 0.671 0.462 0.218 0.320 0.121 0.206 0.345 0.450 
PAx 0.671 1 0.670 0.111 0.224 -0.005 0.082 0.300 0.446 
RAC 0.462 0.670 1 0.266 0.217 0.132 0.099 0.461 0.308 
Mx 0.218 0.111 0.266 1 0.792 0.902 0.701 0.680 0.445 
Mx_a 0.320 0.224 0.217 0.792 1 0.712 0.864 0.535 0.626 
Dx 0.121 -0.005 0.132 0.902 0.712 1 0.803 0.501 0.296 
Dx_a 0.206 0.082 0.099 0.701 0.864 0.803 1 0.362 0.417 
Sx 0.345 0.300 0.461 0.680 0.535 0.501 0.362 1 0.767 
Sx_a 0.450 0.446 0.308 0.445 0.626 0.296 0.417 0.767 1 
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Eigenvalue Table 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
Eigenvalue 4.586 2.088 0.778 0.693 0.399 0.223 0.147 0.067 0.020 
Variability 
(%) 50.953 23.198 8.648 7.698 4.434 2.477 1.633 0.742 0.218 
Cumulative 
% 50.953 74.151 82.799 90.497 94.931 97.408 99.041 99.782 100.000 
 
 
 
Scree Plot 
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Factor Loading Table 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 0.516 0.609 -0.275 -0.297 0.421 -0.144 0.001 -0.009 0.000 
PAx 0.444 0.782 -0.235 -0.041 -0.150 0.329 -0.012 0.055 -0.003 
RAC 0.482 0.628 -0.127 0.520 -0.194 -0.212 -0.006 -0.059 0.003 
Mx 0.863 -0.348 -0.005 0.239 0.165 0.111 0.176 -0.019 0.084 
Mx_a 0.881 -0.256 -0.102 -0.214 -0.194 -0.082 0.230 0.029 -0.066 
Dx 0.771 -0.508 -0.176 0.205 0.149 0.129 -0.145 -0.100 -0.066 
Dx_a 0.773 -0.433 -0.298 -0.185 -0.191 -0.108 -0.186 0.081 0.052 
Sx 0.789 0.130 0.529 0.185 0.136 -0.025 -0.067 0.150 -0.026 
Sx_a 0.745 0.248 0.470 -0.346 -0.139 0.014 -0.052 -0.141 0.023 
 
 
% Contribution 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 5.809 17.781 9.744 12.721 44.481 9.349 0.001 0.113 0.001 
PAx 4.297 29.303 7.104 0.238 5.627 48.686 0.100 4.598 0.046 
RAC 5.066 18.917 2.060 39.036 9.425 20.250 0.024 5.186 0.035 
Mx 16.223 5.799 0.003 8.219 6.860 5.539 21.060 0.522 35.774 
Mx_a 16.916 3.143 1.340 6.582 9.431 3.008 36.096 1.303 22.181 
Dx 12.978 12.338 3.969 6.042 5.573 7.521 14.389 15.020 22.171 
Dx_a 13.036 8.963 11.392 4.934 9.185 5.275 23.474 9.881 13.860 
Sx 13.580 0.804 35.961 4.927 4.601 0.280 3.026 33.499 3.322 
Sx_a 12.096 2.952 28.426 17.301 4.816 0.091 1.829 29.877 2.611 
 
 
Correlation Between Variables and Factors 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 
PRx 0.516 0.609 -0.275 -0.297 0.421 -0.144 0.001 -0.009 0.000 
PAx 0.444 0.782 -0.235 -0.041 -0.150 0.329 -0.012 0.055 -0.003 
RAC 0.482 0.628 -0.127 0.520 -0.194 -0.212 -0.006 -0.059 0.003 
Mx 0.863 -0.348 -0.005 0.239 0.165 0.111 0.176 -0.019 0.084 
Mx_a 0.881 -0.256 -0.102 -0.214 -0.194 -0.082 0.230 0.029 -0.066 
Dx 0.771 -0.508 -0.176 0.205 0.149 0.129 -0.145 -0.100 -0.066 
Dx_a 0.773 -0.433 -0.298 -0.185 -0.191 -0.108 -0.186 0.081 0.052 
Sx 0.789 0.130 0.529 0.185 0.136 -0.025 -0.067 0.150 -0.026 
Sx_a 0.745 0.248 0.470 -0.346 -0.139 0.014 -0.052 -0.141 0.023 
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Appendix D: Section 7.1 - Patient Example and Full Population ARMA Models 
Tested (AIC, LL) 
 
 
Patient Example – ARIMA Modeling  
ARIMA Model Parameters AIC LL 
p q 
2 2 -69.3 39.65 
2 0 -53.06 30.53 
1 0 -40.16 23.08 
3 0 -61.58 35.79 
0 0 153.81 -74.91 
0 1 22.0 -8.0 
0 2 -42.03 25.01 
0 3 -67.76 38.88 
1 1 -47.19 27.59 
1 2 -65.5 37.75 
1 3 -67.66 39.83 
2 1 -55.42 32.71 
2 3 -66.11 40.05 
3 1 -61.12 36.56 
3 2 -66.11 40.06 
3 3 -64.16 40.08 
AIC = Akaike Information Criterion, ARIMA = auto-regressive integrative moving average, LL = log likelihood, p = auto-regression 
parameter for ARIMA model, q = moving average parameter for ARIMA model.*Note: bolded value represents the most 
appropriate ARIMA structure for the patient example.  This was the case for the 10 representative patient examples tested.  
There was no integrative parameter (ie. “d” parameter) included within the ARIMA models, given stationarity testing and 
auto.arima testing displayed stationary signals within the short recordings tested, hence no differencing of the signal was 
required.   
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LME Modelling with Embedded PRx ARIMA Structure – Full Population Assessing Best ARIMA Structure 
LME Model  PRx ARIMA Structure AIC BIC  LL 
Fixed 
Effects 
Random p q 
PRx ~ Sx_a intercept 2 2 -9797.294 -9735.699 4906.647 
PRx ~ Sx_a intercept 3 0 -9795.848 -9741.953 4904.924 
PRx ~ Sx_a intercept 3 1 -9797.767 -9736.172 4906.883 
PRx ~ Sx_a intercept 3 2 -9795.767 -9726.473 4906.884 
PRx ~ Sx_a intercept 3 3 FTC FTC FTC 
PRx ~ Sx_a intercept 2 0 -9795.465 -9749.269 4903.732 
PRx ~ Sx_a intercept 2 1 -9795.409 -9741.514 4904.705 
PRx ~ Sx_a intercept 2 3 -9794.578 -9725.284 4906.289 
PRx ~ Sx_a intercept 1 0 09271.307 -9232.810 4640.653 
PRx ~ Sx_a intercept 1 1 -9752.712 -9706.515 4882.356 
PRx ~ Sx_a intercept 1 2 -9707.924 -9744.029 4905.962 
PRx ~ Sx_a intercept 1 3 FTC FTC FTC 
PRx ~ Sx_a intercept 0 0 FTC FTC FTC 
PRx ~ Sx_a intercept 0 1 -4955.052 -4916.55 2482.526 
PRx ~ Sx_a intercept 0 2 -8254.316 -8208.199 4133.158 
PRx ~ Sx_a intercept 0 3 -9263.106 -9209.210 4638.553 
AIC = Akaike Information Criterion, ARIMA = auto-regressive integrative moving average, BIC = Bayesian Information Criterion, Dx_a = diastolic flow velocity (correlation between 
TCD based FVd and MAP), FTC = “failure to converge” for the model, FVd = TCD based diastolic flow velocity, FVm = mean TCD flow velocity, FVs = TCD based systolic flow velocity, 
ICP = intra-cranial pressure, LL = log likelihood, LME = linear mixed effects model, p = auto-regression parameter for ARIMA model, MAP = mean arterial pressure, PRx = pressure 
reactivity index (correlation between ICP and MAP), q = moving average parameter for ARIMA model, Sx_a = systolic flow index (correlation between TCD based FVs and MAP), 
TCD = transcranial Doppler. *Note: bolded value represents the most appropriate ARIMA structure for the patient population tested, based on principal of parsimony, lowest AIC 
and BIC.   There was no integrative parameter (ie. “d” parameter) included within the ARIMA models, given stationarity testing during patient examples (see appendix A and 
Methodology section of manuscript). 
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Appendix E: Section 7.3 – ACF/PACF/QQ Plots for Top LME Models and Bland-
Altman Plots for Estimated and Predicted PRx Results from LME Models 
 
A. QQ, Residual Density, ACF and PACF Plots for Top Two LME Models 
 
1. PRx ~ Sx_a LME Model (with random effects by patient in intercept and coefficients) 
 
QQ Plot 
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Residual Density Plot 
 
 
 
ACF Plot 
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PACF Plot 
 
 
2. PRx ~ Sx_a + Mx_a LME Model (with random effects by patient in intercept and coefficients) 
QQ Plot 
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Residual Density Plot 
 
 
 
 
 
 
ACF Plot 
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PACF Plot 
 
 
B.  – Bland Altman Analysis for Estimated vs. Observed PRx for Top Two LME Models 
*Grand mean Fisher transformed data utilized for Bland-Altman analysis 
 
1. PRx ~ Sx_a (with random effects introduced into intercept and coefficient) 
 
$lower.limit 
[1] -0.0628747 
 
$mean.diffs 
[1] -0.003253664 
 
$upper.limit 
[1] 0.05636738 
 
$lines 
 lower.limit   mean.diffs  upper.limit  
-0.062874705 -0.003253664  0.056367377  
 
$CI.lines 
lower.limit.ci.lower lower.limit.ci.upper   mean.diff.ci.lower   mean.diff.ci
.upper upper.limit.ci.lower  
         -0.10056477          -0.02518464          -0.02501403           0.01
850671           0.01867731  
upper.limit.ci.upper  
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          0.09405744  
 
$critical.diff 
[1] 0.05962104 
 
 
 
2. PRx ~ Sx_a + Mx_a (with random effects introduced into intercept and coefficient) 
 
$lower.limit 
[1] -0.0664208 
 
$mean.diffs 
[1] -0.003062638 
 
$upper.limit 
[1] 0.06029553 
 
$lines 
 lower.limit   mean.diffs  upper.limit  
-0.066420801 -0.003062638  0.060295526  
 
$CI.lines 
lower.limit.ci.lower lower.limit.ci.upper   mean.diff.ci.lower   mean.diff.ci
.upper upper.limit.ci.lower  
         -0.10647333          -0.02636828          -0.02618697           0.02
006170           0.02024300  
upper.limit.ci.upper  
          0.10034805  
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$critical.diff 
[1] 0.06335816 
 
 
 
 
 
 
 
 C. – Bland Altman Analysis for Predicted vs. Observed PRx for Top Two LME Models 
*Grand mean Fisher transformed data utilized for Bland-Altman analysis 
 
1. PRx ~ Sx_a (with random effects introduced into intercept and coefficient) 
 
$lower.limit 
[1] -0.2826737 
 
$mean.diffs 
[1] -0.05195699 
 
$upper.limit 
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[1] 0.1787597 
 
$lines 
lower.limit  mean.diffs upper.limit  
-0.28267367 -0.05195699  0.17875969  
 
$CI.lines 
lower.limit.ci.lower lower.limit.ci.upper   mean.diff.ci.lower   mean.diff.ci
.upper upper.limit.ci.lower  
         -0.42852364          -0.13682371          -0.13616351           0.03
224952           0.03290972  
upper.limit.ci.upper  
          0.32460965  
 
 
$critical.diff 
[1] 0.2307167 
 
 
 
2. PRx ~ Sx_a + Mx_a (with random effects introduced into intercept and coefficient) 
 
$lower.limit 
[1] -0.2932762 
 
$mean.diffs 
[1] -0.04899657 
 
$upper.limit 
[1] 0.195283 
 
319 
 
 
$lines 
lower.limit  mean.diffs upper.limit  
-0.29327618 -0.04899657  0.19528303  
 
$CI.lines 
lower.limit.ci.lower lower.limit.ci.upper   mean.diff.ci.lower   mean.diff.ci
.upper upper.limit.ci.lower  
         -0.44770008          -0.13885227          -0.13815326           0.04
016011           0.04085912  
upper.limit.ci.upper  
          0.34970694  
 
 
$critical.diff 
[1] 0.2442796 
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Appendix F: Section 8.1 - Sequential Chi-Square Threshold Analysis – 24hr, 72hr, 
5d, 7d and 10d Recording Periods 
 
1. 1st 24hr of Recording 
PRx 
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PAx 
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RAC 
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2. 1st 72hr of Recording 
PRx 
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PAx 
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RAC 
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3. 1st 5d of Recording 
PRx 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
327 
 
PAx 
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RAC 
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4. 1st 7d of Recording 
PRx 
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PAx 
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RAC 
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5. 1st 10d of Recording 
PRx 
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PAx 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
334 
 
RAC 
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Appendix G: Chapter 9 - Injury and Lesion Data, Patient Numbers – Grand Mean Data 
 
Patient Demographics and Injury Characteristics 
Variable\Statistic 
Sum of 
weights Categories 
Frequency per 
category 
Gender 358 F 86.00 
  M 272.00 
Side of Shift (L = R to L; R = L to R) 358 L 40.00 
  NA 259.00 
  R 59.00 
Basal Cisterns (Normal = 0/Compressed = 1/Absent = 2) 358 0 218.00 
  1 81.00 
  2 59.00 
Lateral Ventricles (Normal = 0/mild compression = 
1/compressed-absent = 2) 358 0 165.00 
  1 127.00 
  2 66.00 
4th Ventricle (Normal = 0/mild compression = 1/compressed-
absent = 2) 358 0 329.00 
  1 21.00 
  2 8.00 
4th Vent Shift (mm) 358 0 358.00 
Direction of 4th Shift (L = R to L; R = L to R) 358 NA 358.00 
Convexity Gyri (Normal = 0/mild compression = 
1/compressed-absent = 2) 358 0 89.00 
  1 149.00 
  2 120.00 
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Tonsillor Descent (N = 0/Y = 1) 358 0 342.00 
  1 15.00 
  2 1.00 
Largest Lesion Type 358 0 4.00 
  Contusion 67.00 
  DAI 76.00 
  EDH 25.00 
  
Falcine 
SDH 1.00 
  NA 82.00 
  
Post Fossa 
EDH 2.00 
  SDH 101.00 
Lesion <25 mL (N = 0/Y = 1) 358 0 142.00 
  1 216.00 
Lesion >25 mL (N = 0/Y = 1) 358 0 301.00 
  1 57.00 
Evacuated Lesion (Y/N) 358 N 313.00 
  Y 45.00 
Non-Evacuated Mass (>25 mL) (N = 0/Y = 1) 358 0 337.00 
  1 20.00 
  NA 1.00 
DC (y/n) 358 N 358.00 
Convexity Subdural hematoma (Present = 1, Absent = 0) 358 0 235.00 
  1 123.00 
SDH Side (L or R) 358 L 66.00 
  NA 250.00 
  R 42.00 
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Tentorial SDH (Absent = 0/Present = 1) 358 0 349.00 
  1 9.00 
Falcine SDH (Absent = 0/Present = 1) 358 0 345.00 
  1 13.00 
Bilat SDH (Absent = 0/Present = 1) 358 0 338.0 
  1 20.00 
Epidural Mass Lesion (Present = 1/Absent = 0) 358 0 332.00 
  1 26.00 
EDH Side (L or R) 358 L 9.00 
  NA 334.00 
  R 15.00 
Bilat EDH (Absent = 0/Present = 1) 358 0 356.00 
  1 2.00 
ICH-contusion (Present = 1/ Absent = 0) 358 0 263.00 
  1 95.00 
ICH-contusion Side (L or R) 358 L 29.00 
  NA 297.00 
  R 32.00 
Bilat ICH-contusion (Absent = 0/Present = 1) 358 0 323.00 
  1 34.00 
  2 1.00 
IVH (Absent = 0/Present = 1) 358 0 271.00 
  1 87.00 
tSAH-conv (Extensive bilat (>90% convexity) = 2/visible in gyri 
= 1/ Absent = 0) 358 0 85.00 
  1 259.00 
  2 14.00 
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tSAH-conv thickness (>5mm = 2/1-5mm = 1/no blood = 0; 
*Note: visible blood is at least 1mm) 358 0 84.00 
  1 218.00 
  2 56.00 
tSAH-cist (Filled cisterns = 2/visible blood = 1/Absent = 0) 358 0 255.00 
  1 95.00 
  2 8.00 
DAI-SC (Present = 1/Absent = 0) 358 0 276.00 
  1 82.00 
DAI-CC (Present = 1/Absent = 0) 358 0 337.00 
  1 21.00 
DAI-BG (Present =1/Absent = 0) 358 0 335.00 
  1 23.00 
DAI-BS (Present = 1/Absent = 0) 358 0 346.00 
  1 12.00 
Post Fossa EDH (Present = 1/Absent = 0) 358 0 355.00 
  1 3.00 
Post Fossa SDH (Present = 1/Absent = 0) 358 0 358.00 
Post Fossa ICH-contusion (Present = 1/Absent = 0) 358 0 354.00 
  1 4.00 
BG = basal ganglia, Bilat = bilateral, BS = brain stem, CC = corpus callosum, cist = cistern, DAI = diffuse axonal injury, DC = decompressive craniectomy, EDH = epidural hematoma, 
F = female, ICH = intra-cerebral hemorrhage, IVH = intra-ventricular hemorrhage, L = left, M = male, mm = millimeter, mL = milliliters, N = No, NA = not applicable, R = right, SC = 
sub-cortical, SDH = subdural hematoma, tSAH = traumatic subarachnoid hemorrhage, Y = yes. 
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Appendix H – Chapter 9: IC Scoring Systems and Mean Index/%Time Above Threshold Results 
 
Intra-Cranial Ordinal CT Scoring Systems – KW and JT Testing 
 Marshall CT Grade p-
value 
Rotterdam CT Score p-
value 
I II III IV V VI 1 2 3 4 5 6  
Mean 
PRx 
NA 0.028 
(+/-
0.165) 
0.058 
(+/-
0.176) 
0.088 
(+/- 
0.256) 
0.085 
(+/-
0.143) 
0.053 
(+/-
0.225) 
0.096 0.043 
(+/-
0.167) 
0.031 
(+/-
0.163) 
0.041 
(+/-
0.154) 
0.058 
(+/-
0.210) 
0.164 
(+/-
0.214) 
-0.055 
(+/-
0.076) 
0.001 
Mean 
PAx 
NA -0.078 
(+/-
0.196) 
-0.046 
(+/-
0.169) 
0.003 
(+/-
0.260) 
-0.028 
(+/-
0.195) 
-0.015 
(+/-
0.233) 
0.354 -0.81 
(+/-
0.208) 
-0.071 
(+/-
0.192) 
-0.050 
(+/-
0.165) 
-0.028 
(+/-
0.228) 
0.016 
(+/-
0.208) 
-0.105 
(+/-
0.225) 
0.001 
Mean 
RAC 
NA -0.383 
(+/-
0.251) 
-0.337 
(+/-
0.224) 
-0.275 
(+/-
0.310) 
-0.281 
(+/-
0.259) 
-0.316 
(+/-
0.315) 
0.054 -0.354 
(+/-
0.288) 
-0.385 
(+/-
0.237) 
-0.363 
(+/-
0.230) 
-0.267 
(+/-
0.265) 
-0.224 
(+/-
0.289) 
-0.394 
(+/-
0.348) 
0.001 
% Time 
Above 
PRx of 
0 
NA 49.7 
+/-16.8 
52.6 
+/- 
17.1 
54.8 
+/- 
20.2 
57.8 
+/- 
15.1 
52.2 
+/- 
17.6 
0.037 51.7 
+/- 
18.0 
50.4 
+/- 
16.6 
51.8 
+/- 
16.2 
52.3 
+/- 
17.2 
62.6 
+/- 
17.5 
39.9 
+/-7.8 
0.074 
% Time 
Above 
PRx of 
+0.25 
NA 28.9 
+/- 
15.5 
32.6 
+/- 
17.4 
34.2 
+/- 
22.3 
34.5 
+/- 
15.6 
31.5 
+/- 
18.8 
0.076 30.0 
+/- 
15.7 
29.6 
+/- 
15.4 
30.3 
+/- 
15.7 
32.3 
+/- 
18.9 
41.6 
+/- 
20.9 
21.5 
+/- 7.1 
0.052 
% Time 
Above 
PRx of 
+0.35 
NA 22.3 
+/- 
14.4 
26.1 
+/- 
16.5 
27.8 
+/- 
22.4 
26.3 
+/- 
14.4 
24.8 
+/- 
18.9 
0.130 23.2 +-
/- 14.8 
22.8 
+/- 
14.2 
22.5 
+/- 
14.3 
26.0 
+/- 
19.0 
34.0 
+/- 
21.1 
16.4 
+/- 5.8 
0.04 
% Time 
Above 
PAx of 
0 
NA 40.4 
+/- 
19.6 
43.8 
+/- 
17.3 
49.1 
+/- 
26.6 
45.9 
+/- 
19.4 
44.8 
+/- 
19.0 
0.268 39.8 
+/- 
21.2 
41.3 
+/- 
19.1 
43.0 
+/- 
17.3 
45.4 
+/- 
21.1 
50.4 
+/- 
21.3 
36.4 
+/- 
22.3 
0.022 
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% Time 
Above 
PAx of 
+0.25 
NA 21.0 
+/- 
15.9 
23.2 
+/- 
14.2 
28.3 
+/- 
23.3 
24.5 
+/- 
19.0 
24.45 
+/- 
20.4 
0.310 20/8 
+/- 
15.4 
21.5 
+/- 
15.7 
22.1 
+/- 
15.0 
25.0 
+/- 
19.1 
29.0 
+/- 
19.6 
18.6 
+/- 
19.2 
0.016 
% Time 
Above 
RAC of  
-0.05 
NA 22.0 
+/- 
19.3 
25.4 
+/- 
17.8 
28.8 
+/- 
26.8 
28.6 
+/- 
22.6 
26.2 
+/- 
22.4 
0.119 24.7 
+/- 
22.1 
21.7 
+/- 
18.3 
23.0 
+/- 
18.8 
30.1 
+/- 
20.8 
33.8 
+/- 
25.1 
21.9 
+/- 
26.2 
0.005 
% Time 
Above 
PRx of   
-0.10 
NA 24.6 
+/- 
20.4 
28.3 
+/- 
19.0 
31.4 
+/- 
27.2 
23.2 
+/- 
23.2 
29.1 
+/- 
23.0 
0.117 27.5 
+/- 
23.2 
24.3 
+/- 
19.2 
25.8 
+/- 
19.9 
33.2 
+/- 
21.6 
37.0 
+/- 
25.8 
23.9 
+/- 
27.7 
0.013 
 Helsinki CT Score p-
value 
Stockholm CT Score – “Range” p-
value 
-3 to +14 0 – 1 1.1 – 2 2.1 – 3 3.1 – 4 4.1 – 5 5.1 - 6  
Mean 
PRx 
 
 
 
*Please refer to figure for box plot of PRx, PAx and 
RAC across each category of the Helsinki Score. 
0.001 0.034 
(+/-
0.152) 
0.024 
(+/-
0.165) 
0.065 
(+/-
0.194) 
0.058 
(+/-
0.183) 
0.032 
(+/-
0.097) 
0.301 0.173 
Mean 
PAx 
0.001 -0.082 
(+/-
0.186) 
-0.076 
(+/-
0.185) 
-0.026 
(+/-
0.203) 
-0.031 
(+/-
0.220) 
-0.080 
(+/-
0.119) 
0.268  0.057 
Mean 
RAC 
0.001 -0.356 
(+/-
0.249) 
-0.389 
(+/-
0.234) 
-0.314 
(+/-
0.264) 
-0.291 
(+/-
0.290) 
-0.435 
(+/-
0.135) 
0.194 0.018 
% Time 
Above 
PRx of 
0 
0.002 51.0 
+/- 
16.7 
50.7 
+/- 
17.3 
53.1 
+/- 
16.5 
53.2 
+/- 
17.9 
51.5 
+/- 
10.7 
82.6 0.124 
% Time 
Above 
PRx of 
+0.25 
0.001 29.4 
+/- 
14.1 
29.9 
+/- 
16.1 
32.2 
+/- 
18.2 
32.5 
+/- 
17.4 
28.0 
+/- 9.5 
62.0 0.104 
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% Time 
Above 
PRx of 
+0.35 
0.001 22.7 
+/- 
12.8 
23.2 
+/- 
14.7 
25.5 
+/- 
18.0 
25.8 
+/- 
16.3 
20.5 
+/- 7.9 
50.5 0.134 
% Time 
Above 
PAx of 
0 
0.001 40.1 
+/- 
19.4 
40.7 
+/- 
18.9 
45.2 
+/- 
19.1 
45.3 
+/- 
21.3 
40.4 
+/- 
11.6 
80.1 0.038 
% Time 
Above 
PAx of 
+0.25 
0.001 20.6 
+/- 
14.3 
21.0 
+/- 
15.3 
24.4 
+/- 
18.0 
25.3 
+/- 
20.0 
18.9 
+/- 9.2 
56.3 0.040 
% Time 
Above 
RAC of  
-0.05 
0.001 23.4 
+/- 
19.6 
21.5 
+/- 
18.0 
26.3 
+/- 
20.9 
30.0 
+/- 
23.5 
15.8 
+/- 
12.7 
76.2 0.020 
% Time 
Above 
PRx of   
-0.10 
0.001 26.6 
+/- 
20.8 
24.1 
+/- 
19.1 
29.1 
+/- 
21.6 
32.9 
+/- 
24.5 
18.0 
+/- 
13.3 
80.4 0.029 
KW = Kruskal-Wallis Test for variance, JT = Jonckheere-Terpstra test for ordinal variance, NA = not available, CT = computed tomography, PRx = pressure reactivity index 
(correlation between ICP and MAP), PAx = pulse amplitude index (correlation between pulse amplitude of ICP (AMP) and MAP), RAC = correlation between AMP and CPP.  *NOTE: 
bolded values are those which have reached statistical significance (p<0.05). The mean values for PRx, PAx, RAC and % time above threshold were tested across the Marshall CT 
grades with the KW test.  The mean values for PRx, PAx, RAC and % time above threshold were tested across the ordinal Rotterdam, Helsinki and Stockholm scores using the JT 
test. 
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Appendix I – Chapter 9: Mann U testing for Thresholds of PRx and PAx 
Mann U Testing For Continuous Variables Across Index Thresholds – PRx Thresholds of 0, +0.25, and +0.35 
Demo 
(Mean and 
Medians 
with Std 
Dev/IQR) 
PRx p-value PRx p-value PRx p-value 
<0 ≥0 <0.25 ≥0.25 <0.35 ≥0.35 
N 153 205 - 324 34 - 340 18 - 
Age 37.1 (17.4) 43.2 (16.5) <0.0001 39.8 (16.9) 48.2 (18.1) 0.009 40.1 (17.0) 49.6 (18.7) 0.029 
GCS 7 (4-9) 7 (3-10) 0.674 7 (4-9) 5.5 (3-9) 0.434 7 (4-95) 3.5 (3-8) 0.088 
Marshall 2 (2-3) 3 (2-4) 0.002 2 (2-3) 3 (2-3.75) 0.532 2 (2-3) 3 (2-4) 0.113 
Rotterdam 2 (2-3) 2 (2-3) 0.097 2 (2-3) 2.5 (2-4) 0.222 2 (2-3) 3 (2-4) 0.041 
Helsinki 2 (0-4) 3 (1-5) 0.001 3 (0-5) 4 (2-5) 0.047 3 (0-5) 4 (3.25-5) 0.008 
Stockholm 1.993 
(0.849) 
2.166 
(0.927) 
0.114 2.084 
(0.893) 
2.169 
(0.955) 
0.834 2.072 
(0.901) 
2.479 
(0.759) 
0.034 
Stockholm 
Range 
2 (2-3) 2 (2-3) 0.072 2 (2-3) 2 (2-3) 0.612 2 (2-3) 3 (2-3) 0.033 
ISS 32.732 
(11.342) 
33.175 
(11.379) 
0.614 32.451 
(11.084) 
37.333 
(12.866) 
0.100 32.800 
(11.346) 
35.467 
(11.351) 
0.522 
APACHE II 12.272 
(5.722) 
11.773 
(5.382) 
0.362 11.849 
(5.495) 
14.029 
(6.028) 
0.030 11.838 
(5.467) 
16.167 
(6.167) 
0.004 
MLS (mm) 1.4 (3.2) 2.1 (3.9) 0.044 1.7 (3.6) 2.4 (4.2) 0.391 1.7 (3.6) 3.1 (4.8) 0.165 
Largest 
Lesion 
Volume 
9.5 (19.3) 15.8 (26.0) 0.004 13.1 (24.3) 13.1 (15.4) 0.412 13.1 (24.0) 13.9 (14.8) 0.246 
# 
Contusions 
0.31 (0.73) 0.53 (0.92) 0.008 0.43 (0.84) 0.56 (0.93) 0.362 0.44 (0.85) 0.50 (0.92) 0.816 
# DAI 
Lesions 
1.5 (2.6) 0.74 (2.7) <0.0001 0.35 (1.2) 1.1 (2.8) 0.018 1.1 (2.8) 0.44 (1.3) 0.149 
Total 
Contusion 
Volume 
4.3 (14.0) 7.2 (18.0) 0.003 6.1 (17.0) 4.5 (9.7) 0.741 6.1 (16.8) 3.3 (7.2) 0.847 
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# = number, DAI = diffuse axonal injury, GCS = Glasgow Coma Scale, IQR = inter-quartile range, ISS = injury severity score, mm = millimeters, N = number of patients, Std Dev = 
standard deviation. *Bolded values are those reaching a p<0.05. 
 
 
Mann U Testing For Continuous Variables Across Index Thresholds – PAx Thresholds of 0, and +0.25 
Demo (Mean 
and Medians 
with Std 
Dev/IQR) 
PAx p-value PAx p-value 
<0 ≥0 <0.25 ≥0.25  
N 239 119 - 338 20 - 
Mean Age  36.3 (16.7) 49.2 (14.9) <0.0001 40.0 (16.6) 58.0 (17.3) <0.0001 
Median GCS  6 (3-9) 7 (4-10) 0.120 7 (3-9) 6.5 (3-9.25) 0.855 
Marshall 2 (2-3) 3(2-3) 0.173 2 (2-3) 3 (2-5) 0.035 
Rotterdam 2 (2-3) 2(2-3) 0.077 2 (2-3) 3 (2-4) 0.081 
Helsinki 2 (0-4) 4 (1.5-6) 0.001 3 (0-5) 4 (2.75-7) 0.010 
Stockholm 2.0 (0.90) 2.2 (0.89) 0.169 2.1 
(0.89) 
2.5 (1.0) 0.041 
Stockholm 
Range 
2 (2-3) 2 (2-3) 0.341 2 (2-3) 3 (2-4) 0.010 
ISS 33.3 (11.2) 32.1 (11.7) 0.274 32.8 (11.5) 34.6 (9.2) 0.479 
APACHE II 11.2 (5.6) 13.8 (5.0) <0.0001 11.8 (5.4) 16.3 (6.3) 0.004 
MLS (mm) 1.6 (3.4) 2.1 (4.1) 0.310 1.6 (3.5) 4.0 (4.7) 0.002 
Largest Lesion 
Volume 
11.6 (22.6) 16.2 (25.2) 0.001 12.8 (23.9) 19.1 (16.7 0.007 
# Contusions 0.32 (0.75) 0.68 (0.98) <0.0001 0.43 (0.85) 0.60 (0.94) 0.334 
# DAI Lesions 1.4 (3.1) 0.46 (1.5) <0.0001 1.1 (2.8) 0.15 (0.67) 0.026 
Total Contusion 
Volume 
4.8 (14.7) 8.4 (19.3) <0.0001 6.0 (16.7) 5.2 (11.0) 0.606 
# = number, DAI = diffuse axonal injury, GCS = Glasgow Coma Scale, IQR = inter-quartile range, ISS = injury severity score, mm = millimeters, N = number of patients, Std Dev = 
standard deviation. *Bolded values are those reaching a p<0.05. 
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Appendix J – Chapter 9: Univariate Logistic Regression for CT Injury Characteristics and ICP Indices – Grand 
Mean Data 
 
Univariate Logistic Regression Analysis for Injury Characteristics and ICP Indices – Grand Mean Data 
 PRx >0 PRx >0.25 PRx >0.35 PAx >0 PAx >0.25 RAC >-0.05 RAC>-0.10 
 AUC P AUC P AUC P AUC P AUC P AUC P AUC P 
MLS 0.533 0.084 0.590 0.270 0.629 0.113 0.561 0.204 0.703 0.009 0.590 0.018 0.533 0.072 
Largest 
Lesion 
Volume 
0.590 0.015 0.549 0.001 0.586 0.022 0.607 0.088 0.675 0.251 0.590 0.106 0.568 0.192 
# of 
Contusions 
0.565 0.019 0.588 0.388 0.578 0.753 0.643 0.001 0.613 0.385 0.518 0.955 0.546 0.448 
# of DAI 
Lesions 
0.614 0.017 0.659 0.095 0.667 0.302 0.648 0.003 0.706 0.125 0.618 0.132 0.602 0.050 
Total 
Contusion 
Volume 
0.578 0.114 0.531 0.590 0.568 0.493 0.640 0.058 0.526 0.829 0.513 0.401 0.533 0.958 
Basal Cistern 
Compression 
Grade 
0.557 0.053 0.619 0.111 0.683 0.101 0.591 0.057 0.663 0.159 0.576 0.252 0.560 0.241 
Basal Cistern 
Compression 
– Any 
0.555 0.018 0.610 0.174 0.679 0.057 0.598 0.017 0.678 0.055 0.576 0.213 0.561 0.130 
Basal Cistern 
Compression 
– Severe 
0.512 0.076 0.635 0.037 0.673 0.056 0.558 0.186 0.626 0.296 0.579 0.108 0.536 0.142 
Lat Ventricle 
Compression 
Grade 
0.538 0.183 0.636 0.074 0.624 0.263 0.570 0.263 0.643 0.155 0.592 0.243 0.556 0.415 
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Lat Ventricle 
Compression 
– Any 
0.532 0.165 0.559 0.808 0.602 0.531 0.576 0.124 0.605 0.575 0.553 0.579 0.525 0.729 
Lat Ventricle 
Compression 
- Severe 
0.508 0.089 0.637 0.032 0.651 0.103 0.563 0.241 0.662 0.057 0.575 0.234 0.534 0.317 
4th Ventricle 
Compression 
Grade 
0.495 0.387 0.629 0.249 0.656 0.118 0.570 0.194 0.644 0.571 0.586 0.471 0.543 0.641 
4th Ventricle 
Compression 
– Any 
0.496 0.188 0.606 0.414 0.655 0.185 0.551 0.577 0.622 0.749 0.562 0.797 0.529 0.775 
4th Ventricle 
Compression 
– Severe 
0.480 0.762 0.612 0.691 0.621 0.972 0.570 0.238 0.654 0.973 0.572 0.560 0.353 0.446 
Gyri 
Compression 
Grade 
0.545 0.166 0.653 0.042 0.662 0.214 0.567 0.327 0.623 0.476 0.615 0.109 0.592 0.121 
Gyri 
Compression 
– Any 
0.507 0.627 0.620 0.143 0.606 0.769 0.570 0.353 0.596 0.988 0.604 0.133 0.582 0.090 
Gyri 
Compression 
– Severe 
0.529 0.062 0.608 0.172 0.650 0.136 0.572 0.147 0.628 0.267 0.555 0.444 0.516 0.705 
Tonsillar 
Descent   
0.507 0.113 0.597 0.887 0.624 0.318 0.551 0.981 0.632 0.648 0.557 0.874 0.522 0.971 
Lesion >25 
mL 
0.547 0.003 0.588 0.773 0.614 0.929 0.559 0.529 0.690 0.085 0.552 0.662 0.522 0.409 
Evacuated 
Mass – Any 
Size 
0.528 0.010 0.593 0.693 0.623 0.592 0.558 0.746 0.689 0.094 0.566 0.477 0.524 0.674 
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Non-
Evacuated 
Mass >25 mL 
0.507 0.242 0.617 0.299 0.648 0.562 0.565 0.509 0.614 0.906 0.539 0.749 0.493 0.935 
Convexity 
SDH 
0.538 0.032 0.641 0.019 0.706 0.006 0.631 <0.0001 0.774 0.001 0.633 0.003 0.585 0.008 
Tentorial 
SDH 
0.511 0.088 0.590 0.867 0.638 0.970 0.586 0.164 0.642 0.476 0.589 0.068 0.541 0.155 
Falcine SDH 0.510 0.061 0.639 0.015 0.696 0.008 0.592 0.010 0.748 0.001 0.591 0.239 0.544 0.457 
Bilateral 
Convexity 
SDH 
0.518 0.008 0.631 0.003 0.689 0.001 0.586 0.013 0.708 <0.0001 0.569 0.084 0.531 0.077 
Supra-
tentorial 
EDH 
0.498 0.438 0.608 0.745 0.648 0.775 0.585 0.258 0.677 0.397 0.579 0.619 0.532 0.970 
Bilateral 
Supra-
tentorial 
EDH 
0.491 0.485 0.598 0.743 0.632 0.497 0.570 0.627 0.641 0.534 0.557 0.858 0.519 0.975 
Contusion – 
Any 
0.559 0.011 0.588 0.421 0.579 0.903 0.639 0.001 0.618 0.381 0.552 0.630 0.551 0.175 
Bilateral 
Contusions 
0.527 0.015 0.624 0.112 0.632 0.320 0.613 0.001 0.651 0.124 0.550 0.361 0.523 0.220 
IVH 0.529 0.298 0.572 0.596 0.589 0.833 0.552 0.983 0.614 0.645 0.595 0.217 0.575 0.139 
tSAH 
Convexity 
Grade 
0.516 0.406 0.574 0.846 0.639 0.755 0.583 0.026 0.638 0.640 0.548 0.580 0.540 0.476 
tSAH 
Convexity – 
Any 
0.514 0.357 0.566 0.650 0.612 0.473 0.578 0.031 0.640 0.351 0.542 0.866 0.537 0.262 
tSAH 
Convexity - 
>90% 
0.491 0.282 0.606 0.760 0.658 0.742 0.571 0.062 0.643 0.797 0.566 0.297 0.525 0.546 
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tSAH 
Convexity 
Thickness 
Grade 
0.542 0.016 0.595 0.200 0.662 0.032 0.609 0.001 0.679 0.015 0.547 0.643 0.542 0.454 
tSAH 
Convexity 
Thickness - 
>5mm 
0.521 0.004 0.633 0.073 0.698 0.009 0.598 0.001 0.700 0.004 0.558 0.350 0.529 0.371 
tSAH 
Cisterns 
Grade 
0.542 0.074 0.607 0.285 0.639 0.072 0.590 0.137 0.617 0.642 0.577 0.104 0.557 0.045 
tSAH 
Cisterns – 
Any 
0.540 0.034 0.578 0.756 0.637 0.335 0.591 0.055 0.619 0.528 0.576 0.237 0.553 0.213 
tSAH 
Cisterns – 
Severe 
0.496 0.095 0.601 0.153 0.639 0.023 0.562 0.318 0.638 0.405 0.562 0.044 0.535 0.016 
DAI – SC 0.585 <0.0001 0.647 0.052 0.658 0.236 0.631 0.001 0.695 0.083 0.615 0.027 0.592 0.010 
DAI – CC 0.518 0.028 0.624 0.282 0.654 0.476 0.602 0.032 0.663 0.491 0.587 0.203 0.553 0.143 
DAI – BG 0.512 0.029 0.604 0.398 0.624 0.878 0.585 0.045 0.658 0.450 0.565 0.590 0.533 0.352 
DAI – BS 0.504 0.101 0.619 0.502 0.650 0.822 0.578 0.231 0.659 0.767 0.578 0.388 0.541 0.294 
Post-Fossa 
EDH 
0.484 0.743 0.597 0.871 0.631 0.587 0.561 0.997 0.641 0.630 0.566 1.000 0.528 0.874 
Post-Fossa 
Contusion 
0.495 0.769 0.592 0.985 0.626 0.676 0.568 0.483 0.636 0.724 0.564 0.879 0.526 0.750 
AUC = area under the receiver operative curve, BG = basal ganglia, BS = basal cistern, CC = corpus callosum, DAI = diffuse axonal injury, EDH = 
epidural hematoma, IVH = intra-ventricular hemorrhage, Lat = lateral, mL = milliliter, MLS = midline shift, mm = millimeters, p = p-value, PRx = 
pressure reactivity index (correlation between ICP and MAP), PAx = pulse amplitude index (correlation between pulse amplitude of ICP (AMP) 
and MAP), RAC = correlation between AMP and CPP, SC = sub-cortical, SDH = subdural hematoma, tSAH = traumatic subarachnoid hemorrhage, . 
*NOTE: bolded values are those which have reached statistical significance (p<0.05). 
 
